Original Article
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
N Engl J Med 2005; 352:225-237January 20, 2005
- Abstract
Background
Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has been proposed to improve the prognosis in such patients.
Methods
We randomly assigned 2521 patients with New York Heart Association (NYHA) class II or III CHF and a left ventricular ejection fraction (LVEF) of 35 percent or less to conventional therapy for CHF plus placebo (847 patients), conventional therapy plus amiodarone (845 patients), or conventional therapy plus a conservatively programmed, shock-only, single-lead ICD (829 patients). Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause.
Results
The median LVEF in patients was 25 percent; 70 percent were in NYHA class II, and 30 percent were in class III CHF. The cause of CHF was ischemic in 52 percent and nonischemic in 48 percent. The median follow-up was 45.5 months. There were 244 deaths (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death of 23 percent (0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007) and an absolute decrease in mortality of 7.2 percentage points after five years in the overall population. Results did not vary according to either ischemic or nonischemic causes of CHF, but they did vary according to the NYHA class.
Conclusions
In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.
Media in This Article
Figure 1
Kaplan–Meier Estimates of Death from Any Cause.Figure 2
Kaplan–Meier Estimates of Death from Any Cause for the Prespecified Subgroups of Ischemic CHF (Panel A) and Nonischemic CHF (Panel B).Article Activity
- Article
Patients with congestive heart failure (CHF) can die suddenly and unpredictably from arrhythmia despite the use of proven medical therapies, such as beta-blockade. Two approaches have been developed specifically to prevent sudden death among patients with CHF: therapy with amiodarone and therapy with an implantable cardioverter–defibrillator (ICD). Despite findings in earlier clinical trials, the ability of amiodarone to reduce the risk of death among patients with CHF remains uncertain.1,2 The ability of an ICD to limit mortality in patients with CHF without prior cardiac arrest has been evaluated in small trials focused on patients with nonischemic cardiomyopathy3,4 and also remains unproven. Most of the mortality data on amiodarone and ICD therapy have been obtained in clinical trials performed after myocardial infarction in patients without CHF or those with ventricular arrhythmias.5-10 Such data have not been judged sufficiently relevant to guide therapy for patients who do not meet these criteria.
The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)11 was designed to evaluate the hypothesis that amiodarone or a conservatively programmed shock-only, single-lead ICD would decrease the risk of death from any cause in a broad population of patients with mild-to-moderate heart failure.
Methods
Study Design
From September 16, 1997, to July 18, 2001, we randomly assigned 2521 patients in equal proportions to receive placebo, amiodarone (Cordarone, Wyeth–Ayerst Pharmaceuticals), or a single-chamber ICD programmed to shock-only mode (model 7223, Medtronic). All patients were followed until October 31, 2003. Patients had to be at least 18 years of age and have New York Heart Association (NYHA) class II or III chronic, stable CHF due to ischemic or nonischemic causes and a left ventricular ejection fraction (LVEF) of no more than 35 percent. Ischemic CHF was defined as left ventricular systolic dysfunction associated with at least 75 percent narrowing of at least one of the three major coronary arteries (marked stenosis) or a documented history of a myocardial infarction. Nonischemic CHF was defined as left ventricular systolic dysfunction without marked stenosis.
The primary end point of the trial was death from any cause. The study was approved by the human-subjects' committee of each participating institution. Sponsorship and oversight of the trial were by the National Heart, Lung, and Blood Institute (NHLBI). The trial was funded after peer review. An NHLBI-appointed data-monitoring and safety-monitoring board oversaw the conduct of the trial. Every patient provided written informed consent. A detailed review of SCD-HeFT methods has been published previously.11 Study drugs and ICDs were provided free of charge by the manufacturers (Wyeth–Ayerst and Medtronic, respectively). Additional clinical and research funding was also provided by these companies. Neither company had any role in the design, analysis, or interpretation of the study.
Baseline Assessments and Background Medical Therapies
Before randomization, all patients underwent electrocardiography, a 6-minute walk test, 24-hour ambulatory electrocardiography, liver- and thyroid-function studies, and chest radiography. All patients were required, if such treatment was clinically reasonable, to receive treatment with a beta-blocker and an angiotensin-converting–enzyme inhibitor, as well as aldosterone, aspirin, and statins, when appropriate.
Study Drug
Placebo and amiodarone were administered in a double-blind fashion with the use of identical-appearing 200-mg tablets produced by Wyeth–Ayerst Pharmaceuticals. The dose was based partly on weight. After a loading dose of 800 mg daily was given for one week and 400 mg daily for three weeks, patients weighing more than 200 lb (90.9 kg) received 400 mg daily, patients weighing 150 to 200 lb (68.2 to 90.9 kg) received 300 mg daily, and patients weighing less than 150 lb (68.2 kg) received 200 mg daily. Physicians could lower the loading or maintenance dose if a patient had bradycardia.
ICD Therapy
ICD therapy was intentionally selected to consist of shock-only, single-lead therapy. The goal was to treat only rapid, sustained ventricular tachycardia or ventricular fibrillation. No dual-chamber or biventricular devices were permitted. The ICD was uniformly programmed to have a detection rate of 187 beats per minute or more. To minimize excessively rapid intervention in the event of nonsustained ventricular tachycardia, antitachycardia pacing therapies were not permitted, given the unknown frequency of sustained ventricular tachycardia or fibrillation in the population at the time. Because of the potential for the acceleration of ventricular tachycardia and the resulting increased sensitivity to transient ventricular tachycardia, the use of antitachycardia pacing was considered to pose more risk than benefit. Because of the potential for antibradycardia pacing to worsen CHF, it was initiated only if the intrinsic rate decreased to less than 34 beats per minute, the lowest trigger limit possible in the ICD model (Medtronic model 7223) used. No rate-responsive pacing was allowed.
Initiation of Therapy and Follow-up
Patients assigned to amiodarone or matching placebo began therapy as outpatients immediately after randomization. Patients assigned to ICD therapy received their device a median of three days after randomization (interquartile range, two to five). Outpatient implantation of the device was encouraged. ICD testing could not exceed two inductions of ventricular fibrillation. If an initial 20-J shock terminated induced ventricular fibrillation (as occurred 84 percent of the time), a 10-J shock was tested and no further inductions were recommended. If the 20-J shock was unsuccessful, a 30-J shock was administered at the next induction. If both 20-J and 30-J shocks were unsuccessful, no further testing or lead configurations were recommended. The device was to be inserted without further delay given the risk associated with a prolonged procedure, the low likelihood of improving defibrillation thresholds, and the lack of a clear relation between the results of tests at implantation and long-term efficacy. Patients were followed every three months with alternating clinic visits and telephone calls. Data from the ICD memory log were regularly downloaded at these visits. Some patients may have had ICD discharges that were either not recorded or not reported to the ICD core laboratory, thus limiting our ability to know the true rate of ICD events.
Statistical Analysis
The study was based on the assumption that the placebo group would have an annual mortality rate of 10 percent. The study was powered at 90 percent to detect a 25 percent reduction in death from any cause by amiodarone or ICD therapy, as compared with placebo, on the basis of an α level for each comparison of 0.025. Permuted-block randomization with stratification according to the clinical site, the cause of CHF (ischemic vs. nonischemic), and NYHA class (II vs. III) was used, with block size randomly chosen to be either three or six.
Pairwise comparisons of amiodarone with placebo and ICD with placebo were performed according to the intention-to-treat principle. All statistical tests were two-tailed. Cumulative mortality rates were calculated according to the Kaplan–Meier method.12 Event (or censoring) times for all patients were measured from the time of randomization (time zero). The significance of differences in mortality rates between treatment groups was assessed with the log-rank test, with adjustment for the NYHA class and the cause of CHF.13 Relative risks were expressed as hazard ratios with associated confidence intervals and were derived from the Cox proportional-hazards model.14 Consistent with the choice of an α value of 0.025 for the two main treatment comparisons, 97.5 percent confidence intervals are reported for the hazard ratios. The Cox model was also used to test the significance of interactions between the NYHA class and treatment and between the cause of CHF and treatment.
Six interim analyses of the data were performed and reviewed by the independent data and safety monitoring board appointed by the NHLBI. Interim treatment comparisons were monitored with the use of two-sided, symmetric O'Brien–Fleming boundaries generated with the Lan–DeMets alpha-spending-function approach to group-sequential testing.15,16 Because of the sequential monitoring, the level of significance required for each major treatment comparison at the completion of the study was 0.023.
Results
Study Population
Among the 2521 patients, 847 were randomly assigned to placebo, 845 to amiodarone, and 829 to ICD therapy. Demographic and clinical data for the three treatment groups are shown in Table 1Table 1
Characteristics of the Patients at Baseline or at the Last Follow-up Visit.. There were no significant differences among the three groups, except in the use of beta-blockers at the time of the last follow-up visit (P<0.001). At baseline, the median LVEF of patients was 25 percent; 70 percent had NYHA class II CHF, and 30 percent had class III CHF. The median follow-up for all surviving patients was 45.5 months. All surviving patients were followed at least two years. The longest follow-up was 72.6 months. Vital status was known for all 2521 patients at the time of the last scheduled follow-up visit.Compliance and Crossovers
The median dose of amiodarone and placebo was 300 mg per day three months after randomization and remained so throughout the study. The noncompliance rate for study-drug therapy, defined as the discontinuation of either placebo or amiodarone for any period, was 27 percent (458 patients). Placebo was discontinued in 189 of 847 patients (22 percent), and amiodarone was discontinued in 269 of 845 patients (32 percent). At the time of the last follow-up visit, the only complications observed in the amiodarone group, as compared with the placebo group, were increased tremor (4 percent; P=0.02) and increased hypothyroidism (6 percent; P<0.001).
A total of 125 patients (7 percent) in the drug groups crossed over to open-label treatment with amiodarone at some point, including 44 in the amiodarone group and 81 in the placebo group. Among the 829 patients in the ICD group, 113 (14 percent) received open-label amiodarone during some part of follow-up.
Of the 829 patients assigned to ICD therapy, 17 (2 percent) declined to undergo implantation and implantation was unsuccessful in 1 (less than 1 percent). An additional 32 patients (4 percent) had their ICD removed during follow-up. Clinically significant ICD complications, defined as clinical events requiring surgical correction, hospitalization, or new and otherwise unanticipated drug therapy, occurred in 5 percent of the patients at the time of implantation and in 9 percent later in the course of the trial. Defibrillation-testing data were reported in 716 patients. None of these patients required more than a 30-J shock for defibrillation, the maximal device output.
Crossover to some form of ICD therapy during follow-up occurred in 188 patients (11 percent) in the drug groups. The median time from randomization to crossover was 26.7 months.
ICD Shocks
Of the 829 patients in the ICD group, 259 (31 percent) were known to have received shocks from their device for any cause, with 177 (68 percent of those shocked, or 21 percent of the ICD group) receiving shocks for rapid ventricular tachycardia or fibrillation. During five years of follow-up, the average annual rate of ICD shocks was 7.5 percent. For appropriate shocks only (i.e., shocks for rapid, sustained ventricular tachycardia or fibrillation), the average annual rate of ICD shocks was 5.1 percent.
Primary Outcome
A total of 666 patients died: 244 (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone therapy was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death (hazard ratio, 0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007). Kaplan–Meier mortality curves are shown in Figure 1Figure 1
Kaplan–Meier Estimates of Death from Any Cause.. The relative risk reduction of ICD therapy as compared with placebo was 23 percent, and the absolute reduction at five years was 7.2 percentage points.Prespecified Subgroups
Mortality curves and hazard ratios for the comparison of placebo with amiodarone and with ICD therapy according to the prespecified subgroups defined by the cause of CHF and NYHA class are shown in Figure 2Figure 2
Kaplan–Meier Estimates of Death from Any Cause for the Prespecified Subgroups of Ischemic CHF (Panel A) and Nonischemic CHF (Panel B). and Figure 3Figure 3
Kaplan–Meier Estimates of Death from Any Cause for the Prespecified Subgroups of NYHA Class II (Panel A) and Class III (Panel B)., respectively. There was no interaction of either amiodarone therapy (P=0.93) or ICD therapy (P=0.68) with the cause of CHF. The interaction between amiodarone and NYHA class was significant (P=0.004). Among patients with NYHA class III CHF, there was a relative 44 percent increase in the risk of death among patients in the amiodarone group, as compared with those in the placebo group (hazard ratio, 1.44; 97.5 percent confidence interval, 1.05 to 1.97). Among patients with NYHA class II CHF, no excess risk of death was associated with amiodarone therapy, as compared with placebo (hazard ratio, 0.85; 97.5 percent confidence interval, 0.65 to 1.11).The interaction between ICD therapy and NYHA class was also significant (P<0.001). Among patients with NYHA class II CHF, there was a 46 percent relative reduction in the risk of death (hazard ratio, 0.54; 97.5 percent confidence interval, 0.40 to 0.74). The absolute reduction in mortality among patients in NYHA class II was 11.9 percent at five years. Patients with NYHA class III CHF had no apparent reduction in the risk of death with ICD therapy, as compared with placebo (hazard ratio, 1.16; 97.5 percent confidence interval, 0.84 to 1.61). Hazard ratios for other subgroups of interest pertinent to the comparison of placebo with amiodarone and with ICD therapy are shown in Figure 4Figure 4
Hazard Ratios for the Comparison of Amiodarone and ICD Therapy with Placebo in Various Subgroups of Interest..Discussion
Our study has two principal findings. First, therapy with a conservatively programmed, shock-only ICD significantly decreased the relative risk of death by 23 percent, resulting in an absolute reduction of 7.2 percentage points at five years among patients with CHF who received state-of-the-art background medical therapy, and the benefit did not vary according to the cause of CHF. Second, amiodarone had no beneficial effect on survival, despite the use of appropriate dosage and reasonable compliance rates over longer periods than in other placebo-controlled trials.1,9,10
Our findings raise the standard of care for many patients with CHF by substantiating evidence from earlier trials in favor of ICD therapy in patients with ischemic CHF and by providing evidence of a survival benefit associated with such therapy in patients with nonischemic CHF. ICD therapy had a significant benefit in patients in NYHA class II but not in those in NYHA class III CHF. In contrast, amiodarone therapy had no benefit in patients in NYHA class II and decreased survival among patients in NYHA class III CHF, as compared with those who received placebo.
Subgroup effects, however, are considered most credible if they are prespecified, have a significant interaction with treatment, and are considered biologically plausible. The NYHA subgroups were prespecified, and the results of the interaction tests were significant. Moreover, the results of the six-minute walk test (Figure 4) support the findings with respect to NYHA class, not only for ICD therapy but also for amiodarone. Nevertheless, it is worth pointing out that this subgroup effect was not anticipated before data analysis. Rather, the general trend in prior trials had been for the relative treatment effect to be nearly constant and, thus, for the treatment benefit to be larger in absolute terms for sicker patients. Whether the treatment differences that we observed in NYHA-class subgroups are biologically plausible is uncertain.
The traditional view of clinical trialists is that the results of subgroup analysis are inherently misleading and should be interpreted very conservatively until replicated elsewhere. In the absence of replication, the findings of other trials can guide the interpretation of this particular subgroup effect. In the Multicenter Automatic Defibrillator Implantation Trial II (MADIT II),17 a study of patients who had had a myocardial infarction, and in the Antiarrhythmics versus Implantable Defibrillators (AVID) study,6 a secondary prevention trial, the worse the ejection fraction, the greater the benefit of ICD therapy. In a post hoc analysis, MADIT II showed a benefit of ICD therapy in terms of survival that was similar to the overall trial results when the groups were stratified according to the NYHA class (I, II, or III) (MADIT II Executive Committee: personal communication). In the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial, patients in NYHA class III derived the largest survival benefit from ICD therapy.4 Thus, we do not believe that the unanticipated subgroup effect we found is a sufficient basis for withholding ICD therapy from patients in NYHA class III.
Another pertinent finding of our study was that single-lead ICDs proved beneficial despite a 5 percent rate of acute device-related complications and 9 percent rate of chronic complications. It is not surprising that ICD therapy has complications related to surgery and long-term management limitations, but the survival benefit associated with simple, shock-only ICD therapy outweighs any shortcomings of this approach.
Placing our findings in relation to those of other trials of ICD therapy poses some difficulties. Two previous studies have examined the role of ICD therapy in patients with CHF — the Amiodarone versus Implantable Cardioverter–Defibrillator Trial (AMIOVIRT)3 and the DEFINITE trial4 — but only among those with nonischemic cardiomyopathy. AMIOVIRT randomly assigned 103 patients in NYHA class I, II, or III who had an LVEF of 35 percent or less and had nonsustained ventricular tachycardia during ambulatory monitoring to amiodarone or dual-chamber ICDs programmed as VVI shock only (Strickberger A: personal communication). No mortality advantage had been observed when the trial was aborted after two years. Background use of beta-blockers was somewhat lower in AMIOVIRT than in our trial (53 percent vs. 69 percent at randomization). Differences in outcome between the two trials are probably due to differences in the number of patients enrolled and the duration of follow-up.
The DEFINITE trial randomly assigned 458 patients to ICD or standard therapy and did not find a significant survival benefit (P=0.08). The study used nonsustained ventricular tachycardia and frequent ectopy as entry criteria, and 22 percent of the patients were in NYHA class I. In addition, the threshold for pacing was higher than in our study (40 vs. 34 beats per minute), and the heart rate prompting intervention was lower (180 vs. 187 beats per minute). Moreover, the death rate was higher at two years than among our patients with nonischemic CHF (14 percent vs. 10 percent), suggesting that there may have been fundamental differences in the two study populations.
It is critical to emphasize that the effect of ICD therapy in patients with CHF may differ substantially depending on the programming of the device; whether single-, dual-, or triple-chamber devices are used; whether antibradycardia pacing or rate-responsive pacing is used; which detection algorithm is used; and whether antitachycardia pacing maneuvers are used for ventricular tachycardia. Although physicians understand that different drugs lead to different outcomes, they may fail to realize that the same is true for ICD therapy. ICD therapy cannot be considered a single intervention, given the numerous possible permutations of this approach. Consequently, we cannot emphasize too strongly that we evaluated only very conservatively programmed ICDs with a conservative detection algorithm and shock-only therapy. We found strong evidence that this approach works; however, considerable caution should be used in extrapolating our results to other approaches to ICD therapy, such as those involving dual-chamber or biventricular pacing, since, as reported previously,3,8,18 they may not afford the same benefit or, for that matter, any benefit.
Our findings may also be pertinent to constraining the costs of ICD therapy. ICDs were inserted on an outpatient basis, and testing of the devices was very limited. Outpatient insertion is certainly less expensive than inpatient insertion and can easily be translated to routine practice. Moreover, given the finding that no patient who underwent ICD testing required more than the maximal output of the device to terminate ventricular fibrillation, a reasonable argument can be made that defibrillation testing is unwarranted in this population. The risk and cost of defibrillation testing are likely to outweigh the remote possibility that a rare patient might benefit from it. A simplified, effective approach to the implantation of single-lead, shock-only ICDs such as ours should translate into cost savings.
In conclusion, amiodarone does not improve survival among patients with mild-to-moderate systolic CHF. Simple, shock-only ICD therapy improves survival beyond the improvement afforded by state-of-the-art drug therapy. Our approach to ICD therapy is widely applicable and should have a positive public health effect on the population of patients with CHF.
Supported by grants (UO1 HL55766, UO1 HL55297, and UO1 HL55496) from the NHLBI, National Institutes of Health, and by Medtronic, Wyeth–Ayerst Laboratories, and Knoll Pharmaceuticals.
Dr. Bardy reports having received research grants from Medtronic and Wyeth–Ayerst Pharmaceuticals, having served as a consultant to Guidant, and having received speaking fees from Medtronic; he is a founder of, board member of, consultant to, and equity holder in Cameron Health. Dr. Lee reports having received research funding from Medtronic and Wyeth–Ayerst Pharmaceuticals and having received speaking fees from Guidant and Medtronic. Dr. Mark reports having received grant support and speaking fees from Medtronic. Drs. Poole and Packer report having received speaking fees from Guidant and Medtronic. Dr. Fishbein reports having received research support from Medtronic and speaking fees from Guidant and Medtronic. Dr. Ip reports that he is a consultant for St. Jude Medical and holds equity in Guidant.
Source Information
From the Seattle Institute for Cardiac Research (G.H.B., C.T., J.A., G.J.) and the University of Washington, Seattle (J.E.P., D.P.F.); Duke University, Durham, N.C. (K.L.L., D.B.M., S.E.M., N.C.-C., L.D.D.-R., E.S.F.); the Mayo Clinic, Rochester, Minn. (D.L.P.), the National Heart, Lung, and Blood Institute, Bethesda, Md. (R.B., M.D.), Florida Arrhythmia Consultants, Fort Lauderdale, Fla. (R.M.L.), and Ingham Medical Center, Lansing, Mich. (J.H.I.).
Address reprint requests to Dr. Bardy at the Seattle Institute for Cardiac Research, 7900 East Greenlake Dr. North, No. 300, Seattle, WA 98103, or at gbardy@sicr.org.
A complete list of investigators is provided in the Appendix.
Appendix
The following investigators and institutions participated in the SCD-HeFT trial: Investigators (listed in descending order of the number of randomized patients): Florida Arrhythmia Consultants, Ft. Lauderdale: R. Luceri, C. Russo, P. Zilo, S. Rubin, D. Weaver, J. Gonzalez, T. Ciriello, M. Alcorn; Ingham Medical Center, Lansing, Mich.: J. Ip, M. James, D. Grimes, L. Blaske, A. Crockett; Institut de Cardiologie de Montréal, Montreal: M. Talajic, G. Pelletier, H. Creó, D. Beaudion, V. Perreault; Cardiology of Tulsa, Tulsa, Okla.: D. Ensley, W. Adkisson, A. Brown, L. Klahr, M. Thompson; Oregon Health Sciences University/Providence St. Vincent Medical Center, Portland, Oreg.: J. McAnulty, M. Raitt, B. Halperin, R. Hershberger, J. Krone, J. Matteson, R. Keim; Mid Carolina Cardiology, Charlotte, N.C.: M. Kremers, D. Wise, D. Whisnant, A. Gill; University of Louisville, Louisville, Ky.: I. Singer, S. Wagner, T. Martin, C. Williams, L. Hatter, C. Becher; Stucky Research Center/Parkview Memorial Hospital, Ft. Wayne, Ind.: M. Mirro, M. O'Shaughnessy, R. Dusman, R. Plant, M. Strzelecki, J. Fisher, C. Hart, S. Budzon; Wright Patterson Air Force Base, Wright Patterson Air Force Base, Ohio: R. Reddy, D. Lantz, E. Van DeGraaff, J. Pawletko-Mathews, M. Delgado; Inland Cardiology Associates, Spokane, Wash.: D. Chilson, D. Stagaman, J. Baxter, R. Franks, S. Fulton; University Hospitals of Cleveland, Cleveland: M. Carlson, I. Pina, J. Kandrac, P. Sweeney, L. King; Midwest Heart Research Foundation, Lombard, Ill.: M. O'Toole, M. Nora, J. Cuny, E. Enger, D. Chiaramonte; Memorial Hospital, Colorado Springs, Colo.: K. Curry, T Eastburn, M. McGuire, L. Schwendeman, T.K. Hicks; Sentara Norfolk General Hospital, Norfolk, Va.: J. Herre, J. Parker, K. Barackman, L. Klevan; Cardiology Consultants, Pensacola, Fla.: M. Borganelli, S. Teague, E. Rogers, S. Bennett, B. Lane, J. Lehmann; Bryan LGH Heart Institute, Lincoln, Nebr.: S. Krueger, P. Vermaas, L. Taylor, V. Norton, C. Orosco; Texas Cardiac Arrhythmia, Austin: R. Canby, M Cishek, D. Cardinal, C. Mathews; McGill University Hospital, Montreal: M. Sami, G. Crelinsten, D. Liebling; New York Heart Center, Syracuse: A. Al-Mudamgha, D. Ehrich, L. Snyder, J. Davidenko, M. Gabris, V. DiBiase; Loyola University Medical Center, Maywood, Ill.: B. Olshansky, D. Wilber, J. Mendez, E. Jasky, B. Hockenberry, J. Del Priore; Michaels' Hospital, Toronto: P. Dorian, G. Moe, D. Newell, J. Edwards, M. Kowalewski; Northside Cardiology/The Care Group, Indianapolis: M. Walsh, E. Prystowsky, R. Margiotti; San Diego Cardiac Center, San Diego, Calif.: R. Miller, P. Hoagland, P. Waack; University of Virginia Health System, Charlottesville: J. DiMarco, J. Bergin, C. Howell, C. McDaniel; Pennsylvania State College of Medicine, Hershey: J. Boehmer, G. Naccarelli, R. Weller-Moore, E. Westley-Hetrick, P. Ulsh; Michigan Heart & Vascular Institute, Ypsilanti: J. Kappler, M. Leonen, D. Myers; Carolinas Medical Center, Charlotte, N.C.: J. Fedor, A. Thomley, C. Dellinger, G. Scwartz; The Stern Cardiovascular Center, Memphis, Tenn.: F. McGrew, E. Johnson, B. Hamilton, S. Duffy, D. Culbroht; Foothills Hospital, Calgary, Alta.: L.B. Mitchell, D.V. Exner, P. Russell, J.W. Warnica, P. Cassidy; Regional Cardiology Associates, Sacramento, Calif.: A. Sharma, G. O'Neill, J. Chin, A. Skadsen, E. Vierra, S. Allen; Maine Medical Center, Portland: J. Cutler, J. Wight, Jr., J. Love, C. Berg, S. Boswell-Farrell; University of Maryland, Baltimore: M. Gold, S. Gottleib, R. Freudenberger, S. Shorofsky, H. Scott, S. Sarang, M. McClane; Columbia Presbyterian University, New York: J. Coromilas, D. Aschein, K. Hickey; Presbyterian Heart Group, Albuquerque, N.M.: L. Nair, C. Karaian, P. Nail, C. Paap; LDS Hospital, Salt Lake City: D. Renlund, B. Crandall, C. Allen-Maycock, K. Walker, B. Daniels, M. Louie; South Texas Cardiovascular Center, San Antonio: A. Jain, R. Schnitzler, M. Alonzo, P. Bielke; St. Lukes–Roosevelt Hospital Center/Valley Hospital, New York: J. Steinberg, A. Palazzo, R. Lewis, R. Berkowitz, E. Tan, S. Janc, V. Usinowicz, R. Knox, K. Sayles; Vanderbilt University Medical Center, Nashville: M. Wathen, J. Wilson, B. White; Green Lane Hospital, Auckland, New Zealand: W. Smith, M. Hood, L. Allchorne, J. Youard, R. Smith; Mayo Clinic–St. Mary's Hospital Complex, Rochester, Minn.: D. Packer, R. Frantz, C. Stevens, K. Monahan, L. Peterson; Washington University Medical Center, St. Louis: M. Gleva, J. Rogers, J. Osborne; Metro Health Medical Center, Cleveland: E. Kaufman, O. Costantini, L. Verrelli, L. McGowen; University of Texas Health Science Center, San Antonio: D. Murray, L. Widman, J. Dugan, B. Tuomala; St. Paul Heart Clinic, Minneapolis: S. Adler II, T. Johnson, L. Nelson, J. Ramerth; Quebec Heart Institute, Sainte-Foy, Que.: G. O'Hara, M. LeBlanc, L. Charbonneau, H. Villeneuve; George Washington University Medical Center, Washington, D.C.: S. Lee, R. Katz, P. Verrier, A. Michaels; Washington Regional Medical Center, Fayetteville, Ark.: J. Cooper, E.D. Ensley, A. Courtney-Eighmy, L. Fields; Marshfield Clinic Research Foundation, Marshfield, Wis.: J. Hayes, S. Rezkalla, K. Maassen; University of Texas Medical Branch, Galveston: B. Uretsky, R. Sheahan, S. Lick, M. Potter, A. Parks, J. Allen; University of Ottawa Heart Institute, Ottawa: A. Tang, S. Smith, C. Carey, P. Theoret-Patrick, G. Ewart; Northern Indiana Heart Rhythm Specialists, Hobart: S. Kaufman, J. Zeigler, C. Atherton; Jackson Memorial Hospital/University of Miami, Miami: R. Myerburg, R. Mitrani, M. Mayor, E.J. Bauerlein, L. Munoz, S. Fuget, R. Bolline, C. Arrietta; Montefiore Medical Center, Bronx, N.Y.: S. Kim, R. Moskowitz, A. Ferrick, P. Flynn; Lancaster Heart Foundation–General Hospital, Lancaster, Pa.: S. Worley, R. Small, J. Tuzi, K. Kurtz; University of Chicago, Chicago: D. Wilber, A. Anderson, T. Hughes, M. Carey; Idaho Cardiology Associates, Boise: M. Marks, S. Writer, D. Dvorak, K. Curry, M. Walden, M. McClain; State University of New York at Brooklyn, Brooklyn: J. Mitchell, G. Turrito, K. Pang, S. Houy; University of Washington Medical Center, Seattle: W. Levy, D. Fishbein, P. Kudenchuk, A. Zivin, R. Letterer, K. Hardy; University of Massachusetts Medical Center, Worcester: R. Middleton, L. Rosenthal, T. Meyer, K. Rofino-Nadwany, K. Rofino-Helle; Johns Hopkins Hospital, Baltimore: H. Calkins, E. Kasper, D. Froman, M. Fales-Capps; Lankenau Hospital, Wynnewood, Pa.: R. Marinchak, J. Burke, M. Roth, J. Schain; Mid America Heart Institute, Kansas City, Kans.: R. Canby, D. Steinhaus, A. Magalski, D. Cardinal, J. Cloutier, Rush–Presbyterian–St. Luke's Medical Center, Chicago: S. Pinski, M. Costanzo, R. Trohman, J. Murphy; Cardiology Associates, Johnson City, N.Y.: N. Stamato, R. Ryder, K. McGee, K. Dempsey, C. Waitkus; University of Utah Medical Center, Salt Lake City: R. Klein, E.M. Gilbert, M. Nelson, G. Wadsworth; Geisinger Medical Center, Danville, Pa.: J. Oren IV, H. Fesniak, P. Primarano; Illinois Masonic Medical Center, Chicago: R. Kehoe, R. Nemickas, S. Casey, M. Turner; Christ Hospital and Medical Center, Oaklawn, Ill.: M. Silver, T. Bump, K. Wesselhoff, D. Braun; Arizona Heart Institute & Foundation, Phoenix: T. Mattioni, L.K. Smith, K. Vijayaraghavan, S. Welch, C. Williams, A. Reese; Pepin Heart Center, Tampa, Fla.: J. Garcia, S. Mester, C. Sullivan; St. Mary's Duluth Clinic, Duluth, Minn.: C. Heltne, A. Fenton, M. Mollerus, T. Graham, T. Keinanen, C. Neva; Harborview Medical Center, Seattle: F. DeRook, K. Comess, D. Wuthrich, D. Hinchman, M. Russell, M. Hanrahan; Providence Hospital, Southfield, Mich.: C. Machado, W. Duvernoy, D. Cunningham, N. Wissedi; University of Texas Southwestern Medical Center, Dallas: R. Page, C. Yancy, M. Drazner, J. Jogler, L. Nelson, C. Nguyen, C. Hale; Wadsworth West Los Angeles Veterans Affairs Medical Center, Los Angeles: P. Sager, M. Bersohn, R. Connolly, M. Cui; Brooklyn Veterans Affairs Medical Center, Brooklyn, N.Y.: N. El-Sherif, N. Al Adhamy, L. Knudson; Fairfax Hospital–Inova Health System, Falls Church, Va.: T. Friehling, J. O'Brien, M. Blake, J. Yarvitz; Duke University Medical Center, Durham, N.C.: R. Greenfield, C. O'Connor, C. Grill, B. Smith; University of Pennsylvania Health System Presbyterian Medical Center, Philadelphia: A. Russo, R. Zimmer, C. Schorr; Smith Clinic, Marion, Ohio: R. Malik, K. Kannan, B. Mollenkopf, K. Fosnaugh; Medical University of South Carolina, Charleston: R. Leman, K. Walker, G. Hendrix, M. Schultz, J. Clark, J. Lake; Cardiac Disease Specialists, P.C., Atlanta: T. Deering, W. Mashman, S. Holt; The Heart Care Group, Allentown, Pa.: S. Zelenkofske, B. Feldman, M Gabris, C. Fedak, S. Stufflet; Virginia Mason Medical Center, Seattle: C. Fellows, M. Belz, J. Sanders, E. Davis, C. Hopson; Indiana University Medical Center, Indianapolis: W. Groh, L. Ford, L. Foreman; Catholic Medical Center, Manchester, N.H.: B. Hook, R. Dewey, L. Brown, L. Pimenta; Cleveland Clinic Foundation, Cleveland: P. Tchou, J. Young, J. Pryce, J. Cross; New York University Medical Center, New York: L. Chinitz, B. Rosenzweig, L. Balch, A. Ferrick, J. Plick; University of Florida, Gainesville: A. Curtis, J. Aranda, A. Power, B. Bryant, T. Dempsey; Brigham and Women's Hospital, Boston: M. Sweeney, L. Warner-Stevenson, L. Roberts, L. Andruszkiewicz; Blackstone Cardiology Associates, Pawtucket, R.I.: A. Hordes, S. Riley; Winthrop University Hospital, Mineola, N.Y.: T. Cohen, H. Hirsch, W. Quan, N. Podmore; Hamilton General Hospital, Hamilton, Ont.: S. Connolly, R. McKelvie, S. Carroll, V. Malcolm; University of Medicine and Dentistry of New Jersey, New Brunswick: M. Preminger, R. Hilkert, J. Kostis, N. Cosgrove, D. Max, S. Patella; Kaiser Los Angeles Medical Center, Los Angeles: N. Dullet, P. Mansukhani, R. Browning; New York Hospital–Cornell Medical Center, New York: B. Lerman, R. Campagne, S. Discenza; University of Iowa Hospitals and Clinics, Iowa City: B. Olshansky, H.C. Lee, R. Oren, D. Beadle, M. Costigan, K. Schneider; Swedish Medical Center–Providence Campus, Seattle: D. Broudy, D. Wilkinson, D. Gerity, B. Schubert; St. Elizabeth's Health Center, Youngstown, Ohio: W. Paladino, R. Mikolich, D. Dillon; Community Hospitals East, Indianapolis: L. Klein, R. Hahn, J. Greene-Nashold; Queen Elizabeth II Health Sciences Centre, Halifax, N.S.: M. Gardener, J. Howlett, M. Romeo, K. Giddens; Veterans Affairs Medical Center, Washington, D.C.: P. Karasik, P. Carson, M. Chavez; Hackensack University Medical Center, Hackensack, N.J.: J. Zimmerman, J. Landzberg, T. Arakelian, D. Severino; Cardiovascular Consultants, Minneapolis: J. Simonson, A. Antolick; Rhode Island Hospital, Providence: R. Lemery, D. Foreman, A. Buxton, E. Connolly, P. Corcoran, C. Lamore; Westchester Medical Center, Valhalla, N.Y.: C. Sorbera, R. Belkin, J. Rainaldi; St. Elizabeth's Medical Center of Boston, Boston: C. Haffajee, B. Kosowsky, P. Pacetti; Victoria Heart Institute Foundation, Victoria, B.C.: L. Sterns, J. Bonet, D. O'Neill, H. McNish; Temple University Hospital, Philadelphia: H. Hsia, S. Rubin, S. Rothman, J. Edinger; Albany Medical College, Albany, N.Y.: J. Nattama, J. O'Brien, R. Capone, K. Edmunds, I. Megas-Nowak; St. Joseph's Hospital and Medical Center, Paterson, N.J.: M. Biehl, D. Konlian, C. Irmiere; North Shore University Hospital, Manhasset, N.Y.: R. Jadonath, D. Grossman, E. Figueredo, K. Pajonas; Houston Cardiac Electrophysiology Associates, Houston: A. Pacifico, T. Doyle, K. Trainor, L. Russell; Ochsner Heart and Vascular Institute, New Orleans: F. Abi-Samra, M. Mehra, D. Stapleton, A. Grant, E. Franceware; Heart Place Dallas, Dallas: S. Hall, J. Shinbane, M. Seaton, D. Newding, S. Bruce; Saint Louis University, St. Louis: A. Quattromani, T. Donahue, D. Yip, P. Hauptman, M. Derfler, D. Pummill; Gundersen Lutheran Medical Foundation, LaCrosse, Wis.: W. Brown, K. Akosah, L. Storlie; Evanston Hospital (Northwestern Medical Center), Evanston, Ill.: M. Hamer, T. McDonough, R. Williams, S. Swiryn, M. Giannini, L. Ackatz; St. Patrick Hospital, Missoula, Mont.: C. Goren, G. Reed, C. Cole, S. Anderson; University of California, San Francisco, San Francisco: L. Saxon, K. Chatterjee, T. DiMarco, K. Schiebly, V. Wilby; University of Connecticut Health Center, Farmington: E. Berns, W.D. Hager, L. Kearney, M. Barry; Allegheny University Hospitals-MCP, Philadelphia: M. Jessup, F Marchlinski, D. DiMarzio; Tri-City Cardiology, Mesa, N.M.: A. Kaplan, E. Perlstein, B. Allen, D. Cook, K. Enders; Advanced Heart Center, Fort Myers, Fla.: J. Butler, J. Scrivner-Hanson; Toronto General Hospital, Toronto: D. Cameron, H. Ross, A. Hill; University of Pennsylvania Health System – HUP Medical Center, Philadelphia: M. Jessup, F. Marchlinski, F. Pickering; Iowa Heart Center, Des Moines: S. Bailin, W. Wickemeyer, D. French; WJB Dorn Veterans Affairs Medical Center, Columbia, S.C.: S. Hsu, C. Hassapoyannes, N. Pahtrik, K. Chavarda; McGuire Veterans Affairs Medical Center, Richmond, Va.: K. Ellenbogen, D. Gilligan, P. Mohanty, D. Sargent, A. Hirsch; Hartford Hospital, Hartford, Conn.: J. Kluger, J. Dougherty, H. Rose, A. Adeni; Medical College of Virginia, Richmond: D. Gilligan, K. Ellenbogen, P. Mohanty, M. Hess, C. Dietrich, K. Hall; Louisville Cardiology Medical Group, Louisville, Ky.: J. Dakas, M. Imburgia, M. Springer, P. Tucker, K. Hulsmeyer; Boston Medical Center, Boston: K. Monahan, M. Givertz, A. Dermovsesian, T. Lavey; University of California Los Angeles, Los Angeles: Z. Feliciano, G. Fonarow, N. Livingston, J. Creaser; University of Oklahoma Health Sciences Center, Oklahoma City: K. Beckman, P. Adamson, D. Reynolds, A. Luby; Mission Hospital, Mission Viejo, Calif.: S. Ehrlich, G. Thomas, M. Whalen; Georgetown University Medical Center, Washington, D.C.: A. Solomon, D. Pearle, N. Knowlan; University of Kentucky, Lexington: J. Gurley, M. Hasan, W. Abraham, L. Withrow, J. Zielke; Forum Health, Youngstown, Ohio: M. Raheja, J. Graziano, D. Kaiser, C. Opritza; University of Arkansas for Medical Science, Little Rock: J. Bissett, J. Joseph, S. Shuler; John H. McClellan Memorial Veteran Hospital, Little Rock, Ark.: J. Bissett, J. Joseph, S. Shuler, P. Harrison; Houston Arrhythmia Associates, Houston: S. Jalal, A. Drtil, F. Khan, D. Williams; St. Joseph's Hospital Health Center, Fayetteville, N.Y.: N. Kavesh, G. Kenien, D. Lynch; Hoag Memorial Hospital, Newport Beach, Calif.: N.D. Hunter, R. Haskell, A. Woodson; Buffalo Cardiology & Pulmonary Associates, Williamsville, N.Y.: J. Corbelli, B. Cooke; Tulane University School of Medicine, New Orleans: J. McKinnie, K. Drake, Y. Greenly; Consultants in Cardiology, Lincoln, Nebr.: M. Sarik; University of Minnesota Medical School, Minneapolis: D. Benditt; Heart Care Centers of Illinois, Blue Island: D. Andress, D. Cusick; University of Alberta H-Site, Edmonton, Alta.: S. Kimber, D. Maynari, F. McAlister; National Institutes of Health, NHLBI, Bethesda, Md.: M.J. Domanski, R. Boineau, D. McAreavey, D.V. Exner, I. Mirsky, D. Follman; Data and Safety Monitoring Board: M. Packer (chair), J. Kahn, S. Kelsey, M.A. Konstam, R. Lazzara, C. Tracy; Executive Committee: G.H. Bardy (chair), K.L. Lee, D.B. Mark, D.P. Zipes, R.M. Califf, D.L. Packer, R.D. Fletcher, S.N. Singh, E.N. Prystowsky, J.N. Cohn, G.J. Klein, J.N. Ruskin, B.N. Singh, D.V. Exner, R. Boineau, M.J. Domanski; Events Committee: D.L. Packer (chair), M.N. Walsh, R.P. Frantz, J.G. Rogers, L.B. Mitchell, J.P. Boehmer, M.D. Carlson, D.M. Mancini, S.G. Kim, A.S.L. Tang, D.V. Exner, R.C. Bernstein, C.M. O'Connor; Electrogram Committee: J.E. Poole (chair), M.H. Raitt, D.J. Callans, R. Yee, R.K. Reddy, D.J. Wilber, T. Guarnieri, M. Talajic, F.E. Marchlinski; ICD Complications Committee: M.F. O'Toole (chair), J.P. DiMarco, A.B. Curtis, D.A. Chilson, S.P. Kutalek, S. Erhlich; Clinical Coordinating Center: G.H. Bardy, J.E. Poole, C. Troutman, J. Anderson, G. Johnson; Data Coordinating Center: K.L. Lee, S. McNulty, B. Fraulo, P. Smith, K. Stevens, A. Hellkamp, K. Ross, L. Robinson, T. Gentry-Bumpass, M. Harding, A. Lowe, M. Rund, L. Webb, D. Lemons, N. Hayes, L. Eskenazi, B. Covell, H. Daniels, K. Johnston, D. Glover, P. Smith, F. Wood, K. Mahaffey, J. Battle, C. Tung, V. Christian, P. Sawyer, C. Morris, A. Thomas, D. Smith; EQOL Coordinating Center: D. Mark, L. Davidson-Ray, N. Clapp-Channing, B. Lytle, C. Nelson, J. Lena Sun, J. Stafford, M. Jones-Richmond, K. Agan, J. Poteat, L. Larson; Pharmacy: A. Seidel, V. Clark, J. Mabie; Liaison Staff: N. Stephenson, A. Cicic, L. Johnson, V. Kirby, B. Czenczak, P. Cargo, B. Cooperstone, D. Chazanovitz; Core Laboratory Staff: P. Reinhall, A. Schreuder, M. Gold, R. Fletcher, M. Platt, R. Jones, S. Thomas, E. Friedmann.
- References
References
1
Singh SN ,Fletcher RD ,Gross Fisher S , et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82
Full Text | Web of Science | Medline2
Doval HC ,Nul DR ,Grancelli HO ,Perrone SV ,Bortman GR ,Curiel R . Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-498
CrossRef | Web of Science | Medline3
Strickberger SA ,Hummel JD ,Bartlett TG , et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia -- AMIOVIRT. J Am Coll Cardiol 2003;41:1707-1712
CrossRef | Web of Science | Medline4
Kadish A ,Dyer A ,Daubert JP , et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158
Full Text | Web of Science | Medline5
Moss A ,Hall J ,Cannom D , et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940
Full Text | Web of Science | Medline6
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Full Text | Web of Science | Medline7
Connolly SJ ,Gent M ,Roberts RS , et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302
Web of Science | Medline8
Wilkoff BL ,Cook JR ,Epstein AE , et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123
CrossRef | Web of Science | Medline9
Cairns JA ,Connolly SJ ,Roberts R ,Gent M . Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-682[Erratum, Lancet 1997;349:1776.]
CrossRef | Web of Science | Medline10
Julian DG ,Camm AJ ,Frangin G , et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-674[Erratum, Lancet 1997;349:1180, 1776.]
CrossRef | Web of Science | Medline11
Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). In: Woosley RL, Singh SN, eds. Arrhythmia treatment and therapy: evaluation of clinical trial evidence. New York: Marcel Dekker, 2000:323-42.
12
Kaplan EL ,Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
CrossRef | Web of Science13
Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. 2nd ed. New York: John Wiley, 2002.
14
Cox DR . Regression models and life-tables. J R Stat Soc [B] 1972;34:187-22015
O'Brien PC ,Fleming TR . A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556
CrossRef | Web of Science | Medline16
Lan KKG ,DeMets DL . Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-663
CrossRef | Web of Science17
Moss AJ ,Zareba W ,Hall WJ , et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
Full Text | Web of Science | Medline18
Bigger JT Jr . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-1575
Full Text | Web of Science | Medline
- Citing Articles (1417)
Citing Articles
1
Beth D. Kaufman, Kimberly Y. Lin, Akash R. Patel, Maryam Y. Naim, Maully J. Shah, Robert E. Shaddy. 2012. Cardiac Failure. , 1021-1031.
CrossRef2
M. Bracht, L. Skoljarev, M.W. Prull, H.-J. Trappe. (2012) Einfluss myokardialer Narben auf die Häufigkeit ventrikulärer Rhythmusstörungen bei ICD-Trägern. Der Kardiologe
CrossRef3
, Aneta Aleksova, Serge Masson, Aldo P. Maggioni, Donata Lucci, Renato Urso, Lidia Staszewsky, Stefano Ciaffoni, Giuseppe Cacciatore, Gianfranco Misuraca, Michele Gulizia, Lucio Mos, Gianni Proietti, Calogero Minneci, Roberto Latini, Gianfranco Sinagra. (2012) Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure. Cardiovascular Drugs and Therapy
CrossRef4
D. G. Katritsis, M. E. Josephson. (2012) Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?. Europace
CrossRef5
Elfriede Pahl, Lynn A. Sleeper, Charles E. Canter, Daphne T. Hsu, Minmin Lu, Steven A. Webber, Steven D. Colan, Paul F. Kantor, Melanie D. Everitt, Jeffrey A. Towbin, John L. Jefferies, Beth D. Kaufman, James D. Wilkinson, Steven E. Lipshultz. (2012) Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy. Journal of the American College of Cardiology 59:6, 607-615
CrossRef6
F. Blaschke, T. Knaus, O. Celebi, A. Krebs, A. Nitardy, D. Habedank, R. Dietz, M. Stockburger. (2012) Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Europace 14:2, 224-229
CrossRef7
Arnold J. Greenspon, Jordan M. Prutkin, Muhammad R. Sohail, Holenarasipur R. Vikram, Larry M. Baddour, Stephan B. Danik, James Peacock, Carlos Falces, Jose M. Miro, Elisabeth Blank, Christoph Naber, Roger G. Carrillo, Chi-Hong Tseng, Daniel Z. Uslan. (2012) Timing of the Most Recent Device Procedure Influences the Clinical Outcome of Lead-Associated Endocarditis. Journal of the American College of Cardiology 59:7, 681-687
CrossRef8
L. M. Biasucci, F. Bellocci, M. Landolina, R. Rordorf, A. Vado, E. Menardi, G. Giubilato, S. Orazi, M. Sassara, A. Castro, R. Massa, A. Kheir, G. Zaccone, C. Klersy, F. Accardi, F. Crea. (2012) Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study. European Heart Journal
CrossRef9
N. Klein, M. Klein, H. Weglage, O. Przibille, S. Fischer, H.-J. Trappe, F. Birkenhauer, D. Pfeiffer, . (2012) Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study. Europace
CrossRef10
D. P. Morin, M. N. Saad, O. F. Shams, J. S. Owen, J. Q. Xue, F. M. Abi-Samra, S. Khatib, O. S. Nelson-Twakor, R. V. Milani. (2012) Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace
CrossRef11
George E. Billman, Heinz Gögelein, Hartmut Ruetten, Klaus J. Wirth. (2012) Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs. Naunyn-Schmiedeberg's Archives of Pharmacology
CrossRef12
Andrew J. Epstein, Daniel Polsky, Feifei Yang, Lin Yang, Peter W. Groeneveld. (2012) Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival. Medical Care 50:1, 10-17
CrossRef13
Hou Yu, Fang Pi-hua, Wu Yuan, Li Xiao-feng, Liu Jun, Li Zhi, Lei Sen, Shu Zhang. (2012) Prediction of sudden cardiac death in patients after acute myocardial infarction using T-wave alternans: a prospective study. Journal of Electrocardiology 45:1, 60-65
CrossRef14
Larry R. Jackson, James P. Daubert, Kevin L. Thomas. (2012) Expanding the Benefits of Implantable Cardioverter-Defibrillator Therapy: “Is Less More”?. Progress in Cardiovascular Diseases 54:4, 372-378
CrossRef15
Haris M. Haqqani, Kurt C. Roberts-Thomson. (2012) Radiofrequency Catheter Ablation for Ventricular Tachycardia. Heart, Lung and Circulation
CrossRef16
Chern-En Chiang, Shu Zhang, Hung Fat Tse, Wee Siong Teo, Razali Omar, Charn Sriratanasathavorn. (2012) Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation. International Journal of Cardiology
CrossRef17
JAGMEET P. SINGH, KENNETH A. ELLENBOGEN, NIHAR R. DESAI, FINLAY A. MCALISTER. (2012) ICDs, Guidelines, and National Registries: Opportunities to Enhance Quality of Patient Care. Pacing and Clinical Electrophysiologyno-no
CrossRef18
ANDREAS VOSS, MATTHIAS GOERNIG, RICO SCHROEDER, SANDRA TRUEBNER, ALEXANDER SCHIRDEWAN, HANS R. FIGULLA. (2012) Blood Pressure Variability as Sign of Autonomic Imbalance in Patients with Idiopathic Dilated Cardiomyopathy. Pacing and Clinical Electrophysiologyno-no
CrossRef19
JCS Joint Working Group. (2012) Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010). Circulation Journal 76:2, 489-507
CrossRef20
Barry J. Maron, Christopher Semsarian. (2012) Prevention of Sudden Death for Patients With Cardiomyopathies. Journal of the American College of Cardiology 59:5, 501-502
CrossRef21
Maya Guglin, S. Serge Barold. (2011) Electrical devices for left ventricular dysfunction and heart failure: do we need revised guidelines?. Journal of Interventional Cardiac Electrophysiology
CrossRef22
Paban Saha, Jeffrey J. Goldberger. (2011) Risk Stratification for Prevention of Sudden Cardiac Death. Current Treatment Options in Cardiovascular Medicine
CrossRef23
Nicholas B. Norgard, Mazen S. Abu-Fadel. 2011. Cardiovascular Disease: In-Depth Look. .
CrossRef24
Divy Ravindranath, Frank Pelosi. 2011. Psychiatric Aspects of Sudden Cardiac Arrest and Implantable Cardioverter-Defibrillators. , 77-87.
CrossRef25
H. Furushima, M. Chinushi, K. Iijima, K. Hasegawa, A. Sato, D. Izumi, H. Watanabe, Y. Aizawa. (2011) Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases?. Europace
CrossRef26
Mohan Rao, Ilan Goldenberg, Arthur J. Moss, Helmut Klein, David T. Huang, Nicole R. Bianco, Steven J. Szymkiewicz, Wojciech Zareba, Andrew Brenyo, Jonathan Buber, Alon Barsheshet. (2011) Wearable Defibrillator in Congenital Structural Heart Disease and Inherited Arrhythmias. The American Journal of Cardiology 108:11, 1632-1638
CrossRef27
Stavros E. Mountantonakis, Mathew D. Hutchinson. (2011) Indications for Implantable Cardioverter-Defibrillator Placement in Ischemic Cardiomyopathy and after Myocardial Infarction. Current Heart Failure Reports 8:4, 252-259
CrossRef28
Laura Perrotta, Giuseppe Ricciardi, Paolo Pieragnoli, Luigi Padeletti. (2011) Device Recalls: What’s an Electrophysiologist to Do?. Cardiac Electrophysiology Clinics 3:4, 617-622
CrossRef29
Stephen C. Hammill, Mark S. Kremers, Sana M. Al-Khatib. (2011) Implantable Cardioverter–Defibrillator Registries—What Have We Learned?. Cardiac Electrophysiology Clinics 3:4, 521-527
CrossRef30
Moustafa Banna, Julia H. Indik. (2011) Risk Stratification and Prevention of Sudden Death in Patients with Heart Failure. Current Treatment Options in Cardiovascular Medicine 13:6, 517-527
CrossRef31
Girish M. Nair, Jeffrey S. Healey, Syamkumar M. Divakaramenon, Stuart J. Connolly, Carlos A. Morillo. (2011) Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients. Cardiac Electrophysiology Clinics 3:4, 651-661
CrossRef32
Alexander Burashnikov, Charles Antzelevitch. (2011) Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacology & Therapeutics 132:3, 300-313
CrossRef33
Ashok J. Shah, Shinsuke Miyazaki, Amir S. Jadidi, Daniel Scherr, Stephen B. Wilton, Laurent Roten, Patrizio Pascale, Michala Pedersen, Nicolas Derval, Sebastien Knecht, Frederic Sacher, Pierre Jais, Michel Haissaguerre, Meleze Hocini. (2011) Catheter Ablation of Ventricular Fibrillation Storms: Will this Replace Defibrillators?. Cardiac Electrophysiology Clinics 3:4, 689-695
CrossRef34
Daniel B. Kramer, Mark E. Josephson. (2011) Expanding the Use of Cardiac Resynchronization Therapy: Words of Caution. Cardiac Electrophysiology Clinics 3:4, 529-537
CrossRef35
Renee M. Sullivan, Brian Olshansky. (2011) Is a Dual-Chamber ICD Always Better in Patients Requiring an ICD?. Cardiac Electrophysiology Clinics 3:4, 577-592
CrossRef36
E. S. Williams, S. H. Shah, J. P. Piccini, A. Y. Sun, J. I. Koontz, S. M. Al-Khatib, P. M. Hranitzky. (2011) Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. Europace 13:12, 1717-1722
CrossRef37
Domingo Palacios-Ceña, Marta E. Losa-Iglesias, Cristina Álvarez-López, Miguel Cachón-Pérez, Rosalie Ann R. Reyes, Paloma Salvadores-Fuentes, César Fernández-de-las-Peñas. (2011) Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review. Journal of Advanced Nursing 67:12, 2537-2550
CrossRef38
Krishnakumar Nair, Jack V. Tu, Douglas S. Lee. (2011) Why Are Implantable Cardioverter Defibrillator Outcomes in Practice Different from Clinical Trials?. Cardiac Electrophysiology Clinics 3:4, 511-520
CrossRef39
Ganesh Venkataraman, S. Adam Strickberger. (2011) Evaluation of Defibrillation Efficacy at Implantation is Unnecessary. Cardiac Electrophysiology Clinics 3:4, 559-563
CrossRef40
David J. Whellan, Anil Nigam, Malcolm Arnold, Aijing Z. Starr, James Hill, Gerald Fletcher, Stephen J. Ellis, Lawton Cooper, Anekwe Onwuanyi, Bleakley Chandler, Steven J. Keteyian, Greg Ewald, Andrew Kao, Mihai Gheorghiade. (2011) Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology—findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study. American Heart Journal 162:6, 1003-1010
CrossRef41
DOMINIC A. M. J. THEUNS, TIM SMITH, TAMAS SZILI-TOROK, AGNES MUSKENS-HEEMSKERK R. N., PETTER JANSE, LUC JORDAENS. (2011) Prognostic Role of High-Sensitivity C-Reactive Protein and B-Type Natriuretic Peptide in Implantable Cardioverter-Defibrillator Patients. Pacing and Clinical Electrophysiologyno-no
CrossRef42
Massimo Zecchin, Marco Merlo, Alberto Pivetta, Giulia Barbati, Cristina Lutman, Dario Gregori, Laura Vitali Serdoz, Stefano Bardari, Silvia Magnani, Andrea Di Lenarda, Alessandro Proclemer, Gianfranco Sinagra. (2011) How Can Optimization of Medical Treatment Avoid Unnecessary Implantable Cardioverter-Defibrillator Implantations in Patients With Idiopathic Dilated Cardiomyopathy Presenting With “SCD-HeFT Criteria?”. The American Journal of Cardiology
CrossRef43
M. E. Stone, B. Salter, A. Fischer. (2011) Perioperative management of patients with cardiac implantable electronic devices. British Journal of Anaesthesia 107:suppl 1, i16-i26
CrossRef44
Salvatore Rosanio, Ernst R. Schwarz, David L. Ware, Antonio Vitarelli. (2011) Syncope in adults: Systematic review and proposal of a diagnostic and therapeutic algorithm. International Journal of Cardiology
CrossRef45
A. John Camm, Christian F. Camm, Irina Savelieva. (2011) Medical treatment of atrial fibrillation. Journal of Cardiovascular Medicine1
CrossRef46
D. A. M. J. Theuns, L. Jordaens. (2011) Use of remote monitoring in the management of system-related complications in implantable defibrillator patients. Netherlands Heart Journal
CrossRef47
Carlos Gómez-Navarro, Antonio Bonilla, Jacinto Benítez. (2011) ¿Cómo estratificamos el riesgo en las miocardiopatías? Miocardiopatía dilatada e hipertrófica como paradigmas. Cardiocore
CrossRef48
Iosif Kelesidis, Mark I. Travin. (2011) Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death. Journal of Nuclear Cardiology
CrossRef49
Gudrun Antoons, Rik Willems, Karin R. Sipido. (2011) Alternative strategies in arrhythmia therapy: Evaluation of Na/Ca exchange as an anti-arrhythmic target. Pharmacology & Therapeutics
CrossRef50
Marwan M. Refaat, Toshikazu Tanaka, Robert L. Kormos, Dennis Mcnamara, Jeffrey Teuteberg, Steve Winowich, Barry London, Marc A. Simon. (2011) Survival Benefit of Implantable Cardioverter-Defibrillators in Left Ventricular Assist Device–Supported Heart Failure Patients. Journal of Cardiac Failure
CrossRef51
MANDEEP R. MEHRA, NANCY M. ALBERT, ANNE B. CURTIS, MIHAI GHEORGHIADE, J. THOMAS HEYWOOD, YANG LIU, CHRISTOPHER M. O’CONNOR, DWIGHT REYNOLDS, MARY NORINE WALSH, CLYDE W. YANCY, GREGG C. FONAROW. (2011) Factors Associated with Improvement in Guideline-Based Use of ICDs in Eligible Heart Failure Patients. Pacing and Clinical Electrophysiologyno-no
CrossRef52
D. Erkapic, F. Amberger, P. Bushoven, J. Ehrlich. (2011) More safety with more energy. Herzschrittmachertherapie + Elektrophysiologie
CrossRef53
L. Paranskaya, I. Akin, T. Chatterjee, A. Ritz, P. Paranski, T. Rehders, H. Ince, H. Schneider, C.A. Nienaber, D. Bänsch. (2011) Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy. Herzschrittmachertherapie + Elektrophysiologie
CrossRef54
T. Deneke, T. Lawo, J. Reinecke, C. Buttler, P.H. Grewe, D.-I. Shin, B. Gerritse, A. Mügge, B. Lemke, A. Kloppe. (2011) Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication. Herzschrittmachertherapie + Elektrophysiologie
CrossRef55
J. Seegers, M. A. Vos, P. Flevari, R. Willems, C. Sohns, D. Vollmann, L. Luthje, D. T. Kremastinos, V. Flore, M. Meine, A. Tuinenburg, R. C. Myles, D. Simon, J. Brockmoller, T. Friede, G. Hasenfuss, S. E. Lehnart, M. Zabel, . (2011) Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace
CrossRef56
C. A. Miller, K. Pearce, P. Jordan, R. Argyle, D. Clark, M. Stout, S. G. Ray, M. Schmitt. (2011) Comparison of real-time three-dimensional echocardiography with cardiovascular magnetic resonance for left ventricular volumetric assessment in unselected patients. European Journal of Echocardiography
CrossRef57
M. Licka, L. Jahn, K. Kelemen, F. Voss, K. Trappe, R. Becker, O. Bikou, M. Hauck, M. Koch, H.A. Katus, A. Bauer. (2011) Is the determination of the defibrillation threshold in patients with an implantable cardioverter–defibrillator still required?. Herzschrittmachertherapie + Elektrophysiologie
CrossRef58
T. Weinmann, L. Károlyi, S.G. Spitzer. (2011) ICD-Therapie 2011. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
CrossRef59
U. Mezu, I. Ch, I. Halder, B. London, S. Saba. (2011) Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Europace
CrossRef60
R. Bastiaenen, V. Batchvarov, M. M. Gallagher. (2011) Ventricular automaticity as a predictor of sudden death in ischaemic heart disease. Europace
CrossRef61
TREVOR A. VERGA, JEFFREY M. GILLBERG, RICHARD M. GREENBERG, FLORIN T. DEGER. (2011) True Bipolar and Integrated Bipolar Sensing and Detection by Implantable Defibrillators. Pacing and Clinical Electrophysiology 34:11, 1561-1568
CrossRef62
Luigi Padeletti, Lisa Innocenti, Alessandro Paoletti Perini, Edoardo Gronda. (2011) Arrhythmic complication in cardiorenal syndrome. Heart Failure Reviews 16:6, 569-573
CrossRef63
J. Thijssen, C. J. W. Borleffs, J. B. van Rees, M. K. de Bie, E. T. van der Velde, L. van Erven, J. J. Bax, S. C. Cannegieter, M. J. Schalij. (2011) Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. European Heart Journal 32:21, 2678-2687
CrossRef64
Maria Sheehan, Phillip J. Newton, Paul Stobie, Patricia Mary Davidson. (2011) Implantable cardiac defibrillators and end-of-life care—Time for reflection, deliberation and debate?. Australian Critical Care 24:4, 279-284
CrossRef65
Morten Schou, Nana Valeur, Christian Torp-Pedersen, Finn Gustafsson, Lars Køber. (2011) Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF. European Journal of Clinical Investigation 41:11, 1237-1244
CrossRef66
Javier Alzueta, José Maria Fernández. (2011) Spanish Implantable Cardioverter-Defibrillator Registry. Seventh Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2010). Revista Española de Cardiología (English Edition) 64:11, 1023-1034
CrossRef67
Paul Angaran, George J. Klein, Raymond Yee, Allan C. Skanes, Lorne J. Gula, Peter Leong-Sit, Andrew D. Krahn. (2011) Syncope. Neurologic Clinics 29:4, 903-925
CrossRef68
Daniel Jacoby, Oltjan Albajrami, Lavanya Bellumkonda. (2011) Natural History of End-stage LV Dysfunction: Has It Improved from the Classic Franciosa and Cohn Graph?. Cardiology Clinics 29:4, 485-495
CrossRef69
Yang Pang, Qi Jin, Ning Zhang, Shujing Ren, Tianyou Ling, Ying Chen, Gang Gu, Yongchu Shen, Liqun Wu. (2011) High-energy defibrillation increases the dispersion of regional ventricular repolarization. Journal of Interventional Cardiac Electrophysiology 32:2, 81-86
CrossRef70
Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidência de arritmias ventriculares em doentes com disfunção sistólica ventricular esquerda grave: existe benefício após terapêutica de ressincronização cardíaca. Revista Portuguesa de Cardiologia 30:11, 823-828
CrossRef71
ALON BARSHESHET, ILAN GOLDENBERG, ARTHUR J. MOSS, DAVID T. HUANG, WOJCIECH ZAREBA, SCOTT McNITT, HELMUT U. KLEIN, VICTOR GUETTA. (2011) Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial. Journal of Cardiovascular Electrophysiology 22:11, 1237-1242
CrossRef72
Giovanni B. Forleo, Domenico G. Della Rocca, Lida P. Papavasileiou, Germana Panattoni, Domenico Sergi, Lucia Duro, Karim Mahfouz, Giulia Magliano, Luca Santini, Francesco Romeo. (2011) Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. Journal of Cardiovascular Medicine 12:11, 779-784
CrossRef73
GUO-HUI YAN, MEI WANG, WEN-SHENG YUE, KAI-HANG YIU, GUANG ZHI, CHU-PAK LAU, STEPHEN WL LEE, CHUNG-WAH SIU, HUNG-FAT TSE. (2011) Relationship between Ventricular Dyssynchrony and T-wave Alternans in Patients with Coronary Artery Disease. Pacing and Clinical Electrophysiology 34:11, 1503-1510
CrossRef74
Barak Pertzov, Victor Novack, Doron Zahger, Amos Katz, Guy Amit. (2011) Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality. International Journal of Cardiology
CrossRef75
Javier Alzueta, José Maria Fernández. (2011) Registro Español de Desfibrilador Automático Implantable. VII Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2010). Revista Española de Cardiología 64:11, 1023-1034
CrossRef76
Mihály K. de Bie, Johannes B. van Rees, J. Thijssen, C. Jan Willem Borleffs, Serge A. Trines, Suzanne C. Cannegieter, Martin J. Schalij, Lieselot van Erven. (2011) Cardiac Device Infections are associated with a significant mortality risk. Heart Rhythm
CrossRef77
Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: is there a benefit after cardiac resynchronization therapy?. Revista Portuguesa de Cardiologia (English Edition) 30:11, 823-828
CrossRef78
J. S. Perkiomaki, P.-E. Bloch Thomsen, A. M. Kiviniemi, M. D. Messier, H. V. Huikuri, . (2011) Risk factors of self-terminating and perpetuating ventricular tachyarrhythmias in post-infarction patients with moderately depressed left ventricular function, a CARISMA sub-analysis. Europace 13:11, 1604-1611
CrossRef79
B. Schaer, C. Sticherling, T. Szili-Torok, S. Osswald, L. Jordaens, D. A. Theuns. (2011) Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease. Europace 13:11, 1562-1567
CrossRef80
M. Saeed, M. Razavi, C. G. Neason, S. Petrutiu. (2011) Rationale and design for programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study. Europace 13:11, 1648-1652
CrossRef81
Y. Sobue, E. Watanabe, M. Yamamoto, K. Sano, H. Harigaya, K. Okuda, Y. Ozaki. (2011) Beat-to-beat variability of T-wave amplitude for the risk assessment of ventricular tachyarrhythmia in patients without structural heart disease. Europace 13:11, 1612-1618
CrossRef82
PAUL A. SCOTT, ANDREW WHITTAKER, MEHMOOD ZEB, EDD WATTS, ARTHUR M. YUE, PAUL R. ROBERTS, JOHN M. MORGAN. (2011) Rates of Upgrade of ICD Recipients to CRT in Clinical Practice and the Potential Impact of the More Liberal Use of CRT at Initial Implant. Pacing and Clinical Electrophysiologyno-no
CrossRef83
Alex J.A. McLellan, Scott C. McKenzie, Andrew J. Taylor. (2011) Cardiac Magnetic Resonance Imaging Predicts Recovery of Left Ventricular Function in Acute Onset Cardiomyopathy. Heart, Lung and Circulation
CrossRef84
Prashant D. Bhave, Kurt S. Hoffmayer, Ehrin J. Armstrong, Sonia Garg, Ateet Patel, John S. MacGregor, John C. Stein, Scott Kinlay, Peter Ganz, James M. McCabe. (2011) Predictors of Depressed Left Ventricular Function in Patients Presenting With ST-Elevation Myocardial Infarction. The American Journal of Cardiology
CrossRef85
Joep Thijssen, C. Jan Willem Borleffs, Johannes B. van Rees, SumChe Man, Mihály K. de Bie, Jeroen Venlet, Enno T. van der Velde, Lieselot van Erven, Martin J. Schalij. (2011) Implantable Cardioverter-Defibrillator Longevity under Clinical Circumstances: an Analysis According to Device Type, Generation, and Manufacturer. Heart Rhythm
CrossRef86
Revenco Diana, Morgan James P, Tsao Lana. (2011) The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population. Journal of Geriatric Cardiology 8:3, 195-200
CrossRef87
M. Guenther, T. Rauwolf, B. Bruggemann, M. Gerlach, N. K. Wassnig, M. Christoph, M. U. Braun, R. H. Strasser, C. Wunderlich. (2011) Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: A measure of safety or out of date? A retrospective analysis of 975 patients. Europace
CrossRef88
Juna Misiri, Shawn Candler, Fred M. Kusumoto. (2011) Evaluation of Syncope and Palpitations in Women. Journal of Women's Health 20:10, 1505-1515
CrossRef89
Florian Streitner, Juergen Kuschyk, Claudia Dietrich, Eva Mahl, Ines Streitner, Christina Doesch, Christian Veltmann, Rainer Schimpf, Christian Wolpert, Martin Borggrefe. (2011) Comparison of Ventricular Tachyarrhythmia Characteristics in Patients With Idiopathic Dilated or Ischemic Cardiomyopathy and Defibrillators Implanted for Primary Prevention. Clinical Cardiology 34:10, 604-609
CrossRef90
Peter Oosterhoff, Larisa G. Tereshchenko, Marcel A.G. van der Heyden, Raja N. Ghanem, Barry J. Fetics, Ronald D. Berger, Marc A. Vos. (2011) Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: A comparison with QT variability index. Heart Rhythm 8:10, 1584-1590
CrossRef91
Attila Mihálcz, Pál Ábrahám, Attila Kardos, Csaba Földesi, Tamás Szili-Török. (2011) Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben. Orvosi Hetilap 152:44, 1757-1763
CrossRef92
DAVID S. FRANKEL, STAVROS E. MOUNTANTONAKIS, MELISSA R. ROBINSON, ERICA S. ZADO, DAVID J. CALLANS, FRANCIS E. MARCHLINSKI. (2011) Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention. Journal of Cardiovascular Electrophysiology 22:10, 1123-1128
CrossRef93
H. I. Lehmann, A. Goette, J. Martens-Lobenhoffer, M. Hammwohner, F.-W. Rohl, A. Bukowska, A. Ghanem, H. U. Klein, S. M. Bode-Boger. (2011) Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Europace 13:10, 1428-1435
CrossRef94
Leonardo Calò, Tiziana De Santo, Francesca Nuccio, Luigi Sciarra, Lucia De Luca, Lorenza Mangoni di S. Stefano, Enrico Piroli, Lorenzo Zuccaro, Marco Rebecchi, Ermenegildo de Ruvo, Ernesto Lioy. (2011) Predictive Value of Microvolt T-Wave Alternans for Cardiac Death or Ventricular Tachyarrhythmic Events in Ischemic and Nonischemic Cardiomyopathy Patients: A Meta-Analysis. Annals of Noninvasive Electrocardiology 16:4, 388-402
CrossRef95
Lothar Faber, Marios Vlachojannis, Olaf Oldenburg, Detlef Hering, Nicola Bogunovic, Dieter Horstkotte, Barbara Lamp. (2011) Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival. The International Journal of Cardiovascular Imaging
CrossRef96
MICHAEL R. GOLD, DOMINIC A. THEUNS, BRADLEY P. KNIGHT, J. LACY STURDIVANT, RICK SANGHERA, KENNETH A. ELLENBOGEN, MARK A. WOOD, MARTIN C. BURKE. (2011) Head-To-Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study. Journal of Cardiovascular Electrophysiologyno-no
CrossRef97
ZALMEN BLANCK, KATHI AXTELL, KATHY BRODHAGEN, LAURA O'HEARN, TAMMY ALBELO, CHERYL CERETTO, ANWER DHALA, JASBIR SRA, MASOOD AKHTAR. (2011) Inappropriate Shocks in Patients With Fidelis® Lead Fractures: Impact of Remote Monitoring and the Lead Integrity Algorithm. Journal of Cardiovascular Electrophysiology 22:10, 1107-1114
CrossRef98
Daniel Caldeira, Cláudio David, Cristina Sampaio. (2011) Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials. European Journal of Internal Medicine 22:5, 448-455
CrossRef99
A. Auricchio, A. Meijer, T. Kurita, E. Schloss, K. Brinkman, M. Claessens-van Ooijen, L. Sterns. (2011) Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace 13:10, 1484-1493
CrossRef100
Mustafa Dohadwala, N. A. Mark Estes, Mark S. Link. (2011) New Paradigms in the Prevention of Sudden Cardiac Arrest and Heart Failure Treatment. Current Cardiology Reports 13:5, 377-386
CrossRef101
Ian Crozier. (2011) The subcutaneous defibrillator will replace the transvenous defibrillator. Journal of Interventional Cardiac Electrophysiology 32:1, 73-77
CrossRef102
Ioanna Kosmidou, Keiichi Inada, Jens Seiler, Bruce Koplan, William G. Stevenson, Usha B. Tedrow. (2011) Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm 8:10, 1516-1522
CrossRef103
Fabrice Extramiana, Antoine Leenhardt. (2011) Prolonged QRS duration and sudden cardiac death risk stratification: Not yet ready for prime time. Heart Rhythm 8:10, 1568-1569
CrossRef104
CHRISTINE TOMPKINS, RHONDALYN MCLEAN, ALAN CHENG, JEFFREY A. BRINKER, JOSEPH E. MARINE, SAMAN NAZARIAN, DAVID D. SPRAGG, SUNIL SINHA, HENRY HALPERIN, GORDON F. TOMASELLI, RONALD D. BERGER, HUGH CALKINS, CHARLES A. HENRIKSON. (2011) End-Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants. Journal of Cardiovascular Electrophysiology 22:10, 1099-1104
CrossRef105
D. B. Sims, A. Mignatti, P. C. Colombo, N. Uriel, L. I. Garcia, F. A. Ehlert, U. P. Jorde. (2011) Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. Europace 13:10, 1459-1463
CrossRef106
Carmen Teodorescu, Kyndaron Reinier, Audrey Uy-Evanado, Jo Navarro, Ronald Mariani, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2011) Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm 8:10, 1562-1567
CrossRef107
DAN D. MATLOCK, CAROLYN T. NOWELS, FREDERICK A. MASOUDI, WILLIAM H. SAUER, DAVID B. BEKELMAN, DEBORAH S. MAIN, JEAN S. KUTNER. (2011) Patient and Cardiologist Perceptions on Decision Making for Implantable Cardioverter-Defibrillators: A Qualitative Study. Pacing and Clinical Electrophysiologyno-no
CrossRef108
Benoit Desjardins. (2011) MR Imaging of Myocardial Scar, with Electrophysiology Applications. PET Clinics 6:4, 489-502
CrossRef109
T. Smith, P. F. Dessel, D. A. M. J. Theuns, A. Muskens-Heemskerk, R. T. Domburg, A. A. Wilde, L. Jordaens. (2011) Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Netherlands Heart Journal 19:10, 405-411
CrossRef110
Mitchell T. Saltzberg, Steven Szymkiewicz, Nicole R. Bianco. (2011) Characteristics and Outcomes of Peripartum Versus Nonperipartum Cardiomyopathy in Women Using a Wearable Cardiac Defibrillator. Journal of Cardiac Failure
CrossRef111
Sumeet K. Mainigi, Khalid Almuti, Vincent M. Figueredo, Nils A. Guttenplan, Asma Aouthmany, Jessica Smukler, Bernadette Sheeron, Bryan Meldrum, Agustina D. Saenz, Gia Tran, Allan M. Greenspan. (2011) Usefulness of Radiofrequency Ablation of Supraventricular Tachycardia to Decrease Inappropriate Shocks from Implantable Cardioverter–Defibrillators. The American Journal of Cardiology
CrossRef112
Violeta Monasterio, Pablo Laguna, Iwona Cygankiewicz, Rafael Vázquez, Antoni Bayés-Genís, Antoni Bayés de Luna, Juan Pablo Martínez. (2011) Average T-wave alternans activity in ambulatory ECG records predicts sudden cardiac death in patients with chronic heart failure. Heart Rhythm
CrossRef113
Olivera Gojkovic, Etienne M. Aliot, Alessandro Capucci, Stuart J. Connolly, Harry Crijns, Stefan H. Hohnloser, Piotr Kulakowski, Denis Roy, David Radzik, Bramah N. Singh, Peter R. Kowey. (2011) Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions. Heart Rhythm
CrossRef114
Michael R. Gold, Saleem Ahmad, Kevin Browne, Kellie Chase Berg, Lisa Thackeray, Ronald D. Berger. (2011) Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm
CrossRef115
Samir Saba, Haider Mehdi, Hemal Shah, Zahid Islam, Elie Aoun, Sammy Termanini, Reem Mahjoub, Ryan Aleong, Charles F. McTiernan, Barry London. (2011) Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction. Heart Rhythm
CrossRef116
, Satoshi Shizuta, Kenji Ando, Masakiyo Nobuyoshi, Takanori Ikeda, Hideaki Yoshino, Shinichi Hiramatsu, Yukio Kazatani, Kohei Yamashiro, Katsunori Okajima, Teishi Kajiya, Yoshinori Kobayashi, Takao Kato, Satoki Fujii, Kazuaki Mitsudo, Koichi Inoue, Hiroshi Ito, Yoshisumi Haruna, Takahiro Doi, Yukiko Nishio, Neiko Ozasa, Kei Nishiyama, Toru Kita, Takeshi Morimoto, Takeshi Kimura. (2011) Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study. Clinical Research in Cardiology
CrossRef117
J. B. van Rees, C. J. W. Borleffs, J. Thijssen, M. K. de Bie, L. van Erven, S. C. Cannegieter, J. J. Bax, M. J. Schalij. (2011) Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace
CrossRef118
M. T. Hoogwegt, N. Kupper, D. A. M. J. Theuns, L. Jordaens, S. S. Pedersen. (2011) Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator. Europace
CrossRef119
R. Mollo, A. Cosenza, A. Spinelli, I. Coviello, G. Careri, I. Battipaglia, M. Laurito, G. Pinnacchio, G. A. Lanza, F. Crea. (2011) T-wave alternans in apparently healthy subjects and in different subsets of patients with ischaemic heart disease. Europace
CrossRef120
M.-S. Kim, J.-S. Kim, S.-C. Yun, C.-W. Lee, J.-K. Song, S.-W. Park, S.-J. Park, J.-J. Kim. (2011) Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure. European Heart Journal
CrossRef121
Wolfgang Dichtl, Thomas Wolber, Ursula Paoli, Thomas Theurl, Simon Brüllmann, Markus Stühlinger, Thomas Berger, Karin Spuller, Alexander Strasak, Otmar Pachinger, Laurent Haegeli, Firat Duru, Florian Hintringer. (2011) Elevated γ-glutamyltransferase in implantable cardioverter defibrillator patients. Wiener klinische Wochenschrift
CrossRef122
DARÍO DI TORO, CLAUDIO MURATORE, LUIS AGUINAGA, LUIZ BATISTA, ANTONIO MALAN, OSWALDO GRECO, CHAMIA BENCHETRIT, MAURICIO DUQUE, ADRIAN BARANCHUK, JENNIFER MALONEY. (2011) Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas’ Cardiomyopathy. Pacing and Clinical Electrophysiology 34:9, 1063-1069
CrossRef123
M. Tavenaux, D.M. Ginzburg, A. Boukacem, J. Sperzel, C. Hamm, J. Jordan. (2011) Veränderungen bei Depression, Angst und vitaler Erschöpfung bei Patienten nach einer ICD-Implantation. Herzschrittmachertherapie + Elektrophysiologie 22:3, 174-180
CrossRef124
Todd D. Miller. (2011) Stress testing. Current Opinion in Cardiology 26:5, 363-369
CrossRef125
Norman C. Wang, Gregg C. Fonarow, Mihai Gheorghiade. (2011) The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes. Heart Failure Reviews 16:5, 437-439
CrossRef126
Amala Chirumamilla, Mark I. Travin. (2011) Cardiac Applications of 123I-mIBG Imaging. Seminars in Nuclear Medicine 41:5, 374-387
CrossRef127
Allison C. Hill, Anne M. Dubin. (2011) Implantable Cardioverter–Defibrillator Therapy in Pediatric Patients and Congenital Heart Disease. Cardiac Electrophysiology Clinics 3:3, 349-357
CrossRef128
Fadi G. Hage, Wael AlJaroudi, Himanshu Aggarwal, Vikas Bhatia, John Miller, Harish Doppalapudi, Oussama Wazni, Ami E. Iskandrian. (2011) Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: Primary versus secondary prevention. International Journal of Cardiology
CrossRef129
Marwan Refaat, Samir Saba. (2011) Total Subcutaneous Defibrillators: The Current Status and Future Prospect of a New Technology. Cardiac Electrophysiology Clinics 3:3, 403-408
CrossRef130
F. ROOSEVELT GILLIAM, DAVID L. HAYES, JOHN P. BOEHMER, JOHN DAY, PAUL A. HEIDENREICH, MILAN SETH, PAUL W. JONES, KENNETH M. STEIN, LESLIE A. SAXON. (2011) Real World Evaluation of Dual-Zone ICD and CRT-D Programming Compared to Single-Zone Programming: The ALTITUDE REDUCES Study. Journal of Cardiovascular Electrophysiology 22:9, 1023-1029
CrossRef131
Miyuki Tsuchihashi-Makaya, Hisashi Matsuo, Shigeo Kakinoki, Shigeru Takechi, Hiroyuki Tsutsui. (2011) Rationale and design of the Japanese Heart Failure Outpatients Disease Management and Cardiac Evaluation (J-HOMECARE). Journal of Cardiology 58:2, 165-172
CrossRef132
Jose L. Andrey, Francisco M. Gomez-Soto, Sotero P. Romero, Miguel A. Escobar, A. Antonio García-Egido, Rocio Garcia-Arjona, Francisco Gomez. (2011) Mortality of newly diagnosed heart failure treated with amiodarone. International Journal of Cardiology 151:2, 175-181
CrossRef133
Michael S. Lauer, Richard Hodes. (2011) Commentary: Epidemiology, Comparative Effectiveness Research, and the National Institutes of Health. Epidemiology 22:5, 625-628
CrossRef134
T. Jared Bunch, Heidi T. May, Tami L. Bair, Brian G. Crandall, J. Peter Weiss, Jeffrey S. Osborn, Jeffrey L. Anderson, Joseph B. Muhlestein, Benjamin D. Horne, Donald L. Lappe, John D. Day. (2011) Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy. Heart Rhythm 8:9, 1460-1466
CrossRef135
Sheba Ahmed, Isabelle C. Van Gelder, Ans C. P. Wiesfeld, Dirk J. Van Veldhuisen, Thera P. Links. (2011) Determinants and outcome of amiodarone-associated thyroid dysfunction. Clinical Endocrinology 75:3, 388-394
CrossRef136
Thomas A. Dewland, Jeffrey E. Olgin, Byron K. Lee. (2011) Indications for a Wearable Cardioverter-Defibrillator. Cardiac Electrophysiology Clinics 3:3, 339-347
CrossRef137
Jordan M. Prutkin, Jeanne E. Poole. (2011) Complications of ICD Generator Change and Implantations. Cardiac Electrophysiology Clinics 3:3, 389-401
CrossRef138
ARTHUR SHIYOVICH, AMOS KATZ. (2011) The “Shock Factor”: ICD Configuration and Programming to Optimize Shock Treatment. Journal of Cardiovascular Electrophysiology 22:9, 1030-1033
CrossRef139
James V. Freeman, Aditya Ullal, Mintu P. Turakhia. (2011) Cost-effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Cardiac Electrophysiology Clinics 3:3, 421-440
CrossRef140
Tamam Mohamad, Sony Jacob, Naga VA Kommuri, Shalini Modi, Rajeev Aravindhakshan, Randy Lieberman. (2011) Low Referral Pattern for Implantable Defibrillator Therapy in a Tertiary Hospital: Referral Physician Survey and Monte Carlo Simulation. American Journal of Therapeutics 18:5, 350-354
CrossRef141
Samir Saba. (2011) Death during acute myocardial infarction: Dodging the first bullet. Heart Rhythm 8:9, 1467-1468
CrossRef142
S. N. Burgess, S. A. Harding, I. C. Melton, N. A. Lever, A. H. Swain, B. Shi, P. D. Larsen. (2011) An unmet need for implantable cardioverter-defibrillators in New Zealand. Europace 13:9, 1299-1303
CrossRef143
Sean Balmain, Michael A McDonald. (2011) Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better. Expert Review of Cardiovascular Therapy 9:9, 1147-1153
CrossRef144
Aneta Aleksova, Giulia Barbati, Marco Merlo, Davide Stolfo, Gastone Sabbadini, Andrea Di Lenarda, Gianfranco Sinagra. (2011) Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: Data from the Trieste Cardiomyopathies Registry. Heart & Lung: The Journal of Acute and Critical Care 40:5, 454-461
CrossRef145
Lara Dabiri Abkenari, Dominic A. M. J. Theuns, Suzanne D. A. Valk, Yves Belle, Natasja M. Groot, David Haitsma, Agnes Muskens-Heemskerk, Tamas Szili-Torok, Luc Jordaens. (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clinical Research in Cardiology 100:9, 737-744
CrossRef146
Norman C. Wang, Jonathan P. Piccini, Mihai Gheorghiade. (2011) Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Heart Failure Reviews 16:5, 477-480
CrossRef147
Eric Smith Ketchum, Wayne Cecil Levy. (2011) Establishing Prognosis in Heart Failure: A Multimarker Approach. Progress in Cardiovascular Diseases 54:2, 86-96
CrossRef148
GISELLE A. BAQUERO, JAVIER E. BANCHS, SONDRA DEPALMA, SALLIE K. YOUNG, ERICA D. PENNY-PETERSON, SORAYA M. SAMII, DEBORAH L. WOLBRETTE, GERALD V. NACCARELLI, MARIO D. GONZALEZ. (2011) Dofetilide Reduces the Frequency of Ventricular Arrhythmias and Implantable Cardioverter Defibrillator Therapies. Journal of Cardiovascular Electrophysiologyno-no
CrossRef149
Jason Bradfield, Roderick Tung, Noel G. Boyle, Kalyanam Shivkumar. (2011) Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes. Heart Failure Reviews 16:5, 449-456
CrossRef150
William T. Abraham, Koonlawee Nademanee, Kent Volosin, Steven Krueger, Suresh Neelagaru, Nirav Raval, Owen Obel, Stanislav Weiner, Marc Wish, Peter Carson, Kenneth Ellenbogen, Robert Bourge, Michael Parides, Richard P. Chiacchierini, Rochelle Goldsmith, Sidney Goldstein, Yuval Mika, Daniel Burkhoff, Alan Kadish. (2011) Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure. Journal of Cardiac Failure 17:9, 710-717
CrossRef151
Ngan Lam, Peter Leong-Sit, Amit X. Garg. (2011) The Role of Implantable Cardioverter-Defibrillators in Long-term Dialysis Patients. American Journal of Kidney Diseases 58:3, 338-339
CrossRef152
John A. Schoenhard, Paul C. Zei. (2011) Reducing ICD Shocks for Ventricular Arrhythmias. Cardiac Electrophysiology Clinics 3:3, 493-502
CrossRef153
Jayanthi N. Koneru, Karoly Kaszala, Jose F. Huizar, Kenneth A. Ellenbogen. (2011) Lead Fracture: Incidence, Diagnosis and Preventing Inappropriate ICD Therapy. Cardiac Electrophysiology Clinics 3:3, 409-420
CrossRef154
Joseph J. Gard, Paul A. Friedman. (2011) Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators. Cardiac Electrophysiology Clinics 3:3, 373-387
CrossRef155
David J. Whellan, Suzanne Adams, Lisa Bowerman. (2011) Review of Advanced Heart Failure Device Diagnostics Examined in Clinical Trials and the Potential Benefit from Monitoring Capabilities. Progress in Cardiovascular Diseases 54:2, 107-114
CrossRef156
Daniel B. Kramer, Paul A. Friedman, Linda M. Kallinen, Thomas Ben Morrison, Daniel J. Crusan, David O. Hodge, Matthew R. Reynolds, Robert G. Hauser. (2011) Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm
CrossRef157
Ashish K Govil, Mohit D Gupta, MP Girish, Sanjay Tyagi. (2011) Prediction and Prevention in Sudden Cardiac Death. Apollo Medicine 8:3, 228-237
CrossRef158
Rajeshwari Nayak. (2011) Recent Advances in The Management of Refractory Heart Failure. Apollo Medicine 8:3, 175-179
CrossRef159
Vivian Tsai, Mary K. Goldstein, Henry H. Hsia, Yongfei Wang, Jeptha Curtis, Paul A. Heidenreich, . (2011) Age Differences in Primary Prevention Implantable Cardioverter-Defibrillator Use in U.S. Individuals. Journal of the American Geriatrics Society 59:9, 1589-1595
CrossRef160
Timir S. Baman, Thomas Crawford, Patricia Sovitch, Pascal Meier, Nathan Sovitch, Lindsey Gakenheimer, James Kirkpatrick, Brad Wasserman, George Samson, Hakan Oral, Kim A. Eagle. (2011) Feasibility of postmortem device acquisition for potential reuse in underserved nations. Heart Rhythm
CrossRef161
YI-ZHOU XU, PAUL A. FRIEDMAN, TRACY WEBSTER, KELLY BROOKE, DAVID O. HODGE, HEATHER J. WISTE, WEI HUA, SHU ZHANG, DAVID L. HAYES, YONG-MEI CHA. (2011) Cardiac Resynchronization Therapy: Do Women Benefit More Than Men?. Journal of Cardiovascular Electrophysiologyno-no
CrossRef162
M. K. de Bie, D. A. Fouad, C. J. W. Borleffs, J. B. van Rees, J. Thijssen, S. A. Trines, M. Bootsma, M. J. Schalij, L. van Erven. (2011) Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures. Europace
CrossRef163
, C. Berry, R. N. Doughty, C. Granger, L. Kober, B. Massie, F. McAlister, J. McMurray, S. Pocock, K. Poppe, K. Swedberg, J. Somaratne, G. A. Whalley, A. Ahmed, B. Andersson, A. Bayes-Genis, C. Berry, M. Cowie, R. Cubbon, R. N. Doughty, J. Ezekowitz, J. Gonzalez-Juanatey, M. Gorini, I. Gotsman, L. Grigorian-Shamagian, M. Guazzi, M. Kearney, L. Kober, M. Komajda, A. di Lenarda, M. Lenzen, D. Lucci, S. Macin, B. Madsen, A. Maggioni, M. Martinez-Selles, F. McAlister, F. Oliva, K. Poppe, M. Rich, M. Richards, M. Senni, I. Squire, G. Taffet, L. Tarantini, C. Tribouilloy, R. Troughton, H. Tsutsui, G. A. Whalley, R. N. Doughty, N. Earle, K. Perera, K. Poppe, G. A. Whalley, J. Dobson, S. Pocock, K. Poppe, R. N. Doughty, G. Whalley, B. Andersson, C. Hall, A. M. Richards, R. Troughton, J. Lainchbury, C. Berry, K. Hogg, J. Norrie, K. Stevenson, M. Brett, J. McMurray, M. A. Pfeffer, K. Swedberg, C. B. Granger, P. Held, J. J. V. McMurray, E. L. Michelson, B. Olofsson, J. Ostergren, S. Yusuf, L. Kober, C. Torp-Pedersen, A. Ahmed, M. J. Lenzen, W. J. M. Scholte op Reimer, E. Boersma, P. J. M. J. Vantrimpont, F. Follath, K. Swedberg, J. Cleland, M. Komajda, I. Gotsman, D. Zwas, D. Planer, T. Azaz-Livshits, D. Admon, C. Lotan, A. Keren, L. Grigorian-Shamagian, A. Varela-Roman, P. Mazon-Ramos, P. Rigeiro-Veloso, M. A. Bandin-Dieguez, J. R. Gonzalez-Juanatey, M. Guazzi, J. Myers, R. Arena, F. A. McAlister, J. Ezekowitz, P. W. Armstrong, B. Cujec, I. Paterson, M. R. Cowie, D. A. Wood, A. J. S. Coats, S. G. Thompson, V. Suresh, P. A. Poole-Wilson, G. C. Sutton, M. Martinez-Selles, J. A. G. Robles, L. Prieto, M. D. Munoa, E. Frades, O. Diaz-Castro, J. Almendral, L. Tarantini, P. Faggiano, M. Senni, D. Lucci, D. Bertoli, M. Porcu, C. Opasich, L. Tavazzi, A. P. Maggioni, V. Kirk, M. Bay, J. Parner, K. Krogsgaard, T. M. Herzog, S. Boesgaard, C. Hassager, O. W. Nielsen, J. Aldershvile, H. Nielsen, L. Kober, S. M. Macin, E. R. Perna, J. P. Cimbaro Canella, P. Alvarenga, R. Pantich, N. Rios, E. F. Farias, J. R. Badaracco, B. K. Madsen, J. F. Hansen, K. H. Stokholm, J. Brons, D. Husum, L. S. Mortensen, A. Bayes-Genis, R. Vazquez, T. Puig, C. Fernandez-Palomeque, A. Bardaji, D. Pascual-Figal, J. Ordonez-Llanos, M. Valdes, A. Gabarrus, R. Pavon, L. Pastor, J. R. Gonzalez-Juanatey, J. Almendral, M. Fiol, V. Nieto, C. Macaya, J. Cinca, A. Bayes de Luna, J. D. Newton, H. M. Blackledge, I. B. Squire, S. P. Wright, G. A. Whalley, R. N. Doughty, R. Kerzner, B. F. Gage, K. E. Freedland, M. W. Rich, B. C. Huynh, A. Rovner, K. E. Freedland, R. M. Carney, M. W. Rich, G. E. Taffet, T. A. Teasdale, A. J. Bleyer, N. J. Kutka, R. J. L. Tribouilloy, D. Rusinaru, H. Mahjoub, V. Souliere, F. Levy, M. Peltier, H. Tsutsui, M. Tsuchihashi, A. Takeshita, P. A. MacCarthy, M. T. Kearney, R. Cubbon, J. Nolan, A. J. Lee, R. J. Prescott, A. M. Shah, W. P. Brooksby, K. A. A. Fox, A. Varela-Roman, J. R. Gonzalez-Juanatey, P. Basante, R. Trillo, J. Garcia-Seara, J. L. Martinez-Sande, F. Gude. (2011) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. European Heart Journal
CrossRef164
LAURA PERROTTA, PAOLO PIERAGNOLI, GIUSEPPE RICCIARDI, STEFANIA SACCHI, GIUSEPPE MASCIA, MARGHERITA PADELETTI, MARIA GRAZIA BONGIORNI, ANTONIO CURNIS, FULVIO BELLOCCI, ANTONIO MICHELUCCI, MARIA CRISTINA PORCIANI, LUIGI PADELETTI. (2011) Multicenter Experience with Implantable Defibrillators Subject to Recall. Pacing and Clinical Electrophysiology 34:8, 998-1002
CrossRef165
Eric C. Stecker, Sumeet S. Chugh. (2011) Prediction of sudden cardiac death: next steps in pursuit of effective methodology. Journal of Interventional Cardiac Electrophysiology 31:2, 101-107
CrossRef166
Philipp Boyé, Hassan Abdel-Aty, Udo Zacharzowsky, Steffen Bohl, Carsten Schwenke, Rob J. van der Geest, Rainer Dietz, Alexander Schirdewan, Jeanette Schulz-Menger. (2011) Prediction of Life-Threatening Arrhythmic Events in Patients With Chronic Myocardial Infarction by Contrast-Enhanced CMR. JACC: Cardiovascular Imaging 4:8, 871-879
CrossRef167
Robert Neil Doughty. (2011) Pronóstico de los pacientes con insuficiencia cardiaca y fracción de eyección preservada. ¿Es el mismo que con fracción de eyección baja?. Revista Española de Cardiología 64:8, 646-648
CrossRef168
Craig P. Dobson, Maria Teresa La Rovere, Gian Domenico Pinna, Robert Goldstein, Cara Olsen, Marino Bernardinangeli, Marco Veniani, Paolo Midi, Luigi Tavazzi, Mark Haigney. (2011) QT variability index on 24-hour Holter independently predicts mortality in patients with heart failure: analysis of Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. Heart Rhythm 8:8, 1237-1242
CrossRef169
Thomas A. Dewland, Cara N. Pellegrini, Yongfei Wang, Gregory M. Marcus, Edmund Keung, Paul D. Varosy. (2011) Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry. Journal of the American College of Cardiology 58:10, 1007-1013
CrossRef170
Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, 1340-1356
CrossRef171
Kyndaron Reinier, Celia Dervan, Tejwant Singh, Audrey Uy-Evanado, Shenghan Lai, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2011) Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm 8:8, 1177-1182
CrossRef172
Johannes B. van Rees, Mihály K. de Bie, Joep Thijssen, C. Jan Willem Borleffs, Martin J. Schalij, Lieselot van Erven. (2011) Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices. Journal of the American College of Cardiology 58:10, 995-1000
CrossRef173
Amit K. Mehrotra, Bradley P. Knight, Matthew P. Smelley, Dipak P. Shah, Ian Weisberg, Jose Baez-Escudero, John F. Beshai, Martin C. Burke. (2011) Medtronic Sprint Fidelis lead recall: Determining the initial 5-year management cost to Medicare. Heart Rhythm 8:8, 1192-1197
CrossRef174
Amin Al-Ahmad, James V. Freeman. (2011) Is Less More?. Journal of the American College of Cardiology 58:10, 1014-1015
CrossRef175
Charles F. Jackson, Nanette K. Wenger. (2011) Enfermedad cardiovascular en el anciano. Revista Española de Cardiología 64:8, 697-712
CrossRef176
BRIAN D. POWELL, YONG-MEI CHA, SAMUEL J. ASIRVATHAM, DAVID A. CESARIO, MICHAEL CAO, PAUL W. JONES, MILAN SETH, LESLIE A. SAXON, F. ROOSEVELT GILLIAM III. (2011) Implantable Cardioverter Defibrillator Electrogram Adjudication for Device Registries: Methodology and Observations from ALTITUDE. Pacing and Clinical Electrophysiology 34:8, 1003-1012
CrossRef177
Robert Neil Doughty. (2011) Prognosis for Patients With Heart Failure With Preserved Ejection Fraction. Is It the Same As Low Ejection Fraction?. Revista Española de Cardiología (English Edition) 64:8, 646-648
CrossRef178
Johannes Holzmeister, Christophe Leclercq. (2011) Implantable cardioverter defibrillators and cardiac resynchronisation therapy. The Lancet 378:9792, 722-730
CrossRef179
Esther S.H. Kim, Thomas P. Carrigan, Venu Menon. (2011) International Participation in Cardiovascular Randomized Controlled Trials Sponsored by the National Heart, Lung, and Blood Institute. Journal of the American College of Cardiology 58:7, 671-676
CrossRef180
Leon A. Cannizzaro, Jonathan P. Piccini, Uptal D. Patel, Adrian F. Hernandez. (2011) Device Therapy in Heart Failure Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 58:9, 889-896
CrossRef181
Arnold J. Greenspon, Jasmine D. Patel, Edmund Lau, Jorge A. Ochoa, Daniel R. Frisch, Reginald T. Ho, Behzad B. Pavri, Steven M. Kurtz. (2011) 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States. Journal of the American College of Cardiology 58:10, 1001-1006
CrossRef182
Charles F. Jackson, Nanette K. Wenger. (2011) Cardiovascular Disease in the Elderly. Revista Española de Cardiología (English Edition) 64:8, 697-712
CrossRef183
Martin Stockburger, Alice Krebs, Oezlem Celebi, Aischa Nitardy, Dirk Habedank, Thomas Knaus, Mathias Rauchhaus, Rainer Dietz. (2011) Long-Term Survival of Routine Implantable Cardioverter/Defibrillator Recipients Appears to be Significantly Impaired with Concomitant Diuretics and Improved with Aldosterone Antagonists. Cardiovascular Therapeutics 29:4, 243-250
CrossRef184
Deepak Bhakta, Lynne D. Foreman. (2011) Implantable cardioverter-defibrillator shock reduction: The new paradigm. Heart Rhythm
CrossRef185
Avi Fischer, Kevin T. Ousdigian, James W. Johnson, Jeffrey M. Gillberg, Bruce L. Wilkoff. (2011) The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm
CrossRef186
Gail K. Larsen, John Evans, William E. Lambert, Yiyi Chen, Merritt Raitt. (2011) Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm
CrossRef187
Steve W. Leung, Claude-Samy Elayi, Richard J. Charnigo, Mushabbar A. Syed. (2011) Clinical significance of right ventricular dysfunction in left ventricular non-compaction cardiomyopathy. The International Journal of Cardiovascular Imaging
CrossRef188
Jean-Claude Daubert, Erwan Donal, Cecilia Linde. (2011) A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy. Heart Failure Reviews
CrossRef189
Mauro Biffi, Matteo Ziacchi, Matteo Bertini, Beatrice Gardini, Andrea Mazzotti, Giulia Massaro, Cristian Martignani, Igor Diemberger, Giuseppe Boriani, Daniela Corsini. (2011) How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost?. International Journal of Technology Assessment in Health Care 27:03, 201-206
CrossRef190
Wolfgang Dichtl, Thomas Wolber, Ursula Paoli, Simon Brüllmann, Markus Stühlinger, Thomas Berger, Karin Spuller, Alexander Strasak, Otmar Pachinger, Laurent M. Haegeli, Firat Duru, Florian Hintringer. (2011) Appropriate Therapy But Not Inappropriate Shocks Predict Survival in Implantable Cardioverter Defibrillator Patients. Clinical Cardiology 34:7, 433-436
CrossRef191
Thomas B. Morrison, Paul A. Friedman, Linda M. Kallinen, David O. Hodge, Daniel Crusan, Kapil Kumar, David L. Hayes, Robert F. Rea, Robert G. Hauser. (2011) Impact of Implanted Recalled Sprint Fidelis Lead on Patient Mortality. Journal of the American College of Cardiology 58:3, 278-283
CrossRef192
WILLIAM STRIMEL, SHERI KOPLIK, H. ROBERT CHEN, JUHEE SONG, SHOEI K. STEPHEN HUANG. (2011) Safety and Effectiveness of Primary Prevention Cardioverter defibrillators in Octogenarians. Pacing and Clinical Electrophysiology 34:7, 900-906
CrossRef193
J. Brachmann, M. Bohm, K. Rybak, G. Klein, C. Butter, H. Klemm, R. Schomburg, J. Siebermair, C. Israel, A.-M. Sinha, H. Drexler, . (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). European Journal of Heart Failure 13:7, 796-804
CrossRef194
Domingo Palacios-Ceña, Marta Elena Losa-Iglesias, Paloma Salvadores-Fuentes, Cristina Alonso-Blanco, Cesar Fernández-de-las-Peñas. (2011) Experience of elderly Spanish men with an implantable cardioverter-defibrillator. Geriatrics & Gerontology International 11:3, 320-327
CrossRef195
JENS KREUZ, FRITZ HORLBECK, FELIX HOYER, FRITZ MELLERT, ROLF FIMMERS, LARS LICKFETT, GEORG NICKENIG, JOERG O. SCHWAB. (2011) An Impaired Renal Function: A Predictor of Ventricular Arrhythmias and Mortality in Patients with Nonischemic Cardiomyopathy and Heart Failure. Pacing and Clinical Electrophysiology 34:7, 894-899
CrossRef196
SEK Y. CHAIR, CHUI K. LEE, KAI C. CHOI, SAMUEL F. SEARS. (2011) Quality of Life Outcomes in Chinese Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 34:7, 858-867
CrossRef197
Scott G. Thomas, Jack M. Goodman, Jamie F. Burr. (2011) Evidence-based risk assessment and recommendations for physical activity clearance: established cardiovascular disease 1 1 This paper is one of a selection of papers published in this Special Issue, entitled Evidence-based risk assessment and recommendations for physical activity clearance, and has undergone the Journal’s usual peer review process.. Applied Physiology, Nutrition, and Metabolism 36:S1, S190-S213
CrossRef198
GUIDO H. VAN WELSENES, JOHANNES B. VAN REES, JOEP THIJSSEN, SERGE A. TRINES, LIESELOT VAN ERVEN, MARTIN J. SCHALIJ, C.J.W. BORLEFFS. (2011) Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life. Journal of Cardiovascular Electrophysiologyno-no
CrossRef199
Jan Steffel, Firat Duru. (2011) Rhythm disorders in isolated left ventricular noncompaction. Annals of Medicine1-8
CrossRef200
Lynne Warner Stevenson. (2011) Projecting heart failure into bankruptcy in 2012?. American Heart Journal 161:6, 1007-1011
CrossRef201
P. Lambert, A. Da Costa, P.-Y. Marcy, S. Kreps, G. Angellier, S. Marcié, P.-Y. Bondiau, C. Briand-Amoros, J. Thariat. (2011) Pacemaker, défibrillateur et radiothérapie : propositions de conduite à tenir en 2010 en fonction du type de stimulateur cardiaque, du pronostic et du site du cancer. Cancer/Radiothérapie 15:3, 238-249
CrossRef202
Allen E. Atchley, Ami E. Iskandrian, Dan Bensimhon, Stephen J. Ellis, Dalane W. Kitzman, Linda K. Shaw, Robert A. Pagnanelli, David J. Whellan, Julius M. Gardin, Andrew Kao, Khaled Abdul-Nour, Greg Ewald, Mary Norine Walsh, William E. Kraus, Christopher M. O'Connor, Salvador Borges-Neto. (2011) Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial. American Heart Journal 161:6, 1038-1045
CrossRef203
Gregg C. Fonarow, Clyde W. Yancy, Adrian F. Hernandez, Eric D. Peterson, John A. Spertus, Paul A. Heidenreich. (2011) Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. American Heart Journal 161:6, 1024-1030.e3
CrossRef204
DANIEL B. SIMS, GREGG ROSNER, NIR URIEL, JOSÉ GONZÁLEZ-COSTELLO, FREDERICK A. EHLERT, ULRICH P. JORDE. (2011) Twelve Hours of Sustained Ventricular Fibrillation Supported by a Continuous-Flow Left Ventricular Assist Device. Pacing and Clinical Electrophysiologyno-no
CrossRef205
Sandhya Murthy, Hannah I. Lipman. (2011) Management of End-Stage Heart Failure. Primary Care: Clinics in Office Practice 38:2, 265-276
CrossRef206
Michael W. Fong, Luanda Grazette, David Cesario, Michael Cao, Leslie Saxon. (2011) Treatment of Ventricular Tachycardia in Patients with Heart Failure. Current Cardiology Reports 13:3, 203-209
CrossRef207
Spyridon Deftereos, Georgios Giannopoulos, Charalampos Kossyvakis, Andreas Kaoukis, Konstantinos Raisakis, Vasiliki Panagopoulou, Olga Ntzouvara, Anastasia Perpinia, Ilias Rentoukas, Vlasios Pyrgakis, Antonios S. Manolis, Christodoulos Stefanadis. (2011) Relation of Ventricular Tachycardia/Fibrillation to Beta-Blocker Dose Maximization Guided by Pacing Mode Analysis in Nonpacemaker-Dependent Patients With Implantable Cardioverter–Defibrillator. The American Journal of Cardiology 107:12, 1812-1817
CrossRef208
Hirotaka Kawarai, Katsuya Kajimoto, Yuichiro Minami, Nobuhisa Hagiwara, Hiroshi Kasanuki. (2011) Risk of Sudden Death in End-Stage Hypertrophic Cardiomyopathy. Journal of Cardiac Failure 17:6, 459-464
CrossRef209
S. Arnous, N. F. Murphy, P. Pyne-Daly, Z. Nawoor, D. Keane, M. Ledwidge, K. McDonald. (2011) Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population. Irish Journal of Medical Science 180:2, 369-374
CrossRef210
Sandra L. Carroll, Patricia H. Strachan, Sonya de Laat, Lisa Schwartz, Heather M. Arthur. (2011) Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expectationsno-no
CrossRef211
John R. Wilson. (2011) Rhetorical Strategies Used in the Reporting of Implantable Defibrillator Primary Prevention Trials. The American Journal of Cardiology 107:12, 1806-1811
CrossRef212
M. Hudec, G. Kaliska. (2011) Case report of out-of-hospital heat dissipation of an implantable cardioverter-defibrillator. Europace 13:6, 902-904
CrossRef213
Nicolas Girerd, Emilie Nonin, Julien Pinot, Elodie Morel, Carine Flys, Alina Scridon, Philippe Chevalier. (2011) Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Archives of Cardiovascular Diseases 104:6-7, 388-395
CrossRef214
Kurt C. Roberts-Thomson, Dennis H. Lau, Prashanthan Sanders. (2011) The diagnosis and management of ventricular arrhythmias. Nature Reviews Cardiology 8:6, 311-321
CrossRef215
N. A. Mark Estes, Munther Homoud, Jonathan Weinstock, Caroline Foote, Ania Garlitski, Mark Link, Afshin Ehsan. (2011) Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. Journal of Interventional Cardiac Electrophysiology 31:1, 91-99
CrossRef216
J. J. Glazier, S. R. Dixon. (2011) Skin injury following prolonged fluoroscopy: early and late appearances. QJM
CrossRef217
F. Leyva, I. Fernandez Lozano, J. Morgan. (2011) Cardioverter-defibrillators: a cost or an investment?. Europace 13:Supplement 2, ii25-ii31
CrossRef218
J. B. Johansen, P. T. Mortensen, R. Videbaek, S. Riahi, M. Moller, J. Haarbo, S. S. Pedersen. (2011) Attitudes towards implantable cardioverter-defibrillator therapy: a national survey in Danish health-care professionals. Europace 13:5, 663-667
CrossRef219
C. Wolpert, A. Lubinski, A. Bissinger, B. Merkely, S. Priori, J. Brugada. (2011) Barriers to implementation of evidence-based electrical therapies and the need for outcome research: role of European registries. Europace 13:Supplement 2, ii18-ii20
CrossRef220
Douglas L. Packer, Anne M. Gillis, Hugh Calkins, Thomas F. Deering, Richard I. Fogel, Bruce L. Wilkoff. (2011) ICDs: Evidence, guidelines and glitches. Heart Rhythm 8:5, 800-803
CrossRef221
AMIN MANUCHEHRY, KARTIK AGUSALA, MAURO MONTEVECCHI, ALAN KADISH, ROD PASSMAN. (2011) Ventricular Tachyarrhythmias in Patients Receiving an Implantable Cardioverter-Defibrillator for Primary versus Secondary Prophylaxis Indications. Pacing and Clinical Electrophysiology 34:5, 571-576
CrossRef222
Marlena V. Habal, Vaska Micevski, Sarah Greenwood, Diego H. Delgado, Heather J. Ross. (2011) How Aware of Advanced Care Directives Are Heart Failure Patients, and Are They Using Them?. Canadian Journal of Cardiology 27:3, 376-381
CrossRef223
M. Malik. (2011) Ventricular gradient and cardiac risk. Europace 13:5, 605-607
CrossRef224
PETER STEMPNIEWICZ, ALAN CHENG, ALLISON CONNOLLY, XIN YUAN WANG, HUGH CALKINS, GORDON F. TOMASELLI, RONALD D. BERGER, LARISA G. TERESHCHENKO. (2011) Appropriate and Inappropriate Electrical Therapies Delivered by an Implantable Cardioverter-Defibrillator: Effect on Intracardiac Electrogram. Journal of Cardiovascular Electrophysiology 22:5, 554-560
CrossRef225
Maria Teresa La Rovere. 2011. Evaluation of the Autonomic Nervous System: From Algorithms to Clinical Practice. , 83-97.
CrossRef226
2011. Appendix. , 386-418.
CrossRef227
2011. Arrhythmias in Different Heart Diseases and Situations. , 360-385.
CrossRef228
John J. V. McMurray. (2011) Heart failure: Acute ischemic events in HF—should we include sudden death?. Nature Reviews Cardiology 8:4, 192-193
CrossRef229
Melanie D. Everitt, Amy E. Donaldson, Josef Stehlik, Aditya K. Kaza, Deborah Budge, Rami Alharethi, Emily A. Bullock, Abdallah G. Kfoury, Anji T. Yetman. (2011) Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). The Journal of Heart and Lung Transplantation 30:4, 395-401
CrossRef230
Cameron J. Holloway, Lindsay M. Edwards, Oliver J. Rider, Angela Fast, Kieran Clarke, Jane M. Francis, Saul G. Myerson, Stefan Neubauer. (2011) A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance. The International Journal of Cardiovascular Imaging 27:4, 563-569
CrossRef231
Ayesha Hasan, Benjamin Sun. (2011) Defibrillators and Cardiac Resynchronization Therapy as a Bridge to Cardiac Transplantation. Heart Failure Clinics 7:2, 227-239
CrossRef232
Michael L. Bernard, Michael R. Gold. (2011) Economic Implications and Cost-effectiveness of Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy. Heart Failure Clinics 7:2, 241-250
CrossRef233
FADI MANSOUR, PAUL KHAIRY. (2011) Programming ICDs in the Modern Era beyond Out-of-the Box Settings. Pacing and Clinical Electrophysiology 34:4, 506-520
CrossRef234
Melissa R. Robinson, Andrew E. Epstein, David J. Callans. (2011) Secondary Prevention in Heart Failure. Heart Failure Clinics 7:2, 185-194
CrossRef235
S. Muzzarelli, H. Stricker, O. Pfister, P. Foglia, G. Moschovitis, G. Mombelli, H. Brunner-La Rocca. (2011) Individual dosage of digoxin in patients with heart failure. QJM 104:4, 309-317
CrossRef236
Anurag Gupta, Amin Al-Ahmad, Paul J. Wang. (2011) Subcutaneous Implantable Cardioverter-Defibrillator Technology. Heart Failure Clinics 7:2, 287-294
CrossRef237
H. Voller, W. Kamke, H. U. Klein, M. Block, R. Reibis, S. Treusch, K. Contzen, K. Wegscheider, . (2011) Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II Registry. Europace 13:4, 499-508
CrossRef238
Ragavendra R. Baliga, James B. Young. (2011) Editorial: Sudden Death in Heart Failure: An Ounce of Prediction is Worth a Pound of Prevention. Heart Failure Clinics 7:2, xiii-xviii
CrossRef239
Nicholas H. Bergen, Dianne L. Atkins, Macdonald Dick, David J. Bradley, Susan P. Etheridge, Elizabeth V. Saarel, Peter S. Fischbach, Seshadri Balaji, Narayanswami Sreeram, William N. Evans, Ian H. Law. (2011) Multicenter Study of the Effectiveness of Implantable Cardioverter Defibrillators in Children and Young Adults With Heart Disease. Pediatric Cardiology 32:4, 399-405
CrossRef240
I. M. Hamour, A. Khaghani, P. K. Kanagala, A. G. Mitchell, N. R. Banner. (2011) Current outcome of heart transplantation: a 10-year single centre perspective and review. QJM 104:4, 335-343
CrossRef241
Peem Lorvidhaya, Kamel Addo, Adam Chodosh, Venkat Iyer, Jeremy Lum, Alfred E. Buxton. (2011) Sudden Cardiac Death Risk Stratification in Patients with Heart Failure. Heart Failure Clinics 7:2, 157-174
CrossRef242
Samir Saba. (2011) Sudden Cardiac Death Risk Stratification and Assessment: Primary Prevention Based on Ejection Fraction Criteria. Heart Failure Clinics 7:2, 175-183
CrossRef243
John A Dodson, Mathew S Maurer. (2011) Changing nature of cardiac interventions in older adults. Aging Health 7:2, 283-295
CrossRef244
Jaya Mallidi, Girish N. Nadkarni, Ronald D. Berger, Hugh Calkins, Saman Nazarian. (2011) Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 8:4, 503-510
CrossRef245
Christopher Droogan, Chinmay Patel, Gan-Xin Yan, Peter R. Kowey. (2011) Role of Antiarrhythmic Drugs: Frequent Implantable Cardioverter-Defibrillator Shocks, Risk of Proarrhythmia, and New Drug Therapy. Heart Failure Clinics 7:2, 195-205
CrossRef246
D.M. Ginzburg, M. Tavenaux, J. Sperzel, C. Hamm, J. Jordan. (2011) Psychische Störungen nach ICD-Mehrfachschocks und deren psychotherapeutische Behandlung. Der Kardiologe 5:2, 114-121
CrossRef247
Andrea M. Russo. (2011) Risk stratification early post-MI after percutaneous coronary intervention: Should programmed ventricular stimulation be revisited?. Heart Rhythm 8:4, 500-502
CrossRef248
Moss, Arthur J., Francis, Charles W., Ryan, Daniel, . (2011) Collaborative Clinical Trials. New England Journal of Medicine 364:9, 789-791
Full Text249
Saurabh Malhotra, Mithilesh K Das. (2011) Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death. Future Cardiology 7:2, 203-217
CrossRef250
Rod Passman, Charles A. Herzog. (2011) End-stage renal disease: Sudden cardiac death: stratifying risk in dialysis patients. Nature Reviews Nephrology 7:3, 133-135
CrossRef251
Alexander Burashnikov, Charles Antzelevitch. (2011) Advances in the Pharmacologic Management of Atrial Fibrillation. Cardiac Electrophysiology Clinics 3:1, 157-167
CrossRef252
Brian Clarke, Jonathan Howlett, John Sapp, Pantelis Andreou, Ratika Parkash. (2011) The Effect of Comorbidity on the Competing Risk of Sudden and Nonsudden Death in an Ambulatory Heart Failure Population. Canadian Journal of Cardiology 27:2, 254-261
CrossRef253
N. Freemantle, C. Lafuente-Lafuente, S. Mitchell, L. Eckert, M. Reynolds. (2011) Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 13:3, 329-345
CrossRef254
GREGORY M. MARCUS, DERRICK W. CHAN, RITA F. REDBERG. (2011) Recollection of Pain Due to Inappropriate Versus Appropriate Implantable Cardioverter-Defibrillator Shocks. Pacing and Clinical Electrophysiology 34:3, 348-353
CrossRef255
D. Müller. (2011) Nachsorge von Patienten nach malignen Arrhythmien. Notfall + Rettungsmedizin 14:2, 104-108
CrossRef256
Cynthia M. Tracy. (2011) Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction. Heart Rhythm 8:3, 401-402
CrossRef257
G. H. van Welsenes, J. B. van Rees, C. J. W. Borleffs, S. C. Cannegieter, J. J. Bax, L. van Erven, M. J. Schalij. (2011) Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 13:3, 389-394
CrossRef258
KENT J. VOLOSIN, DEREK V. EXNER, MARK S. WATHEN, LOU SHERFESEE, ANTHONY P. SCINICARIELLO, JEFFREY M. GILLBERG. (2011) Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer Modeling. Journal of Cardiovascular Electrophysiology 22:3, 280-289
CrossRef259
Ayumi Goda, Lars H. Lund, Donna Mancini. (2011) The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. The Journal of Heart and Lung Transplantation 30:3, 315-325
CrossRef260
Hari Prasad, Jaspinder Sra, Wayne C. Levy, Dwight D. Stapleton. (2011) Influence of Predictive Modeling in Implementing Optimal Heart Failure Therapy. The American Journal of the Medical Sciences 341:3, 185-190
CrossRef261
Jonathan P. Piccini, Sana M. Al-Khatib, Anne S. Hellkamp, Kevin J. Anstrom, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2011) Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 8:3, 393-400
CrossRef262
Teresa Bastante Valiente, María J. Ruiz Cano, Juan F. Delgado, María López Gil, Fernando Arribas, Miguel A. Gómez Sánchez, José Cortina, Carlos Sáenz de la Calzada. (2011) Implante de desfibrilador como prevención primaria de muerte súbita en pacientes en lista de espera de trasplante cardiaco: experiencia de un centro. Revista Española de Cardiología 64:3, 240-242
CrossRef263
Raymond Cutro, Michael W. Rich, Paul J. Hauptman. (2011) Device therapy in patients with heart failure and advanced age: Too much too late?. International Journal of Cardiology
CrossRef264
Maryl R Johnson, Walter G Kao, Elaine M Winkel, Joseph L Bobadilla, Takushi Kohmoto, Niloo M Edwards. 2011. Heart Transplantation. , 171-204.
CrossRef265
D. M. Leistner, J. Schmitt, S. Palm, J. Klotsche, S. Estel, A. Fink, C. W. Israel, B. Assmus, G. Z. Duray, S. Dimmeler, S. H. Hohnloser, A. M. Zeiher. (2011) Intracoronary administration of bone marrow-derived mononuclear cells and arrhythmic events in patients with chronic heart failure. European Heart Journal 32:4, 485-491
CrossRef266
Melissa H. Kong, Gregg C. Fonarow, Eric D. Peterson, Anne B. Curtis, Adrian F. Hernandez, Gillian D. Sanders, Kevin L. Thomas, David L. Hayes, Sana M. Al-Khatib. (2011) Systematic Review of the Incidence of Sudden Cardiac Death in the United States. Journal of the American College of Cardiology 57:7, 794-801
CrossRef267
Nagara Tamaki, Keiichiro Yoshinaga. (2011) Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. Journal of Nuclear Cardiology 18:1, 135-143
CrossRef268
H. Issa, M. Buerke, R. Grabitz. (2011) Herzinsuffizienz bei Erwachsenen mit angeborenen Herzfehlern. Intensivmedizin und Notfallmedizin 48:1, 27-33
CrossRef269
William E. Sanders, Mark W. Richey, Robert A. Malkin, Stephen C. Masson, T.J. Ransbury, Mark W. Urtz, Raymond E. Ideker. (2011) Novel intravascular defibrillator: Defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model. Heart Rhythm 8:2, 288-292
CrossRef270
Marco Metra, Valerio Zacà, Gianfranco Parati, Piergiuseppe Agostoni, Maria Bonadies, Marco Ciccone, Alessandra Dei Cas, Massimo Iacoviello, Rocco Lagioia, Carolina Lombardi, Raffaele Maio, Damiano Magrì, Giuseppe Musca, Margherita Padeletti, Francesco Perticone, Natalia Pezzali, Massimo Piepoli, Angela Sciacqua, Luisa Zanolla, Savina Nodari, Pasquale Perrone Filardi, Livio Dei Cas. (2011) Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. Journal of Cardiovascular Medicine 12:2, 76-84
CrossRef271
Stefano Muzzarelli, Karen Ordovas, Charles B. Higgins. (2011) Cardiovascular MRI for the assessment of heart failure: Focus on clinical management and prognosis. Journal of Magnetic Resonance Imaging 33:2, 275-286
CrossRef272
Leah Iles, Heinz Pfluger, Lisa Lefkovits, Michelle J. Butler, Peter M. Kistler, David M. Kaye, Andrew J. Taylor. (2011) Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 57:7, 821-828
CrossRef273
William T Abraham, Philip B Adamson, Robert C Bourge, Mark F Aaron, Maria Rosa Costanzo, Lynne W Stevenson, Warren Strickland, Suresh Neelagaru, Nirav Raval, Steven Krueger, Stanislav Weiner, David Shavelle, Bradley Jeffries, Jay S Yadav. (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. The Lancet 377:9766, 658-666
CrossRef274
Weisfeldt, Myron L., Everson-Stewart, Siobhan, Sitlani, Colleen, Rea, Thomas, Aufderheide, Tom P., Atkins, Dianne L., Bigham, Blair, Brooks, Steven C., Foerster, Christopher, Gray, Randal, Ornato, Joseph P., Powell, Judy, Kudenchuk, Peter J., Morrison, Laurie J., . (2011) Ventricular Tachyarrhythmias after Cardiac Arrest in Public versus at Home. New England Journal of Medicine 364:4, 313-321
Full Text275
David G. Strauss, Jeanne E. Poole, Galen S. Wagner, Ronald H. Selvester, Julie M. Miller, Jill Anderson, George Johnson, Steven E. McNulty, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, Katherine C. Wu. (2011) An ECG index of myocardial scar enhances prediction of defibrillator shocks: An analysis of the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm 8:1, 38-45
CrossRef276
Sanjeev Saksena. (2011) Twenty-five years of implantable defibrillator practice in the USA: Are we ready for globalization?. Journal of Interventional Cardiac Electrophysiology 30:1, 1-3
CrossRef277
Sana M. Al-Khatib, Gillian D. Sanders, Sean M. O’Brien, Daniel Matlock, Louise O. Zimmer, Frederick A. Masoudi, Eric Peterson. (2011) Do Physicians’ Attitudes toward Implantable Cardioverter Defibrillator Therapy Vary by Patient Age, Gender, or Race?. Annals of Noninvasive Electrocardiology 16:1, 77-84
CrossRef278
Toshinori SOEJIMA, Eisaku YODEN, Yasumasa NISHIMURA, Seiji ONO, Akihiro YOSHIDA, Haruyuki FUKUDA, Noboru FUKUHARA, Ryohei SASAKI, Kayoko TSUJINO, Yoshiki NORIHISA. (2011) Radiation Therapy in Patients with Implanted Cardiac Pacemakers and Implantable Cardioverter Defibrillators: A Prospective Survey in Japan. Journal of Radiation Research 52:4, 516-521
CrossRef279
Kristin M. Burns, Frank Evans, Jonathan R. Kaltman. (2011) Pediatric ICD utilization in the United States from 1997 to 2006. Heart Rhythm 8:1, 23-28
CrossRef280
Norbert M. van Hemel. (2011) The ECG: The old ally for a better selection of preventive ICD treatment?. Heart Rhythm 8:1, 46-47
CrossRef281
W. Frank Peacock, Ileana L. Piña. (2011) Primary Role of B-Type Natriuretic Peptide Across the Clinical Spectrum: From Emergency Medicine to Transitional Care and Beyond Into the Community. Congestive Heart Failure 17:1, 8-13
CrossRef282
Arnold Pinter, Paul Dorian. (2011) Device therapy: Who may and who may not benefit from an ICD?. Nature Reviews Cardiology 8:1, 10-12
CrossRef283
MAREK MALIK. (2011) Autonomic Tests to Detect Cardiac Risk and Their Clinical Practicality. Journal of Cardiovascular Electrophysiologyno-no
CrossRef284
D. A. M. J. Theuns, B. A. Schaer, O. I. I. Soliman, D. Altmann, C. Sticherling, M. L. Geleijnse, S. Osswald, L. Jordaens. (2011) The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 13:1, 62-69
CrossRef285
JÉRÔME SCHWARTZ, HUGUES BLANGY, PIERRE YVES ZINZIUS, LUC FREYSZ, ETIENNE ALIOT, NICOLAS SADOUL. (2011) Recall Alerts in Implantable Cardioverter-Defibrillator Recipients: Implications for Patients and Physicians. Pacing and Clinical Electrophysiology 34:1, 96-103
CrossRef286
P. Santangeli, A. Dello Russo, M. Casella, G. Pelargonio, L. Di Biase, A. Natale. (2011) Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?. Internal Medicine Journal 41:1a, 55-60
CrossRef287
G. Földes, S.E. Harding. 2011. Stem Cell Therapy to Treat Heart Failure. , 407-423.
CrossRef288
M. F. Nageh, J. J. Kim, J. Chung, J. F. Yao. (2011) The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery. Europace 13:1, 70-76
CrossRef289
Akihiko Shimizu. (2011) Indication of Implantable Devices for the Prevention of Sudden Cardiac Death. Journal of Arrhythmia 27:1, 87-90
CrossRef290
Roman Laszlo, Mathias C. Busch, Jüergen Schreieck. (2011) Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy. ISRN Cardiology 2011, 1-5
CrossRef291
David Bello, Arnold Einhorn, Rishi Kaushal, Satish Kenchaiah, Aidan Raney, David Fieno, Jagat Narula, Jeffrey Goldberger, Kalyanam Shivkumar, Haris Subacius, Alan Kadish. (2011) Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magnetic Resonance Imaging 29:1, 50-56
CrossRef292
J. Dizon, K. Chen, S. Dizon, A. Biviano, W. Whang, F. Ehlert, J. Vazquez, T. Nazif, H. Garan. (2011) A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS. Europace 13:1, 77-81
CrossRef293
Tim Smith, Dominic A.M.J. Theuns, Kadir Caliskan, Luc Jordaens. (2011) Long-Term Follow-Up of Prophylactic Implantable Cardioverter-Defibrillator-Only Therapy: Comparison of Ischemic and Nonischemic Heart Disease. Clinical Cardiologyn/a-n/a
CrossRef294
Sandeep Talwar, Leslie A. Saxon. 2011. Clinical Trials of Cardiac Resynchronization Therapy. , 279-299.
CrossRef295
Haris M. Haqqani, Laurence M. Epstein, Joshua M. Cooper. 2011. Engineering and Construction of Pacemaker and ICD Leads. , 127-143.
CrossRef296
Andrew E. Epstein, Michael P. Riley. 2011. Troubleshooting of Implantable Cardioverter-Defibrillators. , 889-910.
CrossRef297
Charles D. Swerdlow, Jeffrey M. Gillberg, Paul Khairy. 2011. Sensing and Detection. , 56-126.
CrossRef298
G. H. Welsenes, C. J. W. Borleffs, J. B. Rees, J. Z. Atary, J. Thijssen, E. E. Wall, M. J. Schalij. (2011) Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy. Netherlands Heart Journal 19:1, 24-30
CrossRef299
Takashi Kurita. (2011) Japanese Journal of Electrocardiology 31:4, 376-386
CrossRef300
Hideo Mitamura. (2011) Japanese Journal of Electrocardiology 31:4, 346-355
CrossRef301
Tsuyoshi Shiga. (2011) Japanese Journal of Electrocardiology 31:4, 365-375
CrossRef302
Tang, Anthony S.L., Wells, George A., Talajic, Mario, Arnold, Malcolm O., Sheldon, Robert, Connolly, Stuart, Hohnloser, Stefan H., Nichol, Graham, Birnie, David H., Sapp, John L., Yee, Raymond, Healey, Jeffrey S., Rouleau, Jean L., . (2010) Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. New England Journal of Medicine 363:25, 2385-2395
Full Text303
K. Kraaier, T. McCracken, J. Palen, A. A. M. Wilde, M. F. Scholten. (2010) Is T-Wave Alternans Testing Feasible in Candidates for Prophylactic Implantable Defibrillators?. Netherlands Heart Journal
CrossRef304
Ayesha Hasan. (2010) Does Cardiac Resynchronization Therapy Prevent Heart Failure?. Current Heart Failure Reports
CrossRef305
G.C. Grönefeld, D. Bänsch. (2010) Antiarrhythmische Therapie mit β-Rezeptor-Antagonisten. Herzschrittmachertherapie + Elektrophysiologie 21:4, 222-227
CrossRef306
U.C. Hoppe, E. Erdmann. (2010) Herzinsuffizienz Update 2010 und aktuelle ESC-Leitlinien. Herz 35:8, 535-541
CrossRef307
MOHAMMAD SAEED, CURTIS G. NEASON, MEHDI RAZAVI, SHANKER CHANDIRAMANI, JOSEPH ALONSO, SENTHIL NATARAJAN, JOHN H. IP, DARREN F. PERESS, SUMATI RAMADAS, ALI MASSUMI. (2010) Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial. Journal of Cardiovascular Electrophysiology 21:12, 1349-1354
CrossRef308
H.H. Klein, A. Krämer, B.M. Pieske, H.-J. Trappe, H. Vries. (2010) Fahreignung bei kardiovaskulären Erkrankungen. Der Kardiologe 4:6, 441-473
CrossRef309
CHARLES D. SWERDLOW, MICHAEL SHEHATA. (2010) Antitachycardia Pacing in Primary-Prevention ICDs. Journal of Cardiovascular Electrophysiology 21:12, 1355-1357
CrossRef310
B. A. Schaer, S. Osswald, M. Di Valentino, O. I. Soliman, C. Sticherling, F. J. ten Cate, L. Jordaens, D. A. Theuns. (2010) Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients. European Journal of Heart Failure 12:12, 1325-1332
CrossRef311
J. S. HEALEY, D. H. BIRNIE, D. S. LEE, A. D. Krahn, E. Crystal, C. S. Simpson, P. Dorian, Z. Chen, D. Cameron, A. Verma, S. J. Connolly, L. J. Gula, E. Lockwood, G. Nair, J. V. Tu, . (2010) Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry. Journal of Cardiovascular Electrophysiology 21:12, 1344-1348
CrossRef312
SUSANNE S. PEDERSEN, KRISTA C. VAN DEN BROEK, MARTHA VAN DEN BERG, DOMINIC A. M. J. THEUNS. (2010) Shock as a Determinant of Poor Patient-Centered Outcomes in Implantable Cardioverter Defibrillator Patients: Is There More to It Than Meets the Eye?. Pacing and Clinical Electrophysiology 33:12, 1430-1436
CrossRef313
Deepak Bhakta, Miriam R. Groh, Changyu Shen, Robert M. Pascuzzi, William J. Groh. (2010) Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. American Heart Journal 160:6, 1137-1141.e1
CrossRef314
C. Sohns, M. Zabel. (2010) Aktueller Stellenwert von Amiodaron in der antiarrhythmischen Therapie. Herzschrittmachertherapie + Elektrophysiologie 21:4, 239-243
CrossRef315
Javier Alzueta, Antonio Linde, Alberto Barrera, Jose Peña, Rafael Peinado. (2010) Registro Español de Desfibrilador Automático Implantable. VI Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2009). Revista Española de Cardiología 63:12, 1468-1481
CrossRef316
Stefano Maffè, Antonello Perucca, Fabiana Signorotti, Massimo Pistono, Paola Paffoni, Umberto Parravicini, Pierfranco Dellavesa, Lorenzo Cucchi, Anna Maria Paino, Franco Zenone, Nicolò Franchetti Pardo, Massimo Bielli, Marco Zanetta. (2010) Electrophysiological interactions between implantable cardioverter defibrillators and left ventricular assist device. International Journal of Cardiology 145:3, 620-623
CrossRef317
Eileen O’Meara, Simon Denus. (2010) Management of Anemia and Iron Deficiency in Heart Failure. Current Treatment Options in Cardiovascular Medicine 12:6, 532-548
CrossRef318
EDWARD DUNCAN, GLYN THOMAS, NEVILLE JOHNS, CAMERON PFEFFER, GAUTHAM APPANNA, NIRAV SHAH, ROSS HUNTER, MALCOLM FINLAY, RICHARD J. SCHILLING, SIMON SPORTON. (2010) Do Traditional VT Zones Improve Outcome in Primary Prevention ICD Patients?. Pacing and Clinical Electrophysiology 33:11, 1353-1358
CrossRef319
Casey S. Hager, Sunil Jain, Jeffry Blackwell, Benjamin Culp, Juhee Song, Christopher D. Chiles. (2010) Effect of Renal Function on Survival After Implantable Cardioverter Defibrillator Placement. The American Journal of Cardiology 106:9, 1297-1300
CrossRef320
Eric C. Stecker. (2010) Is there new hope for sudden cardiac death prevention early after myocardial infarction?. Heart Rhythm 7:11, 1598-1599
CrossRef321
, K. Dickstein, P. E. Vardas, A. Auricchio, J.-C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S. G. Priori, R. Sutton, D. J. van Veldhuisen, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , M. Tendera, S. D. Anker, J.-J. Blanc, M. Gasparini, A. W. Hoes, C. W. Israel, Z. Kalarus, B. Merkely, K. Swedberg, A. J. Camm. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy * Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12:11, 1526-1536
CrossRef322
, K. Dickstein, P. E. Vardas, A. Auricchio, J.-C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S. G. Priori, R. Sutton, D. J. van Veldhuisen, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , M. Tendera, S. D. Anker, J.-J. Blanc, M. Gasparini, A. W. Hoes, C. W. Israel, Z. Kalarus, B. Merkely, K. Swedberg, A. J. Camm. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy * Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Journal of Heart Failure 12:11, 1143-1153
CrossRef323
Shibaji Shome, Dan Li, Julie Thompson, Aaron McCabe. (2010) Improving contemporary algorithms for implantable cardioverter-defibrillator function. Journal of Electrocardiology 43:6, 503-508
CrossRef324
Gust H. Bardy. (2010) The end is near . . . . of tinkering that is. Heart Rhythm 7:11, 1578-1579
CrossRef325
Wilbert S Aronow. (2010) Implantable Cardioverter-Defibrillators. American Journal of Therapeutics 17:6, e208-e220
CrossRef326
Diego Chemello, Anandaraja Subramanian, Sheila Watkins, Krishnakumar Nair, Kumaraswamy Nanthakumar. (2010) Implantable cardioverter defibrillator: Charge saver, not syncope saver!. Canadian Journal of Cardiology 26:9, e341-e343
CrossRef327
Michael O. Sweeney, Kenneth A. Ellenbogen, Anthony S.L. Tang, David Whellan, Peter T. Mortensen, Francesco Giraldi, David A. Sandler, Lou Sherfesee, Todd Sheldon. (2010) Atrial pacing or ventricular backup–only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm 7:11, 1552-1560
CrossRef328
, K. Dickstein, P. E. Vardas, A. Auricchio, J.-C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S. G. Priori, R. Sutton, D. J. van Veldhuisen, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , M. Tendera, S. D. Anker, J.-J. Blanc, M. Gasparini, A. W. Hoes, C. W. Israel, Z. Kalarus, B. Merkely, K. Swedberg, A. J. Camm. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Heart Journal 31:21, 2677-2687
CrossRef329
Wilbert S Aronow. (2010) Use of implantable cardioverter-defibrillators. Future Cardiology 6:6, 859-870
CrossRef330
Massimo Volpe, Pietro Francia, Giuliano Tocci, Speranza Rubattu, Sara Cangianiello, Maria Assunta Elena Rao, Bruno Trimarco, Mario Condorelli. (2010) Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study. Clinical Cardiology 33:11, 700-707
CrossRef331
Fadi A. Saab, Philippe Gabriel Steg, Álvaro Avezum, José López-Sendón, Frederick A. Anderson, Wei Huang, Kim A. Eagle. (2010) Can an elderly woman's heart be too strong?. American Heart Journal 160:5, 849-854
CrossRef332
D. A. M. J. Theuns, T. Smith, M. G. M. Hunink, G. H. Bardy, L. Jordaens. (2010) Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 12:11, 1564-1570
CrossRef333
Larisa G. Tereshchenko, Lichy Han, Alan Cheng, Joseph E. Marine, David D. Spragg, Sunil Sinha, Darshan Dalal, Hugh Calkins, Gordon F. Tomaselli, Ronald D. Berger. (2010) Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients. Heart Rhythm 7:11, 1606-1613
CrossRef334
J. Z. Atary, C. J. W. Borleffs, J. G. van der Bom, S. A. I. P. Trines, M. Bootsma, K. Zeppenfeld, L. van Erven, M. J. Schalij. (2010) Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease. Europace 12:11, 1581-1588
CrossRef335
Arthur E. Fass. (2010) Chronic Coronary Disease in the Post-COURAGE Era. Cardiology in Review 18:6, 292-297
CrossRef336
Sanjiv M. Narayan. 2010. Preventing Sudden Cardiac Arrest in the Heart Failure Patient. , 177-195.
CrossRef337
Ronald Freudenberger. 2010. Management of Advanced Heart Failure. , 357-383.
CrossRef338
Philip B. Adamson. 2010. Devices for Following Heart Failure Patients. , 235-254.
CrossRef339
Nico R. Van de Veire, Jeroen J. Bax. 2010. Imaging the Failing Heart. , 45-81.
CrossRef340
Vijay U. Rao, John R. Teerlink. 2010. Treating Systolic Heart Failure. , 287-326.
CrossRef341
Dan Sorajja, Win-Kuang Shen. (2010) Driving Guidelines and Restrictions in Patients With a History of Cardiac Arrhythmias, Syncope,or Implantable Devices. Current Treatment Options in Cardiovascular Medicine 12:5, 443-456
CrossRef342
J. Kreuz, O. Balta, M. Linhart, R. Fimmers, L. Lickfett, F. Mellert, G. Nickenig, J. O. Schwab. (2010) An impaired renal function and advanced heart failure represent independent predictors of the incidence of malignant ventricular arrhythmias in patients with an implantable cardioverter/defibrillator for primary prevention. Europace 12:10, 1439-1445
CrossRef343
Matthew J. O'Connor, David N. Rosenthal, Robert E. Shaddy. (2010) Outpatient Management of Pediatric Heart Failure. Heart Failure Clinics 6:4, 515-529
CrossRef344
H. S. Lim, C. B. Singleton, M. Alasady, A. D. McGavigan. (2010) Catheter ablation for ventricular tachycardia. Internal Medicine Journal 40:10, 673-681
CrossRef345
, , , A. J. Camm, P. Kirchhof, G. Y. H. Lip, U. Schotten, I. Savelieva, S. Ernst, I. C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S. H. Hohloser, P. Kolh, J.-Y. Le Heuzey, P. Ponikowski, F. H. Rutten, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. E. Vardas, V. Agladze, E. Aliot, T. Balabanski, C. Blomstrom-Lundqvist, A. Capucci, H. Crijns, B. Dahlof, T. Folliguet, M. Glikson, M. Goethals, D. C. Gulba, S. Y. Ho, R. J. M. Klautz, S. Kose, J. McMurray, P. Perrone Filardi, P. Raatikainen, M. J. Salvador, M. J. Schalij, A. Shpektor, J. Sousa, J. Stepinska, H. Uuetoa, J. L. Zamorano, I. Zupan. (2010) Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:10, 1360-1420
CrossRef346
Michael S. Lauer. (2010) Risk Stratification for Sudden Cardiac Death. Journal of the American College of Cardiology 56:18, 1484-1485
CrossRef347
Melissa H. Kong, Eric D. Peterson, Gregg C. Fonarow, Gillian D. Sanders, Clyde W. Yancy, Andrea M. Russo, Anne B. Curtis, Samuel F. Sears, Kevin L. Thomas, Susan Campbell, Mark D. Carlson, Chris Chiames, Nakela L. Cook, David L. Hayes, Michelle LaRue, Adrian F. Hernandez, Edward L. Lyons, Sana M. Al-Khatib. (2010) Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. American Heart Journal 160:4, 605-618.e1
CrossRef348
, , , A. J. Camm, P. Kirchhof, G. Y. H. Lip, U. Schotten, I. Savelieva, S. Ernst, I. C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S. H. Hohloser, P. Kolh, J.-Y. Le Heuzey, P. Ponikowski, F. H. Rutten, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. E. Vardas, V. Agladze, E. Aliot, T. Balabanski, C. Blomstrom-Lundqvist, A. Capucci, H. Crijns, B. Dahlof, T. Folliguet, M. Glikson, M. Goethals, D. C. Gulba, S. Y. Ho, R. J. M. Klautz, S. Kose, J. McMurray, P. Perrone Filardi, P. Raatikainen, M. J. Salvador, M. J. Schalij, A. Shpektor, J. Sousa, J. Stepinska, H. Uuetoa, J. L. Zamorano, I. Zupan. (2010) Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal 31:19, 2369-2429
CrossRef349
S. S. Pedersen, K. C. van den Broek, R. A. M. Erdman, L. Jordaens, D. A. M. J. Theuns. (2010) Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 12:10, 1446-1452
CrossRef350
Giuseppe Boriani, Igor Diemberger, Cinzia Valzania, Mauro Biffi, Cristian Martignani, Emanuel Raschi, Valentina Mantovani, Matteo Ziacchi, Matteo Bertini, Fabrizio De Ponti, Angelo Branzi. (2010) Role of drugs and devices in patients at risk of sudden cardiac death. Fundamental & Clinical Pharmacology 24:5, 575-594
CrossRef351
M. Juhani Junttila, Petra Barthel, Robert J. Myerburg, Timo H. Mäkikallio, Axel Bauer, Kurt Ulm, Antti Kiviniemi, Mikko Tulppo, Juha S. Perkiömäki, Georg Schmidt, Heikki V. Huikuri. (2010) Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm 7:10, 1396-1403
CrossRef352
Alon Barsheshet, Ilan Goldenberg, Craig R. Narins, Arthur J. Moss, Scott McNitt, Paul J. Wang, David T. Huang, W. Jackson Hall, Wojciech Zareba, Michael Eldar, Victor Guetta. (2010) Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT. Heart Rhythm 7:10, 1421-1427
CrossRef353
Palaniappan Saravanan, Gavin Freeman, Neil C. Davidson. (2010) Risk assessment for sudden cardiac death in dialysis patients: How relevant are conventional cardiac risk factors?. International Journal of Cardiology 144:3, 431-432
CrossRef354
Timm-Michael L. Dickfeld. 2010. Image-Guided Electrophysiology Mapping and Ablation. , 334-353.
CrossRef355
Rajdeep S. Gaitonde, Roopa Subbarao, Mark A. Michael, Gopi Dandamudi, Deepak Bhakta, Jo Mahenthiran, Mithilesh K. Das. (2010) Segmental wall-motion abnormalities of the left ventricle predict arrhythmic events in patients with nonischemic cardiomyopathy. Heart Rhythm 7:10, 1390-1395
CrossRef356
Niels F. Otani, Stefan Luther, Rupinder Singh, Robert F. Gilmour. (2010) Transmural Ultrasound-based Visualization of Patterns of Action Potential Wave Propagation in Cardiac Tissue. Annals of Biomedical Engineering 38:10, 3112-3123
CrossRef357
Sony Jacob, Prasad K. Cherian, Waqas S. Ghumman, Mithilesh K. Das. (2010) “Pseudo” Faraday cage: a solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator. Journal of Interventional Cardiac Electrophysiology 28:3, 221-225
CrossRef358
Niloufar Tabatabaei, Stephen C. Hammill. (2010) Role of the Automatic Implantable Cardioverter Defibrillator in the Post-myocardial Infarction Patient. Current Cardiovascular Risk Reports 4:5, 321-326
CrossRef359
Alexander Burashnikov, Luiz Belardinelli, Charles Antzelevitch. (2010) Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria. Heart Rhythm 7:9, 1273-1279
CrossRef360
Yuri B. Pride, Jennifer L. Giuseffi, Satishkumar Mohanavelu, Caitlin J. Harrigan, Warren J. Manning, C. Michael Gibson, Evan Appelbaum. (2010) Relation Between Infarct Size in ST-Segment Elevation Myocardial Infarction Treated Successfully by Percutaneous Coronary Intervention and Left Ventricular Ejection Fraction Three Months After the Infarct. The American Journal of Cardiology 106:5, 635-640
CrossRef361
LAUREN D. VAZQUEZ, JAMIE B. CONTI, SAMUEL F. SEARS. (2010) Female-Specific Education, Management, and Lifestyle Enhancement for Implantable Cardioverter Defibrillator Patients: The FEMALE-ICD Study. Pacing and Clinical Electrophysiology 33:9, 1131-1140
CrossRef362
Javed Butler, Inder S. Anand, Michael A. Kuskowski, Thomas Rector, Peter Carson, Jay N. Cohn, . (2010) Digoxin Use and Heart Failure Outcomes: Results from the Valsartan Heart Failure Trial (Val-HeFT). Congestive Heart Failure 16:5, 191-195
CrossRef363
Michael W Rich. (2010) Device therapy in the elderly heart failure patient: what is the evidence?. Expert Review of Cardiovascular Therapy 8:9, 1203-1205
CrossRef364
Ann Marie P. Mauro. (2010) Long-term follow-up study of uncertainty and psychosocial adjustment among implantable cardioverter defibrillator recipients. International Journal of Nursing Studies 47:9, 1080-1088
CrossRef365
Brian Feingold, Gaurav Arora, Steven A. Webber, Kenneth J. Smith. (2010) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children With Dilated Cardiomyopathy. Journal of Cardiac Failure 16:9, 734-741
CrossRef366
Francisco J. Pastor-Pérez, Sergio Manzano-Fernández, Rebeca Goya-Esteban, Domingo A. Pascual-Figal, Oscar Barquero-Pérez, Jose Luis Rojo-Álvarez, Maria Dolores Martinez Martinez-Espejo, Mariano Valdés Chavarri, Arcadio García-Alberola. (2010) Comparison of Detection of Arrhythmias in Patients With Chronic Heart Failure Secondary to Non-Ischemic Versus Ischemic Cardiomyopathy by 1 Versus 7-Day Holter Monitoring. The American Journal of Cardiology 106:5, 677-681
CrossRef367
J. Jimenez-Candil, J. Hernandez, A. Martin, M. Ruiz-Olgado, J. Herrero, C. Ledesma, J. Morinigo, C. Martin-Luengo. (2010) Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect. Europace 12:9, 1231-1238
CrossRef368
Stephen C. Hammill, Mark S. Kremers, Lynne Warner Stevenson, Paul A. Heidenreich, Christine M. Lang, Jeptha P. Curtis, Yongfei Wang, Charles I. Berul, Alan H. Kadish, Sana M. Al-Khatib, Ileana L. Pina, Mary Norine Walsh, Michael J. Mirro, Bruce D. Lindsay, Matthew R. Reynolds, Kathryn Pontzer, Laura Blum, Frederick Masoudi, John Rumsfeld, Ralph G. Brindis. (2010) Review of the Registry's Fourth Year, Incorporating Lead Data and Pediatric ICD Procedures, and Use as a National Performance Measure. Heart Rhythm 7:9, 1340-1345
CrossRef369
Cara N. Pellegrini, Melvin M. Scheinman. (2010) Clinical Management of Ventricular Tachycardia. Current Problems in Cardiology 35:9, 453-504
CrossRef370
M. Moretti, M. Merlo, G. Barbati, A. Di Lenarda, F. Brun, B. Pinamonti, D. Gregori, L. Mestroni, G. Sinagra. (2010) Prognostic impact of familial screening in dilated cardiomyopathy. European Journal of Heart Failure 12:9, 922-927
CrossRef371
EATHAR RAZAK, SWAPNA KAMIREDDY, SAMIR SABA. (2010) Implantable Cardioverter-Defibrillators Confer Survival Benefit in Patients with Chronic Obstructive Pulmonary Disease. Pacing and Clinical Electrophysiology 33:9, 1125-1130
CrossRef372
Shane F. Tsai, David P. Chan, Pamela S. Ro, Bethany Boettner, Curt J. Daniels. (2010) Rate of Inducible Ventricular Arrhythmia in Adults With Congenital Heart Disease. The American Journal of Cardiology 106:5, 730-736
CrossRef373
Anoop K Shetty, Miles WH Behan, Julian Bostock, C Aldo Rinaldi. (2010) Device therapy for the management of cardiac tachyarrhythmias. Expert Review of Cardiovascular Therapy 8:9, 1257-1266
CrossRef374
PAUL S. CHAN, MICHAEL R. GOLD, BRAHMAJEE K. NALLAMOTHU. (2010) Do Beta-Blockers Impact Microvolt T-Wave Alternans Testing in Patients at Risk for Ventricular Arrhythmias? A Meta-Analysis. Journal of Cardiovascular Electrophysiology 21:9, 1009-1014
CrossRef375
Michael S. Lauer. (2010) The historical and moral imperatives of comparative effectiveness research. Statistics in Medicine 29:19, 1982-1984
CrossRef376
Faris Khan, Evan Adelstein, Samir Saba. (2010) Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients. Journal of Interventional Cardiac Electrophysiology 28:2, 117-123
CrossRef377
H. V. Huikuri. (2010) Timing of implantation of cardioverter-defibrillator after acute myocardial infarction. Europace 12:8, 1057-1058
CrossRef378
Sang Yong Ji, Mark I. Travin. (2010) Radionuclide imaging of cardiac autonomic innervation. Journal of Nuclear Cardiology 17:4, 655-666
CrossRef379
R. F. E. Pedretti, A. Curnis, R. Massa, F. Morandi, M. Tritto, L. Manca, E. Occhetta, G. Molon, G. M. De Ferrari, S. Sarzi Braga, G. Raciti, C. Klersy, J. A. Salerno-Uriarte, . (2010) Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry. Europace 12:8, 1105-1111
CrossRef380
PREETHAM REDDY, DAVID G. BENDITT, SELCUK ADABAG. (2010) CASE REPORT: Electromagnetic Device-Device Interaction between a New Generation Implantable Pacemaker and Left Ventricular Assist Device: Recognition and Potential Solutions. Pacing and Clinical Electrophysiologyno-no
CrossRef381
Christopher Adlbrecht, Martin Hülsmann, Marianne Gwechenberger, Senta Graf, Franz Wiesbauer, Guido Strunk, Cesar Khazen, Isabella Brodnjak, Stephanie Neuhold, Thomas Binder, Gerald Maurer, Richard Pacher. (2010) Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome. European Journal of Clinical Investigation 40:8, 678-684
CrossRef382
S. M. Al-Khatib, G. Hafley, K. L. Lee, A. E. Buxton. (2010) Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace 12:8, 1112-1118
CrossRef383
Pavittarpaul Dhesi, Robert D Willix, Anita Phan, Faramarz Tehrani, Daniel Daneshvar, Ernst R Schwarz. (2010) Heart failure in the elderly: diastolic heart failure, medical therapy, women and end-of-life care. Aging Health 6:4, 429-437
CrossRef384
KENT R. NILSSON, KEVIN P. JACKSON. (2010) CASE REPORT: Hemiazygous Coil Placement for High-Defibrillation Thresholds in a Patient with a Right-Sided Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiologyno-no
CrossRef385
Badri Chandrasekaran, Peter J Cowburn. (2010) Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy. Expert Review of Medical Devices 7:4, 461-467
CrossRef386
Gary S. Francis, Barry H. Greenberg, Daphne T. Hsu, Brian E. Jaski, Mariell Jessup, Martin M. LeWinter, Francis D. Pagani, Ileana L. Piña, Marc J. Semigran, Mary Norine Walsh, David H. Wiener, Clyde W. Yancy. (2010) ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant. Journal of the American College of Cardiology 56:5, 424-453
CrossRef387
Hamid Ghanbari, Christian Machado. (2010) ICD therapy in women: Are men from Mars and women from Venus?. Heart Rhythm 7:7, 883-884
CrossRef388
Norman C Wang, Jonathan P Piccini, Marvin A Konstam, Aldo P Maggioni, Brian Traver, Karl Swedberg, James E Udelson, Faiez Zannad, Thomas Cook, Christopher M OʼConnor, Alan B Miller, Liliana Grinfeld, Mihai Gheorghiade. (2010) Implantable Cardioverter-Defibrillators in Patients Hospitalized for Heart Failure With Chronically Reduced Left Ventricular Ejection Fraction. American Journal of Therapeutics 17:4, e78-e87
CrossRef389
Ganesh Venkataraman, S Adam Strickberger. (2010) Cardiac resynchronization therapy in patients with minimally symptomatic heart failure. Expert Review of Cardiovascular Therapy 8:7, 959-963
CrossRef390
Beata Sredniawa, Sylwia Cebula, Jacek Kowalczyk, Velislav N. Batchvarov, Agata Musialik-Lydka, Anna Sliwinska, Aleksandra Wozniak, Michal Zakliczynski, Marian Zembala, Zbigniew Kalarus. (2010) Heart Rate Turbulence for Prediction of Heart Transplantation and Mortality in Chronic Heart Failure. Annals of Noninvasive Electrocardiology 15:3, 230-237
CrossRef391
Jonathan P. Piccini, Aijing Z. Starr, John R. Horton, Linda K. Shaw, Kerry L. Lee, Sana M. Al-Khatib, Ami E. Iskandrian, Christopher M. O'Connor, Salvador Borges-Neto. (2010) Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging and the Risk of Sudden Cardiac Death in Patients With Coronary Disease and Left Ventricular Ejection Fraction >35%. Journal of the American College of Cardiology 56:3, 206-214
CrossRef392
Mina K. Chung, Steven J. Szymkiewicz, Mingyuan Shao, Edwin Zishiri, Mark J. Niebauer, Bruce D. Lindsay, Patrick J. Tchou. (2010) Aggregate National Experience With the Wearable Cardioverter-Defibrillator. Journal of the American College of Cardiology 56:3, 194-203
CrossRef393
Sanders H. Chae, Todd M. Koelling. (2010) Patient and Physician Determinants of Implantable Cardioverter Defibrillator Use in the Heart Failure Population. Congestive Heart Failure 16:4, 141-146
CrossRef394
M. R. Cowie. (2010) Response to Editorial: Pitfalls in economic analysis. Europace 12:7, 1044-1046
CrossRef395
Pasquale Santangeli, Gemma Pelargonio, Antonio Dello Russo, Michela Casella, Caterina Bisceglia, Stefano Bartoletti, Pietro Santarelli, Luigi Di Biase, Andrea Natale. (2010) Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis. Heart Rhythm 7:7, 876-882
CrossRef396
Gillian D. Sanders, Melissa H. Kong, Sana M. Al-Khatib, Eric D. Peterson. (2010) Cost-effectiveness of implantable cardioverter defibrillators in patients ≥65 years of age. American Heart Journal 160:1, 122-131
CrossRef397
Martin Hinterseer, Britt-Maria Beckmann, Morten B. Thomsen, Arne Pfeufer, Michael Ulbrich, Moritz F. Sinner, Siegfried Perz, H.-Erich Wichmann, Csaba Lengyel, Rainer Schimpf, Sebastian K.G. Maier, András Varró, Marc A. Vos, Gerhard Steinbeck, Stefan Kääb. (2010) Usefulness of Short-Term Variability of QT Intervals as a Predictor for Electrical Remodeling and Proarrhythmia in Patients With Nonischemic Heart Failure. The American Journal of Cardiology 106:2, 216-220
CrossRef398
Sandra L. Carroll, Heather M. Arthur. (2010) A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death. International Journal of Nursing Studies 47:7, 836-845
CrossRef399
EVAN C. ADELSTEIN, ALAA SHALABY, SAMIR SABA. (2010) Response to Cardiac Resynchronization Therapy in Patients with Heart Failure and Renal Insufficiency. Pacing and Clinical Electrophysiology 33:7, 850-859
CrossRef400
Bardy, Gust H., Smith, Warren M., Hood, Margaret A., Crozier, Ian G., Melton, Iain C., Jordaens, Luc, Theuns, Dominic, Park, Robert E., Wright, David J., Connelly, Derek T., Fynn, Simon P., Murgatroyd, Francis D., Sperzel, Johannes, Neuzner, Jörg, Spitzer, Stefan G., Ardashev, Andrey V., Oduro, Amo, Boersma, Lucas, Maass, Alexander H., Van Gelder, Isabelle C., Wilde, Arthur A., van Dessel, Pascal F., Knops, Reinoud E., Barr, Craig S., Lupo, Pierpaolo, Cappato, Riccardo, Grace, Andrew A., . (2010) An Entirely Subcutaneous Implantable Cardioverter–Defibrillator. New England Journal of Medicine 363:1, 36-44
Full Text401
(2010) Section 13: Evaluation and Therapy for Heart Failure in the Setting of Ischemic Heart Disease. Journal of Cardiac Failure 16:6, e157-e165
CrossRef402
Emmanuel M. Kanoupakis, Emmanuel G. Manios, Eleftherios M. Kallergis, Hercules E. Mavrakis, Christos A. Goudis, Ilias G. Saloustros, Maria E. Milathianaki, Gregory I. Chlouverakis, Panos E. Vardas. (2010) Serum Markers of Collagen Turnover Predict Future Shocks in Implantable Cardioverter-Defibrillator Recipients With Dilated Cardiomyopathy on Optimal Treatment. Journal of the American College of Cardiology 55:24, 2753-2759
CrossRef403
T. BEN MORRISON, ROBERT F. REA, DAVID O. HODGE, DANIEL CRUSAN, CELESTE KOESTLER, SAMUEL J. ASIRVATHAM, DAVID BRADLEY, WIN K. SHEN, THOMAS M. MUNGER, STEPHEN C. HAMMILL, PAUL A. FRIEDMAN. (2010) Risk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled Lead. Journal of Cardiovascular Electrophysiology 21:6, 671-677
CrossRef404
Harikrishna Tandri. (2010) ICD shocks: Not just the “straw that broke the camel's back”. Heart Rhythm 7:6, 761-762
CrossRef405
Sanjeev P. Bhavnani, Jeffrey Kluger, Craig I. Coleman, C. Michael White, Danette Guertin, Nabil A. Shafi, Ravi K. Yarlagadda, Christopher A. Clyne. (2010) The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm 7:6, 755-760
CrossRef406
MANOJ N. OBEYESEKERE, WILLIAM CHAN, DION STUB, S PRABHU, ELIZA P TEO, GEOFF TOOGOOD, JUSTIN MARIANI, ARCHER BROUGHTON, PETER M KISTLER. (2010) Left Ventricular Ejection Fraction and Absence of ACE Inhibitor/Angiotensin II Receptor Blocker Predicts Appropriate Defibrillator Therapy in the Primary Prevention Population. Pacing and Clinical Electrophysiology 33:6, 696-704
CrossRef407
H. Oswald, C. Schultz-Wildelau, A. Gardiwal, U. Lusebrink, T. Konig, A. Meyer, D. Duncker, M. A. Pichlmaier, G. Klein, M. Struber. (2010) Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. European Journal of Heart Failure 12:6, 593-599
CrossRef408
JERRY M. JOHN, AHMED HUSSEIN, NASER IMRAN, SAMUEL J. DURHAM, BLAIR P. GRUBB, YOUSUF KANJWAL. (2010) Underutilization of Implantable Cardioverter Defibrillators Post Coronary Artery Bypass Grafting in Patients with Systolic Dysfunction. Pacing and Clinical Electrophysiology 33:6, 727-733
CrossRef409
Heart Failure Society of America. (2010) Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. Journal of Cardiac Failure 16:6, 475-539
CrossRef410
Sumeet S. Chugh. (2010) Early identification of risk factors for sudden cardiac death. Nature Reviews Cardiology 7:6, 318-326
CrossRef411
(2010) Section 7: Heart Failure in Patients With Reduced Ejection Fraction. Journal of Cardiac Failure 16:6, e73-e97
CrossRef412
(2010) Section 9: Electrophysiology Testing and the Use of Devices in Heart Failure. Journal of Cardiac Failure 16:6, e115-e121
CrossRef413
D. Bänsch, G. Grönefeld. (2010) Der Patient mit chronischer Herzinsuffizienz. Herzschrittmachertherapie + Elektrophysiologie 21:2, 112-116
CrossRef414
Scott M. Berry, K. Jack Ishak, Bryan R. Luce, Donald A. Berry. (2010) Bayesian Meta-Analyses for Comparative Effectiveness and Informing Coverage Decisions. Medical Care 48, S137-S144
CrossRef415
Robert Guidoin, Yvan Douville, Marie-Annick Clavel, Ze Zhang, Mark Nutley, Philippe Pîbarot, Guy Dionne. (2010) The marvel of percutaneous cardiovascular devices in the elderly. Annals of the New York Academy of Sciences 1197:1, 188-199
CrossRef416
Guy Amit, David S. Rosenbaum, Dennis M. Super, Otto Costantini. (2010) Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: Implications for identifying patients at risk for sudden cardiac death. Heart Rhythm 7:6, 763-768
CrossRef417
Aaron L. Baggish, Roland R. J. van Kimmenade, Yigal Pinto, A. Mark Richards, John Lainchbury, Antoni Bayes-Genis, Miquel Santaló, Jordi Ordonez-Llanos, James L. Januzzi. (2010) New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis. Biomarkers 15:4, 307-314
CrossRef418
Gregory M. Marcus. (2010) Can Serologic Markers of Fibrosis Reveal an Arrhythmogenic Ventricular Substrate in Nonischemic Dilated Cardiomyopathy?
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 55:24, 2760-2761
CrossRef419
T. Sellmann, M. Winterhalter, U. Herold, P. Kienbaum. (2010) Implantation von Kardioverter-Defibrillatoren. Der Anaesthesist 59:6, 507-518
CrossRef420
C. Mewis, H.-R. Neuberger, A. Buob. (2010) Ist die intraoperative ICD-Testung noch nötig?. Herzschrittmachertherapie + Elektrophysiologie 21:2, 123-128
CrossRef421
BRETT D. ATWATER, JAMES P. DAUBERT. (2010) Can We Improve the Identification of Ventricular Scar to Guide Substrate-Based Ventricular Tachycardia Ablation?. Journal of Cardiovascular Electrophysiology 21:6, 685-687
CrossRef422
Wael A. AlJaroudi, Fadi G. Hage, Daniel Hermann, Harish Doppalapudi, Rajesh Venkataraman, Jaekyeong Heo, Ami E. Iskandrian. (2010) Relation of left-ventricular dyssynchrony by phase analysis of gated SPECT images and cardiovascular events in patients with implantable cardiac defibrillators. Journal of Nuclear Cardiology 17:3, 398-404
CrossRef423
Beata Sredniawa, Michal Mazurek, Radoslaw Lenarczyk, Oskar Kowalski, Jacek Kowalczyk, Zbigniew Kalarus. (2010) Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators. Future Cardiology 6:3, 315-323
CrossRef424
Dawood Darbar. (2010) Genomics, heart failure and sudden cardiac death. Heart Failure Reviews 15:3, 229-238
CrossRef425
J. Becher, S. G. Kaufmann, S. Paule, B. Fahn, O. Skerl, W. R. Bauer, G. Ertl, S. K. G. Maier. (2010) Device-based impedance measurement is a useful and accurate tool for direct assessment of intrathoracic fluid accumulation in heart failure. Europace 12:5, 731-740
CrossRef426
RISHI ARORA, ERICA SPATZ, PUGAZHENDHI VIJAYARAMAN, MICHAEL ROSENGARTEN, JAY GROSS, SOO KIM, JOHN FISHER, KEVIN J. FERRICK. (2010) Just How Stable Are Escape Rhythms after Atrioventricular Junction Ablation?. Pacing and Clinical Electrophysiologyno-no
CrossRef427
D. Chemello, L. E. Rohde, K. G. Santos, D. Silvello, L. Goldraich, M. Pimentel, P. R. Rosa, L. Zimerman, N. Clausell. (2010) Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure. Europace 12:5, 686-691
CrossRef428
F. Duru, P. Dorian, S. Favale, C. Perings, S. S. Pedersen, V. Willems, . (2010) Effects of an alert system on implantable cardioverter defibrillator-related anxiety: rationale, design, and endpoints of the PANORAMIC multicentre trial. Europace 12:5, 726-730
CrossRef429
Darren Green, Paul R. Roberts. (2010) VENTRICULAR ARRHYTHMIAS AND SUDDEN DEATH IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Renal Care 36, 54-60
CrossRef430
Cihan Cevik, Kenneth Nugent, Alejandro Perez-Verdia, R. David Fish. (2010) Prophylactic Implantation of Cardioverter Defibrillators in Idiopathic Nonischemic Cardiomyopathy for the Primary Prevention of Death: A Narrative Review. Clinical Cardiology 33:5, 254-260
CrossRef431
Bodh I Jugdutt. (2010) Heart failure in the elderly: advances and challenges. Expert Review of Cardiovascular Therapy 8:5, 695-715
CrossRef432
Bruce D. Gunderson, Charles D. Swerdlow, Jay M. Wilcox, Jean E. Hayman, Kevin T. Ousdigian, Kenneth A. Ellenbogen. (2010) Causes of ventricular oversensing in implantable cardioverter-defibrillators: Implications for diagnosis of lead fracture. Heart Rhythm 7:5, 626-633
CrossRef433
Richard N Vest, Michael R Gold. (2010) Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Current Opinion in Cardiology 25:3, 268-275
CrossRef434
H. Van Herendael, A. Pinter, K. Ahmad, V. Korley, I. Mangat, P. Dorian. (2010) Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Europace 12:5, 618-625
CrossRef435
SANA M. AL-KHATIB, JONATHAN P. PICCINI, DAVID KNIGHT, MARGARET STEWART, NANCY CLAPP-CHANNING, GILLIAN D. SANDERS. (2010) Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial. Journal of Cardiovascular Electrophysiology 21:5, 545-550
CrossRef436
David J. Whellan, Kevin T. Ousdigian, Sana M. Al-Khatib, Wenji Pu, Shantanu Sarkar, Charles B. Porter, Behzad B. Pavri, Christopher M. O'Connor. (2010) Combined Heart Failure Device Diagnostics Identify Patients at Higher Risk of Subsequent Heart Failure Hospitalizations. Journal of the American College of Cardiology 55:17, 1803-1810
CrossRef437
S. de Haan, P. Knaapen, A. M. Beek, C. C. de Cock, A. A. Lammertsma, A. C. van Rossum, C. P. Allaart. (2010) Risk stratification for ventricular arrhythmias in ischaemic cardiomyopathy: the value of non-invasive imaging. Europace 12:4, 468-474
CrossRef438
Massimo Giammaria, Claudio Bruna, Roberto Gnavi. (2010) Trend in implantable cardioverter defibrillators and relation to need. Journal of Cardiovascular Medicine 11:4, 265-270
CrossRef439
Anju Bhardwaj, Shafiq U. Rehman, Asim Mohammed, Aaron L. Baggish, Stephanie A. Moore, James L. Januzzi. (2010) Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. American Heart Journal 159:4, 532-538.e1
CrossRef440
SERGIO THAL, TALAL MOUKABARY, RAVICHANDRA BOYELLA, MADHAN SHANMUGASUNDARAM, MARY K. PIERCE, HOANG THAI, STEVEN GOLDMAN. (2010) The Relationship between Warfarin, Aspirin, and Clopidogrel Continuation in the Peri-procedural Period and the Incidence of Hematoma Formation after Device Implantation. Pacing and Clinical Electrophysiology 33:4, 385-388
CrossRef441
ANDREW VOIGT, ALAA SHALABY, SAMIR SABA. (2010) Continued Rise in Rates of Cardiovascular Implantable Electronic Device Infections in the United States: Temporal Trends and Causative Insights. Pacing and Clinical Electrophysiology 33:4, 414-419
CrossRef442
Emile G Daoud, John D Hummel, Troy E Rhodes. (2010) Management of sudden cardiac death risk in the very early postmyocardial infarction period. Current Opinion in Cardiology1
CrossRef443
David A. Philips, Terry D. Bauch. (2010) Rapid Correction of Hypokalemia in a Patient with an Implantable Cardioverter-Defibrillator and Recurrent Ventricular Tachycardia. The Journal of Emergency Medicine 38:3, 308-316
CrossRef444
C. JAN WILLEM BORLEFFS, JOEP THIJSSEN, MIHÁLY K. De BIE, JOHANNES B. Van REES, GUIDO H. Van WELSENES, LIESELOT Van ERVEN, JEROEN J. BAX, SUZANNE C. CANNEGIETER, MARTIN J. SCHALIJ. (2010) Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications. Pacing and Clinical Electrophysiologyno-no
CrossRef445
S. A. Lubitz, P. Leong-Sit, N. Fine, D. B. Kramer, J. Singh, P. T. Ellinor. (2010) Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. European Journal of Heart Failure 12:4, 360-366
CrossRef446
Jenny Tagney. (2010) A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs). Journal of Clinical Nursingno-no
CrossRef447
A. Selcuk Adabag, Russell V. Luepker, Véronique L. Roger, Bernard J. Gersh. (2010) Sudden cardiac death: epidemiology and risk factors. Nature Reviews Cardiology 7:4, 216-225
CrossRef448
R. Cáceres, J. Richter, K. G. Säfström, A. M. Landtblom. (2010) Increased need for combinated nervus vagus-stimulators and electronic cardiac devices: aspects on methods and safety. Acta Neurologica Scandinavica 121:4, 287-288
CrossRef449
J. Malcolm O. Arnold, Lorne J. Gula. (2010) The Art and Science of Heart Failure. Journal of the American College of Cardiology 55:17, 1811-1813
CrossRef450
DAVID D. SPRAGG, JOSEPH E. MARINE. (2010) Inappropriate Biventricular Implantable Cardioverter Defibrillator Firing Due to Cryptogenic Double Counting. Pacing and Clinical Electrophysiology 33:4, 486-490
CrossRef451
C. J. W. Borleffs, G. H. van Welsenes, R. J. van Bommel, E. T. van der Velde, J. J. Bax, L. van Erven, H. Putter, J. G. van der Bom, F. R. Rosendaal, M. J. Schalij. (2010) Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease. European Heart Journal 31:6, 712-718
CrossRef452
Alexander Burashnikov, Charles Antzelevitch. (2010) New developments in atrial antiarrhythmic drug therapy. Nature Reviews Cardiology 7:3, 139-148
CrossRef453
HELMUT U. KLEIN, ULF MELTENDORF, SVEN REEK, JAN SMID, SEBASTIAN KUSS, IWONA CYGANKIEWICZ, CHRISTIAN JONS, STEVEN SZYMKIEWICZ, FRANK BUHTZ, ANKE WOLLBRUECK, WOJCIECH ZAREBA, ARTHUR J. MOSS. (2010) Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD). Pacing and Clinical Electrophysiology 33:3, 353-367
CrossRef454
Kristina H. Haugaa, Marit Kristine Smedsrud, Torkel Steen, Erik Kongsgaard, Jan Pål Loennechen, Terje Skjaerpe, Jens-Uwe Voigt, Rik Willems, Gunnar Smith, Otto A. Smiseth, Jan P. Amlie, Thor Edvardsen. (2010) Mechanical Dispersion Assessed by Myocardial Strain in Patients After Myocardial Infarction for Risk Prediction of Ventricular Arrhythmia. JACC: Cardiovascular Imaging 3:3, 247-256
CrossRef455
STEVEN M. MARKOWITZ. (2010) Defibrillator Implantation in the Elderly: Patients Are Older, But Are Physicians Wiser?. Journal of Cardiovascular Electrophysiology 21:3, 242-244
CrossRef456
H. Wieneke, S. Spencker, J. H. Svendsen, J. G. Martinez, B. Strohmer, L. Toivonen, H. Le Marec, J. Garcia, B. Kaup, O. Soykan, D. Corrado, W. Siffert. (2010) Polymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study. Europace 12:3, 424-429
CrossRef457
Hannah Asghar, Peter S. Rahko. (2010) Quality of Heart Failure Management: A Comparison of Care Between a Comprehensive Heart Failure Program and a General Cardiology Practice. Congestive Heart Failure 16:2, 65-70
CrossRef458
Christopher Lane, Paul Dorian, Nina Ghosh, Maria Radina, Suzan O’Donnell, Kevin Thorpe, Iqwal Mangat, Victoria Korley, Arnold Pinter. (2010) Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern Ontario. Canadian Journal of Cardiology 26:3, e118-e124
CrossRef459
ATUL VERMA, BRADLEY SARAK, ALEXANDER J. KAPLAN, RICHARD OOSTHUIZEN, MARIANNE BEARDSALL, ZAEV WULFFHART, JANET HIGENBOTTAM, YAARIV KHAYKIN. (2010) Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic Cardiomyopathy. Pacing and Clinical Electrophysiology 33:3, 320-329
CrossRef460
Rodrigo Antonini Ribeiro, Steffan Frosi Stella, Suzi Alves Camey, Leandro Ioschpe Zimerman, Maurício Pimentel, Luis Eduardo Rohde, Carísi Anne Polanczyk. (2010) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brazil: Primary Prevention Analysis in the Public Sector. Value in Health 13:2, 160-168
CrossRef461
H.-J. Trappe. (2010) Externe automatisierte Defibrillatoren. Notfall + Rettungsmedizin 13:2, 119-124
CrossRef462
Jason Bradfield, Noel G. Boyle. (2010) The paradox of ICD shocks: Sudden cardiac death prevention—Heart failure death acceleration. Heart Rhythm 7:3, 361-362
CrossRef463
JAMES D. DANIELS, JUSTIN SAUNDERS, SUNTHOSH PARVATHANENI, AMANDA BYRD, JOSE A. JOGLAR, OWEN OBEL. (2010) Electrocardiographic Findings, Device Therapies, and Comorbidities in Octogenarian Implantable Defibrillator Recipients. Journal of Cardiovascular Electrophysiology 21:3, 236-241
CrossRef464
C. Jan Willem Borleffs, Johannes B. van Rees, Guido H. van Welsenes, Enno T. van der Velde, Lieselot van Erven, Jeroen J. Bax, Martin J. Schalij. (2010) Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients. Journal of the American College of Cardiology 55:9, 879-885
CrossRef465
N. Valli. (2010) Évaluation de l’innervation sympathique cardiaque par la scintigraphie myocardique à la 123I-métaiodobenzylguanidine. Médecine Nucléaire 34:3, 184-190
CrossRef466
Massimo Santini, Maurizio Lunati, Pascal Defaye, Johann Mermi, Alessandro Proclemer, Silvia Castillo-Arroys, Giulio Molon, Elisabetta Santi, Tiziana Santo, Xavier Navarro, Axel Kloppe. (2010) Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. Journal of Interventional Cardiac Electrophysiology 27:2, 127-135
CrossRef467
INDIRESHA RAMACHANDRA. (2010) Impact of ICD Battery Longevity on Need for Device Replacements-Insights from a Veterans Affairs Database. Pacing and Clinical Electrophysiology 33:3, 314-319
CrossRef468
Eva R. Serber, Nancy J. Finch, Lawrence B. Afrin, W. James Greenland. (2010) Using a webcast support service: Experiences of in-person attendees of an implantable cardioverter defibrillator support group. Heart & Lung: The Journal of Acute and Critical Care 39:2, 94-104
CrossRef469
Jon A. Grammes, Christopher M. Schulze, Mohammad Al-Bataineh, George A. Yesenosky, Christine S. Saari, Michelle J. Vrabel, Jay Horrow, Mashiul Chowdhury, John M. Fontaine, Steven P. Kutalek. (2010) Percutaneous Pacemaker and Implantable Cardioverter-Defibrillator Lead Extraction in 100 Patients With Intracardiac Vegetations Defined by Transesophageal Echocardiogram. Journal of the American College of Cardiology 55:9, 886-894
CrossRef470
DREW ERTEL, KAVITA PHATAK, KEVIN MAKATI, MARIAN HOLLAND, SARA BAIG, MICHAEL H. KIM, MARK LINK, ROD PASSMAN. (2010) Predictors of Early Mortality in Patients Age 80 and Older Receiving Implantable Defibrillators. Pacing and Clinical Electrophysiology
CrossRef471
DANIEL B. SIMS, LUIS I. GARCIA, ANDREA MIGNATTI, PAOLO C. COLOMBO, MARGARET JONES, NIR URIEL, DONNA M. MANCINI, ULRICH P. JORDE. (2010) Utilization of Defibrillators and Resynchronization Therapy at the Time of Evaluation at a Heart Failure and Cardiac Transplantation Center. Pacing and Clinical Electrophysiology
CrossRef472
HANS J. MOORE, MATTHEW N. PETERS, MICHAEL R. FRANZ, PAMELA E. KARASIK, STEVEN N. SINGH, ROSS D. FLETCHER. (2010) Intrathoracic Impedance Preceding Ventricular Tachyarrhythmia Episodes. Pacing and Clinical Electrophysiology
CrossRef473
Adrian F. Hernandez, Bradley G. Hammill, Eric D. Peterson, Clyde W. Yancy, Kevin A. Schulman, Lesley H. Curtis, Gregg C. Fonarow. (2010) Relationships between emerging measures of heart failure processes of care and clinical outcomes. American Heart Journal 159:3, 406-413
CrossRef474
Pablo B. Nery, Nisha D’Mello, Rob Beanlands. (2010) Screening patients for primary prophylaxis implantable cardioverter defibrillators: Insights into current practices. Canadian Journal of Cardiology 26:3, e125-e127
CrossRef475
OSMAN FAHEEM, ARUN PADALA, JEFFREY KLUGER, STEVEN ZWEIBEL, CHRISTOPHER A. CLYNE. (2010) Coronary Sinus Shocking Lead As Salvage In Patients with Advanced CHF and High Defibrillation Thresholds. Pacing and Clinical Electrophysiology
CrossRef476
CHUNG-WAH SIU, VINCENT PONG, HEE-HWA HO, SHASHA LIU, CHU-PAK LAU, SHEUNG-WAI LI, HUNG-FAT TSE. (2010) Are MADIT II Criteria for Implantable Cardioverter Defibrillator Implantation Appropriate for Chinese Patients?. Journal of Cardiovascular Electrophysiology 21:3, 231-235
CrossRef477
Michael Kühne, Michaela Sakumura, Stephen Scott Reich, Jean-Francois Sarrazin, Darryl Wells, Nagib Chalfoun, Thomas Crawford, Warangkna Boonyapisit, Laura Horwood, Aman Chugh, Eric Good, Krit Jongnarangsin, Frank Bogun, Hakan Oral, Fred Morady, Francis Pagani, Frank Pelosi. (2010) Simultaneous Use of Implantable Cardioverter-Defibrillators and Left Ventricular Assist Devices in Patients With Severe Heart Failure. The American Journal of Cardiology 105:3, 378-382
CrossRef478
John G. F. Cleland, Laszlo Buga. (2010) Device therapy: Defibrillators—a shocking therapy for cardiomyopathy?. Nature Reviews Cardiology 7:2, 69-70
CrossRef479
Garrick C. Stewart, Joanne R. Weintraub, Parakash P. Pratibhu, Marc J. Semigran, Janice M. Camuso, Kimberly Brooks, Sui W. Tsang, Mary Susan Anello, Viviane T. Nguyen, Eldrin F. Lewis, Anju Nohria, Akshay S. Desai, Michael M. Givertz, Lynne W. Stevenson. (2010) Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure. Journal of Cardiac Failure 16:2, 106-113
CrossRef480
Miia K. Hyytinen-Oinas, Kari Ylitalo, Mari Karsikas, Tapio Seppänen, M. J. Pekka Raatikainen, Paavo Uusimaa, Heikki V. Huikuri, Juha S. Perkiömäki. (2010) Electrocardiographic abnormalities and ventricular tachyarrhythmias after myocardial infarction. Scandinavian Cardiovascular Journal 44:1, 15-23
CrossRef481
Giuseppe Boriani, Claudio Rapezzi, Igor Diemberger, Lucio Gonzini, Marco Gorini, Donata Lucci, Gianfranco Sinagra, Robin M. T. Cooke, Giuseppe Di Pasquale, Luigi Tavazzi, Aldo P. Maggioni. (2010) Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. Journal of Evaluation in Clinical Practice 16:1, 82-91
CrossRef482
Douglas S. Lee, Andrew D. Krahn, Jeffrey S. Healey, David Birnie, Eugene Crystal, Paul Dorian, Christopher S. Simpson, Yaariv Khaykin, Douglas Cameron, Amir Janmohamed, Raymond Yee, Peter C. Austin, Zhongliang Chen, Judy Hardy, Jack V. Tu. (2010) Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation. Journal of the American College of Cardiology 55:8, 774-782
CrossRef483
Mithilesh K Das, Douglas P Zipes. (2010) Antiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention. Journal of Cardiovascular Pharmacology1
CrossRef484
M. Lainscak, A. P. Coletta, N. Sherwi, J. G.F. Cleland. (2010) Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1. European Journal of Heart Failure 12:2, 193-196
CrossRef485
MAYURKUMAR BHAKTA, CHEDOZIE C. OBIOHA, DAN SORAJJA, KOMADOOR SRIVATHSAN, FRANCISCO A. ARABIA, PATRICK A. DEVALERIA, DAWN E. JAROSZEWSKI, LUIS R. SCOTT, GREGORY T. ALTEMOSE. (2010) Nontraditional Implantable Cardioverter Defibrillator Placement in Adult Patients with Limited Venous Access: A Case Series. Pacing and Clinical Electrophysiology 33:2, 217-225
CrossRef486
Ingvild Margreta Morken, Elisabeth Severinsson, Bjørg Karlsen. (2010) Reconstructing unpredictability: experiences of living with an implantable cardioverter defibrillator over time. Journal of Clinical Nursing 19:3-4, 537-546
CrossRef487
Bharat K Kantharia. (2010) Cardiac arrhythmias in congestive heart failure. Expert Review of Cardiovascular Therapy 8:2, 137-140
CrossRef488
John Lynn Jefferies, Jeffrey A Towbin. (2010) Dilated cardiomyopathy. The Lancet 375:9716, 752-762
CrossRef489
Alfred E Buxton, Kristin E Ellison, Peem Lorvidhaya, Ohad Ziv. (2010) Left Ventricular Ejection Fraction for Sudden Death Risk Stratification and Guiding ICD Implantation. Journal of Cardiovascular Pharmacology1
CrossRef490
KARIN KRAAIER, PASCAL F.H.M. VAN DESSEL, JOB VAN DER PALEN, ARTHUR A.M. WILDE, MARCOEN F. SCHOLTEN. (2010) ECG Quantification of Myocardial Scar Does Not Differ between Primary and Secondary Prevention ICD Recipients with Ischemic Heart Disease. Pacing and Clinical Electrophysiology 33:2, 192-197
CrossRef491
McMurray, John J.V., . (2010) Systolic Heart Failure. New England Journal of Medicine 362:3, 228-238
Full Text492
Hiro Kawata, Takashi Noda, Takashi Kurita, Kenichiro Yamagata, Yuko Yamada, Hideo Okamura, Kazuhiro Satomi, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Mitsuaki Isobe, Shiro Kamakura. (2010) Clinical Effect of Implantable Cardioverter Defibrillator Replacements. Circulation Journal 74:11, 2301-2307
CrossRef493
William H. Sauer, Erica Zado, Edward P. Gerstenfeld, Francis E. Marchlinski, David J. Callans. (2010) Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm 7:1, 9-14
CrossRef494
Elizabeth A. Stephenson, Andrew M. Davis. 2010. Electrophysiology, Pacing, and Devices. , 379-413.
CrossRef495
Masateru Takigawa, Takashi Noda, Takashi Kurita, Naohiko Aihara, Yuko Yamada, Hideo Okamura, Kazuhiro Satomi, Kazuhiro Suyama, Wataru Shimizu, Shiro Kamakura. (2010) Predictors of Electrical Storm in Patients With Idiopathic Dilated Cardiomyopathy. Circulation Journal 74:9, 1822-1829
CrossRef496
Alexander Rusanov, Henry M. Spotnitz. (2010) A 15-Year Experience With Permanent Pacemaker and Defibrillator Lead and Patch Extractions. The Annals of Thoracic Surgery 89:1, 44-50
CrossRef497
Naomichi Matsumoto, Koichiro Kumagai, Masahiro Ogawa, Kunihiro Matsuo, Tomoo Yasuda, Hideo Takashima, Chiharu Mitsutake, Soichi Muraoka, Akira Matsunaga, Shin-ichiro Miura, Keijiro Saku. (2010) Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator. Journal of Arrhythmia 26:2, 103-110
CrossRef498
Aamir Cheema, Tejwant Singh, Manreet Kanwar, Karuna Chilukuri, Viqar Maria, Fareena Saleem, Katrina Johnson, John Frank, Luis Pires, Sohail Hassan. (2010) Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients. Cardiology Research and Practice 2010, 1-6
CrossRef499
Shepard D. Weiner, LeRoy E. Rabbani. (2010) Secondary prevention strategies for coronary heart disease. Journal of Thrombosis and Thrombolysis 29:1, 8-24
CrossRef500
Hisaki Makimoto, Kazuhiro Satomi, Ikutaro Nakajima, Teruki Yokoyama, Atsushi Doi, Hiro Kawata, Kenichiro Yamagata, Yuko Yamada, Hideo Okamura, Takashi Noda, Takeshi Aiba, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Shiro Kamakura. (2010) Japanese Journal of Electrocardiology 30:5, 385-394
CrossRef501
Valeria Calvi, Daniela Dugo, Davide Capodanno, Rocco Arancio, Angelo Di Grazia, Claudio Liotta, Euglena Puzzangara, Antonio Ragusa, Alberto Arestia, Corrado Tamburino. (2010) Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it?. American Heart Journal 159:1, 98-102
CrossRef502
Juan Pablo Kaski, Perry Elliott. 2010. Cardiomyopathies. , 1003-1034.
CrossRef503
Robert E. Shaddy, Daniel J. Penny. 2010. Chronic Cardiac Failure. , 257-268.
CrossRef504
Jens Seiler, William G. Stevenson. (2010) Atrial Fibrillation in Congestive Heart Failure. Cardiology in Review 18:1, 38-50
CrossRef505
Nam-Ho Kim, Kyeong Ho Yun, Seok Kyu Oh. (2010) Sudden Cardiac Death. Journal of the Korean Medical Association 53:3, 214
CrossRef506
JONATHAN P. PICCINI, SANA M. AL-KHATIB, EVAN R. MYERS, KEVIN J. ANSTROM, ALFRED E. BUXTON, ERIC D. PETERSON, GILLIAN D. SANDERS. (2010) Optimal Timing of Implantable Cardioverter-Defibrillator Implantation After Myocardial Infarction: A Decision Analysis. Journal of Cardiovascular Electrophysiology
CrossRef507
Takayuki Nagai, Kazuhiro Satomi, Takashi Noda, Hideo Okamura, Yuko Yamada, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Shiro Kamakura, Takashi Kurita. (2010) Relationship Between Oral Amiodarone and Inappropriate Therapy From an Implantable Cardioverter Defibrillator. Circulation Journal 74:7, 1302-1307
CrossRef508
Mithilesh Kumar Das, Waddah Maskoun, Changyu Shen, Mark A. Michael, Hussam Suradi, Mona Desai, Roopa Subbarao, Deepak Bhakta. (2010) Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 7:1, 74-80
CrossRef509
Yasushi Oginosawa, Haruhiko Abe, Ritsuko Kohno, Hitoshi Minamiguchi. (2010) Resume Driving After a Refueling Pit Stop. Circulation Journal 74:11, 2283-2284
CrossRef510
Michiro Kiryu, Shinichi Niwano, Jun Kishihara, Yuya Aoyama, Shoko Ishikawa, Masami Murakami, Sayaka Kurokawa, Yoshihiro Yumoto, Ryuta Imaki, Hidehira Fukaya, Hiroe Niwano, Tohru Izumi. (2010) Preventive Effect of Amiodarone on VT/VF Events in ICD Patients with Structural Heart Diseases. Journal of Arrhythmia 26:4, 250-258
CrossRef511
Eric N. Prystowsky. (2010) Atrial fibrillation: Dronedarone and amiodarone—the safety versus efficacy debate. Nature Reviews Cardiology 7:1, 5-6
CrossRef512
Ignasi Carrió, Martin R. Cowie, Junichi Yamazaki, James Udelson, Paolo G. Camici. (2010) Cardiac Sympathetic Imaging With mIBG in Heart Failure. JACC: Cardiovascular Imaging 3:1, 92-100
CrossRef513
Masaomi Chinushi, Yukio Hosaka, Shinsuke Okada, Kenichi Iijima, Hiroshi Furushima, Yoshifusa Aizawa. (2010) Delayed Pericardial Effusion Due to Perforation of the Right Ventricular Outflow Tract by an ICD Lead. Internal Medicine 49:5, 389-392
CrossRef514
Kumral Ergun Cagli, Umit Guray, İbrahim Akpınar, Nihat Sen, Dursun Aras, Serkan Topaloglu. (2010) Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report. Journal of Electrocardiology 43:1, 68-70
CrossRef515
Makoto Taoka, Eiichi Tei, Imun Tei, Atsushi Fukumoto, Kazuki Satoh. (2010) Study on the Implantation of a Left Ventricular Epicardial Lead during CABG in Patients with Low Cardiac Function. Japanese Journal of Cardiovascular Surgery 39:6, 285-288
CrossRef516
Slaughter, Mark S., Rogers, Joseph G., Milano, Carmelo A., Russell, Stuart D., Conte, John V., Feldman, David, Sun, Benjamin, Tatooles, Antone J., Delgado, Reynolds M. III, Long, James W., Wozniak, Thomas C., Ghumman, Waqas, Farrar, David J., Frazier, O. Howard, . (2009) Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device. New England Journal of Medicine 361:23, 2241-2251
Full Text517
Jennifer L. Dorosz, Keith D. Aaronson, Eric D. Good, Theodore J. Kolias. (2009) A Restrictive Inflow Pattern Does Not Predict Implantable Cardioverter-Defibrillator Therapy in Primary Prevention. Clinical Cardiology 32:12, E32-E35
CrossRef518
Ernest Matthew Quin, Michael R. Gold. (2009) Implantable device use in systolic heart failure: Lessons learned from IMPROVE HF. Heart Rhythm 6:12, 1735-1736
CrossRef519
Stavros Mountantonakis, Mathew D. Hutchinson. (2009) Who should receive an implantable cardioverter-defibrillator after myocardial infarction?. Current Heart Failure Reports 6:4, 236-244
CrossRef520
Philip B. Adamson. (2009) Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices. Current Heart Failure Reports 6:4, 287-292
CrossRef521
Mandeep R. Mehra, Clyde W. Yancy, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas Heywood, Mark L. McBride, Christopher M. O'Connor, Dwight Reynolds, Mary Norine Walsh, Gregg C. Fonarow. (2009) Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post–myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm 6:12, 1727-1734
CrossRef522
D. J. van Veldhuisen, A. H. Maass, S. G. Priori, P. Stolt, I. C. van Gelder, K. Dickstein, K. Swedberg. (2009) Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. European Journal of Heart Failure 11:12, 1143-1151
CrossRef523
D. P. Morin, L. Oikarinen, M. Viitasalo, L. Toivonen, M. S. Nieminen, S. E. Kjeldsen, B. Dahlof, M. John, R. B. Devereux, P. M. Okin. (2009) QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. European Heart Journal 30:23, 2908-2914
CrossRef524
Carsten Stoepel, Jean Boland, Rachele Busca, Gauri Saal, Mário Oliveira. (2009) Usefulness of Remote Monitoring in Cardiac Implantable Device Follow-Up. Telemedicine and e-Health 15:10, 1026-1030
CrossRef525
S. Brenner, S. Störk, C.E. Angermann. (2009) Behandlung der chronischen Linksherzinsuffizienz. Der Internist 50:12, 1325-1336
CrossRef526
Rafael Peinado, Esteban G. Torrecilla, José Ormaetxe, Miguel Álvarez, Rocío Cózar, Javier Alzueta. (2009) Registro Español de Desfibrilador Automático Implantable. V Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2008). Revista Española de Cardiología 62:12, 1435-1449
CrossRef527
MEHMET K. AKTAS, DAVID D. KIM, SCOTT MCNITT, DAVID T. HUANG, SPENCER Z. ROSERO, BURR W. HALL, WOJCIECH ZAREBA, JAMES P. DAUBERT. (2009) Right Ventricular Dysfunction and the Incidence of Implantable Cardioverter-Defibrillator Therapies. Pacing and Clinical Electrophysiology 32:12, 1501-1508
CrossRef528
Corinna Lenz, Thomas Dietze, Michael Möller, Wolfgang Schöbel, Jens Wicke, Hans-Jörg Kellner, Rainer Gradaus, Jörg Neuzner. (2009) Incessant ventricular tachycardia, refractory to catheter ablation, in an ICD patient terminated by ICD lead extraction: a case report. Clinical Research in Cardiology 98:12, 803-805
CrossRef529
Nathaniel Hall, T Jared Bunch. (2009) Defining new risk factors for out-of-hospital cardiac arrest: A hot opportunity for discovery*. Critical Care Medicine 37:12, 3178-3179
CrossRef530
Sing-Chien Yap, Louise Harris. (2009) Sudden cardiac death in adults with congenital heart disease. Expert Review of Cardiovascular Therapy 7:12, 1605-1620
CrossRef531
Beat Andreas Schaer, Michael Theodor Koller, Christian Sticherling, David Altmann, Lucas Joerg, Stefan Osswald. (2009) Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 6:12, 1737-1743
CrossRef532
Tobias Tönnis, Karl-Heinz Kuck. (2009) Grenzen und Möglichkeiten der nichtinvasiven Risikostratifikation für den plötzlichen Herztod. Herz 34:7, 506-516
CrossRef533
Begoña Benito, Josep Brugada, Ramón Brugada, Pedro Brugada. (2009) Síndrome de Brugada. Revista Española de Cardiología 62:11, 1297-1315
CrossRef534
Joseph D. Mishkin, Sherry J. Saxonhouse, Gregory W. Woo, Thomas A. Burkart, William M. Miles, Jamie B. Conti, Richard S. Schofield, Samuel F. Sears, Juan M. Aranda. (2009) Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge. Journal of the American College of Cardiology 54:22, 1993-2000
CrossRef535
E. M. Kanoupakis, E. G. Manios, P. E. Vardas. (2009) Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers. Europace 11:11, 1434-1439
CrossRef536
M. Gasparini, F. Regoli, P. Galimberti, C. Ceriotti, A. Cappelleri. (2009) Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. Europace 11:Supplement 5, v82-v86
CrossRef537
A. Takahashi, T. Shiga, M. Shoda, T. Manaka, K. Ejima, N. Hagiwara. (2009) Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy. Europace 11:11, 1476-1482
CrossRef538
Giuseppe Stabile, Assunta Iuliano, Pietro Turco, Carmine Ciardiello, Antonio De Simone. (2009) Cardiac resynchronization therapy: a review of CRT-D versus CRT-P. Future Cardiology 5:6, 567-572
CrossRef539
Arash Arya, Christopher Piorkowski, Simon Kircher, Philipp Sommer, Andreas Bollmann, Thomas Gaspar, Gerhard Hindricks. (2009) Results of Recent Studies in Catheter Ablation of Ventricular Tachycardias. Herz 34:7, 539-544
CrossRef540
Axel Bauer, Petra Barthel, Alexander Müller, Kurt Ulm, Heikki Huikuri, Marek Malik, Georg Schmidt. (2009) Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. Journal of Electrocardiology 42:6, 597-601
CrossRef541
SAMUEL F. SEARS, MELISSA MATCHETT, JAMIE B. CONTI. (2009) Effective Management of ICD Patient Psychosocial Issues and Patient Critical Events. Journal of Cardiovascular Electrophysiology 20:11, 1297-1304
CrossRef542
Claude Daubert, Michael R. Gold, William T. Abraham, Stefano Ghio, Christian Hassager, Grahame Goode, Tamás Szili-Török, Cecilia Linde. (2009) Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction. Journal of the American College of Cardiology 54:20, 1837-1846
CrossRef543
Hoong Sern Lim, Roger Beadle, Michael Frenneaux. (2009) Death and Dying in Heart Failure With Normal Ejection Fraction. The American Journal of Cardiology 104:9, 1311-1314
CrossRef544
Andrew E. Epstein. (2009) Subject of the year: Who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy. Journal of Interventional Cardiac Electrophysiology 26:2, 91-94
CrossRef545
Jeffrey J. Goldberger, Rod Passman. (2009) Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction. Journal of the American College of Cardiology 54:22, 2001-2005
CrossRef546
H.-J. Trappe. (2009) Antiarrhythmische Therapie mit Amiodaron bei tachykarden Rhythmusstörungen. Intensivmedizin und Notfallmedizin 46:8, 563-572
CrossRef547
SAMIR SABA, LAKSHMI PRASAD RAVIPATI, ANDREW VOIGT. (2009) Recent Trends in Utilization of Implantable Cardioverter-Defibrillators in Survivors of Cardiac Arrest in the United States. Pacing and Clinical Electrophysiology 32:11, 1444-1449
CrossRef548
JORGE E. SCHLIAMSER, MOEEN A. SALEEM, JEFFREY J. GOLDBERGER. (2009) Use of a Custom-Designed Adapter to Manage ICD Lead Fracture. Journal of Cardiovascular Electrophysiology 20:11, 1284-1286
CrossRef549
Christopher S. King, William Kelly. (2009) Treatment of Sarcoidosis. Disease-a-Month 55:11, 704-718
CrossRef550
Sascha Rolf, Wilhelm Haverkamp. (2009) Grenzen und Möglichkeiten der invasiven Risikostratifikation. Herz 34:7, 528-538
CrossRef551
Jason I. Koontz, Daniel Haithcock, Valerie Cumbea, Anthony Waldron, Kristie Stricker, Amy Hughes, Kent Nilsson, Albert Sun, Jonathan P. Piccini, William E. Kraus, Geoffrey S. Pitt, Svati H. Shah, Patrick Hranitzky. (2009) Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository. American Heart Journal 158:5, 719-725
CrossRef552
J. C. Daubert, C. Leclercq, P. Mabo. (2009) Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. Europace 11:Supplement 5, v87-v92
CrossRef553
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2009) 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 54:22, e13-e118
CrossRef554
Atul Aggarwal, Yongfei Wang, John S. Rumsfeld, Jeptha P. Curtis, Paul A. Heidenreich. (2009) Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 6:11, 1565-1571
CrossRef555
G. Breithardt. (2009) MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. European Heart Journal 30:21, 2551-2553
CrossRef556
D. Di Pietro Paolo, H.-P. Mueller, M. Goernig, J. Haueisen, S.N. Erne. (2009) Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators. Medical Engineering & Physics 31:9, 1087-1094
CrossRef557
Steinbeck, Gerhard, Andresen, Dietrich, Seidl, Karlheinz, Brachmann, Johannes, Hoffmann, Ellen, Wojciechowski, Dariusz, Kornacewicz-Jach, Zdzisława, Sredniawa, Beata, Lupkovics, Géza, Hofgärtner, Franz, Lubinski, Andrzej, Rosenqvist, Mårten, Habets, Alphonsus, Wegscheider, Karl, Senges, Jochen, . (2009) Defibrillator Implantation Early after Myocardial Infarction. New England Journal of Medicine 361:15, 1427-1436
Full Text558
Juan Carlos Claro, Roberto Candia, Gabriel Rada, Francisco Larrondo, Fernando Baraona, Luz M Letelier, Juan Carlos Claro. 2009. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death. .
CrossRef559
PAUL KNOPS, DOMINIC A. M. J. THEUNS, JAN C. J. RES, LUC JORDAENS. (2009) Analysis of Implantable Defibrillator Longevity Under Clinical Circumstances: Implications for Device Selection. Pacing and Clinical Electrophysiology 32:10, 1276-1285
CrossRef560
HARIS M. HAQQANI, HARRY G. MOND. (2009) The Implantable Cardioverter-Defibrillator Lead: Principles, Progress, and Promises. Pacing and Clinical Electrophysiology 32:10, 1336-1353
CrossRef561
Naveen L. Pereira, Richard M. Weinshilboum. (2009) Cardiovascular pharmacogenomics and individualized drug therapy. Nature Reviews Cardiology 6:10, 632-638
CrossRef562
M. Meine, T. Smith, R. N.W. Hauer. (2009) The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe? Reply. Europace 11:10, 1408-1410
CrossRef563
Brenda S. Thompson. (2009) Sudden Cardiac Death and Heart Failure. AACN Advanced Critical Care 20:4, 356-365
CrossRef564
Nina Ghosh, Iqwal Mangat, Suzan S O’Donnell, Arnold Pinter, Victoria Korley, Chris Lane, Paul Dorian. (2009) Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: What are the risks of waiting?. Canadian Journal of Cardiology 25:10, e342-e346
CrossRef565
H.-J. Trappe. (2009) 25 Jahre Defibrillatortherapie in Deutschland. Der Kardiologe 3:5, 413-424
CrossRef566
SANDRA B. DUNBAR, JONATHAN J. LANGBERG, CAROLYN M. REILLY, BINDU VISWANATHAN, FRANCES MCCARTY, STEVEN D. CULLER, MARIAN C. O’BRIEN, WILLIAM S. WEINTRAUB. (2009) Effect of a Psychoeducational Intervention on Depression, Anxiety, and Health Resource Use in Implantable Cardioverter Defibrillator Patients. Pacing and Clinical Electrophysiology 32:10, 1259-1271
CrossRef567
Byron K. Lee, Jeffery E. Olgin. (2009) Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death. Current Treatment Options in Cardiovascular Medicine 11:5, 360-365
CrossRef568
B. McHale, S. A. Harding, N. A. Lever, P. D. Larsen. (2009) A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators. Europace 11:10, 1313-1316
CrossRef569
K. Kraaier, P. M.J. Verhorst, J. van der Palen, P. F.H.M. van Dessel, A. A.M. Wilde, M. F. Scholten. (2009) Microvolt T-wave alternans during exercise and pacing are not comparable. Europace 11:10, 1375-1380
CrossRef570
EMILY C. SIMONS, DAVID Y. FEIGENBLUM, DMITRY NEMIROVSKY, GRANT R. SIMONS. (2009) Alert Tones Are Frequently Inaudible among Patients with Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 32:10, 1272-1275
CrossRef571
H.-J. Trappe. (2009) Tachykarde Rhythmusstörungen in der Notfall- und Rettungsmedizin: Von der Tablette bis zur Ablation. Notfall + Rettungsmedizin 12:6, 429-435
CrossRef572
S. Thavapalachandran, D. P. Leong, M. K. Stiles, B. John, H. Dimitri, D. H. Lau, P. J. Psaltis, A. G. Brooks, M. Alasady, H. S. Lim, G. D. Young, P. Sanders. (2009) Evidence-based management of heart failure in clinical practice: a review of device-based therapy use. Internal Medicine Journal 39:10, 669-675
CrossRef573
Moss, Arthur J., Hall, W. Jackson, Cannom, David S., Klein, Helmut, Brown, Mary W., Daubert, James P., Estes, N.A. Mark III, Foster, Elyse, Greenberg, Henry, Higgins, Steven L., Pfeffer, Marc A., Solomon, Scott D., Wilber, David, Zareba, Wojciech, . (2009) Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. New England Journal of Medicine 361:14, 1329-1338
Full Text574
Adam T. Hirsh, Samuel F. Sears, Jamie B. Conti. (2009) Cognitive and Behavioral Treatments for Anxiety and Depression in a Patient with an Implantable Cardioverter Defibrillator (ICD): A Case Report and Clinical Discussion. Journal of Clinical Psychology in Medical Settings 16:3, 270-279
CrossRef575
Andrew E. Epstein. (2009) Update on primary prevention implantable cardioverter-defibrillator therapy. Current Cardiology Reports 11:5, 335-342
CrossRef576
ANDREA M. RUSSO, JOHN D. DAY, KIRA STOLEN, CHRISTOPHER M. MULLIN, VINAYAK DORAISWAMY, DARIN L. LEREW, BRIAN OLSHANSKY. (2009) Implantable Cardioverter Defibrillators: Do Women Fare Worse Than Men? Gender Comparison in the INTRINSIC RV Trial. Journal of Cardiovascular Electrophysiology 20:9, 973-978
CrossRef577
Aneta Aleksova, Gastone Sabbadini, Marco Merlo, Bruno Pinamonti, Giulia Barbati, Massimo Zecchin, Rossana Bussani, Furio Silvestri, Anna M Iorio, Davide Stolfo, Matteo Dal Ferro, Andreea M Dragos, Gennaro Meringolo, Stelios Pyxaras, Francesco Lo Giudice, Andrea Perkan, Andrea di Lenarda, Gianfranco Sinagra. (2009) Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure – a subgroup analysis from the Trieste Cardiomyopathy Registry. Journal of Cardiovascular Medicine 10:9, 699-705
CrossRef578
R. Berger, A. Shankar, F. Fruhwald, A. Fahrleitner-Pammer, N. Freemantle, L. Tavazzi, J. G.F. Cleland, R. Pacher. (2009) Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study. European Heart Journal 30:17, 2109-2116
CrossRef579
Amaar Ujeyl, Lynne Warner Stevenson. (2009) Populations for CRT devices. Heart Rhythm 6:9, 1373-1377
CrossRef580
Ilknur Can, Venkatakrishna N. Tholakanahalli. (2009) Current status of implantable cardioverter-defibrillator therapy in heart failure. Current Heart Failure Reports 6:3, 199-209
CrossRef581
WENJIE XU, HANS J. MOORE, PAMELA E. KARASIK, MICHAEL R. FRANZ, STEVE N. SINGH, ROSS D. FLETCHER. (2009) Management Strategies When Implanted Cardioverter Defibrillator Leads Fail: Survey Findings. Pacing and Clinical Electrophysiology 32:9, 1130-1141
CrossRef582
M. Kullmer, M. Albanese, W. Schöls. (2009) Kardiale Resynchronisationstherapie. Herzschrittmachertherapie + Elektrophysiologie 20:3, 143-147
CrossRef583
Hubertus Degen, Thomas Lickfeld, Carsten Stoepel, Michael Haude. (2009) Perkutane Mitralklappenanulorrhaphie mit dem Carillon™ XE2 Mitral Contour System™ von Cardiac Dimensions™. Herz 34:6, 451-457
CrossRef584
Andrea Colella, Marzia Giaccardi, Raffaele Molino Lova, Carmine Liccardi, Gian Franco Gensini. (2009) Ventricular tachycardia inducibility after radiofrequency ablation affects the outcomes in patients with coronary artery disease and implantable cardioverter-defibrillators: The role of left ventricular function. Journal of Interventional Cardiac Electrophysiology 25:3, 229-234
CrossRef585
Zian H. Tseng. (2009) Genetic association studies of sudden cardiac death/arrest: The importance of context. Heart Rhythm 6:9, 1315-1317
CrossRef586
Derek R. MacFadden, Jack V. Tu, Alice Chong, Peter C. Austin, Douglas S. Lee. (2009) Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: Role of cardiac conditions and noncardiac comorbidities. Heart Rhythm 6:9, 1289-1296
CrossRef587
Stephen C. Hammill, Mark S. Kremers, Alan H. Kadish, Lynne Warner Stevenson, Paul A. Heidenreich, Bruce D. Lindsay, Michael J. Mirro, Martha J. Radford, Chuck McKay, Yongfei Wang, Christine M. Lang, Kathryn Pontzer, John Rumsfeld, Steve E. Phurrough, Jeptha P. Curtis, Ralph G. Brindis. (2009) Review of the ICD Registry's Third Year, Expansion to include Lead Data and Pediatric ICD Procedures, and Role for Measuring Performance. Heart Rhythm 6:9, 1397-1401
CrossRef588
ALAN H. KADISH, DAVID BELLO, J. PAUL FINN, ROBERT O. BONOW, ANDI SCHAECHTER, HARIS SUBACIUS, CHRISTINE ALBERT, JAMES P. DAUBERT, CARISSA G. FONSECA, JEFFREY J. GOLDBERGER. (2009) Rationale and Design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) Trial. Journal of Cardiovascular Electrophysiology 20:9, 982-987
CrossRef589
Luís Beck-da-Silva, Lívia Goldraich, Laísa Bonzanini, Gabriela Rossi, Gabriela Nuernberg, Suzi A. Camey, Luís Eduardo Rohde, Nadine Clausell. (2009) Pulse Pressure and QRS Width Evaluation as an Inexpensive Tool for Heart Failure Assessment. Congestive Heart Failure 15:5, 222-227
CrossRef590
Deborah Meyers. (2009) Medical therapies for the management of cardiomyopathy and chronic congestive heart failure. Current Cardiovascular Risk Reports 3:5, 315-322
CrossRef591
Robert C. Sheppard, Jason C. Levine, Joshua Rovin, Hugh M. van Gelder. (2009) A novel way an implantable cardioverter-defibrillator prevents death: Protection from a gunshot. Heart Rhythm 6:9, 1390
CrossRef592
PIETRO FRANCIA, CRISTINA BALLA, ARIANNA UCCELLINI, RICCARDO CAPPATO. (2009) Arrhythmia Detection in Single- and Dual-Chamber Implantable Cardioverter Defibrillators: The More Leads, the Better?. Journal of Cardiovascular Electrophysiology 20:9, 1077-1082
CrossRef593
Rashmee U Shah, Liviu Klein, Donald M Lloyd-Jones. (2009) Heart failure in women: epidemiology, biology and treatment. Women's Health 5:5, 517-527
CrossRef594
M. Schlößer, C. Stellbrink. (2009) Indikationen zur CRT. Herzschrittmachertherapie + Elektrophysiologie 20:3, 103-108
CrossRef595
Weiwei Li, Brian Olshansky. (2009) Electrophysiological device therapy (implantable defibrillators) in older adults. Current Cardiovascular Risk Reports 3:5, 347-354
CrossRef596
M. Brignole. (2009) Are complications of implantable defibrillators under-estimated and benefits over-estimated?. Europace 11:9, 1129-1133
CrossRef597
Rakesh Gopinathannair, Renee M. Sullivan, Brian Olshansky. (2009) Update on medical management of atrial fibrillation in the modern era. Heart Rhythm 6:8, S17-S22
CrossRef598
P. A. Scott, N. G. Turner, A. Chungh, J. M. Morgan, P. R. Roberts. (2009) Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace 11:8, 1048-1051
CrossRef599
Eileen M. Hsich, Ileana L. Piña. (2009) Heart Failure in Women. Journal of the American College of Cardiology 54:6, 491-498
CrossRef600
SUSANNE S. PEDERSEN, MARTHA VAN DEN BERG, DOMINIC A. M. J. THEUNS. (2009) A Viewpoint on the Impact of Device Advisories on Patient-Centered Outcomes. Pacing and Clinical Electrophysiology 32:8, 1006-1011
CrossRef601
Giovanni Lucignani. (2009) Metaiodobenzylguanidine (mIBG) molecular imaging in implantable cardioverter defibrillator (ICD) therapy planning: a health technology assessment issue. European Journal of Nuclear Medicine and Molecular Imaging 36:8, 1346-1350
CrossRef602
Akli Otmani, Ludovic Trinquart, Eloi Marijon, Thomas Lavergne, Xavier Waintraub, Antoine Lepillier, Gilles Chatellier, Jean-Yves Le Heuzey. (2009) Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study. American Heart Journal 158:2, 230-237.e1
CrossRef603
Mintu P. Turakhia, Paul J. Wang. (2009) “Low ejection fraction prophylaxis” with implantable defibrillators in the elderly: Call for a randomized trial?. Heart Rhythm 6:8, 1144-1145
CrossRef604
Andrew E. Epstein, G. Neal Kay, Vance J. Plumb, H. Thomas McElderry, Harish Doppalapudi, Takumi Yamada, Jeff Shafiroff, Zaffer A. Syed, Sergio Shkurovich. (2009) Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm 6:8, 1136-1143
CrossRef605
E. Marijon, S. Boveda, N. Combes, J.-P. Albenque, J.-Y. Le Heuzey. (2009) Comment évaluer le risque de mort subite dans les suites d’un infarctus du myocarde ?. Annales de Cardiologie et d'Angéiologie 58:4, 220-225
CrossRef606
Stacie L. Daugherty, Pamela N. Peterson, Yongfei Wang, Jeptha P. Curtis, Paul A. Heidenreich, JoAnn Lindenfeld, Humberto J. Vidaillet, Frederick A. Masoudi. (2009) Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria?. American Heart Journal 158:2, 224-229
CrossRef607
Geoffrey S Pitt. (2009) Channeling a New Focus for Heart Failure: Insights Into Ion Channels. Journal of Cardiovascular Pharmacology 54:2, 95-97
CrossRef608
Yuri B. Pride, Evan Appelbaum, Erin E. Lord, Sarah Sloan, Christopher P. Cannon, Marc S. Sabatine, C. Michael Gibson. (2009) Relation Between Myocardial Infarct Size and Ventricular Tachyarrhythmia Among Patients With Preserved Left Ventricular Ejection Fraction Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 104:4, 475-479
CrossRef609
Deryk L. McDowell, Paul J. Hauptman. (2009) Implantable Defibrillators and Cardiac Resynchronization Therapy in Heart Transplant Recipients: Results of a National Survey. The Journal of Heart and Lung Transplantation 28:8, 847-850
CrossRef610
C. W. Israel. (2009) Do some implant too many defibrillators or others too few?. Europace 11:8, 982-984
CrossRef611
Michael J. Cutler, David S. Rosenbaum. (2009) Risk stratification for sudden cardiac death: Is there a clinical role for T wave alternans?. Heart Rhythm 6:8, S56-S61
CrossRef612
S. Genovesi, M. G. Valsecchi, E. Rossi, D. Pogliani, I. Acquistapace, V. De Cristofaro, A. Stella, A. Vincenti. (2009) Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrology Dialysis Transplantation 24:8, 2529-2536
CrossRef613
H. S. Lim, G. Y.H. Lip. (2009) Defibrillation testing in patients with atrial fibrillation. Europace 11:8, 1108-1109
CrossRef614
Sebastian Haas, Hans Peter Richter, Jens C Kubitz. (2009) Anesthesia during cardiologic procedures. Current Opinion in Anaesthesiology 22:4, 519-523
CrossRef615
Tetsuo Sasano, Kamilla Kelemen, Ian D. Greener, J. Kevin Donahue. (2009) Ventricular tachycardia from the healed myocardial infarction scar: Validation of an animal model and utility of gene therapy. Heart Rhythm 6:8, S91-S97
CrossRef616
, J. Vijgen, G. Botto, J. Camm, C.-J. Hoijer, W. Jung, J.-Y. Le Heuzey, A. Lubinski, T. M. Norekval, M. Santomauro, M. Schalij, J.-P. Schmid, P. Vardas. (2009) Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11:8, 1097-1107
CrossRef617
Robert J. Myerburg, Vivek Reddy, Agustin Castellanos. (2009) Indications for Implantable Cardioverter-Defibrillators Based on Evidence and Judgment. Journal of the American College of Cardiology 54:9, 747-763
CrossRef618
DAVID FOO, BRUCE D. WALKER, DENNIS L. KUCHAR, CHARLES W. THORBURN, ANDRE TAY, CHRISTOPHER S. HAYWARD, PETER MACDONALD, ANNE KEOGH, EUGENE KOTLYAR, PHILIP SPRATT, PAUL JANSZ. (2009) Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case Series. Pacing and Clinical Electrophysiology 32:7, 879-887
CrossRef619
M. Stockburger, O. Celebi, A. Krebs, T. Knaus, A. Nitardy, D. Habedank, R. Dietz. (2009) Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing. Europace 11:7, 924-930
CrossRef620
CHARLES I. BERUL. (2009) Implantable Cardioverter Defibrillator Criteria for Primary and Secondary Prevention of Pediatric Sudden Cardiac Death. Pacing and Clinical Electrophysiology 32, S67-S70
CrossRef621
Roberto Marchioli, Giacomo Levantesi, Maria G Silletta, Simona Barlera, Marino Bernardinangeli, Emanuele Carbonieri, Francesco Cosmi, Maria G Franzosi, Roberto Latini, Donata Lucci, Aldo Pietro Maggioni, Luciano Moretti, Gian L Nicolosi, Maurizio Porcu, Maria G Rossi, Gianni Tognoni, Luigi Tavazzi. (2009) Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Expert Review of Cardiovascular Therapy 7:7, 735-748
CrossRef622
ANGELO BIVIANO, DONNA MANCINI, YOSHIFUMI NAKA, JERRY ARELLANO, HASAN GARAN. (2009) Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable. Pacing and Clinical Electrophysiology 32:7, 945-948
CrossRef623
M. K. de Bie, B. van Dam, A. Gaasbeek, M. van Buren, L. van Erven, J. J. Bax, M. J. Schalij, T. J. Rabelink, J. W. Jukema. (2009) The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. European Heart Journal 30:13, 1559-1564
CrossRef624
Komandoor Srivathsan, Daniel WC Ng, Farouk Mookadam. (2009) Ventricular tachycardia and ventricular fibrillation. Expert Review of Cardiovascular Therapy 7:7, 801-809
CrossRef625
Alpesh Mehta, Mark I. Travin, Jeffrey M. Levsky, Vineet R. Jain, William B. Burton, Linda B. Haramati. (2009) Ejection Fractions Determined by Cardiac Computed Tomographic Angiography and Single Photon Emission Computed Tomographic Myocardial Perfusion Imaging Are Not Interchangeable. Journal of Computer Assisted Tomography 33:4, 489-497
CrossRef626
ROBERT M. HAMILTON, EDUARDO R. AZEVEDO. (2009) Sudden Cardiac Death in Dilated Cardiomyopathies. Pacing and Clinical Electrophysiology 32, S32-S40
CrossRef627
Paul Khairy, Annie Dore, Nancy Poirier, François Marcotte, Reda Ibrahim, François-Pierre Mongeon, Lise-Andrée Mercier. (2009) Risk stratification in surgically repaired tetralogy of Fallot. Expert Review of Cardiovascular Therapy 7:7, 755-762
CrossRef628
S. Krishnamoorthy, G. Y.H. Lip. (2009) How safe is the antiarrhythmic drug therapy in atrial fibrillation?. Europace 11:7, 837-839
CrossRef629
Kathy Hebert, Barbara Lopez, Francisco Yuri Bulcao Macedo, Conrado Rios Gomes, Johan Urena, Lee M. Arcement. (2009) Peripheral Vascular Disease and Erectile Dysfunction as Predictors of Mortality in Heart Failure Patients. Journal of Sexual Medicine 6:7, 1999-2007
CrossRef630
Haris M. Haqqani, Jonathan M. Kalman, Kurt C. Roberts-Thomson, Richard N. Balasubramaniam, Raphael Rosso, Richard L. Snowdon, Paul B. Sparks, Jitendra K. Vohra, Joseph B. Morton. (2009) Fundamental Differences in Electrophysiologic and Electroanatomic Substrate Between Ischemic Cardiomyopathy Patients With and Without Clinical Ventricular Tachycardia. Journal of the American College of Cardiology 54:2, 166-173
CrossRef631
Frank Grothues, Ruediger Braun-Dullaeus. (2009) Serial Assessment of Ventricular Morphology and Function. Heart Failure Clinics 5:3, 301-314
CrossRef632
SJOERD A. MOLLEMA, PATRICK KLEIN, JOGIEN HEERSCHE, MARTIN J. SCHALIJ, ERNST E. VAN DER WALL, MICHEL I.M. VERSTEEGH, ROBERT J.M. KLAUTZ, LIESELOT VAN ERVEN, JEROEN J. BAX. (2009) Left Ventricular Ejection Fraction as Criterion for Implantation of an Implantable Cardioverter-Defibrillator in Heart Failure Patients Undergoing Surgical Left Ventricular Reconstruction. Pacing and Clinical Electrophysiology 32:7, 913-917
CrossRef633
G. C. Digby, M. E. Daubney, J. Baggs, D. Campbell, C. S. Simpson, D. P. Redfearn, F. J. Brennan, H. Abdollah, A. Baranchuk. (2009) Physiotherapy and cardiac rhythm devices: a review of the current scope of practice. Europace 11:7, 850-859
CrossRef634
M. Meine, T. Smith, R. N.W. Hauer. (2009) The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?. Europace 11:6, 689-691
CrossRef635
K. M. Stein, S. Mittal, F. R. Gilliam, D. M. Gilligan, Q. Zhong, S. M. Kraus, T. E. Meyer. (2009) Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace 11:6, 734-740
CrossRef636
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, J. Kautzner, G. N. Kay, K.-H. Kuck, B. B. Lerman, F. Marchlinski, V. Reddy, M.-J. Schalij, R. Schilling, K. Soejima, D. Wilber. (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 11:6, 771-817
CrossRef637
Derek V. Exner. (2009) Noninvasive risk stratification after myocardial infarction: Rationale, current evidence and the need for definitive trials. Canadian Journal of Cardiology 25, 21A-27A
CrossRef638
BRETT GIDNEY, DAVID S. CANNOM. (2009) The Role of Electrophysiologic Studies in Dilated Cardiomyopathy: Definitive Results from the DEFINITE Trial. Pacing and Clinical Electrophysiology 32:6, 753-754
CrossRef639
Hein J. Verberne, G. Aernout Somsen, Berthe L.F. van Eck-Smit. (2009) 123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects. Nuclear Medicine Communications 30:6, 411-414
CrossRef640
Martin R. Cowie, Vivianne Conraads, Luigi Tavazzi, C.M. Yu. (2009) Rationale and Design of a Prospective Trial to Assess the Sensitivity and Positive Predictive Value of Implantable Intrathoracic Impedance Monitoring in the Prediction of Heart Failure Hospitalizations: The SENSE-HF Study. Journal of Cardiac Failure 15:5, 394-400
CrossRef641
MOHAMAD A. ALAITI, ANJLI MAROO, THOMAS B. EDEL. (2009) Troponin Levels after Cardiac Electrophysiology Procedures: Review of the Literature. Pacing and Clinical Electrophysiology 32:6, 800-810
CrossRef642
ARABINDRA B. KATWAL, CRAIG J. McCOTTER. (2009) Use of a Wireless Implantable Cardioverter Defibrillator in a Patient with a Preexisting Neurostimulator. Pacing and Clinical Electrophysiology 32:6, 822-824
CrossRef643
M. R. Cowie, D. Marshall, M. Drummond, N. Ferko, M. Maschio, M. Ekman, L. de Roy, H. Heidbuchel, Y. Verboven, F. Braunschweig, C. Linde, G. Boriani. (2009) Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace 11:6, 716-726
CrossRef644
J. G.F. Cleland, A. P. Coletta, A. L. Clark, D. Cullington. (2009) Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA. European Journal of Heart Failure 11:6, 622-630
CrossRef645
William H. Maisel, Robert G. Hauser, Stephen C. Hammill, Robert G. Hauser, Kenneth A. Ellenbogen, Andrew E. Epstein, David L. Hayes, Joseph S. Alpert, Ronald D. Berger, Anne B. Curtis, Anne M. Dubin, N.A. Mark Estes, Melanie T. Gura, Andrew D. Krahn, Rachel Lampert, Bruce D. Lindsay, Bruce L. Wilkoff. (2009) Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines. Heart Rhythm 6:6, 869-885
CrossRef646
JAMES P. DAUBERT, STEPHEN L. WINTERS, HARIS SUBAČIUS, RONALD D. BERGER, KENNETH A. ELLENBOGEN, SARAH G. TAYLOR, ANDI SCHAECHTER, ADAM HOWARD, ALAN KADISH, . (2009) Ventricular Arrhythmia Inducibility Predicts Subsequent ICD Activation in Nonischemic Cardiomyopathy Patients: A DEFINITE Substudy. Pacing and Clinical Electrophysiology 32:6, 755-761
CrossRef647
Etienne M. Aliot, William G. Stevenson, Jesus Ma Almendral-Garrote, Frank Bogun, C. Hugh Calkins, Etienne Delacretaz, Paolo Della Bella, Gerhard Hindricks, Pierre Jaïs, Mark E. Josephson, Josef Kautzner, G. Neal Kay, Karl-Heinz Kuck, Bruce B. Lerman, Francis Marchlinski, Vivek Reddy, Martin-Jan Schalij, Richard Schilling, Kyoko Soejima, David Wilber. (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. Heart Rhythm 6:6, 886-933
CrossRef648
E. Agricola, A. Ielasi, M. Oppizzi, P. Faggiano, L. Ferri, A. Calabrese, E. Vizzardi, O. Alfieri, A. Margonato. (2009) Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. European Journal of Heart Failure 11:6, 581-587
CrossRef649
C. Cevik, A. Perez-Verdia, K. Nugent. (2009) Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11:6, 710-715
CrossRef650
J. P. Piccini, J. S. Berger, C. M. O'Connor. (2009) Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. European Heart Journal 30:10, 1245-1253
CrossRef651
D. R. Tomlinson, Y. Bashir, T. R. Betts, K. Rajappan. (2009) Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11:5, 638-642
CrossRef652
Joseph C. Lee, Laurence M. Epstein, Linda L. Huffer, William G. Stevenson, Bruce A. Koplan, Usha B. Tedrow. (2009) ICD lead proarrhythmia cured by lead extraction. Heart Rhythm 6:5, 613-618
CrossRef653
Daniel R. Frisch, Evaldas Giedrimas, Satishkumar Mohanavelu, Amy Shui, Kalon K.L. Ho, C. Michael Gibson, Mark E. Josephson, Peter J. Zimetbaum. (2009) Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction. The American Journal of Cardiology 103:9, 1206-1209
CrossRef654
Jean-Marc Raymond, Frederic Sacher, Robert Winslow, Usha Tedrow, William G. Stevenson. (2009) Catheter Ablation for Scar-related Ventricular Tachycardias. Current Problems in Cardiology 34:5, 225-270
CrossRef655
Maria A. Castel, Herbert Nägele. (2009) Sudden Cardiac Arrest in Patients With Severe Nonischemic Heart Failure: Risk Stratification With the Heart Failure Survival Score. Congestive Heart Failure 15:3, 112-116
CrossRef656
Christopher R. Ellis, Jeffrey N. Rottman. (2009) Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. Heart Rhythm 6:5, 619-624
CrossRef657
HELLE SPINDLER, JENS B. JOHANSEN, KIRSTEN ANDERSEN, PETER MORTENSEN, SUSANNE S. PEDERSEN. (2009) Gender Differences in Anxiety and Concerns about the Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 32:5, 614-621
CrossRef658
Wilbert S. Aronow. (2009) Treatment of Ventricular Arrhythmias in the Elderly. Cardiology in Review 17:3, 136-146
CrossRef659
C. J. W. Borleffs, R. J. van Bommel, S. G. Molhoek, J. G. de Leeuw, M. J. Schalij, L. van Erven. (2009) Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device. Europace 11:5, 607-611
CrossRef660
SAMIR SABA, SANDEEP JAIN, RAVEEN BAZAZ, DAVID SCHWARTZMAN. (2009) Time Shift of Marker Legend in Stored Intracardiac Events in Three Patients with the Vitality 2 EL DR (Model T167) and Prizm 2DR (Model 1861) Dual-Chamber Defibrillators. Journal of Cardiovascular Electrophysiology 20:5, 564-567
CrossRef661
Robbert H.J. Crusio, Yisachar J. Greenberg. (2009) An unusual presentation of implantable cardioverter-defibrillator lead perforation. Journal of Electrocardiology 42:3, 265-266
CrossRef662
A. R. Lyon, K. T. MacLeod, Y. Zhang, E. Garcia, G. K. Kanda, M. J. Lab, Y. E. Korchev, S. E. Harding, J. Gorelik. (2009) Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proceedings of the National Academy of Sciences 106:16, 6854-6859
CrossRef663
M. Komajda. (2009) Heart failure guidelines in North America and Europe: agreement or disagreement?. European Journal of Heart Failure Supplements 8:Supplement 1, i11-i14
CrossRef664
Mariell Jessup, William T. Abraham, Donald E. Casey, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Marvin A. Konstam, Donna M. Mancini, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, 1343-1382
CrossRef665
D.T. Connelly. (2009) Current controversies in using electrical devices. European Journal of Heart Failure Supplements 8:Supplement 1, i21-i24
CrossRef666
Katherine C. Wu. (2009) MRI with late gadolinium enhancement as a predictor of ventricular arrhythmias. Current Cardiovascular Imaging Reports 2:2, 116-123
CrossRef667
Amy S. Kelley, M. Carrington Reid, David H. Miller, Joseph J. Fins, Mark S. Lachs. (2009) Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey. American Heart Journal 157:4, 702-708.e1
CrossRef668
ALESSANDRO PROCLEMER, MARCO GHIDINA, DOMENICO FACCHIN, LUCA REBELLATO, DOMENICO CORRADO, MAURIZIO GASPARINI, DARIO GREGORI. (2009) Use of Implantable Cardioverter-Defibrillator in Inherited Arrhythmogenic Diseases: Data from Italian ICD Registry for the Years 2001-6. Pacing and Clinical Electrophysiology 32:4, 434-445
CrossRef669
Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, e1-e90
CrossRef670
Clyde W. Yancy, Gregg C. Fonarow, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas Heywood, Mark L. McBride, Mandeep R. Mehra, Christopher M. O'Connor, Dwight Reynolds, Mary Norine Walsh. (2009) Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. American Heart Journal 157:4, 754-762.e2
CrossRef671
Kristian B. Filion, Xuanqian Xie, Charlotte J. van der Avoort, Nandini Dendukuri, James M. Brophy. (2009) Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: A cost-effectiveness study. International Journal of Technology Assessment in Health Care 25:02, 151
CrossRef672
Tom D. J. Smilde, Dirk J. Veldhuisen, Maarten P. Berg. (2009) Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clinical Research in Cardiology 98:4, 233-239
CrossRef673
Iwona Cygankiewicz, John Gillespie, Wojciech Zareba, Mary W. Brown, Ilan Goldenberg, Helmut Klein, Scott McNitt, Slava Polonsky, Mark Andrews, Edward M. Dwyer, W. Jackson Hall, Arthur J. Moss. (2009) Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 6:4, 468-473
CrossRef674
Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, Antoni Bayes-Genis, Domingo Pascual, Carlos Macaya, Jesus Almendral, Miquel Fiol, Alfredo Bardaji, Jose R. Gonzalez-Juanatey, Vicente Nieto, Mariano Valdes, Juan Cinca, Antoni Bayes de Luna. (2009) Risk Stratification of Mortality in Patients With Heart Failure and Left Ventricular Ejection Fraction >35%. The American Journal of Cardiology 103:7, 1003-1010
CrossRef675
Manuel Martínez-Sellés, María Teresa Vidán, Ramón López-Palop, Lourdes Rexach, Elisabet Sánchez, Tomás Datino, María Cornide, Pilar Carrillo, José M. Ribera, Óscar Díaz-Castro, Camino Bañuelos. (2009) El anciano con cardiopatía terminal. Revista Española de Cardiología 62:4, 409-421
CrossRef676
GRZEGORZ PIETRASIK, ILAN GOLDENBERG, SCOTT McNITT, BRONISLAVA POLONSKY, ARTHUR J. MOSS, WOJCIECH ZAREBA. (2009) Efficacy of Medical Therapy for the Reduction of Heart Failure Events in Patients with Implanted Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 20:4, 395-400
CrossRef677
Judith L. Meadows, David Carballo, Raymond Y. Kwong. (2009) The prognostic value of cardiac MRI. Current Cardiovascular Imaging Reports 2:2, 145-156
CrossRef678
Richard D. Lane, Harry T. Reis, Derick R. Peterson, Wojciech Zareba, Arthur J. Moss. (2009) Happiness and Stress Alter Susceptibility to Cardiac Events in Long QT Syndrome. Annals of Noninvasive Electrocardiology 14:2, 193-200
CrossRef679
Daphna Y. Gelblum, Howard Amols. (2009) Implanted Cardiac Defibrillator Care in Radiation Oncology Patient Population. International Journal of Radiation Oncology*Biology*Physics 73:5, 1525-1531
CrossRef680
Michael P. Slawnych, Tuomo Nieminen, Mika Kähönen, Katherine M. Kavanagh, Terho Lehtimäki, Darlene Ramadan, Jari Viik, Sandeep G. Aggarwal, Rami Lehtinen, Linda Ellis, Kjell Nikus, Derek V. Exner. (2009) Post-Exercise Assessment of Cardiac Repolarization Alternans in Patients With Coronary Artery Disease Using the Modified Moving Average Method. Journal of the American College of Cardiology 53:13, 1130-1137
CrossRef681
Maulik D. Majmudar, Christine Tompkins, Justin M. Bachmann, Roger S. Blumenthal, Joseph E. Marine. (2009) Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death. Cardiology in Review 17:2, 60-69
CrossRef682
MARTIN STOCKBURGER, ALICE KREBS, AISCHA NITARDY, DIRK HABEDANK, ÖZLEM CELEBI, THOMAS KNAUS, RAINER DIETZ. (2009) Survival and Appropriate Device Interventions in Recipients of Cardioverter Defibrillators Implanted for the Primary Versus Secondary Prevention of Sudden Cardiac Death. Pacing and Clinical Electrophysiology 32, S16-S20
CrossRef683
Eric J. Rashba. (2009) Anger Management May Save Your Life. Journal of the American College of Cardiology 53:9, 779-781
CrossRef684
(2009) Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Revista Española de Cardiología 62:3, 293.e1-293.e47
CrossRef685
JASON BRADFIELD, ALBERTA WARNER, MALCOLM M. BERSOHN. (2009) Low Referral Rate for Prophylactic Implantation of Cardioverter-Defibrillators in a Tertiary Care Medical Center. Pacing and Clinical Electrophysiology 32, S194-S197
CrossRef686
Michael J. Mirro. (2009) Strategies for reducing sudden cardiac death: Application of microvolt T-wave alternans testing in clinical practice. Heart Rhythm 6:3, S45-S48
CrossRef687
NIRAJ VARMA, MARK A. JOHNSON. (2009) Prevalence of Cancelled Shock Therapy and Relationship to Shock Delivery in Recipients of Implantable Cardioverter-Defibrillators Assessed by Remote Monitoring. Pacing and Clinical Electrophysiology 32, S42-S46
CrossRef688
PAUL W.X. FOLEY, CLARA E. ADDISON, STEPHANIE B. WHINNEY, KIRAN PATEL, DAVID CUNNINGHAM, MICHAEL P. FRENNEAUX, FRANCISCO LEYVA. (2009) Implantable Cardioverter Defibrillator Therapy for Primary Prevention of Sudden Cardiac Death after Myocardial Infarction:. Pacing and Clinical Electrophysiology 32, S131-S134
CrossRef689
WOLFRAM GRIMM, JULIA SHARKOVA, JÖRG HEITMANN, ANDREAS JERRENTRUP, ULRICH KOEHLER, BERNHARD MAISCH. (2009) Sleep-Disordered Breathing in Recipients of Implantable Defibrillators. Pacing and Clinical Electrophysiology 32, S8-S11
CrossRef690
Gaetano M. De Ferrari, Antonio Sanzo. (2009) T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation?. Heart Rhythm 6:3, S29-S35
CrossRef691
Mishi Bhushan, Samuel J. Asirvatham. (2009) The conundrum of ventricular arrhythmia and cardiomyopathy: Which abnormality came first?. Current Heart Failure Reports 6:1, 7-13
CrossRef692
Donah Zachariah, Philip A. Kalra, Paul R. Kalra. (2009) OPTIMAL MANAGEMENT OF CHRONIC HEART FAILURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Renal Care 35:1, 2-10
CrossRef693
Guy Amit, Otto Costantini, David S. Rosenbaum. (2009) Can we alternate between T-wave alternans testing methods?. Heart Rhythm 6:3, 338-340
CrossRef694
GIUSEPPE STABILE, FRANCESCO SOLIMENE, EMANUELE BERTAGLIA, VINCENZO LA ROCCA, MICHELE ACCOGLI, ALBERTO SCACCIA, NATALE MARRAZZO, FRANCO ZOPPO, PIETRO TURCO, ASSUNTA IULIANO, GERGANA SHOPOVA, CARMINE CIARDIELLO, ANTONIO DE SIMONE. (2009) Long-Term Outcomes of CRT-PM Versus CRT-D Recipients. Pacing and Clinical Electrophysiology 32, S141-S145
CrossRef695
Henry Krum, William T Abraham. (2009) Heart failure. The Lancet 373:9667, 941-955
CrossRef696
Michael S. Lauer. (2009) Comparative Effectiveness Research: The View From the NHLBI. Journal of the American College of Cardiology 53:12, 1084-1086
CrossRef697
Rahul Sakhuja, Mary Keebler, Tai-Shuan Lai, Cara McLaughlin Gavin, Ranjan Thakur, Deepak L. Bhatt. (2009) Meta-Analysis of Mortality in Dialysis Patients With an Implantable Cardioverter Defibrillator. The American Journal of Cardiology 103:5, 735-741
CrossRef698
Brian Olshansky, Rakesh Gopinathannair, Renee M. Sullivan. (2009) DAVID II Did Not Slay Goliath. Journal of the American College of Cardiology 53:10, 881-883
CrossRef699
David G. Strauss, Katherine C. Wu. (2009) Imaging myocardial scar and arrhythmic risk prediction—a role for the electrocardiogram?. Journal of Electrocardiology 42:2, 138.e1-138.e8
CrossRef700
Eyal Herzog, Emad F. Aziz, Marrick Kukin, Jonathan S. Steinberg, Suneet Mittal. (2009) Novel Pathway for Sudden Cardiac Death Prevention. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 8:1, 1-6
CrossRef701
Christina M. Holmgren, Britta M. Nyström, Thomas K. Karlsson, Johan D. Herlitz, Nils G. Edvardsson. (2009) Presumed arrhythmic death in consecutive survivors of acute myocardial infarction – implications for primary implantable cardioverter defibrillator implantation. Coronary Artery Disease 20:2, 155-162
CrossRef702
Jeffrey J. Goldberger. (2009) Evidence-based analysis of risk factors for sudden cardiac death. Heart Rhythm 6:3, S2-S7
CrossRef703
DOMINIC A.M.J. THEUNS, MAXIMO RIVERO-AYERZA, PAUL KNOPS, JAN C.J. RES, LUC JORDAENS. (2009) Analysis of 57,148 Transmissions by Remote Monitoring of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 32, S63-S65
CrossRef704
Paul S. Chan, John D. Birkmeyer, Harlan M. Krumholz, John A. Spertus, Brahmajee K. Nallamothu. (2009) Racial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003. Congestive Heart Failure 15:2, 51-57
CrossRef705
Stefan H. Hohnloser, Takanori Ikeda, Richard J. Cohen. (2009) Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 6:3, S36-S44
CrossRef706
B. A. Koplan, W. G. Stevenson. (2009) Ventricular Tachycardia and Sudden Cardiac Death. Mayo Clinic Proceedings 84:3, 289-297
CrossRef707
J. F. Doyle, K. M. Ho. (2009) Benefits and Risks of Long-term Amiodarone Therapy for Persistent Atrial Fibrillation: A Meta-analysis. Mayo Clinic Proceedings 84:3, 234-242
CrossRef708
(2009) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 360:9, 937-938
Full Text709
A. Bauer, P. Barthel, R. Schneider, K. Ulm, A. Muller, A. Joeinig, R. Stich, A. Kiviniemi, K. Hnatkova, H. Huikuri, A. Schomig, M. Malik, G. Schmidt. (2009) Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). European Heart Journal 30:5, 576-583
CrossRef710
Vikas Kuriachan, Derek V. Exner. (2009) Role of risk stratification after myocardial infarction. Current Treatment Options in Cardiovascular Medicine 11:1, 10-21
CrossRef711
Jaydutt B. Patel, Bruce A. Koplan. (2009) ICD implantation in patients with ischemic left ventricular dysfunction. Current Treatment Options in Cardiovascular Medicine 11:1, 3-9
CrossRef712
Bimal Shah, Adrian F. Hernandez, Li Liang, Sana M. Al-Khatib, Clyde W. Yancy, Gregg C. Fonarow, Eric D. Peterson. (2009) Hospital Variation and Characteristics of Implantable Cardioverter-Defibrillator Use in Patients With Heart Failure. Journal of the American College of Cardiology 53:5, 416-422
CrossRef713
Stavros G Drakos, John V Kanakakis, Serafim Nanas, Michael Bonios, Elisabeth Kaldara, Fotios Katsaros, Christos Pantsios, John N Nanas. (2009) Intermittent Inotropic Infusions Combined With Prophylactic Oral Amiodarone for Patients With Decompensated End-stage Heart Failure. Journal of Cardiovascular Pharmacology 53:2, 157-161
CrossRef714
Gregory K. Feld, Paul Clopton. (2009) Comparability of Noninvasive Microvolt T-Wave Alternans Versus Invasive Ventricular Programmed Stimulation to Guide Implantable Cardioverter-Defibrillator Implantation in Patients at Risk of Sudden Death
CrossRef715
Mithilesh Das. (2009) Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Expert Review of Cardiovascular Therapy 7:2, 181-195
CrossRef716
Jonathan G. Howlett, Robert S. McKelvie, J Malcolm O. Arnold, Jeannine Costigan, Paul Dorian, Anique Ducharme, Estrellita Estrella-Holder, Justin A. Ezekowitz, Nadia Giannetti, Haissam Haddad, George A. Heckman, Anthony M. Herd, Debra Isaac, Philip Jong, Simon Kouz, Peter Liu, Elizabeth Mann, Gordon W. Moe, Ross T. Tsuyuki, Heather J. Ross, Michel White. (2009) Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Canadian Journal of Cardiology 25:2, 85-105
CrossRef717
A. Lepillier, O. Paziaud, G. Lascault, X. Copie, O. Piot. (2009) Prise en charge d’une tachycardie ventriculaire récidivante sur cardiopathie non ischémique chez un patient implanté d’un défibrillateur. Annales de Cardiologie et d'Angéiologie 58:1, 34-39
CrossRef718
Jeff S. Healey, Andrew D. Krahn. (2009) Bad lead? Good lead? What should we believe?. Heart Rhythm 6:2, 210-211
CrossRef719
SUSANNE S. PEDERSEN, SAMUEL F. SEARS, MATTHEW M. BURG, KRISTA C. VAN DEN BROEK. (2009) Does ICD Indication Affect Quality of Life and Levels of Distress?. Pacing and Clinical Electrophysiology 32:2, 153-156
CrossRef720
ROGER A. FREEDMAN, ALEX PETRAKIAN, KER BOYCE, CHARLES HAFFAJEE, JESUS E. VAL-MEJIAS, ASHISH L. OZA. (2009) Performance of Dedicated Versus Integrated Bipolar Defibrillator Leads with CRT-Defibrillators: Results from a Prospective Multicenter Study. Pacing and Clinical Electrophysiology 32:2, 157-165
CrossRef721
Sanjiv M. Narayan. (2009) From nonuniform repolarization to abnormal calcium dynamics: The elusive culprit for ventricular arrhythmias in heart failure. Heart Rhythm 6:2, 260-262
CrossRef722
U.C. Hoppe, M. Böhm, H. Drexler, G. Hasenfuß, B. Lemke, A. Osterspey, M. Pauschinger. (2009) Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Der Kardiologe 3:1, 16-23
CrossRef723
Otto Costantini, Stefan H. Hohnloser, Malcolm M. Kirk, Bruce B. Lerman, James H. Baker, Barathi Sethuraman, Mary M. Dettmer, David S. Rosenbaum. (2009) The ABCD (Alternans Before Cardioverter Defibrillator) Trial. Journal of the American College of Cardiology 53:6, 471-479
CrossRef724
M. Rivero-Ayerza, B. Schaer. (2009) Device therapy in heart failure: do all treatment goals apply to all patients?. Europace 11:3, 280-282
CrossRef725
W. C. Levy, D. Mozaffarian, D. T. Linker, K. W. Kenyon, J. G.F. Cleland, M. Komajda, W. J. Remme, C. Torp-Pedersen, M. Metra, P. A. Poole-Wilson, . (2009) Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. European Journal of Heart Failure 11:3, 256-263
CrossRef726
GEORGE H. CROSSLEY, KAZUTAKA AONUMA, CHARLES HAFFAJEE, MORIO SHODA, ALBERT MEIJER, ALEXANDER BAUER, GIUSEPPE BORIANI, JESPER SVENDSEN, SHELLEY THOMAS, CHRISTOPHER WIGGENHORN, CHRISTINA UNTERBERG-BUCHWALD, . (2009) Atrial Fibrillation Therapy in Patients with a CRT Defibrillator with Wireless Telemetry. Pacing and Clinical Electrophysiology 32:1, 13-23
CrossRef727
Jessica S. Kim, Marc A. Judson, Robert Donnino, Michael Gold, Leslie T. Cooper, Eric N. Prystowsky, Stephen Prystowsky. (2009) Cardiac sarcoidosis. American Heart Journal 157:1, 9-21
CrossRef728
Derek V Exner. (2009) Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction. Current Opinion in Cardiology 24:1, 61-67
CrossRef729
Melissa Matchett, Samuel F Sears, Garrett Hazelton, Kari Kirian, Elynor Wilson, Rajasekhar Nekkanti. (2009) The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Review of Medical Devices 6:1, 43-50
CrossRef730
Fabian J. Arnaldo, Nikolaos Anatoliotakis, Carlos Palacio, David R. Nabert, Steve S. Hsu. (2009) Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies. Heart & Lung: The Journal of Acute and Critical Care 38:1, 10-16
CrossRef731
Melanie Hauck, Alexander Bauer, Frederik Voss, Slawomir Weretka, Hugo A. Katus, Ruediger Becker. (2009) “Home monitoring” for early detection of implantable cardioverter-defibrillator failure. Clinical Research in Cardiology 98:1, 19-24
CrossRef732
Kristin Watson, Kelly M Summers. (2009) Depression in Patients with Heart Failure: Clinical Implications and Management. Pharmacotherapy 29:1, 49-63
CrossRef733
Massimo Santini, Renato P. Ricci, Maurizio Lunati, Maurizio Landolina, Giovanni B. Perego, Maurizio Marzegalli, Milena Schirru, Chiara Belvito, Roberto Brambilla, Giuseppe Guenzati, Serena Gilardi, Sergio Valsecchi. (2009) Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. Journal of Interventional Cardiac Electrophysiology 24:1, 53-61
CrossRef734
Jon W. Schrock, Charles L. Emerman. (2009) Observation Unit Management of Acute Decompensated Heart Failure. Heart Failure Clinics 5:1, 85-100
CrossRef735
Yoshiyuki Nishimura, Yasuhide Ookawa, Hiroshi Baba, Syunsuke Fukaya, Masakazu Aoki, Shinji Ogawa, Masashi Komeda. (2009) The Long-Term Survival and Predictors of Heart Failure after Endoventricular Circular Patch Plasty. Japanese Journal of Cardiovascular Surgery 38:1, 1-6
CrossRef736
James D. Flaherty, Jeroen J. Bax, Leonardo De Luca, Joseph S. Rossi, Charles J. Davidson, Gerasimos Filippatos, Peter P. Liu, Marvin A. Konstam, Barry Greenberg, Mandeep R. Mehra, Günter Breithardt, Peter S. Pang, James B. Young, Gregg C. Fonarow, Robert O. Bonow, Mihai Gheorghiade. (2009) Acute Heart Failure Syndromes in Patients With Coronary Artery Disease. Journal of the American College of Cardiology 53:3, 254-263
CrossRef737
Akihiko Shimizu. (2009) Cardiac Resynchronization Therapy With and Without Implantable Cardioverter-Defibrillator. Circulation Journal 73:SupplementA, A29-A35
CrossRef738
Henry Greenberg. (2009) The Future of Sudden Cardiac Death. Annals of Noninvasive Electrocardiology 14:1, 1-3
CrossRef739
David Birnie, Jeffrey S Healey, Andrew Krahn, Vidal Essebag, Soori Sivakumaran, Anthony Tang, Christopher Simpson. (2009) Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design. Current Opinion in Cardiology 24:1, 82-87
CrossRef740
Mark C. Haigney, Willem J. Kop, Shama Alam, David S. Krantz, Pamela Karasik, Albert A. DelNegro, John S. Gottdiener. (2009) QT Variability during Rest and Exercise in Patients with Implantable Cardioverter Defibrillators and Healthy Controls. Annals of Noninvasive Electrocardiology 14:1, 40-49
CrossRef741
Christian Meyer, Per Schueller, Astrid Rodenbeck, Marcus Hennersdorf, Marc Merx, Joachim Winter, Tienush Rassaf, Malte Kelm, Patrick Schauerte. (2009) Primary and Secondary Prevention of Ventricular Arrhythmias in Dilated Cardiomyopathy. International Heart Journal 50:6, 741-751
CrossRef742
James F. Neuenschwander. (2009) Cardiac Devices in Emergency Department Heart Failure Patients. Heart Failure Clinics 5:1, 63-73
CrossRef743
Alessandro Capucci. (2009) Atrial fibrillation and congestive heart failure: should we aim to control the heart's rate or its rhythm?. Nature Clinical Practice Cardiovascular Medicine 6:1, 6-7
CrossRef744
Denis Roy, Mario Talajic, Marc Dubuc, Bernard Thibault, Peter Guerra, Laurent Macle, Paul Khairy. (2009) Atrial fibrillation and congestive heart failure. Current Opinion in Cardiology 24:1, 29-34
CrossRef745
J. Alberto Lopez. (2009) Total Transvenous Approach to Pacing and Defibrillation After Ebstein's Anomaly. The Annals of Thoracic Surgery 87:1, 303-305
CrossRef746
F. Zanon, S. Aggio, E. Baracca, G. Pastore, G. Corbucci, G. Boaretto, G. Braggion, C. Piergentili, G. Rigatelli, L. Roncon. (2009) Ventricular-arterial coupling in patients with heart failure treated with cardiac resynchronization therapy: may we predict the long-term clinical response?. European Journal of Echocardiography 10:1, 106-111
CrossRef747
Nabil El-Sherif, Abdullah Khan, Joseph Savarese, Gioia Turitto. (2009) Sudden Cardiac Death and Coronary Artery Disease-Pathophysiology and Risk Stratification. Journal of Arrhythmia 25:3, 122-129
CrossRef748
Anthony S Tang, George A Wells, Malcolm Arnold, Stuart Connolly, Stefan Hohnloser, Graham Nichol, Jean Rouleau, Robert Sheldon, Mario Talajic. (2009) Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design. Current Opinion in Cardiology 24:1, 1-8
CrossRef749
S. Spencker, N. Coban, L. Koch, A. Schirdewan, D. Muller. (2008) Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 11:4, 483-488
CrossRef750
A. Proclemer, M. Ghidina, D. Gregori, D. Facchin, L. Rebellato, P. Fioretti, M. Brignole. (2008) Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 11:4, 465-475
CrossRef751
M. Santini, M. Russo, G. Botto, M. Lunati, A. Proclemer, B. Schmidt, A. Erdogan, E. Helmling, W. Rauhe, M. Desaga, E. Santi, M. Messier, G. Boriani. (2008) Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 11:4, 476-482
CrossRef752
S. Valk, L. Jordaens. (2008) Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction. Europace 11:4, 407-408
CrossRef753
Leo H. B. Baur. (2008) Evaluation of left ventricular function: does the imaging technique matter?. The International Journal of Cardiovascular Imaging 24:8, 803-805
CrossRef754
LAUREN D. VAZQUEZ, EMILY A. KUHL, JULIE BISHOP SHEA, ANN KIRKNESS, JIM LEMON, DAVID WHALLEY, JAMIE B. CONTI, SAMUEL F. SEARS. (2008) Age-Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study. Pacing and Clinical Electrophysiology 31:12, 1528-1534
CrossRef755
Giovanni B. Perego, Maurizio Landolina, Giuseppe Vergara, Maurizio Lunati, Gabriele Zanotto, Alessia Pappone, Gabriele Lonardi, Giancarlo Speca, Saverio Iacopino, Annamaria Varbaro, Shantanu Sarkar, Doug A. Hettrick, Alessandra Denaro, . (2008) Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. Journal of Interventional Cardiac Electrophysiology 23:3, 235-242
CrossRef756
Martin Seifert, Jana Hoffmann, Jürgen Meyhöfer, Christian Butter. (2008) Verbesserung der linksventrikulären Kontraktilität durch Stimulation in der absoluten Refraktärperiode –. Herzschrittmachertherapie + Elektrophysiologie 19:S1, 69-76
CrossRef757
Emil Loldrup Fosbøl, Marie Seibæk, Bente Brendorp, Christian Torp-Pedersen, Lars Køber. (2008) Prognostic Importance of Change in QRS Duration Over Time Associated With Left Ventricular Dysfunction in Patients With Congestive Heart Failure: The DIAMOND Study. Journal of Cardiac Failure 14:10, 850-855
CrossRef758
Antonio Curnis, Giosue Mascioli, Luca Bontempi, Manuel Cerini, Tommaso Bignotti, Gabriele Bonetti, Livio Dei Cas. (2008) Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience. Journal of Cardiovascular Medicine 9:12, 1241-1245
CrossRef759
Lorne J. Gula, George J. Klein, Anne S. Hellkamp, David Massel, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, Jill Anderson, George W. Johnson, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 156:6, 1196-1200
CrossRef760
MITESH S. AMIN, AARON D. FOX, GAUTHAM KALAHASTY, RICHARD K. SHEPARD, MARK A. WOOD, KENNETH A. ELLENBOGEN. (2008) Benefit of Primary Prevention Implantable Cardioverter-Defibrillators in the Setting of Chronic Kidney Disease: A Decision Model Analysis. Journal of Cardiovascular Electrophysiology 19:12, 1275-1280
CrossRef761
Martin Stockburger. (2008) Ein- und Zweikammer-ICD: Sind die Unterschiede zum Schrittmacher in Implantation und Nachsorge heutzutage noch bedeutsam?. Herzschrittmachertherapie + Elektrophysiologie 19:S1, 6-13
CrossRef762
(2008) Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008). Revista Española de Cardiología 61:12, 1329.e1-1329.e70
CrossRef763
Michael J. Root. (2008) Implantable Cardiac Rhythm Device Batteries. Journal of Cardiovascular Translational Research 1:4, 254-257
CrossRef764
ILAN GOLDENBERG, ARTHUR J. MOSS. (2008) Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality. Journal of Cardiovascular Electrophysiology 19:12, 1281-1283
CrossRef765
George V. Moukarbel, Scott D. Solomon. (2008) Treatment of asymptomatic left ventricular dysfunction. Current Treatment Options in Cardiovascular Medicine 10:6, 476-485
CrossRef766
Alfred P. Hallstrom, D. George Wyse, John McAnulty, . (2008) Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. Journal of Interventional Cardiac Electrophysiology 23:3, 159-166
CrossRef767
Jerry P. Nolan, Robert W. Neumar, Christophe Adrie, Mayuki Aibiki, Robert A. Berg, Bernd W. Böttiger, Clifton Callaway, Robert S.B. Clark, Romergryko G. Geocadin, Edward C. Jauch, Karl B. Kern, Ivan Laurent, W.T. Longstreth, Raina M. Merchant, Peter Morley, Laurie J. Morrison, Vinay Nadkarni, Mary Ann Peberdy, Emanuel P. Rivers, Antonio Rodriguez-Nunez, Frank W. Sellke, Christian Spaulding, Kjetil Sunde, Terry Vanden Hoek. (2008) Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. Resuscitation 79:3, 350-379
CrossRef768
Cecilia Linde, William T. Abraham, Michael R. Gold, Martin St. John Sutton, Stefano Ghio, Claude Daubert. (2008) Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms. Journal of the American College of Cardiology 52:23, 1834-1843
CrossRef769
Christian G. Wollmann, Dirk Böcker, Andreas Löher, Hans H. Scheld, Günter Breithardt, Rainer Gradaus. (2008) Diagnostik und Therapie von ICD-Elektrodendefekten. Herzschrittmachertherapie + Elektrophysiologie 19:4, 169-180
CrossRef770
Myerburg, Robert J., . (2008) Implantable Cardioverter–Defibrillators after Myocardial Infarction. New England Journal of Medicine 359:21, 2245-2253
Full Text771
A. Lepillier, O. Piot, B. Gerritse, X. Copie, T. Lavergne, O. Paziaud, G. Lascault, X. Waintraub, A. Otmani, J.-Y. Le Heuzey. (2008) Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator. Europace 11:1, 80-85
CrossRef772
C. A. Muratore, L. A. Batista Sa, P. A. Chiale, R. Eloy, M. C. Tentori, J. Escudero, A. M. C. Lima, L. E. Medina, R. Garillo, J. Maloney. (2008) Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 11:2, 164-168
CrossRef773
BEATRICE BREMBILLA-PERROT, FRANÇOIS ALLA, CHRISTINE SUTY-SELTON, OLIVIER HUTTIN, HUGUES BLANGY, NICOLAS SADOUL, FRÉDÉRIC CHOMETON, LAURENT GROBEN, JEAN D. LUPORSI, NOURA ZANNAD, ETIENNE ALIOT, JUANICO CEDANO, SONIA AMMAR, AHMED ABDELAAL, YVES JUILLIÈRE. (2008) Nonischemic Dilated Cardiomyopathy: Results of Noninvasive and Invasive Evaluation in 310 Patients and Clinical Significance of Bundle Branch Block. Pacing and Clinical Electrophysiology 31:11, 1383-1390
CrossRef774
JONAS A. COOPER, MATTHEW P. LATACHA, GABRIEL E. SOTO, RICHARD G. GARMANY, MARYE J. GLEVA, JANE CHEN, MITCHELL N. FADDIS, TIMOTHY W. SMITH. (2008) The Azygos Defibrillator Lead for Elevated Defibrillation Thresholds: Implant Technique, Lead Stability, and Patient Series. Pacing and Clinical Electrophysiology 31:11, 1405-1410
CrossRef775
Rajesh Subbiah, Lorne J. Gula, George J. Klein, Allan C. Skanes, James White, Raymond Yee, Andrew D. Krahn. (2008) Workup of the Cardiac Arrest Survivor. Progress in Cardiovascular Diseases 51:3, 195-203
CrossRef776
FELIX YANG, BINDI SHAH, SEI IWAI, STEVEN M. MARKOWITZ, BRUCE B. LERMAN, KENNETH M. STEIN. (2008) ICD Implantation and Arrhythmia-Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease. Pacing and Clinical Electrophysiology 31:11, 1419-1424
CrossRef777
Mark V. Sherrid, James P. Daubert. (2008) Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults. Progress in Cardiovascular Diseases 51:3, 237-263
CrossRef778
Maurizio Gasparini, Maurizio Lunati, Maurizio Landolina, Massimo Santini, Luigi Padeletti, Gianni Perego, Antonio Vincenti, Antonio Curnis, Angelo Carboni, Alessandra Denaro, Alessia Spotti, Andrea Grammatico, François Regoli, Giuseppe Boriani. (2008) Electrical storm in patients with biventricular implantable cardioverter defibrillator: Incidence, predictors, and prognostic implications. American Heart Journal 156:5, 847-854
CrossRef779
DAVID SCHWARTZMAN. (2008) Getting the Most Out of Life. Journal of Cardiovascular Electrophysiology 19:11, 1167-1168
CrossRef780
Sumeet S. Chugh, Kyndaron Reinier, Carmen Teodorescu, Audrey Evanado, Elizabeth Kehr, Mershed Al Samara, Ronald Mariani, Karen Gunson, Jonathan Jui. (2008) Epidemiology of Sudden Cardiac Death: Clinical and Research Implications. Progress in Cardiovascular Diseases 51:3, 213-228
CrossRef781
MANISH UNDAVIA, NATHAN E. GOLDSTEIN, PILAR COHEN, KAMOLTIP SINTHAWANARONG, MAGDALENA SINGSON, DIVAYA BHUTANI, TRACEY MUNSON, JOSEPH ANTHONY GOMES, AVI FISCHER, DAVENDRA MEHTA. (2008) Impact of Implantable Cardioverter-Defibrillator Recalls on Patients' Anxiety, Depression, and Quality of Life. Pacing and Clinical Electrophysiology 31:11, 1411-1418
CrossRef782
Theodore Chow, Dean J. Kereiakes, John Onufer, Alan Woelfel, Sinan Gursoy, Brett J. Peterson, Mark L. Brown, Wenji Pu, David G. Benditt. (2008) Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?. Journal of the American College of Cardiology 52:20, 1607-1615
CrossRef783
MICHAEL O SWEENEY, ANNE S HELLKAMP, KENNETH A ELLENBOGEN, GERVASIO A LAMAS. (2008) Reduced Ejection Fraction, Sudden Cardiac Death, and Heart Failure Death in the Mode Selection Trial (MOST): Implications for Device Selection in Elderly Patients with Sinus Node Disease. Journal of Cardiovascular Electrophysiology 19:11, 1160-1166
CrossRef784
David J. Whellan, Christopher M. O'Connor, Kevin T. Ousdigian, Te-Hsin Lung. (2008) Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). American Heart Journal 156:5, 833-839.e2
CrossRef785
George Crossley, Andrew Boyle, Holly Vitense, Lou Sherfesee, R. Hardwin Mead. (2008) Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study. American Heart Journal 156:5, 840-846
CrossRef786
, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P. G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, M. Weis, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , S. Silber, F. V. Aguirre, N. Al-Attar, E. Alegria, F. Andreotti, W. Benzer, O. Breithardt, N. Danchin, C. D. Mario, D. Dudek, D. Gulba, S. Halvorsen, P. Kaufmann, R. Kornowski, G. Y. H. Lip, F. Rutten. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. European Heart Journal 29:23, 2909-2945
CrossRef787
P. Peter Borek, Bruce L. Wilkoff. (2008) Pacemaker and ICD leads: Strategies for long-term management. Journal of Interventional Cardiac Electrophysiology 23:1, 59-72
CrossRef788
Ian N. Sabir, Juliet A. Usher-Smith, Christopher L.-H. Huang, Andrew A. Grace. (2008) Risk stratification for sudden cardiac death. Progress in Biophysics and Molecular Biology 98:2-3, 340-346
CrossRef789
Yaariv Khaykin, Allan Skanes, Bonnie Whaley, Carol Hill, Marianne Beardsall, Catherine Seabrook, Zaev Wulffhart, Richard Oosthuizen, Lorne Gula, Atul Verma. (2008) Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation. Heart Rhythm 5:10, 1396-1402
CrossRef790
Jozef Bartunek, Marc Vanderheyden. (2008) Cardiac Dyssynchrony in Congestive Heart Failure and Atrial Fibrillation. Journal of the American College of Cardiology 52:15, 1247-1249
CrossRef791
Sanjeev Saksena, Rangadham Nagarakanti. (2008) The future of implantable defibrillator and cardiac resynchronization therapy trials. Journal of Interventional Cardiac Electrophysiology 23:1, 29-39
CrossRef792
, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori, K. Swedberg, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P. M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.-L. Vachiery, F. W. A. Verheugt, J. L. Zamorano, F. Zannad. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29:19, 2388-2442
CrossRef793
GISSI-HF investigators. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. The Lancet 372:9645, 1223-1230
CrossRef794
BARRY J. MARON, PAOLO SPIRITO. (2008) Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 19:10, 1118-1126
CrossRef795
Sana M. Al-Khatib, Gillian D. Sanders, Mark Carlson, Aida Cicic, Anne Curtis, Gregg C. Fonarow, Peter W. Groeneveld, David Hayes, Paul Heidenreich, Daniel Mark, Eric Peterson, Eric N. Prystowsky, Philip Sager, Marcel E. Salive, Kevin Thomas, Clyde W. Yancy, Wojciech Zareba, Douglas Zipes. (2008) Preventing tomorrow's sudden cardiac death today. American Heart Journal 156:4, 613-622
CrossRef796
J. Kreuz, L. M. Lickfett, J. O. Schwab. (2008) Modern noninvasive risk stratification in primary prevention of sudden cardiac death. Journal of Interventional Cardiac Electrophysiology 23:1, 23-28
CrossRef797
G. C. Gronefeld. (2008) Discrimination of ventricular tachycardia from supraventricular tachycardia in implantable cardioverter defibrillators by automated electrogram morphology analysis: can leads finally replace the electrophysiologist?. Europace 10:10, 1131-1132
CrossRef798
J. Tebbenjohanns, S. Willems, M. Antz, D. Pfeiffer, K.-H. Seidl, T. Lewalter. (2008) Kommentar zu den „ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary“. Der Kardiologe 2:5, 363-388
CrossRef799
DAVID S. CANNOM, JOHN FISHER. (2008) The Fidelis Recall: How Much Pressure Can the ICD World Bear?. Pacing and Clinical Electrophysiology 31:10, 1233-1235
CrossRef800
JAMES D. ALLRED, HUGH T. McELDERRY, HARISH DOPPALAPUDI, TAKUMI YAMADA, G. NEAL KAY. (2008) Biventricular ICD Implantation Using the Iliofemoral Approach: Providing CRT to Patients with Occluded Superior Venous Access. Pacing and Clinical Electrophysiology 31:10, 1351-1354
CrossRef801
Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes. (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. Heart Rhythm 5:10, e1-e21
CrossRef802
H.-J. Trappe. (2008) Kardiale Resynchronisationstherapie. Der Kardiologe 2:5, 407-416
CrossRef803
CHRISTOPHER R. ELLIS, KATHERINE T. MURRAY. (2008) When an ICD is Not the Answer… Hypothyroidism-Induced Cardiomyopathy and Torsades de Pointes. Journal of Cardiovascular Electrophysiology 19:10, 1105-1107
CrossRef804
SANA M AL-KHATIB, ANNE S. HELLKAMP, KERRY L LEE, JILL ANDERSON, JEANNE E. POOLE, DANIEL B. MARK, GUST H. BARDY, . (2008) Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Journal of Cardiovascular Electrophysiology 19:10, 1059-1065
CrossRef805
Endrj Menardi, Antonello Vado, Guido Rossetti, Emanuela Racca, Enrica Conte, Antonella Deorsola, Marco Bobbio, Mauro Feola. (2008) Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients. Archives of Medical Research 39:7, 702-708
CrossRef806
S. Sherazi, J. P. Daubert, R. C. Block, V. Jeevanantham, K. Abdel-Gadir, M. R. DiSalle, J. M. Haley, A. H. Shah. (2008) Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator. Mayo Clinic Proceedings 83:10, 1139-1141
CrossRef807
Poole, Jeanne E., Johnson, George W., Hellkamp, Anne S., Anderson, Jill, Callans, David J., Raitt, Merritt H., Reddy, Ramakota K., Marchlinski, Francis E., Yee, Raymond, Guarnieri, Thomas, Talajic, Mario, Wilber, David J., Fishbein, Daniel P., Packer, Douglas L., Mark, Daniel B., Lee, Kerry L., Bardy, Gust H., . (2008) Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure. New England Journal of Medicine 359:10, 1009-1017
Full Text808
Mark, Daniel B., Anstrom, Kevin J., Sun, Jie L., Clapp-Channing, Nancy E., Tsiatis, Anastasios A., Davidson-Ray, Linda, Lee, Kerry L., Bardy, Gust H., . (2008) Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure. New England Journal of Medicine 359:10, 999-1008
Full Text809
Healey, Jeff, Connolly, Stuart, . (2008) Life and Death after ICD Implantation. New England Journal of Medicine 359:10, 1058-1059
Full Text810
Paul Dorian, Hussein R. Al-Khalidi, Stefan H. Hohnloser, Jose M. Brum, Preston M. Dunnmon, Craig M. Pratt, Michael J. Holroyde, Peter Kowey. (2008) Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial. Journal of the American College of Cardiology 52:13, 1076-1083
CrossRef811
Andrew E. Epstein. (2008) Benefits of the Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 52:14, 1122-1127
CrossRef812
Kenneth M. Stein. (2008) Noninvasive Risk Stratification for Sudden Death: Signal-Averaged Electrocardiography, Nonsustained Ventricular Tachycardia, Heart Rate Variability, Baroreflex Sensitivity, and QRS Duration. Progress in Cardiovascular Diseases 51:2, 106-117
CrossRef813
Roderick Tung, Peter Zimetbaum, Mark E. Josephson. (2008) A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1111-1121
CrossRef814
Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes. (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1179-1199
CrossRef815
Kevin E. Steel, Raymond Y. Kwong. (2008) Application of cardiac magnetic resonance imaging in cardiomyopathy. Current Heart Failure Reports 5:3, 128-135
CrossRef816
Sanjiv M. Narayan. (2008) T-Wave Alternans Testing for Ventricular Arrhythmias. Progress in Cardiovascular Diseases 51:2, 118-127
CrossRef817
Lutz Frankenstein, Christian Zugck, Manfred Nelles, Dieter Schellberg, Andrew Remppis, Hugo Katus. (2008) Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials. Clinical Research in Cardiology 97:9, 594-600
CrossRef818
Douglas S. Lee, David Birnie, Douglas Cameron, Eugene Crystal, Paul Dorian, Lorne J. Gula, Jeffrey S. Healey, Amir Janmohammed, Yaariv Khaykin, Andrew D. Krahn, Catherine LeFeuvre, Christopher S. Simpson, Raymond Yee, Judy Hardy, Pamela M. Slaughter, Zhongliang Chen, David A. Alter, Andreas Laupacis, Jack V. Tu. (2008) Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario. Heart Rhythm 5:9, 1250-1256
CrossRef819
Stephen C. Hammill, Mark S. Kremers, Lynne Warner Stevenson, Alan H. Kadish, Paul A. Heidenreich, Bruce D. Lindsay, Michael J. Mirro, Martha J. Radford, Yongfei Wang, Jeptha P. Curtis, Christine M. Lang, Joel C. Harder, Ralph G. Brindis. (2008) Review of the Registry's Second Year, Data Collected, and Plans to Add Lead and Pediatric ICD Procedures. Heart Rhythm 5:9, 1359-1363
CrossRef820
Andrew D. Krahn, Jeffrey S. Hoch, Marie Antoinette Rockx, Peter Leong-Sit, Lorne J. Gula, Raymond Yee, Allan C. Skanes, George J. Klein. (2008) Cost of Preimplantation Cardiac Imaging in Patients Referred for a Primary-Prevention Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 102:5, 588-592
CrossRef821
Roger Villuendas, Alan H. Kadish. (2008) Cardiac Magnetic Resonance for Risk Stratification: The Sudden Death Risk Portrayed. Progress in Cardiovascular Diseases 51:2, 128-134
CrossRef822
Scott W Ferreira, Paul J Hauptman. (2008) Implantation of cardiac defibrillators for primary prevention: a pendulum too far?. Expert Review of Cardiovascular Therapy 6:8, 1047-1050
CrossRef823
SUSANNE S. PEDERSEN, HELLE SPINDLER, JENS B. JOHANSEN, PETER T. MORTENSEN, SAMUEL F. SEARS. (2008) Correlates of Patient Acceptance of the Cardioverter Defibrillator: Cross-Validation of the Florida Patient Acceptance Survey in Danish Patients. Pacing and Clinical Electrophysiology 31:9, 1168-1177
CrossRef824
H. V. Huikuri, M.J. P. Raatikainen, R. Moerch-Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, N. Hoest, L. V.A. Boersma, E. S. Platou, M. D. Messier, P.-E. Bloch-Thomsen, . (2008) Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. European Heart Journal 30:6, 689-698
CrossRef825
S. Tzeis, G. Andrikopoulos, C. Kolb, P. E. Vardas. (2008) Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 10:11, 1256-1265
CrossRef826
C. N. Pellegrini, K. Lee, J. E. Olgin, M. P. Turakhia, Z. H. Tseng, R. Lee, N. Badhwar, B. Lee, P. D. Varosy. (2008) Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10:11, 1296-1301
CrossRef827
M. Biffi, M. Ziacchi, M. Bertini, D. Sangiorgi, D. Corsini, C. Martignani, I. Diemberger, G. Boriani. (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:11, 1288-1295
CrossRef828
L. Ding, W. Hua, H. Niu, K. Chen, S. Zhang. (2008) Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 10:9, 1034-1041
CrossRef829
T. Schefer, T. Wolber, C. Binggeli, J. Holzmeister, C. Brunckhorst, F. Duru. (2008) Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function. Europace 10:9, 1052-1059
CrossRef830
D. A.M.J. Theuns, M. Rivero-Ayerza, D. M. Goedhart, M. Miltenburg, L. J. Jordaens. (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:9, 1060-1066
CrossRef831
ALAWI A. ALSHEIKH-ALI, MICHAEL HOMER, PRASAD V. MADDUKURI, BENJAMIN KALSMITH, N. A. MARK ESTES, MARK S. LINK. (2008) Time-Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 19:8, 784-789
CrossRef832
Samuel F. Sears, Lauren D. Vazquez, Melissa Matchett, Mariavittoria Pitzalis. (2008) State-of-the-art: anxiety management in patients with implantable cardioverter defibrillators. Stress and Health 24:3, 239-248
CrossRef833
Joseph A. Blatt, Jeanne E. Poole, George W. Johnson, David J. Callans, Merritt H. Raitt, Ramakota K. Reddy, Francis E. Marchlinski, Raymond Yee, Thomas Guarnieri, Mario Talajic, David J. Wilber, Jill Anderson, Kiyon Chung, Wai Shun Wong, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). Journal of the American College of Cardiology 52:7, 551-556
CrossRef834
Paul S. Chan, Dean J. Kereiakes, Cheryl Bartone, Theodore Chow. (2008) Usefulness of Microvolt T-Wave Alternans to Predict Outcomes in Patients With Ischemic Cardiomyopathy Beyond One Year. The American Journal of Cardiology 102:3, 280-284
CrossRef835
Stephen Westaby. (2008) Destination therapy: time for real progress. Nature Clinical Practice Cardiovascular Medicine 5:8, 477-483
CrossRef836
Bruce L. Wilkoff, Brian D. Williamson, Richard S. Stern, Stephen L. Moore, Fei Lu, Sung W. Lee, Ulrika M. Birgersdotter-Green, Mark S. Wathen, Isabelle C. Van Gelder, Brooke M. Heubner, Mark L. Brown, Keith K. Holloman. (2008) Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients. Journal of the American College of Cardiology 52:7, 541-550
CrossRef837
Marc A. Simon, John Watson, J. Timothy Baldwin, William R. Wagner, Harvey S. Borovetz. (2008) Current and Future Considerations in the Use of Mechanical Circulatory Support Devices*. Annual Review of Biomedical Engineering 10:1, 59-84
CrossRef838
Deepak Bhakta, Lynne D. Foreman. (2008) Cosmic radiation: Not science fiction, but clinical reality. Heart Rhythm 5:8, 1204-1205
CrossRef839
Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, Montserrat Vallverdu, Jose R. Gonzalez-Juanatey, Mariano Valdes, Jesus Almendral, Juan Cinca, Pere Caminal, Antoni Bayes de Luna. (2008) Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm 5:8, 1095-1102
CrossRef840
Michael R. Rosen, Peter R. Brink, Ira S. Cohen, Peter Danilo, Richard B. Robinson, Amy B. Rosen, Matthias J. Szabolcs. (2008) Regenerative therapies in electrophysiology and pacing. Journal of Interventional Cardiac Electrophysiology 22:2, 87-98
CrossRef841
Inder S. Anand. (2008) Anemia and Chronic Heart Failure. Journal of the American College of Cardiology 52:7, 501-511
CrossRef842
Leonardo Calo, Ermenegildo de Ruvo. (2008) A turbulent era for congestive heart failure patients?. Heart Rhythm 5:8, 1103-1104
CrossRef843
Kathryn A. Yamada. (2008) A change of heart: Heterogeneous remodeling in heart failure. Heart Rhythm 5:8, 1186-1188
CrossRef844
Anne B. Curtis. (2008) Defibrillation Threshold Testing in Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 52:7, 557-558
CrossRef845
NAHUM A. FREEDBERG. (2008) Passive Ventricular Restraint Device with Defibrillation Capabilities: Is There a Panacea for Heart Failure on the Horizon?. Journal of Cardiovascular Electrophysiology 19:8, 858-860
CrossRef846
BRETT FAULKNIER, DAVID T. HUANG, JAMES P. DAUBERT. (2008) Time Dependence of Arrhythmias in ICD Patients. Journal of Cardiovascular Electrophysiology 19:8, 790-793
CrossRef847
Juan M. Aranda, Tomas D. Martin, Dana D. Leach, Charles T. Klodell. (2008) Reoperative Cardiac Surgery After Long-term Ventricular Support Therapy. The Journal of Heart and Lung Transplantation 27:7, 789-791
CrossRef848
A. John Camm. (2008) Safety considerations in the pharmacological management of atrial fibrillation. International Journal of Cardiology 127:3, 299-306
CrossRef849
David Feldman, Doron M. Menachemi, William T. Abraham, Randell K. Wexler. (2008) Management Strategies for Stage‐D Patients with Acute Heart Failure. Clinical Cardiology 31:7, 297-301
CrossRef850
Andrew Remppis, Eberhard Ritz. (2008) NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Cardiac Problems in the Dialysis Patient: Beyond Coronary Disease. Seminars in Dialysis 21:4, 319-325
CrossRef851
Julia H. Indik, Craig M. Peters, Richard L. Donnerstein, Peter Ott, Karl B. Kern, Robert A. Berg. (2008) Direction of signal recording affects waveform characteristics of ventricular fibrillation in humans undergoing defibrillation testing during ICD implantation. Resuscitation 78:1, 38-45
CrossRef852
Michael Becker, Nora Erdmann, Emilia Stegemann, Dirk Benke, Patrick N. Schauerte, Wolfgang M. Schaefer, Ruediger Autschbach, Malte Kelm, Karl-Christian Koch. (2008) Survival and Quality of Life in Patients With Cardiac Resynchronization Therapy for Severe Heart Failure and in Heart Transplant Recipients Within a Contemporary Heart Failure Management Program. The Journal of Heart and Lung Transplantation 27:7, 746-752
CrossRef853
Theodore Chow, Deepak Joshi. (2008) Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification. Expert Review of Cardiovascular Therapy 6:6, 833-842
CrossRef854
Claudia Lerma, Niels Wessel, Alexander Schirdewan, Jürgen Kurths, Leon Glass. (2008) Ventricular arrhythmias and changes in heart rate preceding ventricular tachycardia in patients with an implantable cardioverter defibrillator. Medical & Biological Engineering & Computing 46:7, 715-727
CrossRef855
Begoña Benito, Ramon Brugada, Josep Brugada, Pedro Brugada. (2008) Brugada Syndrome. Progress in Cardiovascular Diseases 51:1, 1-22
CrossRef856
ANDREA M. RUSSO, JEANNE E. POOLE, DANIEL B. MARK, JILL ANDERSON, ANNE S. HELLKAMP, KERRY L. LEE, GEORGE W. JOHNSON, MICHAEL DOMANSKI, GUST H. BARDY. (2008) Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial. Journal of Cardiovascular Electrophysiology 19:7, 720-724
CrossRef857
William T. Abraham, Robin J. Trupp, Barbara Phillips, Robert C. Bourge, Susan M. Harding, Peter Schofield, Samantha Pilsworth, John M. Shneerson, Thomas Di Salvo, Janice Camuso, Douglas C. Johnson, Martin King. (2008) Effect of Treatment With Continuous Positive Airway Pressure or Oxygen on Sleep-Disordered Breathing in Patients With Heart Failure: Results of the Sleep Events, Arrhythmias, and Respiratory Analysis in Chronic Heart Failure (SEARCH) Study. Congestive Heart Failure 14:4, 197-201
CrossRef858
Charles A. Herzog, J. Michael Mangrum, Rod Passman. (2008) NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients. Seminars in Dialysis 21:4, 300-307
CrossRef859
P. M. Spooner. (2008) Sudden cardiac death: influence of diabetes. Diabetes, Obesity and Metabolism 10:7, 523-532
CrossRef860
Roy, Denis, Talajic, Mario, Nattel, Stanley, Wyse, D. George, Dorian, Paul, Lee, Kerry L., Bourassa, Martial G., Arnold, J. Malcolm O., Buxton, Alfred E., Camm, A. John, Connolly, Stuart J., Dubuc, Marc, Ducharme, Anique, Guerra, Peter G., Hohnloser, Stefan H., Lambert, Jean, Le Heuzey, Jean-Yves, O'Hara, Gilles, Pedersen, Ole Dyg, Rouleau, Jean-Lucien, Singh, Bramah N., Stevenson, Lynne Warner, Stevenson, William G., Thibault, Bernard, Waldo, Albert L., . (2008) Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure. New England Journal of Medicine 358:25, 2667-2677
Full Text861
Køber, Lars, Torp-Pedersen, Christian, McMurray, John J.V., Gøtzsche, Ole, Lévy, Samuel, Crijns, Harry, Amlie, Jan, Carlsen, Jan, . (2008) Increased Mortality after Dronedarone Therapy for Severe Heart Failure. New England Journal of Medicine 358:25, 2678-2687
Full Text862
Cain, Michael E., Curtis, Anne B., . (2008) Rhythm Control in Atrial Fibrillation — One Setback after Another. New England Journal of Medicine 358:25, 2725-2727
Full Text863
M. Gasparini, A. Auricchio, M. Metra, F. Regoli, C. Fantoni, B. Lamp, A. Curnis, J. Vogt, C. Klersy, . (2008) Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. European Heart Journal 29:13, 1644-1652
CrossRef864
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N. A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Heart Rhythm 5:6, e1-e62
CrossRef865
Christine M. Albert. (2008) Omega-3 fatty acids and ventricular arrhythmias: Nothing is simple. American Heart Journal 155:6, 967-970
CrossRef866
James N. Weiss. (2008) Beyond the implantable cardioverter-defibrillator: Are we making progress?. Heart Rhythm 5:6, S45-S47
CrossRef867
Martin C. Burke. (2008) Poor survival of the fittest: A call for resources, research and public awareness. Heart Rhythm 5:6, 800-801
CrossRef868
Matthias Wilhelm, Rueth Tobias, Fatima Asskali, Robert Kraehner, Simone Kuly, Lutz Klinghammer, Hansjosef Boehles, Werner Guenther Daniel. (2008) Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. American Heart Journal 155:6, 971-977
CrossRef869
Bao C. Huynh, Aleksandr Rovner, Michael W. Rich. (2008) Identification of Older Patients with Heart Failure Who May Be Candidates for Hospice Care: Development of a Simple Four-Item Risk Score. Journal of the American Geriatrics Society 56:6, 1111-1115
CrossRef870
David Amar. (2008) Prevention and Management of Perioperative Arrhythmias in the Thoracic Surgical Population. Anesthesiology Clinics 26:2, 325-335
CrossRef871
Ronni Levy, Andrea DellaValle, A. Serdar Atav, Afazal ur Rehman, Allan H. Sklar, Nicolas J. Stamato. (2008) The Relationship Between Glomerular Filtration Rate and Survival in Patients Treated with an Implantable Cardioverter Defibrillator. Clinical Cardiology 31:6, 265-269
CrossRef872
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Heart Rhythm 5:6, 934-955
CrossRef873
Katherine C. Wu, Robert G. Weiss, David R. Thiemann, Kakuya Kitagawa, André Schmidt, Darshan Dalal, Shenghan Lai, David A. Bluemke, Gary Gerstenblith, Eduardo Marbán, Gordon F. Tomaselli, João A.C. Lima. (2008) Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy. Journal of the American College of Cardiology 51:25, 2414-2421
CrossRef874
Grace Lin, Ryan A. Meverden, David O. Hodge, Daniel Z. Uslan, David L. Hayes, Peter A. Brady. (2008) Age and gender trends in implantable cardioverter defibrillator utilization: A population based study. Journal of Interventional Cardiac Electrophysiology 22:1, 65-70
CrossRef875
D. A. Arvanitis, D. Sanoudou, F. Kolokathis, E. Vafiadaki, V. Papalouka, A. Kontrogianni-Konstantopoulos, G. N. Theodorakis, I. A. Paraskevaidis, S. Adamopoulos, G. W. Dorn, D. Th. Kremastinos, E. G. Kranias. (2008) The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. European Heart Journal 29:20, 2514-2525
CrossRef876
Henry Greenberg. (2008) Sudden Cardiac Death. An Essay for 2008. Progress in Cardiovascular Diseases 50:6, 384-389
CrossRef877
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Journal of the American College of Cardiology 51:21, e1-e62
CrossRef878
Andreas Brieke, Joseph Cleveland, JoAnn Lindenfeld. (2008) Mechanical support in acute and chronic heart failure. Current Cardiology Reports 10:3, 168-175
CrossRef879
Ganesh S. Kamath, Suneet Mittal. (2008) The Role of Antiarrhythmic Drug Therapy for the Prevention of Sudden Cardiac Death. Progress in Cardiovascular Diseases 50:6, 439-448
CrossRef880
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Journal of the American College of Cardiology 51:21, 2085-2105
CrossRef881
Matthew E Harinstein, Jennifer I Berliner, Sanjiv J Shah, Heinrich Taegtmeyer, Mihai Gheorghiade. (2008) Normalization of Ejection Fraction and Resolution of Symptoms in Chronic Severe Heart Failure is Possible With Modern Medical Therapy: Clinical Observations in 11 Patients. American Journal of Therapeutics 15:3, 206-213
CrossRef882
Wayne C. Levy, David T. Linker. (2008) Prediction of mortality in patients with heart failure and systolic dysfunction. Current Cardiology Reports 10:3, 198-205
CrossRef883
Arthur J. Moss. (2008) What is the real world for analyzing outcomes and costs of ICD therapy?. Heart Rhythm 5:5, 654-655
CrossRef884
Katherine J. Hoercher, Edward R. Nowicki, Eugene H. Blackstone, Gurmeet Singh, Joan M. Alster, Gonzalo V. Gonzalez-Stawinski, Randall C. Starling, James B. Young, Nicholas G. Smedira. (2008) Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status 2 patients. The Journal of Thoracic and Cardiovascular Surgery 135:5, 1159-1166
CrossRef885
Peter W. Groeneveld, Steven A. Farmer, Janice J. Suh, Mary Anne Matta, Feifei Yang. (2008) Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 5:5, 646-653
CrossRef886
Ilan Goldenberg, Arthur J. Moss. (2008) Implantable Device Therapy. Progress in Cardiovascular Diseases 50:6, 449-474
CrossRef887
Aysha Arshad, Anisha Mandava, Ganesh Kamath, Dan Musat. (2008) Sudden Cardiac Death and the Role of Medical Therapy. Progress in Cardiovascular Diseases 50:6, 420-438
CrossRef888
Melvin M. Scheinman, Edmund Keung. (2008) The Year in Review of Clinical Cardiac Electrophysiology. Journal of the American College of Cardiology 51:21, 2075-2081
CrossRef889
Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Toff, William D., Tonkin, Andrew M., Smith, Warren, Dorian, Paul, Packer, Douglas L., White, Roger D., Longstreth, W.T. Jr., Anderson, Jill, Johnson, George, Bischoff, Eric, Yallop, Julie J., McNulty, Steven, Ray, Linda Davidson, Clapp-Channing, Nancy E., Rosenberg, Yves, Schron, Eleanor B., . (2008) Home Use of Automated External Defibrillators for Sudden Cardiac Arrest. New England Journal of Medicine 358:17, 1793-1804
Full Text890
Michael T. Koller, Theo Stijnen, Ewout W. Steyerberg, Jacobus Lubsen. (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios. Journal of Clinical Epidemiology 61:4, 365-372
CrossRef891
Charles I. Berul, George F. Van Hare, Naomi J. Kertesz, Anne M. Dubin, Frank Cecchin, Kathryn K. Collins, Bryan C. Cannon, Mark E. Alexander, John K. Triedman, Edward P. Walsh, Richard A. Friedman. (2008) Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients. Journal of the American College of Cardiology 51:17, 1685-1691
CrossRef892
Jalal K Ghali, JoAnn Lindenfeld. (2008) Sex differences in response to chronic heart failure therapies. Expert Review of Cardiovascular Therapy 6:4, 555-565
CrossRef893
STEVEN M. MARKOWITZ. (2008) To Test or Not to Test During Defibrillator Implantation? A Reassessment of the Conventional Wisdom. Journal of Cardiovascular Electrophysiology 19:4, 406-408
CrossRef894
Wolfram Grimm. (2008) Outcomes of elderly heart failure recipients of ICD and CRT. International Journal of Cardiology 125:2, 154-160
CrossRef895
Merritt H. Raitt. (2008) Implantable Cardioverter-Defibrillator Shocks. Journal of the American College of Cardiology 51:14, 1366-1368
CrossRef896
Maria Teresa La Rovere, Gian Domenico Pinna, Grzegorz Raczak. (2008) Baroreflex Sensitivity: Measurement and Clinical Implications. Annals of Noninvasive Electrocardiology 13:2, 191-207
CrossRef897
James P. Daubert, Wojciech Zareba, David S. Cannom, Scott McNitt, Spencer Z. Rosero, Paul Wang, Claudio Schuger, Jonathan S. Steinberg, Steven L. Higgins, David J. Wilber, Helmut Klein, Mark L. Andrews, W. Jackson Hall, Arthur J. Moss. (2008) Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II. Journal of the American College of Cardiology 51:14, 1357-1365
CrossRef898
Brian Olshansky, Jeanne E. Poole, George Johnson, Jill Anderson, Anne S. Hellkamp, Douglas Packer, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) Syncope Predicts the Outcome of Cardiomyopathy Patients. Journal of the American College of Cardiology 51:13, 1277-1282
CrossRef899
Samuel O. Jones, Robert E. Eckart, Christine M. Albert, Laurence M. Epstein. (2008) Large, single-center, single-operator experience with transvenous lead extraction: Outcomes and changing indications. Heart Rhythm 5:4, 520-525
CrossRef900
Dominic A.M.J. Theuns, Maximo Rivero-Ayerza, Erik Boersma, Luc Jordaens. (2008) Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. International Journal of Cardiology 125:3, 352-357
CrossRef901
Rohit Mehta, Amit A. Doshi, Ayesha K. Hasan, Charles J. Love, Marg Pizzuto, Chittoor Sai-Sudhakar, David P. Chan. (2008) Device Interactions in Patients With Advanced Cardiomyopathy. Journal of the American College of Cardiology 51:16, 1613-1614
CrossRef902
LORNE J. GULA, DAVID MASSEL, ANDREW D. KRAHN, RAYMOND YEE, ALLAN C. SKANES, GEORGE J. KLEIN. (2008) Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov Model. Journal of Cardiovascular Electrophysiology 19:4, 400-405
CrossRef903
Christiana O. Adesanya, Kabir A. Yousuf, Carter Co, Shobhana Gaur, Sameer Ahmed, Anthony Pothoulakis, Agaram Suryaprasad, Satyendra Gupta. (2008) Is Wider Worse? QRS Duration Predicts Cardiac Mortality in Patients with Right Bundle Branch Block. Annals of Noninvasive Electrocardiology 13:2, 165-170
CrossRef904
Augusto Cardinalli-neto, Reinaldo B. Bestetti, José A. Cordeiro. (2008) To the Editor:. Journal of Cardiovascular Electrophysiology 19:4, E34-E35
CrossRef905
Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, William D. Toff, Andrew M. Tonkin, Warren Smith, Paul Dorian, Julie J. Yallop, Douglas L. Packer, Roger D. White, Will Longstreth, Jill Anderson, George Johnson, Eric Bischoff, Crystal D. Munkers, Amanda Brown, Steven McNulty, Linda Davidson Ray, Nancy E. Clapp-Channing, Yves Rosenberg, Marcel Salive, Eleanor B. Schron. (2008) Rationale and design of the Home Automatic External Defibrillator Trial (HAT). American Heart Journal 155:3, 445-454
CrossRef906
Timm Dickfeld, Christopher Kocher. (2008) The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations. Current Cardiology Reports 10:2, 149-157
CrossRef907
Joseph B. Thibodeau, Jayasree Pillarisetti, Taiyeb M. Khumri, Philip G. Jones, Michael L. Main. (2008) Mortality Rates and Clinical Predictors of Reduced Survival After Cardioverter Defibrillator Implantation. The American Journal of Cardiology 101:6, 861-864
CrossRef908
Bettina F. Cuneo, Janette F. Strasburger, Ronald T. Wakai. (2008) Magnetocardiography in the evaluation of fetuses at risk for sudden cardiac death before birth. Journal of Electrocardiology 41:2, 116.e1-116.e6
CrossRef909
MASSIMO ZECCHIN, ANDREA DI LENARDA, DARIO GREGORI, MARCO MERLO, ALBERTO PIVETTA, GIANCARLO VITRELLA, GASTONE SABBADINI, LUISA MESTRONI, GIANFRANCO SINAGRA. (2008) Are Nonsustained Ventricular Tachycardias Predictive of Major Arrhythmias in Patients with Dilated Cardiomyopathy on Optimal Medical Treatment?. Pacing and Clinical Electrophysiology 31:3, 290-299
CrossRef910
Sami Viskin, Raphael Rosso. (2008) The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 5:3, 391-393
CrossRef911
Denis Agostini, Hein J. Verberne, Wolfgang Burchert, Juhani Knuuti, Pavol Povinec, Gianmario Sambuceti, Mustafa Unlu, Montserrat Estorch, Gopa Banerjee, Arnold F. Jacobson. (2008) I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. European Journal of Nuclear Medicine and Molecular Imaging 35:3, 535-546
CrossRef912
Gardar Sigurdsson. (2008) CT for assessing ventricular remodeling: Is it ready for prime time?. Current Heart Failure Reports 5:1, 16-22
CrossRef913
Judith E. Mitchell, Anne S. Hellkamp, Daniel B. Mark, Jill Anderson, Jeanne E. Poole, Kerry L. Lee, Gust H. Bardy. (2008) Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 155:3, 501-506
CrossRef914
ANDREI CATANCHIN, LISA ANDERSON, SUE JONES, DAVID WARD. (2008) When Life-Saving Devices Terminate Life. Journal of Cardiovascular Electrophysiology 19:3, 316-318
CrossRef915
Malek G. Massad, Sunil M. Prasad, Edgar G. Chedrawy, Himalaya Lele. (2008) A Perspective on the Surgical Management of Congestive Heart Failure. World Journal of Surgery 32:3, 375-380
CrossRef916
Sunil K. Sinha. (2008) AVID revisited: Quality of life is important too. Heart Rhythm 5:3, 366
CrossRef917
Björn C. Knollmann, Dan M. Roden. (2008) A genetic framework for improving arrhythmia therapy. Nature 451:7181, 929-936
CrossRef918
Kapil Kumar, Kevin F. Kwaku, Richard L. Verrier. (2008) Treatment options for patients with coronary artery disease identified as high risk by T-wave alternans testing. Current Treatment Options in Cardiovascular Medicine 10:1, 39-48
CrossRef919
Maria R. Costanzo, Roger M. Mills, Janet Wynne. (2008) Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). American Heart Journal 155:2, 339-347
CrossRef920
Dario Gregori, Rosalba Rosato, Massimo Zecchin, Ileana Baldi, Andrea Di Lenarda. (2008) Heart failure and sudden death in dilated cardiomyopathy: a hidden competition we should not forget about when modelling mortality. Journal of Evaluation in Clinical Practice 14:1, 53-58
CrossRef921
Dennis T. Ko, David A. Alter, Peter C. Austin, John J. You, Douglas S. Lee, Feng Qiu, Therese A. Stukel, Jack V. Tu. (2008) Life expectancy after an index hospitalization for patients with heart failure: A population-based study. American Heart Journal 155:2, 324-331
CrossRef922
William H Frishman, Wilbert S Aronow, Angela Cheng-Lai. 2008. Cardiovascular Drug Therapy in the Elderly. , 99-136.
CrossRef923
Paul J. Hauptman, Jason Swindle, Zainal Hussain, Lois Biener, Thomas E. Burroughs. (2008) Physician Attitudes Toward End-Stage Heart Failure: A National Survey. The American Journal of Medicine 121:2, 127-135
CrossRef924
Dalane W. Kitzman, Jerome L. Fleg. 2008. Heart Failure. , 542-576.
CrossRef925
Wilbert S. Aronow. 2008. Management of the Older Patient After Myocardial Infarction. , 327-350.
CrossRef926
Robert E Shaddy, Gary Webb. (2008) Applying heart failure guidelines to adult congenital heart disease patients. Expert Review of Cardiovascular Therapy 6:2, 165-174
CrossRef927
Damian P. Redfearn. (2008) Non-Gaussian index: Hope yet for the grail seekers?. Heart Rhythm 5:2, 269-270
CrossRef928
Ken Kiyono, Junichiro Hayano, Eiichi Watanabe, Zbigniew R. Struzik, Yoshiharu Yamamoto. (2008) Non-Gaussian heart rate as an independent predictor of mortality in patients with chronic heart failure. Heart Rhythm 5:2, 261-268
CrossRef929
Melanie D Everitt, Anji T Yetman. (2008) Congestive heart failure in the pediatric patient with congenital heart disease. Pediatric Health 2:1, 33-45
CrossRef930
Wilbert S. Aronow, Carmine Sorbera. 2008. Ventricular Arrhythmias in the Elderly. , 605-626.
CrossRef931
Mattias Neyt, Nancy Thiry, Dirk Ramaekers, Hans Van Brabandt. (2008) Cost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context. Applied Health Economics and Health Policy 6:1, 67-80
CrossRef932
Nathan E. Goldstein, Davendra Mehta, Saima Siddiqui, Ezra Teitelbaum, Jessica Zeidman, Magdelena Singson, Elena Pe, Elizabeth H. Bradley, R. Sean Morrison. (2008) “That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators. Journal of General Internal Medicine 23:S1, 7-12
CrossRef933
Jayanthi N Koneru, Jonathan S Steinberg. (2008) Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure. Current Opinion in Cardiology 23:1, 9-15
CrossRef934
Naomi Kawashiro, Hiroshi Kasanuki, Hiroshi Ogawa, Naoki Matsuda, Nobuhisa Hagiwara, The Heart Institute of Japan - Depa. (2008) Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure. Circulation Journal 72:12, 2015-2020
CrossRef935
Anna Legreid Dopp, John M Miller, James E Tisdale. (2008) Effect of Drugs on Defibrillation Capacity. Drugs 68:5, 607-630
CrossRef936
Hillel A Steiner, John M Miller. (2008) Disparity in utilization of implantable cardioverter-defibrillators in treatment of heart failure based on sex and race. Women's Health 4:1, 23-25
CrossRef937
Ilan Goldenberg, Anant K. Vyas, W. Jackson Hall, Arthur J. Moss, Hongyue Wang, Hua He, Wojciech Zareba, Scott McNitt, Mark L. Andrews. (2008) Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 51:3, 288-296
CrossRef938
Neiko Ozasa, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Kei Nishiyama, Toru Kita, Takeshi Kimura. (2008) Effects of ICD implantation on quality-adjusted life years in patients with congestive heart failure. International Journal of Cardiology 123:2, 213-216
CrossRef939
Arthur L. Riba. (2008) Evidence-Based Performance and Quality Improvement in the Acute Cardiac Care Setting. Critical Care Clinics 24:1, 201-229
CrossRef940
Kenneth R. Laurita, David S. Rosenbaum. (2008) Mechanisms and potential therapeutic targets for ventricular arrhythmias associated with impaired cardiac calcium cycling. Journal of Molecular and Cellular Cardiology 44:1, 31-43
CrossRef941
Feixiong Zhang, Kishore B S Pasumarthi. (2008) Embryonic Stem Cell Transplantation. BioDrugs 22:6, 361-374
CrossRef942
Remzi Karaoguz, Timuein Altln, E. Cem Atbasoglu, Canan Isikay, Bahar Güraslan, Ömer Akyürek, Osman Beton, Kutay Vurgun, Nezih Yüceman, Kazim Soylu, Muharrem Güldal. (2008) Defibrillation Testing and Early Neurologic Outcome. International Heart Journal 49:5, 553-563
CrossRef943
Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Takeshi Kimura, Yoshinori Kobayashi, Kyoko Soejima, Shinichi Niwano, Shigeyuki Watanabe, Haruhiko Abe. (2008) Current status of implantable defibrillator devices in patients with left ventricular dysfunction-The first report from the online registry database. Journal of Arrhythmia 24:3, 133-140
CrossRef944
LIVIU KLEIN, ROBERT O. BONOW. 2008. Diabetes Mellitus. , 333-342.
CrossRef945
William H. Sauer, Michael R. Bristow. (2008) The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. Journal of Interventional Cardiac Electrophysiology 21:1, 3-11
CrossRef946
Christopher H George, Steven R Barberini-Jammaers, Carsten T Muller. (2008) Refocussing therapeutic strategies for cardiac arrhythmias: defining viable molecular targets to restore cardiac ion flux. Expert Opinion on Therapeutic Patents 18:1, 1-19
CrossRef947
Carsten W Israel. (2008) How to avoid inappropriate therapy. Current Opinion in Cardiology 23:1, 65-71
CrossRef948
Takeshi Aiba, Kenichiro Yamagata, Wataru Shimizu, Atsushi Taguchi, Kazuhiro Satomi, Takashi Noda, Hideo Okamura, Kazuhiro Suyama, Naohiko Aihara, Shiro Kamakura, Takashi Kurita. (2008) Electrophysiologic Study-Guided Amiodarone for Sustained Ventricular Tachyarrhythmias Associated With Structural Heart Diseases. Circulation Journal 72:1, 88-93
CrossRef949
Folke Rönn, Milos Kesek, Niklas Höglund, Steen M. Jensen. (2008) Long-term follow-up of patients treated with ICD: Benefit in patients with preserved left ventricular function. Scandinavian Cardiovascular Journal 42:2, 125-129
CrossRef950
Paul Foley, Paul Kalra, Neil Andrews. (2008) Amiodarone—Avoid the danger of Torsade de Pointes. Resuscitation 76:1, 137-141
CrossRef951
Kevin L. Thomas, Sana M. Al-Khatib, Yuliya Lokhnygina, Scott D. Solomon, Lars Kober, John J.V. McMurray, Robert M. Califf, Eric J. Velazquez. (2008) Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. American Heart Journal 155:1, 87-93
CrossRef952
Nathan E. Goldstein, Davendra Mehta, Ezra Teitelbaum, Elizabeth H. Bradley, R. Sean Morrison. (2008) “It’s Like Crossing a Bridge” Complexities Preventing Physicians from Discussing Deactivation of Implantable Defibrillators at the End of Life. Journal of General Internal Medicine 23:S1, 2-6
CrossRef953
SUSANNE S PEDERSEN, DOMINIC AMJ THEUNS, RUUD AM ERDMAN, LUC JORDAENS. (2008) Clustering of Device-Related Concerns and Type D Personality Predicts Increased Distress in ICD Patients Independent of Shocks1. Pacing and Clinical Electrophysiology 31:1, 20-27
CrossRef954
Suneet Mittal. (2008) Selecting Patients for an Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 51:3, 297-299
CrossRef955
Takashi Miura, Kiyoyuki Eishi, Shiro Yamachika, Koji Hashizume, Seiichi Tada, Kentaro Yamane, Kazuyoshi Tanigawa, Shun Nakaji. (2008) Isolated Undersized Mitral Annuloplasty for Functional Mitral Regurgitation in Non-Ischemic Dilated Cardiomyopathy. Circulation Journal 72:11, 1744-1750
CrossRef956
Randy Lieberman, William J. Havel, Eric Rashba, Paul J. DeGroot, Kurt Stromberg, Stephen R. Shorofsky. (2008) Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients. Heart Rhythm 5:1, 28-34
CrossRef957
Luis Alonso-Pulpón, Xavier Borrás, Josep Brugada, Juan Cinca, Arturo Fernández Cruz, José R. González Juanatey, Carlos Sáenz de la Calzada, Mariano Valdés, Rafael Vázquez, Julián Pérez Villacastín. (2008) Red de investigación clínica y básica en insuficiencia cardiaca (REDINSCOR). Redes temáticas de investigación cooperativa del Instituto de Salud Carlos III. Revista Española de Cardiología 61:1, 76-81
CrossRef958
MAURIZIO LUNATI, MAURIZIO GASPARINI, MASSIMO SANTINI, MAURIZIO LANDOLINA, GIOVANNI B. PEREGO, CARLO PAPPONE, MAURIZIO MARZEGALLI, CARLO ARGIOLAS, ANANT MURTHY, SERGIO VALSECCHI, . (2008) Follow-Up of CRT-ICD: Implications for the Use of Remote Follow-Up Systems. Data from the InSync ICD Italian Registry. Pacing and Clinical Electrophysiology 31:1, 38-46
CrossRef959
H.-J. Trappe. (2007) Plötzlicher Herztod. Der Kardiologe 1:4, 261-271
CrossRef960
Michael R. Da Rosa, John L. Sapp, Jonathan G. Howlett, Alec Falkenham, Jean-Francois Légaré. (2007) Implantable Cardioverter-Defibrillator Implantation as a Bridge to Cardiac Transplantation. The Journal of Heart and Lung Transplantation 26:12, 1336-1339
CrossRef961
James N Kirkpatrick, Savitri E Fedson, Ralph Verdino. (2007) Ethical dilemmas in device treatment for advanced heart failure. Current Opinion in Supportive and Palliative Care 1:4, 267-273
CrossRef962
SANA M. AL-KHATIB, LINDA K. SHAW, CHRISTOPHER O'CONNOR, MELISSA KONG, ROBERT M. CALIFF. (2007) Incidence and Predictors of Sudden Cardiac Death in Patients with Diastolic Heart Failure. Journal of Cardiovascular Electrophysiology 18:12, 1231-1235
CrossRef963
J. Michael Bostwick, Christopher L. Sola. (2007) An Updated Review of Implantable Cardioverter/Defibrillators, Induced Anxiety, and Quality of Life. Psychiatric Clinics of North America 30:4, 677-688
CrossRef964
Derek V. Exner, Katherine M. Kavanagh, Michael P. Slawnych, L. Brent Mitchell, Darlene Ramadan, Sandeep G. Aggarwal, Catherine Noullett, Allie Van Schaik, Ryan T. Mitchell, Mariko A. Shibata, Sajad Gulamhussein, James McMeekin, Wayne Tymchak, Gregory Schnell, Anne M. Gillis, Robert S. Sheldon, Gordon H. Fick, Henry J. Duff. (2007) Noninvasive Risk Assessment Early After a Myocardial Infarction. Journal of the American College of Cardiology 50:24, 2275-2284
CrossRef965
Eric J. Velazquez, Kerry L. Lee, Christopher M. O’Connor, Jae K. Oh, Robert O. Bonow, Gerald M. Pohost, Arthur M. Feldman, Daniel B. Mark, Julio A. Panza, George Sopko, Jean L. Rouleau, Robert H. Jones. (2007) The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. The Journal of Thoracic and Cardiovascular Surgery 134:6, 1540-1547.e4
CrossRef966
P. Alter, H. Rupp, M. B. Rominger, K. J. Klose, B. Maisch. (2007) A new methodological approach to assess cardiac work by pressure–volume and stress–length relations in patients with aortic valve stenosis and dilated cardiomyopathy. Pflügers Archiv - European Journal of Physiology 455:4, 627-636
CrossRef967
M. Christ, A. Thuerlimann, K. Laule, T. Klima, W. Hochholzer, A. P. Perruchoud, C. Mueller. (2007) Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. European Journal of Clinical Investigation 37:11, 834-841
CrossRef968
Kurt Fritzsche, Florian Forster, Axel Schweickhardt, Hartmut Kanwischer, Arno Drinkmann, Sven Rabung, Günter Bergmann, Annette Geibel, Christoph Herrmann-Lingen. (2007) Depressive coping is a predictor for emotional distress and poor quality of life in a German–Austrian sample of cardioverter-defibrillator implant recipients at 3 months and 1 year after implantation. General Hospital Psychiatry 29:6, 526-536
CrossRef969
Jorge A. Salerno-Uriarte, Gaetano M. De Ferrari, Catherine Klersy, Roberto F.E. Pedretti, Massimo Tritto, Luciano Sallusti, Luigi Libero, Giacinto Pettinati, Giulio Molon, Antonio Curnis, Eraldo Occhetta, Fabrizio Morandi, Paolo Ferrero, Francesco Accardi. (2007) Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy. Journal of the American College of Cardiology 50:19, 1896-1904
CrossRef970
ALESSIO LILLI, GIUSEPPE RICCIARDI, MARIA CRISTINA PORCIANI, ALESSANDRO PAOLETTI PERINI, PAOLO PIERAGNOLI, NICOLA MUSILLI, ANDREA COLELLA, STEFANO DEL PACE, ANTONIO MICHELUCCI, FEDERICO TURRENI, MASSIMO SASSARA, AUGUSTO ACHILLI, S. SERGE BAROLD, LUIGI PADELETTI. (2007) Cardiac Resynchronization Therapy:. Gender Related Differences in Left Ventricular Reverse Remodeling. Pacing and Clinical Electrophysiology 30:11, 1349-1355
CrossRef971
Philip B. Adamson, Jamie B. Conti, Andrew L. Smith, William T. Abraham, Mark F. Aaron, Juan M. Aranda, Jr., James Baker, Robert C. Bourge, Lynne Warner-Stevenson, Brandon Sparks. (2007) Reducing Events in Patients with Chronic Heart Failure (REDUCEhf ) Study Design: Continuous Hemodynamic Monitoring with an Implantable Defibrillator. Clinical Cardiology 30:11, 567-575
CrossRef972
Chinmay Patel, Gan-Xin Yan. (2007) Race and gender equality in health care: Are we there yet?. Heart Rhythm 4:11, 1427-1429
CrossRef973
Rachel Lampert. (2007) Implantable Cardioverter-Defibrillator Use and Benefit in Women. Cardiology in Review 15:6, 298-303
CrossRef974
Mikhael F. El-Chami, Ibrahim R. Hanna, Heather Bush, Jonathan J. Langberg. (2007) Impact of race and gender on cardiac device implantations. Heart Rhythm 4:11, 1420-1426
CrossRef975
Ulrik Sartipy, Anders Albåge, Per Insulander, Dan Lindblom. (2007) Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach. Journal of Interventional Cardiac Electrophysiology 19:3, 171-178
CrossRef976
VENKU JAYANTI, MENEKHEM M. ZVIMAN, SAMAN NAZARIAN, HENRY R. HALPERIN, RONALD D. BERGER. (2007) Novel Electrode Design for Potentially Painless Internal Defibrillation Also Allows for Successful External Defibrillation. Journal of Cardiovascular Electrophysiology 18:10, 1095-1100
CrossRef977
Indranill Basu Ray, Lahn Fendelander, Jagmeet P. Singh. (2007) Cardiac Resynchronization Therapy and its Potential Proarrhythmic Effect. Clinical Cardiology 30:10, 498-502
CrossRef978
Guy Amit, Otto Costantini. (2007) SCD in patients with cardiomyopathy: Use of microvolt T-wave alternans and other noninvasive tests for risk stratification and prevention of SCD. Current Treatment Options in Cardiovascular Medicine 9:5, 345-355
CrossRef979
John Arthur McClung. (2007) End-of-Life Care in the Treatment of Heart Failure in the Elderly. Heart Failure Clinics 3:4, 539-547
CrossRef980
Vincent E. Friedewald, John P. Boehmer, Robert C. Kowal, Leslie Saxon, Clyde W. Yancy, William C. Roberts. (2007) The Editor’s Roundtable: Cardiac Resynchronization Therapy. The American Journal of Cardiology 100:7, 1145-1152
CrossRef981
Wilbert S. Aronow. (2007) Heart Failure–Complicating Acute Myocardial Infarction. Heart Failure Clinics 3:4, 465-475
CrossRef982
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 50:17, e159-e242
CrossRef983
Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Heart Failure Clinics 3:4, 519-528
CrossRef984
Wilbert S. Aronow. (2007) Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in the Elderly. Heart Failure Clinics 3:4, 423-436
CrossRef985
JENNIFER COWGER MATTHEWS, DAPHNE BETLEY, FRED MORADY, FRANK PELOSI. (2007) Adverse Interaction Between a Left Ventricular Assist Device and an Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 18:10, 1107-1108
CrossRef986
Gudula Christ, Ruediger Becker, Frederik Voss, Kamilla Kelemen, Julia Senges-Becker, Melanie Hauck, Wolfgang Schoels, Ingo Bald, Hugo A. Katus, Alexander Bauer. (2007) Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator. Clinical Research in Cardiology 96:9, 613-620
CrossRef987
Deirdre J. Nauman, Ray E. Hershberger. (2007) The use of positive inotropes in end-of-life heart failure care. Current Heart Failure Reports 4:3, 158-163
CrossRef988
Alfred E. Buxton, Kerry L. Lee, Gail E. Hafley, Luis A. Pires, John D. Fisher, Michael R. Gold, Mark E. Josephson, Michael H. Lehmann, Eric N. Prystowsky. (2007) Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease. Journal of the American College of Cardiology 50:12, 1150-1157
CrossRef989
Maurizio Landolina, Maurizio Lunati, Maurizio Gasparini, Massimo Santini, Luigi Padeletti, Augusto Achilli, Stefano Bianchi, Francesco Laurenzi, Antonio Curnis, Antonio Vincenti, Sergio Valsecchi, Alessandra Denaro. (2007) Comparison of the Effects of Cardiac Resynchronization Therapy in Patients With Class II Versus Class III and IV Heart Failure (from the InSync/InSync ICD Italian Registry)††Conflicts of interest: Sergio Valsecchi and Alessandra Denaro are employees of Medtronic Italia, Rome, Italy.,‡‡A list of centers and investigators participating in the InSync/InSync ICD Italian Registry is provided in the Appendix.. The American Journal of Cardiology 100:6, 1007-1012
CrossRef990
Kevin L. Thomas, Sana M. Al-Khatib, Richard C. Kelsey, Heather Bush, Lynne Brosius, Eric J. Velazquez, Eric D. Peterson, F. Roosevelt Gilliam. (2007) Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%. The American Journal of Cardiology 100:6, 924-929
CrossRef991
Mithilesh K. Das, Rajdeep Gaitonde, John M. Miller. (2007) Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death. Current Cardiology Reports 9:5, 371-380
CrossRef992
Nora Goldschlager, Andrew E. Epstein, Gerald V. Naccarelli, Brian Olshansky, Bramah Singh, Harold R. Collard, Elizabeth Murphy. (2007) A Practical Guide for Clinicians Who Treat Patients with Amiodarone: 2007. Heart Rhythm 4:9, 1250-1259
CrossRef993
Massimo Baravelli, Cecilia Fantoni, Silvia Rogiani, Stefania Farina, Claudio Anzà, Valeria Caltabiano, Teresio Forzani, Jorge A. Salerno-Uriarte. (2007) Combined prognostic value of peak O2 uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy. International Journal of Cardiology 121:1, 23-29
CrossRef994
Francesco Grigioni, Luciano Potena, Antonio Russo, Giuseppe Boriani, Marco Masetti, Gaia Magnani, Fabio Coccolo, Francesco Fallani, Angelo Branzi. (2007) Potential of Medical Treatment, Device Therapy, and Conventional Surgery in Patients Referred for Heart Transplantation. Journal of Cardiac Surgery 22:5, 456-458
CrossRef995
Kelley P. Anderson. (2007) Risk Assessment for Defibrillator Therapy. Journal of the American College of Cardiology 50:12, 1158-1160
CrossRef996
Eric J Kessler, Bradley P Knight. (2007) Catheter ablation for ventricular tachycardia: indications and techniques. Expert Review of Cardiovascular Therapy 5:5, 977-988
CrossRef997
HAITHAM HREYBE, EATHAR RAZAK, SAMIR SABA. (2007) Effect of End-Stage Renal Failure and Hemodialysis on Mortality Rates in Implantable Cardioverter-Defibrillator Recipients. Pacing and Clinical Electrophysiology 30:9, 1091-1095
CrossRef998
Jan Paul Ottervanger, Anand R. Ramdat Misier, Jan-Henk E. Dambrink, Menko-Jan de Boer, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Harry Suryapranata, Stoffer Reiffers, Arnoud W.J. van ‘t Hof. (2007) Mortality in Patients With Left Ventricular Ejection Fraction ≤30% After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. The American Journal of Cardiology 100:5, 793-797
CrossRef999
Stephan Willems, Lars Eckardt, Ellen Hoffmann, Hanno Klemm, Heinz Friedrich Pitschner, Christopher Reithmann, Jürgen Tebbenjohanns, Bernhard Zrenner. (2007) Leitlinie invasive elektrophysiologische Diagnostik. Clinical Research in Cardiology 96:9, 634-651
CrossRef1000
Mintu Turakhia, Zian H. Tseng. (2007) Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapy. Current Problems in Cardiology 32:9, 501-546
CrossRef1001
C. Stellbrink. (2007) Elektrotherapie der Herzinsuffizienz. Der Internist 48:9, 961-970
CrossRef1002
U.C. Hoppe. (2007) Leitliniengerechte Therapie der chronischen Herzinsuffizienz. Der Internist 48:9, 929-937
CrossRef1003
Stephen C. Hammill, Lynne Warner Stevenson, Alan H. Kadish, Mark S. Kremers, Paul Heidenreich, Bruce D. Lindsay, Michael J. Mirro, Martha J. Radford, Yongfei Wang, Christine M. Lang, Joel C. Harder, Ralph G. Brindis. (2007) Review of the Registry’s First Year, Data Collected, and Future Plans. Heart Rhythm 4:9, 1260-1263
CrossRef1004
Deepak Natarajan. (2007) Cardiac Resynchronization Therapy for Severe Drug Refractory Systolic Heart Failure. Apollo Medicine 4:3, 184-188
CrossRef1005
Martin Cadeiras, Manuel Bayern, Mario C. Deng. (2007) Managing drugs and devices in patients with permanent ventricular assist devices. Current Treatment Options in Cardiovascular Medicine 9:4, 318-331
CrossRef1006
Douglas C Shook, Wendy Gross. (2007) Offsite anesthesiology in the cardiac catheterization lab. Current Opinion in Anaesthesiology 20:4, 352-358
CrossRef1007
Chetan Patel, Girish Shirali, Naveen Pereira. (2007) Left Ventricular Noncompaction Mimicking Peripartum Cardiomyopathy. Journal of the American Society of Echocardiography 20:8, 1009.e9-1009.e12
CrossRef1008
Theodore Chow, Sayed Saghir, Cheryl Bartone, Megan Goebel, Julia Schneider, Terri Booth, Paul S. Chan. (2007) Usefulness of Microvolt T-Wave Alternans on Predicting Outcome in Patients With Ischemic Cardiomyopathy With and Without Defibrillators. The American Journal of Cardiology 100:4, 598-604
CrossRef1009
David J. Whellan, Eman Hamad. (2007) Natural history, adherence, or iatrogenic insult: Repeat hospitalizations as a predictor of survival. American Heart Journal 154:2, 203-205
CrossRef1010
JOHN D. FISHER, HUGO E. ECTOR. (2007) Relative and Absolute Benefits: Main Results Should be Reported in Absolute Terms. Pacing and Clinical Electrophysiology 30:8, 935-937
CrossRef1011
DAVID J. FOX, NEIL C. DAVIDSON, DAVID H. BENNETT, BERNARD CLARKE, CLIFFORD J. GARRATT, MARK C.S. HALL, AMIR M. ZAIDI, KAY PATTERSON, ADAM P. FITZPATRICK. (2007) Safety and Acceptability of Implantation of Internal Cardioverter-Defibrillators Under Local Anesthetic and Conscious Sedation. Pacing and Clinical Electrophysiology 30:8, 992-997
CrossRef1012
M. Roser, S. Götze. (2007) ICD-Therapie. Der Kardiologe 1:2, 149-164
CrossRef1013
Eiichi Watanabe, Tomoharu Arakawa, Tatsushi Uchiyama, MaoQing Tong, Kenji Yasui, Hiroshi Takeuchi, Toshiaki Terasawa, Itsuo Kodama, Hitoshi Hishida. (2007) Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart Rhythm 4:8, 999-1005
CrossRef1014
Mark S. Link, N.A. Mark Estes. (2007) How to Manage Athletes with Syncope. Cardiology Clinics 25:3, 457-466
CrossRef1015
SHEETAL CHANDHOK, DAVID SCHWARTZMAN. (2007) Amiodarone Therapy for Atrial Rhythm Control: Insights Gained From a Single Center Experience. Journal of Cardiovascular Electrophysiology 18:7, 714-718
CrossRef1016
JAY CHEN, R. HARIS NASEEM, OWEN OBEL, JOSE A. JOGLAR. (2007) Habitual Cocaine Use Is Associated with High Defibrillation Threshold During ICD Implantation. Journal of Cardiovascular Electrophysiology 18:7, 722-725
CrossRef1017
SAMUEL F. SEARS, LAUREN D. VAZQUEZ SOWELL, EMILY A. KUHL, ADRIENNE H. KOVACS, EVA R. SERBER, EILEEN HANDBERG, SHAWN M. KNEIPP, ISSAM ZINEH, JAMIE B. CONTI. (2007) The ICD Shock and Stress Management Program: A Randomized Trial of Psychosocial Treatment to Optimize Quality of Life in ICD Patients. Pacing and Clinical Electrophysiology 30:7, 858-864
CrossRef1018
Waseem Sharieff, Kellee Kaulback. (2007) Assessing automated external defibrillators in preventing deaths from sudden cardiac arrest: An economic evaluation. International Journal of Technology Assessment in Health Care 23:03,
CrossRef1019
Ayesha Hasan, Clyde W. Yancy. (2007) Treatment of Ventricular Dysrhythmias and Sudden Cardiac Death: A Guideline-Based Approach for Patients With Chronic Left Ventricular Dysfunction. Congestive Heart Failure 13:4, 228-235
CrossRef1020
Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas Heywood, Mandeep Mehra, Christopher M. O'Connor, Dwight Reynolds, Mary Norine Walsh. (2007) Improving the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting: The IMPROVE HF performance improvement registry. American Heart Journal 154:1, 12-38
CrossRef1021
RICHARD KOBZA, PAUL ERNE. (2007) End-of-life Decisions in ICD Patients with Malignant Tumors. Pacing and Clinical Electrophysiology 30:7, 845-849
CrossRef1022
Michael R. Gold, Hue-Teh Shih, John Herre, David Breiter, Yunlong Zhang, Mark Schwartz. (2007) Comparison of Defibrillation Efficacy and Survival Associated With Right Versus Left Pectoral Placement for Implantable Defibrillators. The American Journal of Cardiology 100:2, 243-246
CrossRef1023
Wojciech Zareba. (2007) Holter Electrocardiogram Parameters in Risk Stratification of Arrhythmic Events in Idiopathic Dilated Cardiomyopathy. Journal of the American College of Cardiology 50:3, 232-233
CrossRef1024
ALI F. SONEL, ALAA SHALABY, JOSEPH P. MCCONNELL, TAMMY CZARNECKI, SCOTT HOGEN, MALIHA ZAHID, MORTEZA AMIDI. (2007) Detectable Troponin Levels Predict Poor Prognosis in Patients With Left Ventricular Dysfunction Undergoing Internal Defibrillator Implantation. Pacing and Clinical Electrophysiology 30:7, 839-844
CrossRef1025
Salvatore Rosanio, Ernst R. Schwarz, Antonio Vitarelli, Ignatius Gerardo E. Zarraga, Sanjay Kunapuli, David L. Ware, Yochai Birnbaum, Enrique Tuero, Barry F. Uretsky. (2007) Sudden death prophylaxis in heart failure. International Journal of Cardiology 119:3, 291-296
CrossRef1026
Massimo Iacoviello, Cinzia Forleo, Pietro Guida, Roberta Romito, Antonio Sorgente, Sandro Sorrentino, Silvana Catucci, Filippo Mastropasqua, Mariavittoria Pitzalis. (2007) Ventricular Repolarization Dynamicity Provides Independent Prognostic Information Toward Major Arrhythmic Events in Patients With Idiopathic Dilated Cardiomyopathy. Journal of the American College of Cardiology 50:3, 225-231
CrossRef1027
Wilbert S. Aronow, William H. Frishman, Angela Cheng-Lai. (2007) Cardiovascular Drug Therapy in the Elderly. Cardiology in Review 15:4, 195-215
CrossRef1028
Jacob A. Udell, David N. Juurlink, Alexander Kopp, Douglas S. Lee, Jack V. Tu, Muhammad M. Mamdani. (2007) Inequitable distribution of implantable cardioverter defibrillators in Ontario. International Journal of Technology Assessment in Health Care 23:03,
CrossRef1029
Daniel J. Cantillon, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, Bindi K. Shah, Daniel P. Morin, Eran S. Zacks, Matthew Janik, Shaun Ageno, Andreas C. Mauer, Bruce B. Lerman, Sei Iwai. (2007) Predictive Value of Microvolt T-Wave Alternans in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 50:2, 166-173
CrossRef1030
Thomas Klingenheben. (2007) Microvolt T-Wave Alternans for Arrhythmia Risk Stratification in Left Ventricular Dysfunction. Journal of the American College of Cardiology 50:2, 174-175
CrossRef1031
Leslie Levin, Ron Goeree, Nancy Sikich, Birthe Jorgensen, Melissa C. Brouwers, Tony Easty, Catherine Zahn. (2007) Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. International Journal of Technology Assessment in Health Care 23:03,
CrossRef1032
Martin Cadeiras, Manuel Prinz von Bayern, Mario C. Deng. (2007) Cardiac Transplantation: Any Role Left?. Heart Failure Clinics 3:3, 321-347
CrossRef1033
James N. Kirkpatrick, Mani A. Vannan, Jagat Narula, Roberto M. Lang. (2007) Echocardiography in Heart Failure. Journal of the American College of Cardiology 50:5, 381-396
CrossRef1034
Manuel Prinz von Bayern, Martin Cadeiras, Mario C. Deng. (2007) Destination Therapy: Does Progress Depend on Left Ventricular Assist Device Development?. Heart Failure Clinics 3:3, 349-367
CrossRef1035
Daniel P. Morin, Eran S. Zacks, Andreas C. Mauer, Shaun Ageno, Matthew Janik, Steven M. Markowitz, Suneet Mittal, Sei Iwai, Bindi K. Shah, Bruce B. Lerman, Kenneth M. Stein. (2007) Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy. Heart Rhythm 4:7, 904-912
CrossRef1036
Frieder Braunschweig. (2007) Therapeutic and diagnostic role of electrical devices in acute heart failure. Heart Failure Reviews 12:2, 157-166
CrossRef1037
(2007) Amiodarone for Atrial Fibrillation. New England Journal of Medicine 356:23, 2424-2426
Full Text1038
William Cahoon, Maureen P. Flattery, Michael L. Hess. (2007) Amiodarone: Development, Clinical Indications, and Safety. Progress in Cardiovascular Nursing 22:3, 173-176
CrossRef1039
SURAJ KAPA, LINDA HYBERGER, ROBERT F. REA, DAVID L. HAYES. (2007) Complication Risk with Pulse Generator Change: Implications When Reacting to a Device Advisory or Recall. Pacing and Clinical Electrophysiology 30:6, 730-733
CrossRef1040
David Conen, Ludovic Melly, Christoph Kaufmann, Stefan Bilz, Peter Ammann, Beat Schaer, Christian Sticherling, Beat Muller, Stefan Osswald. (2007) Amiodarone-Induced Thyrotoxicosis. Journal of the American College of Cardiology 49:24, 2350-2355
CrossRef1041
PANAYOTA FLEVARI, PANAGIOTA GEORGIADOU, DIONYSSIOS LEFTHERIOTIS, EFTHIMIOS LIVANIS, GEORGE THEODORAKIS, DIMITRIOS TH KREMASTINOS. (2007) Heart Rate Turbulence After Short Runs of Nonsustained Ventricular Tachycardia in Chronic Heart Failure. Pacing and Clinical Electrophysiology 30:6, 787-795
CrossRef1042
Sumeet S. Chugh, Kyndaron Reinier, Eric C. Stecker. (2007) Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients. Journal of the American College of Cardiology 49:25, 2416-2418
CrossRef1043
Paul Khairy. (2007) Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nature Clinical Practice Cardiovascular Medicine 4:6, 292-293
CrossRef1044
Juan M. Aranda, Stephen E. McIntyre, Charles T. Klodell, Kaki M. York, Carl A. Dragstedt, Peter J. Chaille, Jamie B. Conti, Daniel F. Pauly, James A. Hill, Richard S. Schofield. (2007) Initial Heart Rate and Systolic Blood Pressure Predict Outcomes in Chronic Heart Failure Patients who are Evaluated for Cardiac Transplant. Clinical Cardiology 30:6, 282-287
CrossRef1045
Christian Torp-Pedersen, Marco Metra, Philip Spark, Mary Ann Lukas, Christine Moullet, Armin Scherhag, Michel Komajda, John G.F. Cleland, Willem Remme, Andrea Di Lenarda, Karl Swedberg, Philip A. Poole-Wilson. (2007) The Safety of Amiodarone in Patients With Heart Failure. Journal of Cardiac Failure 13:5, 340-345
CrossRef1046
Marc A Rozner. (2007) The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia. Current Opinion in Anaesthesiology 20:3, 261-268
CrossRef1047
J.G. Coghlan, C.E. Handler, P.D. Kottaridis. (2007) Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Practice & Research Clinical Haematology 20:2, 247-263
CrossRef1048
Douglas S. Lee, Jack V. Tu, Peter C. Austin, Paul Dorian, Raymond Yee, Alice Chong, David A. Alter, Andreas Laupacis. (2007) Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation. Journal of the American College of Cardiology 49:25, 2408-2415
CrossRef1049
Massimo Baravelli, Cecilia Fantoni, Claudio Anzà. (2007) The novel role of Micro T-Wave alternans in arrhythmic risk stratification of patients with left ventricular dysfunction. International Journal of Cardiology 119:1, 129-130
CrossRef1050
H. Tanner, P. Mohacsi, G.A. Fuller-Bicer, R. Rieben, B. Meier, O. Hess, R. Hullin. (2007) Cytokine Activation and Disease Progression in Patients With Stable Moderate Chronic Heart Failure. The Journal of Heart and Lung Transplantation 26:6, 622-629
CrossRef1051
Maria G. Agelaki, Constantinos Pantos, Panagiotis Korantzopoulos, Dimitrios G. Tsalikakis, Giannis G. Baltogiannis, Andreas Fotopoulos, Theofilos M. Kolettis. (2007) Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. European Journal of Pharmacology 564:1-3, 150-157
CrossRef1052
Sana M. Al-Khatib, Gillian D. Sanders, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne Curtis, Jeptha Curtis, Eric Fain, Bernard J. Gersh, Michael R. Gold, Ali Haghighi-Mood, Stephen C. Hammill, Jeff Healey, Mark Hlatky, Stefan Hohnloser, Raymond J. Kim, Kerry Lee, Daniel Mark, Marcus Mianulli, Brent Mitchell, Eric N. Prystowsky, Joseph Smith, David Steinhaus, Wojciech Zareba. (2007) Preventing tomorrow's sudden cardiac death today. American Heart Journal 153:6, 941-950
CrossRef1053
Brian Olshansky, Freda Wood, Anne S. Hellkamp, Jeanne E. Poole, Jill Anderson, George W. Johnson, Robin Boineau, Michael J. Domanski, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2007) Where patients with mild to moderate heart failure die: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 153:6, 1089-1094
CrossRef1054
Gillian D. Sanders, Sana M. Al-Khatib, Elise Berliner, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne B. Curtis, Jeptha P. Curtis, Michael Domanski, Eric Fain, Bernard J. Gersh, Michael R. Gold, Jeffrey Goldberger, Ali Haghighi-Mood, Stephen C. Hammill, Joel Harder, Jeffrey Healey, Mark A. Hlatky, Stefan H. Hohnloser, Kerry L. Lee, Daniel B. Mark, Brent Mitchell, Steve Phurrough, Eric Prystowsky, Joseph M. Smith, Norman Stockbridge, Robert Temple. (2007) Preventing tomorrow's sudden cardiac death today. American Heart Journal 153:6, 951-959
CrossRef1055
A. Robert Denniss, David A.B. Richards. (2007) Mechanisms, Prediction and Treatment of Ventricular Tachyarrhythmias Occurring Late After Myocardial Infarction. Heart, Lung and Circulation 16:3, 156-161
CrossRef1056
Giuseppe Boriani, Paolo Artale, Mauro Biffi, Cristian Martignani, Lorenzo Frabetti, Cinzia Valzania, Igor Diemberger, Matteo Ziacchi, Matteo Bertini, Claudio Rapezzi, Mario Parlapiano, Angelo Branzi. (2007) Outcome of cardioverter–defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart and Vessels 22:3, 184-192
CrossRef1057
CHARLES D. SWERDLOW, ANDREA M. RUSSO, PAUL J. DEGROOT. (2007) The Dilemma of ICD Implant Testing. Pacing and Clinical Electrophysiology 30:5, 675-700
CrossRef1058
Giuseppe Boriani, Cinzia Valzania, Igor Diemberger, Mauro Biffi, Cristian Martignani, Matteo Bertini, Matteo Ziacchi, Giulia Domenichini, Davide Saporito, Claudio Rapezzi, Angelo Branzi. (2007) Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death. Expert Opinion on Investigational Drugs 16:5, 605-623
CrossRef1059
J Thomas Bigger, Daniel M Bloomfield. (2007) Microvolt T-wave alternans: an effective approach to risk stratification in ischemic cardiomyopathy?. Nature Clinical Practice Cardiovascular Medicine
CrossRef1060
David J. Fox, Neil C. Davidson, Adam P. Fitzpatrick. (2007) How should we cost ICD therapy?. International Journal of Cardiology 118:1, 1-3
CrossRef1061
Alessandro Proclemer, Marco Ghidina. (2007) Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of Cardiovascular Medicine 8:5, 320-323
CrossRef1062
Joel S. Mindel, Jill Anderson, George Johnson, Anne Hellkamp, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2007) Absence of bilateral vision loss from amiodarone: A randomized trial. American Heart Journal 153:5, 837-842
CrossRef1063
George J. Klein. (2007) Electrophysiology at crossroads: A time of great opportunity. Heart Rhythm 4:5, 662-664
CrossRef1064
Arijit Dasgupta, Jessica Montalvo, Sara Medendorp, Donald M. Lloyd-Jones, Cybele Ghossein, Jeffrey Goldberger, Rod Passman. (2007) Increased Complication Rates of Cardiac Rhythm Management Devices in ESRD Patients. American Journal of Kidney Diseases 49:5, 656-663
CrossRef1065
Heather L. Bloom, Irfan Shukrullah, Jose R. Cuellar, Michael S. Lloyd, Samuel C. Dudley, A. Maziar Zafari. (2007) Long-term survival after successful inhospital cardiac arrest resuscitation. American Heart Journal 153:5, 831-836
CrossRef1066
Luis Beck-da-Silva, Luis E. Rohde, Livia Goldraich, Nadine Clausell. (2007) Clinical Findings, Natriuretic Peptides, and Echocardiography: Integrating Tools to Optimize Heart Failure Management. Congestive Heart Failure 13:3, 158-163
CrossRef1067
Edward K. Rhee, Charles E. Canter, Susan Basile, Steven A. Webber, David C. Naftel. (2007) Sudden Death Prior to Pediatric Heart Transplantation: Would Implantable Defibrillators Improve Outcome?. The Journal of Heart and Lung Transplantation 26:5, 447-452
CrossRef1068
(2007) Persistent Coronary Occlusion after Myocardial Infarction. New England Journal of Medicine 356:16, 1681-1684
Full Text1069
Heath E. Saltzman, Kumar Sharma, Paul J. Mather, Sharon Rubin, Suzanne Adams, David Joshua Whellan. (2007) Renal dysfunction in heart failure patients: what is the evidence?. Heart Failure Reviews 12:1, 37-47
CrossRef1070
Anne B. Curtis. (2007) Are women worldwide under-treated with regard to cardiac resynchronization and sudden death prevention?. Journal of Interventional Cardiac Electrophysiology 17:3, 169-175
CrossRef1071
Timothy W. Smith, Michael E. Cain. (2007) Sudden cardiac death: Epidemiologic and financial worldwide perspective. Journal of Interventional Cardiac Electrophysiology 17:3, 199-203
CrossRef1072
Michael E. Field, Michael O. Sweeney. (2007) Socio-economic analysis of cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology 17:3, 225-236
CrossRef1073
John G. F. Cleland, Periaswamy Velavan, Mansour Nasir. (2007) Fighting against sudden death: A single or multidisciplinary approach. Journal of Interventional Cardiac Electrophysiology 17:3, 205-210
CrossRef1074
Stephan B. Danik, Moussa Mansour, Jagmeet Singh, Vivek Y. Reddy, Patrick T. Ellinor, David Milan, E. Kevin Heist, Andre d’Avila, Jeremy N. Ruskin, Theofanie Mela. (2007) Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 4:4, 439-442
CrossRef1075
Yuksel Cavusoglu. (2007) The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Expert Opinion on Pharmacotherapy 8:5, 665-677
CrossRef1076
Paul S. Chan, Cheryl Bartone, Terri Booth, Dean Kereiakes, Theodore Chow. (2007) Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. American Heart Journal 153:4, 523-529
CrossRef1077
Javed Butler, Angel Leon. (2007) The Elusive Scourge of Sudden Cardiac Death. Journal of the American College of Cardiology 49:13, 1434-1435
CrossRef1078
Fulvio Bellocci, Luigi M Biasucci, Gian Franco Gensini, Luigi Padeletti, Antonio Raviele, Massimo Santini, Giovanna Giubilato, Maurizio Landolina, Giuseppe Biondi-Zoccai, Giovanni Raciti, Massimo Sassara, Antonello Castro, Antoine Kheir, Filippo Crea. (2007) Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Journal of Cardiovascular Medicine 8:4, 293-299
CrossRef1079
Michael G. Dickinson, John H. Ip, Brian Olshansky, Anne S. Hellkamp, Jill Anderson, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2007) Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 153:4, 573-578
CrossRef1080
Georg Delle Karth, Anton Buberl, Mariam Nikfardjam, Brigitte Meyer, Gregor Wollenek, Michael Grimm, Andrea Lassnigg, Werner Brannath, Michael Hiesmayr, Gottfried Heinz. (2007) Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 54:4, 262-268
CrossRef1081
Bret T. Petersen, Nadeem Hussain, Joseph E. Marine, Richard G. Trohman, Steven Carpenter, Ram Chuttani, Joseph Croffie, James DiSario, Poonputt Chotiprasidhi, Julia Liu, Lehel Somogyi. (2007) Endoscopy in patients with implanted electronic devices. Gastrointestinal Endoscopy 65:4, 561-568
CrossRef1082
A. Selcuk Adabag, Barry J. Maron. (2007) Implications of Arrhythmias and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Annals of Noninvasive Electrocardiology 12:2, 171-180
CrossRef1083
PETER W. GROENEVELD, MARY A. MATTA, JANICE J. SUH, FEIFEI YANG, JUDY A. SHEA. (2007) Quality of Life Among Implantable Cardioverter-Defibrillator Recipients in the Primary Prevention Therapeutic Era. Pacing and Clinical Electrophysiology 30:4, 463-471
CrossRef1084
Lydia Close, Perry Elliott. (2007) Optimization of concomitant medication in Fabry cardiomyopathy. Acta Paediatrica 96, 81-83
CrossRef1085
Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Rosenberg, Eric S., Cort, Alice M., Ebeling, Sally H.Peters, Christine C., Lewis, Gregory D., Holmes, Charles B., Holmvang, Godtfred, Butterton, Joan R., . (2007) Case 8-2007. New England Journal of Medicine 356:11, 1153-1162
Full Text1086
Alexander Crössmann, Paul Pauli, Wilhelm Dengler, Volker Kühlkamp, Georg Wiedemann. (2007) Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: A longitudinal two-year follow-up. Heart & Lung: The Journal of Acute and Critical Care 36:2, 87-95
CrossRef1087
William G. Stevenson, Usha Tedrow. (2007) Management of atrial fibrillation in patients with heart failure. Heart Rhythm 4:3, S28-S30
CrossRef1088
MINTU P. TURAKHIA, PAUL D VAROSY, KEANE LEE, ZIAN H. TSENG, RANDALL LEE, NITISH BADHWAR, MELVIN SCHEINMAN, BYRON K. LEE, JEFFREY E. OLGIN. (2007) Impact of Renal Function on Survival in Patients with Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 30:3, 377-384
CrossRef1089
Eran S. Zacks, Daniel P. Morin, Shaun Ageno, Matthew Janik, Andreas C. Mauer, Steven M. Markowitz, Suneet Mittal, Sei Iwai, Bindi K. Shah, Bruce B. Lerman, Kenneth M. Stein. (2007) Effect of oral β-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. American Heart Journal 153:3, 392-397
CrossRef1090
HAITHAM HREYBE, SAMIR SABA. (2007) A Clinical Risk Score to Predict the Time to First Appropriate Device Therapy in Recipients of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 30:3, 385-389
CrossRef1091
VERONICA COX, MITUL PATEL, JASON KIM, TAYLOR LIU, GOWRI SIVARAMAN, SANJIV M. NARAYAN. (2007) Predicting Arrhythmia-Free Survival Using Spectral and Modified-Moving Average Analyses of T-Wave Alternans. Pacing and Clinical Electrophysiology 30:3, 352-358
CrossRef1092
T. Klingenheben, P. Ptaszynski. (2007) Clinical significance of microvolt T-wave alternans. Herzschrittmachertherapie & Elektrophysiologie 18:1, 39-44
CrossRef1093
Andrew E. Epstein, Christina A. Baessler, Anne B. Curtis, N.A. Mark Estes, Bernard J. Gersh, Blair Grubb, L. Brent Mitchell. (2007) Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”. Heart Rhythm 4:3, 386-393
CrossRef1094
HENRY A. CHEN, HENRY H. HSIA, RANDALL VAGELOS, MICHAEL FOWLER, PAUL WANG, AMIN AL-AHMAD. (2007) The Effect of Gender on Mortality or Appropriate Shock in Patients with Nonischemic Cardiomyopathy Who Have Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 30:3, 390-394
CrossRef1095
Wei Kong, Jian Huang, Dennis L Rollins, Raymond E Ideker, William M Smith. (2007) A semi-implantable multichannel telemetry system for continuous electrical, mechanical and hemodynamical recordings in animal cardiac research. Physiological Measurement 28:3, 249-257
CrossRef1096
Mitesh S. Amin, Kenneth A. Ellenbogen. (2007) Critical Pathway for Management of Pacemaker and Implantable Cardioverter-Defibrillator Advisories. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 6:1, 1-4
CrossRef1097
S. M. Marcovina, F. Crea, J. Davignon, J. C. Kaski, W. Koenig, U. Landmesser, P. L. Pieri, J. Schulz-Menger, L. J. Shaw, J. Sobesky. (2007) Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. Journal of Internal Medicine 261:3, 214-234
CrossRef1098
E. Friedmann, S. A. Thomas, P. Inguito, C. W. Kao, M. Metcalf, F. J. Kelley, S. S. Gottlieb. (2007) Quality of life and psychological status of patients with implantable cardioverter defibrillators. Journal of Interventional Cardiac Electrophysiology 17:1, 65-72
CrossRef1099
Wilbert S. Aronow. (2007) Heart-Failure–Complicating Acute Myocardial Infarction. Clinics in Geriatric Medicine 23:1, 123-139
CrossRef1100
Marco Pocar, Andrea Moneta, Adalberto Grossi, Francesco Donatelli. (2007) Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow-Up. The Annals of Thoracic Surgery 83:2, 468-474
CrossRef1101
Lauren A. Stutts, Natalie J. Cross, Jamie B. Conti, Samuel F. Sears. (2007) Examination of Research Trends on Patient Factors in Patients with Implantable Cardioverter Defibrillators. Clinical Cardiology 30:2, 64-68
CrossRef1102
Rainer Gradaus, Günter Breithardt. (2007) Should all patients with heart failure and left ventricular dysfunction receive combined CRT–ICD therapy?. Nature Clinical Practice Cardiovascular Medicine 4:2, 68-69
CrossRef1103
Eduardo Campos Moreno, Matilde Merino Sanjuán, Virginia Merino, Amparo Nácher, Rafael V. Martín Algarra, Vicente G. Casabó. (2007) Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding. European Journal of Pharmaceutical Sciences 30:2, 190-197
CrossRef1104
Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Clinics in Geriatric Medicine 23:1, 205-219
CrossRef1105
J. Kreuz, O. Balta, N. Liliegren, B. Ezmailzadeh, C. Schneider, A. Welz, G. Nickenig, J. O. Schwab. (2007) Inzidenz und Charakteristika von inadäquaten und adäquaten Therapieabgaben bei Patienten mit implantierbarem Cardioverter/Defibrillator zur Primärprophylaxe. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 21:1, 8-12
CrossRef1106
James O. O’Neill, Randall C. Starling, Mina K. Chung. (2007) Reply to Di Donato and colleagues. The Journal of Thoracic and Cardiovascular Surgery 133:2, 292-293
CrossRef1107
Wilbert S. Aronow. (2007) Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in the Elderly. Clinics in Geriatric Medicine 23:1, 61-81
CrossRef1108
John Arthur McClung. (2007) End-of-Life Care in the Treatment of Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 235-248
CrossRef1109
BRUCE D. GUNDERSON, ATHULA I. ABEYRATNE, WALTER H. OLSON, CHARLES D. SWERDLOW. (2007) Effect of Programmed Number of Intervals to Detect Ventricular Fibrillation on Implantable Cardioverter-Defibrillator Aborted and Unnecessary Shocks. Pacing and Clinical Electrophysiology 30:2, 157-165
CrossRef1110
Lorne J. Gula, David Massel, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, George J. Klein. (2007) Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls—Adding statistical insight to clinical intuition. American Heart Journal 153:2, 253-259
CrossRef1111
Elizabeth M. McNally. (2007) New Approaches in the Therapy of Cardiomyopathy in Muscular Dystrophy. Annual Review of Medicine 58:1, 75-88
CrossRef1112
PHILLIP S. CUCULICH, JOSÉ MAURICIO SÁNCHEZ, ROGER KERZNER, SCOTT L. GREENBERG, JAY SENGUPTA, JANE CHEN, MITCHELL N. FADDIS, MARYE J. GLEVA, TIMOTHY W. SMITH, BRUCE D. LINDSAY. (2007) Poor Prognosis for Patients with Chronic Kidney Disease Despite ICD Therapy for the Primary Prevention of Sudden Death. Pacing and Clinical Electrophysiology 30:2, 207-213
CrossRef1113
Maxime Cannesson, Masaki Tanabe, Matthew S. Suffoletto, Dennis M. McNamara, Shobhit Madan, Joan M. Lacomis, John Gorcsan. (2007) A Novel Two-Dimensional Echocardiographic Image Analysis System Using Artificial Intelligence-Learned Pattern Recognition for Rapid Automated Ejection Fraction. Journal of the American College of Cardiology 49:2, 217-226
CrossRef1114
Ilan Goldenberg, Arthur J. Moss. (2007) Reply. Journal of the American College of Cardiology 49:1, 125
CrossRef1115
Jackie Bryant, Hakan Brodin, Emma Loveman, Andrew Clegg. (2007) Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 23:01,
CrossRef1116
M.D. Cheitlin. (2007) A history of heart failure predicts arrhythmia treatment efficacy: Data from the Antiarrythmics versus Implantable Defibrillators (AVID) Study. Yearbook of Cardiology 2007, 368-369
CrossRef1117
Alexander Crössmann, Wolfram Voelker, Paul Pauli, Sabine Bär, Regina Borst, Matthias Spindler. (2007) Angstreduktion durch audio-visuelle Information vor der Koronarangiographie. Verhaltenstherapie 17:1, 46-51
CrossRef1118
Sae Sasaki, Shinichi Niwano, Hidehira Fukaya, Masaru Yuge, Ryuta Imaki, Takayuki Inomata, Tohru Izumi. (2007) Clinical Usefulness of Electrophysiologic Study (EPS)-Guided Risk Stratification for Life-Threatening Arrhythmia in Patients With Heart Failure. International Heart Journal 48:2, 155-163
CrossRef1119
STEVEN M. GREENBERG, ANDREW E. EPSTEIN, THOMAS DEERING, DANIEL S. GOLDMAN, MARCO GHIDINA, CURTIS NEASON, ALESSANDRO PROCLEMER. (2007) A Comparison of ICD Implantations in the United States Versus Italy. Pacing and Clinical Electrophysiology 30:s1,
CrossRef1120
Vijay S Chauhan, Raja J Selvaraj. (2007) Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Current Opinion in Cardiology 22:1, 25-32
CrossRef1121
Rishi Sukhija, Vimal Mehta, Marino Leonardi, Jawahar L. Mehta. (2007) Implantable cardioverter defibrillators for prevention of sudden cardiac Death. Clinical Cardiology 30:1, 3-8
CrossRef1122
Andrea M. Russo, Francis E. Marchlinski. (2007) Should Microvolt T-Wave Alternans Be Utilized Routinely in Selecting Patients for Prophylactic Implantable Cardioverter-Defibrillator Insertion in the Setting of Ischemic Heart Disease?. Journal of the American College of Cardiology 49:1, 59-61
CrossRef1123
Glenn Gandelman, William H. Frishman, Cristina Wiese, Vanessa Green-Gastwirth, Steven Hong, Wilbert S. Aronow, Harold W. Horowitz. (2007) Intravascular Device Infections. Cardiology in Review 15:1, 13-23
CrossRef1124
Rahul Mehra, Paul DeGroot. (2007) Where are we, and where are we heading in the device management of ventricular tachycardia/ventricular fibrillation?. Heart Rhythm 4:1, 99-103
CrossRef1125
Kazuo Matsumoto. (2007) Cardiac Resynchronization Therapy (CRT)-Its History, Indication, Usefulness and Problems-. Journal of Arrhythmia 23:3, 223-228
CrossRef1126
Angelo Auricchio, Marco Metra, Maurizio Gasparini, Barbara Lamp, Catherine Klersy, Antonio Curnis, Cecilia Fantoni, Edoardo Gronda, Juergen Vogt. (2007) Long-Term Survival of Patients With Heart Failure and Ventricular Conduction Delay Treated With Cardiac Resynchronization Therapy. The American Journal of Cardiology 99:2, 232-238
CrossRef1127
J. Jaime Caro, Alexandra Ward, H. Baris Deniz, Judith A. O'Brien, Jenifer L. Ehreth. (2007) Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone. Value in Health 10:1, 13-22
CrossRef1128
Giovanni Quarta, Laura Marino, Jasmine Passerini, Valentina Francione, Francesco Paneni, Camillo Autore. (2007) The Microvolt T-Wave Alternans Test. High Blood Pressure & Cardiovascular Prevention 14:4, 213-219
CrossRef1129
Deviprasad Venugopal, Rajat Jhanjee, David G Benditt. (2007) Current Management of Syncope. American Journal of Cardiovascular Drugs 7:6, 399-411
CrossRef1130
Gregor Leibundgut, Matthias Pfisterer, Hans-Peter Brunner-La Rocca. (2007) Drug Treatment of Chronic Heart Failure in the Elderly. Drugs & Aging 24:12, 991-1006
CrossRef1131
Anne M Dubin, Charles I Berul. (2007) Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease. Expert Review of Cardiovascular Therapy 5:1, 111-118
CrossRef1132
Raban V. Jeger, Susan F. Assmann, Loran Yehudai, Krishnan Ramanathan, Michael E. Farkouh, Judith S. Hochman. (2007) Causes of death and re‐hospitalization in cardiogenic shock. Acute Cardiac Care 9:1, 25-33
CrossRef1133
JENS KREUZ, OSMAN BALTA, NORA LILIEGREN, FRITZ MELLERT, BAHMAN ESMAILZADEH, GEORG NICKENIG, JÖRG OTTO SCHWAB. (2007) Incidence and Characteristics of Appropriate and Inappropriate Therapies in Recipients of ICD Implanted for Primary Prevention of Sudden Cardiac Death. Pacing and Clinical Electrophysiology 30:s1,
CrossRef1134
Brian Olshansky. (2007) Placebo and Nocebo in Cardiovascular Health. Journal of the American College of Cardiology 49:4, 415-421
CrossRef1135
WOLFRAM GRIMM, ASTRID STULA, JULIA SHARKOVA, PETER ALTER, BERNHARD MAISCH. (2007) Outcomes of Elderly Recipients of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 30:s1,
CrossRef1136
Richard Kobza, Therese Resink, Paul Erne. (2007) Implantable cardioverter-defibrillator malfunction with out-of-range lead measurements: What is the cause?. Heart Rhythm 4:1, 106-107
CrossRef1137
Theodore Chow, Dean J. Kereiakes, Cheryl Bartone, Terri Booth, Edward J. Schloss, Theodore Waller, Eugene Chung, Santosh Menon, Brahmajee K. Nallamothu, Paul S. Chan. (2007) Microvolt T-Wave Alternans Identifies Patients With Ischemic Cardiomyopathy Who Benefit From Implantable Cardioverter-Defibrillator Therapy. Journal of the American College of Cardiology 49:1, 50-58
CrossRef1138
FABRIZIO DRAGO, MASSIMO S. SILVETTI, ANTONELLA DE SANTIS, GIOVANNI FAZIO, GIANLUCA BIANCALANA, GIORGIA GRUTTER, GABRIELE RINELLI. (2007) Closed Loop Stimulation Improves Ejection Fraction in Pediatric Patients with Pacemaker and Ventricular Dysfunction. Pacing and Clinical Electrophysiology 30:1,
CrossRef1139
Masaomi Chinushi, Yoshifusa Aizawa. (2007) Non-Pharmacological Management of Ventricular Tachycardia. Circulation Journal 71:SupplementA, A97-A105
CrossRef1140
Takashi Kurita. (2007) Primary Prevention of Sudden Cardiac Death in Patients with Ischemic Heart Disease-Possible Role of the Shock Device in the Asia-. Journal of Arrhythmia 23:4, 264-268
CrossRef1141
Akira Ueno, Yoshinori Kobayashi, Kenji Yodogawa, Yasushi Miyauchi, Toshimi Yajima, Takashi Nitta, Takao Kato, Teruo Takano. (2007) A Prospective Study on the Risk-Stratification for Patients With Non-Sustained Ventricular Tachycardia Using a Novel Algorithm. Circulation Journal 71:7, 1107-1114
CrossRef1142
Sanjiv M. Narayan. (2007) T-Wave Alternans and Human Ventricular Arrhythmias. Journal of the American College of Cardiology 49:3, 347-349
CrossRef1143
Makoto NAGASAKA, Masahiro KOHZUKI. (2007) The Japanese Journal of Rehabilitation Medicine 44:7, 402-415
CrossRef1144
Wilbert S. Aronow. (2006) Treatment of heart failure with decreased left ventricular ejection fraction. Comprehensive Therapy 32:4, 218-225
CrossRef1145
ALESSANDRO PROCLEMER, MARCO GHIDINA, GLORIA CICUTTINI, DARIO GREGORI, PAOLO MARIA FIORETTI. (2006) Impact of the Main Implantable Cardioverter-Defibrillator Trials for Primary and Secondary Prevention in Italy: A Survey of the National Activity During the Years 2001?2004. Pacing and Clinical Electrophysiology 29:s2, S20-S28
CrossRef1146
, G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:2, 103-117
CrossRef1147
Takanori Ikeda, Hideaki Yoshino, Kaoru Sugi, Kaoru Tanno, Hiroki Shimizu, Jun Watanabe, Yuji Kasamaki, Akihiro Yoshida, Takao Kato. (2006) Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction. Journal of the American College of Cardiology 48:11, 2268-2274
CrossRef1148
Rafael Peinado, Esteban G. Torrecilla, José Ormaetxe, Miguel Álvarez. (2006) Registro Español de Desfibrilador Automático Implantable. II Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (2005). Revista Española de Cardiología 59:12, 1292-1302
CrossRef1149
GIOVANNI LUCA BOTTO, MARIO LUZI, FRANCO RUFFA, GIOVANNI RUSSO, GIOVANNI FERRARI. (2006) Atrial Tachyarrhythmias in Primary and Secondary Prevention ICD Recipients: Clinical and Prognostic Data. Pacing and Clinical Electrophysiology 29:s2, S48-S53
CrossRef1150
Giovanni Pulignano, Donatella Del Sindaco, Andrea Di Lenarda, Gianfranco Sinagra. (2006) The evolving care of the elderly with heart failure: from the ‘high-tech’ to the ‘high-touch’ approach. Journal of Cardiovascular Medicine 7:12, 841-846
CrossRef1151
Kathy Hebert, James Mckinnie, Ron Horswell, Lee Arcement, Lynne Stevenson. (2006) Expansion of Heart Failure Device Therapy Into a Rural Indigent Population in Louisiana: Potential Economic and Health Policy Implications. Journal of Cardiac Failure 12:9, 689-693
CrossRef1152
MAURIZIO LUNATI, MAURIZIO GASPARINI, MARIO BOCCHIARDO, ANTONIO CURNIS, MAURIZIO LANDOLINA, ANGELO CARBONI, GIANNI LUZZI, GABRIELE ZANOTTO, PIERANTONIO RAVAZZI, GIOVANNI MAGENTA, ALESSANDRA DENARO, PAOLA DISTEFANO, ANDREA GRAMMATICO, . (2006) Clustering of Ventricular Tachyarrhythmias in Heart Failure Patients Implanted with a Biventricular Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 17:12, 1299-1306
CrossRef1153
Werner Jung, Dietrich Andresen, Michael Block, Dirk Böcker, Stefan H. Hohnloser, Karl-Heinz Kuck, Johannes Sperzel. (2006) Leitlinien zur Implantation von Defibrillatoren. Clinical Research in Cardiology 95:12, 696-708
CrossRef1154
George Hayashi, Kenichi Kurosaki, Shigeyuki Echigo, Hideki Kado, Norihide Fukushima, Michio Yokota, Kouichirou Niwa, Tokuko Shinohara, Makoto Nakazawa. (2006) Prevalence of Arrhythmias and Their Risk Factors Mid- and Long-Term After the Arterial Switch Operation. Pediatric Cardiology 27:6, 689-694
CrossRef1155
(2006) Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita.Versión resumida. Revista Española de Cardiología 59:12, 1328.e1-1328.e51
CrossRef1156
, D.G. Benditt. (2006) The ACCF/AHA Scientific Statement on Syncope. Clinical Autonomic Research 16:6, 363-368
CrossRef1157
Isaac Pourati, Lawrence Rosenthal. (2006) Indications for cardiac defibrillators in patients with congestive heart failure. Current Heart Failure Reports 3:4, 197-202
CrossRef1158
John D. Harding, Mariell Jessup. (2006) New Directions in the Medical Management of Heart Failure. Seminars in Thoracic and Cardiovascular Surgery 17:4, 334-342
CrossRef1159
Adnan Siddiqui, Peter R Kowey. (2006) Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Current Opinion in Internal Medicine 5:6, 544-552
CrossRef1160
GIUSEPPE BORIANI, MAURO BIFFI, MAURIZIO RUSSO, MAURIZIO LUNATI, GIANLUCA BOTTO, ALESSANDRO PROCLEMER, GIUSEPPE VERGARA, WERNER RAHUE, CRISTIAN MARTIGNANI, RENATO RICCI, MASSIMO SANTINI, . (2006) Primary Prevention of Sudden Cardiac Death: Can We Afford the Cost of Cardioverter-Defibrillators? Data from the Search-MI Registry-Italian Sub-study. Pacing and Clinical Electrophysiology 29:s2, S29-S34
CrossRef1161
Thomas Klingenheben. (2006) Arrhythmia Risk Prediction in Patients With Preserved Left Ventricular Function. Journal of the American College of Cardiology 48:11, 2275-2276
CrossRef1162
MAURIZIO GASPARINI, MAURIZIO LUNATI, MASSIMO SANTINI, MASSIMO TRITTO, ANTONIO CURNIS, MARIO BOCCHIARDO, ANTONIO VINCENTI, GIANFRANCO PISTIS, SERGIO VALSECCHI, ALESSANDRA DENARO, . (2006) Long-Term Survival in Patients Treated with Cardiac Resynchronization Therapy: A 3-Year Follow-Up Study from the InSync/InSync ICD Italian Registry. Pacing and Clinical Electrophysiology 29:s2, S2-S10
CrossRef1163
Michael Colquhoun, Sue Jones, Thomas Clarke, Mark Cooke, Simon Brown, Janet McComb. (2006) Emergency management of arrhythmias and/or shocks in patients with implantable cardioverter defibrillators (ICDs). Resuscitation 71:3, 278-282
CrossRef1164
MICHAEL CAO, LESLIE A. SAXON. (2006) Selection of Patients for CRT?Prevention or Reversal of Remodeling as a Therapeutic Endpoint for CRT. Journal of Cardiovascular Electrophysiology 17:12, 1293-1294
CrossRef1165
MICHAEL O. SWEENEY, KENNETH A. ELLENBOGEN, ELAINE HOGAN MILLER, LOU SHERFESEE, TODD SHELDON, DAVID WHELLAN. (2006) The Managed Ventricular Pacing? Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation. Journal of Cardiovascular Electrophysiology 17:12, 1295-1298
CrossRef1166
DAVID N. KENIGSBERG, KENNETH A. ELLENBOGEN. (2006) ICD Arrhythmia Detection and Discrimination: Are We There Yet?. Journal of Cardiovascular Electrophysiology 17:12, 1320-1322
CrossRef1167
Philip B. Adamson, Edward M. Gilbert. (2006) Reducing the Risk of Sudden Death in Heart Failure With β-Blockers. Journal of Cardiac Failure 12:9, 734-746
CrossRef1168
Syed Nasir Ghani, James N. Kirkpatrick, Kirk T. Spencer, Gwendolyn L. Smith, Martin C. Burke, Susan S. Kim, Aseem D. Desai, Bradley P. Knight. (2006) Rapid assessment of left ventricular systolic function in a pacemaker clinic using a hand-carried ultrasound device. Journal of Interventional Cardiac Electrophysiology 16:1, 39-43
CrossRef1169
Michael J. Yarnoz, Anne B. Curtis. (2006) Sex-Based Differences in Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapies. Cardiology in Review 14:6, 292-298
CrossRef1170
Ravi G. Assomull, Sanjay K. Prasad, Jonathan Lyne, Gillian Smith, Elizabeth D. Burman, Mohammed Khan, Mary N. Sheppard, Philip A. Poole-Wilson, Dudley J. Pennell. (2006) Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy. Journal of the American College of Cardiology 48:10, 1977-1985
CrossRef1171
P. Bru, C. Duplantier, M. Fratu, M. Bourrat, B. Vaquette, C. Moreau, R. Lorillard. (2006) Suivi des défibrillateurs automatiques implantables en centre hospitalier général. Annales de Cardiologie et d'Angéiologie 55:6, 342-345
CrossRef1172
N. N. HENYAN, C. M. WHITE, E. L. GILLESPIE, K. SMITH, C. I. COLEMAN, J. KLUGER. (2006) The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. Journal of Internal Medicine 260:5, 467-473
CrossRef1173
Michael A. Weber, Nanette K. Wenger, Stephen Scheidt. (2006) Who Should Be Treated With Implantable Cardioverter-Defibrillators?. The American Journal of Geriatric Cardiology 15:6, 336-337
CrossRef1174
Rong Zhou, Paul D. Acton, Victor A. Ferrari. (2006) Imaging Stem Cells Implanted in Infarcted Myocardium. Journal of the American College of Cardiology 48:10, 2094-2106
CrossRef1175
Nanette K. Wenger. (2006) Enrollment and Maintenance of Elderly Patients in Cardiovascular Clinical Trials. The American Journal of Geriatric Cardiology 15:6, 352-356
CrossRef1176
Francesco Grigioni, Giuseppe Boriani, Andrea Barbieri, Antonio Russo, Letizia Reggianini, Francesca Bursi, Luciano Potena, Caterina Ricci, Francesco Fallani, Fabio Coccolo, Gaia Magnani, Carlo Magelli, Maria G. Modena, Angelo Branzi. (2006) Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. Clinical Transplantation 20:6, 684-688
CrossRef1177
Alfred E. Boxton. (2006) Implantable Cardioverter-Defibrillators Should Be Used Routinely in the Elderly. The American Journal of Geriatric Cardiology 15:6, 361-364
CrossRef1178
Sandeep Nathan, William Piccione, Arun Kumar, Steve Attanasio, Gary L. Schaer. (2006) Erosion of an Extrapericardial Implantable Cardioverter Defibrillator Patch Through the Gastric Fundus With Fistulous Tract Formation. Cardiology in Review 14:6, e21-e23
CrossRef1179
Michael J. Yarnoz, Anne B. Curtis. (2006) Why Cardioverter-Defibrillator Implantation Might Not Be the Best Idea for Your Elderly Patient. The American Journal of Geriatric Cardiology 15:6, 367-371
CrossRef1180
2006. Chronic Heart Failure. .
CrossRef1181
Liza A. Prudente, Juanita Reigle, Cheryl Bourguignon, David E. Haines, John P. DiMarco. (2006) Psychological indices and phantom shocks in patients with ICD. Journal of Interventional Cardiac Electrophysiology 15:3, 185-190
CrossRef1182
Nicolas W Shammas. 2006. Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies. , 525-544.
CrossRef1183
Michael G. McLaughlin, Peter J. Zimetbaum. (2006) Electrocardiographic Predictors of Arrhythmic Death. Annals of Noninvasive Electrocardiology 11:4, 327-337
CrossRef1184
Elizabeth S. Kaufman, Daniel M. Bloomfield, Richard C. Steinman, Pearila B. Namerow, Ottorino Costantini, Richard J. Cohen, J. Thomas Bigger. (2006) “Indeterminate” Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 48:7, 1399-1404
CrossRef1185
D. Steven, B. Lutomsky, T. Rostock, S. Willems. (2006) Moderne Pharmakotherapie bei supraventrikulären und ventrikulären Herzrhythmusstörungen. Der Internist 47:10, 1013-1023
CrossRef1186
H. U. Klein. (2006) Prävention des plötzlichen Herztodes. Der Internist 47:10, 1040-1050
CrossRef1187
N. Klein, M. Klein, A. Salameh, D. Pfeiffer. (2006) Moderne Herzschrittmachertherapie. Der Internist 47:10, 1024-1033
CrossRef1188
Stefan H Hohnloser. (2006) Can microvolt T-wave alternans predict mortality in patients with ischemic cardiomyopathy?. Nature Clinical Practice Cardiovascular Medicine 3:9, 470-471
CrossRef1189
Michael W. Rich. (2006) Heart Failure in Older Adults. Medical Clinics of North America 90:5, 863-885
CrossRef1190
, G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:1, 8-30
CrossRef1191
ROBERT E. ECKART, LORNE J. GULA, MATTHEW R. REYNOLDS, ERIC A. SHRY, WILLIAM H. MAISEL. (2006) Mortality Following Defibrillator Implantation in Patients with Renal Insufficiency. Journal of Cardiovascular Electrophysiology 17:9, 940-943
CrossRef1192
Mitesh S. Amin, Kenneth A. Ellenbogen. (2006) Focus on management of pacemaker and ICD advisories, recalls, and alerts. Current Treatment Options in Cardiovascular Medicine 8:5, 347-352
CrossRef1193
CHRISTIAN G. WOLLMANN, ULRICH GOTTKER, DIRK BOCKER, RAINER GRADAUS. (2006) Near Fatal Arrhythmia Induction by An Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 17:9, 1026-1028
CrossRef1194
M. W. H. BEHAN, C. A. RINALDI. (2006) Cardiac resynchronisation therapy for heart failure. International Journal of Clinical Practice 60:9, 1107-1114
CrossRef1195
Lauren Vazquez Sowell, Emily A. Kuhl, Samuel F. Sears, Charles T. Klodell, Jamie B. Conti. (2006) Device Implant Technique and Consideration of Body Image: Specific Procedures for Implantable Cardioverter Defibrillators in Female Patients. Journal of Women's Health 15:7, 830-835
CrossRef1196
Peter Cram, David Katz, Sandeep Vijan, David M. Kent, Kenneth M. Langa, A. Mark Fendrick. (2006) Implantable or External Defibrillators for Individuals at Increased Risk of Cardiac Arrest: Where Cost-Effectiveness Hits Fiscal Reality. Value in Health 9:5, 292-302
CrossRef1197
Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 48:5, e247-e346
CrossRef1198
Jeanne E. Poole. (2006) New indications for implantable defibrillator therapy. Current Cardiology Reports 8:5, 330-335
CrossRef1199
Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary. Journal of the American College of Cardiology 48:5, 1064-1108
CrossRef1200
Apiradee Thammanomai, Michael O. Sweeney, Solomon R. Eisenberg. (2006) A comparison of the output characteristics of several implantable cardioverter-defibrillators. Heart Rhythm 3:9, 1053-1059
CrossRef1201
JEFFREY L. WILLIAMS, VLADIMIR SHUSTERMAN, SAMIR SABA. (2006) A Pilot Study Examining the Performance of Polynomial-Modeled Ventricular Shock Electrograms for Rhythm Discrimination in Implantable Devices. Pacing and Clinical Electrophysiology 29:9, 930-939
CrossRef1202
Andrew Ho, Ramin Assadi, Sudha M. Pai, Ramdas G. Pai. (2006) Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?. Current Cardiology Reports 8:5, 365-369
CrossRef1203
Lynne Warner Stevenson, Akshay S. Desai. (2006) Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure. Journal of Cardiac Failure 12:6, 407-412
CrossRef1204
Leslie A. Saxon. (2006) Patient Selection for Primary Prevention ICDs—Are EPs Shocking Patients Into Consent?. Journal of Cardiac Failure 12:6, 413-415
CrossRef1205
Claudia Ypenburg, Lieselot van Erven, Gabe B. Bleeker, Jeroen J. Bax, Marianne Bootsma, Maurits C. Wijffels, Ernst E. van der Wall, Martin J. Schalij. (2006) Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias. Journal of the American College of Cardiology 48:3, 464-470
CrossRef1206
Jarcho, John A., . (2006) Biventricular Pacing. New England Journal of Medicine 355:3, 288-294
Full Text1207
Charles I. Berul, Anne M. Dubin. (2006) Rhythm Management in Pediatric Heart Failure. Congenital Heart Disease 1:4, 140-147
CrossRef1208
S. R. Kaufman, J. K. Shim, A. J. Russ. (2006) Old Age, Life Extension, and the Character of Medical Choice. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 61:4, S175-S184
CrossRef1209
N. A. MARK ESTES. (2006) Discrimination When Dual-Chamber Termination Fails: A New Paradigm for ICDs?. Journal of Cardiovascular Electrophysiology 17:7, 702-704
CrossRef1210
Leslie W. Miller, Katherine Lietz. (2006) Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart Failure. The Journal of Heart and Lung Transplantation 25:7, 756-764
CrossRef1211
H. Ross, J. Howlett, J. Malcolm O. Arnold, P. Liu, B.J. O’Neill, J.M. Brophy, C.S. Simpson, M.M. Sholdice, M. Knudtson, D.B. Ross, J. Rottger, K. Glasgow. (2006) Treating the right patient at the right time: Access to heart failure care. Canadian Journal of Cardiology 22:9, 749-754
CrossRef1212
WOLFRAM GRIMM, EVELINE PLACHTA, BERNHARD MAISCH. (2006) Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients with Prophylactic Cardioverter-Defibrillator Therapy. Pacing and Clinical Electrophysiology 29:7, 759-764
CrossRef1213
B. A. SCHAER, C. STICHERLING, S. OSSWALD. (2006) What are the professional and logistic demands to appropriately follow patients with an implantable cardioverter-defibrillator?. Journal of Internal Medicine 260:1, 88-92
CrossRef1214
María G. Crespo Leiro, María J. Paniagua Martín. (2006) Insuficiencia cardiaca. ¿Son diferentes las mujeres?. Revista Española de Cardiología 59:7, 725-735
CrossRef1215
Julius Gy. Papp, Piero Pollesello, Andras Varro, Agnes Vegh, Eva Udvary. (2006) The Effect of Levosimendan during Long-Term Amiodarone Treatment in Dogs. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 99:1, 27-32
CrossRef1216
W. Frank Peacock, Alex Harrison, Alan S. Maisel. (2006) The Utility of Heart Sounds and Systolic Intervals Across the Care Continuum. Congestive Heart Failure 12, 2-7
CrossRef1217
Bruce L. Wilkoff, Kevin T. Ousdigian, Laurence D. Sterns, Zengri J. Wang, Ryan D. Wilson, John M. Morgan. (2006) A Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 48:2, 330-339
CrossRef1218
SAMIR SABA, LINDA BAKER, LEONARD GANZ, WILLIAM BARRINGTON, SANDEEP JAIN, OGUNDU NGWU, JILL CHRISTENSEN, MARK BROWN. (2006) Simultaneous Atrial and Ventricular Anti-Tachycardia Pacing as a Novel Method of Rhythm Discrimination. Journal of Cardiovascular Electrophysiology 17:7, 695-701
CrossRef1219
W. Frank Peacock, Alex Harrison, Alan S. Maisel. (2006) The Utility of Heart Sounds and Systolic Intervals Across the Care Continuum. Congestive Heart Failure 12:s4, 2-7
CrossRef1220
Matthew R. Reynolds, David J. Cohen, Aaron D. Kugelmass, Phillip P. Brown, Edmund R. Becker, Steven D. Culler, April W. Simon. (2006) The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:12, 2493-2497
CrossRef1221
Francis E. Marchlinski, Mariell Jessup. (2006) Timing the Implantation of Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy
CrossRef1222
Wojciech Zareba, Jonathan S. Steinberg, Scott McNitt, James P. Daubert, Katarzyna Piotrowicz, Arthur J. Moss. (2006) Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 3:6, 631-637
CrossRef1223
Rachele Adorisio, Leonardo De Luca, Joseph Rossi, Mihai Gheorghiade. (2006) Pharmacological treatment of chronic heart failure. Heart Failure Reviews 11:2, 109-123
CrossRef1224
Bertram Pitt. (2006) Whither Withering? The Role of Digoxin in Patients With Heart Failure Due to Systolic Left Ventricular Dysfunction in Sinus Rhythm. Journal of Cardiac Failure 12:5, 347-348
CrossRef1225
EMILY A. KUHL, NEHA K. DIXIT, ROBYN L. WALKER, JAMIE B. CONTI, SAMUEL F. SEARS. (2006) Measurement of Patient Fears About Implantable Cardioverter Defibrillator Shock: An Initial Evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology 29:6, 614-618
CrossRef1226
Alan Kadish, Andi Schaechter, Haris Subacius, Emil Thattassery, William Sanders, Kelley P. Anderson, Alan Dyer, Jeffrey Goldberger, Joseph Levine. (2006) Patients With Recently Diagnosed Nonischemic Cardiomyopathy Benefit From Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:12, 2477-2482
CrossRef1227
AHMET KAYA BILGE, BESTE OZBEN, SABRI DEMIRCAN, MUTLU CINAR, ERCUMENT YILMAZ, KAMIL ADALET. (2006) Depression and Anxiety Status of Patients with Implantable Cardioverter Defibrillator and Precipitating Factors. Pacing and Clinical Electrophysiology 29:6, 619-626
CrossRef1228
Eric C. Stecker, Megan Sono, Erin Wallace, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 3:6, 697-700
CrossRef1229
Lee A. Biblo, Johan Aasbo. (2006) To catch a moving target. Heart Rhythm 3:6, 638-639
CrossRef1230
SAMUEL F. SEARS, LAUREN VAZQUEZ SOWELL, EMILY A. KUHL, EILEEN M. HANDBERG, JORDANA KRON, JUAN M. ARANDA, JAMIE B. CONTI. (2006) Quality of Death: Implantable Cardioverter Defibrillators and Proactive Care. Pacing and Clinical Electrophysiology 29:6, 637-642
CrossRef1231
Robert G. Hauser, David L. Hayes, Andrew E. Epstein, David S. Cannom, Stephen C. Vlay, Susan L. Song, G. Frank O. Tyers. (2006) Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 3:6, 640-644
CrossRef1232
Oscar Bernal, Concepción Moro. (2006) Arritmias cardiacas en la mujer. Revista Española de Cardiología 59:6, 609-618
CrossRef1233
J. Claude Daubert, Christophe Leclercq, Erwan Donal, Philippe Mabo. (2006) Cardiac resynchronisation therapy in heart failure: Current status. Heart Failure Reviews 11:2, 147-154
CrossRef1234
Jack Zwanziger, W. Jackson Hall, Andrew W. Dick, Hongwei Zhao, Alvin I. Mushlin, Rebecca Marron Hahn, Hongkun Wang, Mark L. Andrews, Cathleen Mooney, Hongyue Wang, Arthur J. Moss. (2006) The Cost Effectiveness of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:11, 2310-2318
CrossRef1235
Eric J. Rashba, Stephen R. Shorofsky, Avram Scheiner, Robert W. Peters, Carol Ma, Michael R. Gold. (2006) Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm 3:6, 647-652
CrossRef1236
Fred Kusumoto, Nora Goldschlager. (2006) Implantable cardiac arrhythmia devices-Part II: Implantable cardioverter defibrillators and implantable loop recorders. Clinical Cardiology 29:6, 237-242
CrossRef1237
Wilbert S. Aronow. (2006) Epidemiology, Pathophysiology, Prognosis, and Treatment of Systolic and Diastolic Heart Failure. Cardiology in Review 14:3, 108-124
CrossRef1238
MICHAEL H. LEHMANN, KEITH D. AARONSON. (2006) CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit?. Journal of Cardiovascular Electrophysiology 17:5, 491-494
CrossRef1239
F. ROOSEVELT GILLIAM. (2006) T-Wave Oversensing in Implantable Cardiac Defibrillators Is Due to Technical Failure of Device Sensing. Journal of Cardiovascular Electrophysiology 17:5, 553-556
CrossRef1240
Jay N. Cohn, Peter E. Carson, Christopher O'Connor, Cristina Opasich, Ileana L. Piña, Marino Scherillo, Gianfranco Sinagra, Lynne Warner-Stevenson, Felix E. Tristani, Alberto Volpi. (2006) Prognosis and Mechanism of Death in Treated Heart Failure: Data From the Placebo Arm of Val-HeFT. Congestive Heart Failure 12:3, 127-131
CrossRef1241
E. M. L. Wong, E. B. Wu, W. W. M. Chan, C. M. Yu. (2006) A review of the management of patients after percutaneous coronary intervention. International Journal of Clinical Practice 60:5, 582-589
CrossRef1242
Markus Flesch, Erland Erdmann. (2006) The problem of polypharmacy in heart failure. Current Cardiology Reports 8:3, 217-225
CrossRef1243
Janet K. Shim, Ann J. Russ, Sharon R. Kaufman. (2006) Risk, life extension and the pursuit of medical possibility. Sociology of Health and Illness 28:4, 479-502
CrossRef1244
Sheharyar Ali, Eduardo S. Antezano. (2006) Sudden Cardiac Death. Southern Medical Journal 99:5, 502-510
CrossRef1245
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews, David J. Wilber, Helmut U. Klein. (2006) Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology 47:9, 1811-1817
CrossRef1246
Jigar Patel, J. Thomas Heywood. (2006) Management of the cardiorenal syndrome in heart failure. Current Cardiology Reports 8:3, 211-216
CrossRef1247
Theodore Chow, Dean J. Kereiakes, Cheryl Bartone, Terri Booth, Edward J. Schloss, Theodore Waller, Eugene S. Chung, Santosh Menon, Brahmajee K. Nallamothu, Paul S. Chan. (2006) Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy. Journal of the American College of Cardiology 47:9, 1820-1827
CrossRef1248
ASEEM D. DESAI, MARTIN C. BURKE, THOMAS E. HONG, SUSAN KIM, YASSER SALEM, PATRICK G. YONG, BRADLEY P. KNIGHT. (2006) Predictors of Appropriate Defibrillator Therapy Among Patients with an Implantable Defibrillator That Delivers Cardiac Resynchronization Therapy. Journal of Cardiovascular Electrophysiology 17:5, 486-490
CrossRef1249
Paul A. Friedman, Sohail Jalal, Scott Kaufman, Rollo Villareal, Scott Brown, Stephen J. Hahn, Darin R. Lerew. (2006) Effects of a rate smoothing algorithm for prevention of ventricular arrhythmias: Results of the Ventricular Arrhythmia Suppression Trial (VAST). Heart Rhythm 3:5, 573-580
CrossRef1250
Merritt Raitt. (2006) Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?. Future Cardiology 2:3, 273-279
CrossRef1251
C. Perings, T. Korte, H.-J. Trappe, . (2006) IEGM-online based evaluation of implantable cardioverter defibrillator therapy appropriateness. Clinical Research in Cardiology 95:S3, iii22-iii28
CrossRef1252
Gastone Sabbadini, Marco Metra, Andrea Di Lenarda, Savina Nodari, Gianfranco Sinagra, Livio Dei Cas. (2006) Managing heart failure in the very old. Aging Health 2:2, 253-275
CrossRef1253
Haris M. Haqqani, Jonathan M. Kalman. (2006) Recently diagnosed nonischemic dilated cardiomyopathy: When should we implant the defibrillator?. Heart Rhythm 3:4, 404-405
CrossRef1254
Lars Eckardt, Günter Breithardt. (2006) Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?. Heart Rhythm 3:4, 484-487
CrossRef1255
Gabor Duray, Carsten W Israel, Stefan H Hohnloser. (2006) Recent primary prevention implantable cardioverter defibrillator trials. Current Opinion in Internal Medicine 5:2, 154-158
CrossRef1256
JONATHAN S. STEINBERG, HOWARD LEVITT. (2006) Magnetocardiography Throws Its Hat in the Ring. Journal of Cardiovascular Electrophysiology 17:4, 402-404
CrossRef1257
S. Götze, C. Butter, E. Fleck. (2006) Kardiale Resynchronisation bei Herzinsuffizienz. Clinical Research in Cardiology 95:S4, 18-35
CrossRef1258
Kevin J. Makati, Airley E. Fish, Hannah H. England, Hocine Tighiouart, N.A. Mark Estes, Mark S. Link. (2006) Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more. Heart Rhythm 3:4, 397-403
CrossRef1259
Stephen Hammill, Steve Phurrough, Ralph Brindis. (2006) The National ICD Registry: Now and into the future. Heart Rhythm 3:4, 470-473
CrossRef1260
David A. Cesario, G. William Dec. (2006) Implantable Cardioverter- Defibrillator Therapy in Clinical Practice. Journal of the American College of Cardiology 47:8, 1507-1517
CrossRef1261
S. Jolly, P. Dorian, D. A. Alter. (2006) The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits. Journal of Evaluation in Clinical Practice 12:2, 190-195
CrossRef1262
P. Brugada. (2006) What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up?. Clinical Research in Cardiology 95:S3, iii3-iii9
CrossRef1263
Melvin M. Scheinman, Edmund Keung. (2006) The Year in Clinical Electrophysiology. Journal of the American College of Cardiology 47:6, 1207-1213
CrossRef1264
Jack F. Price, Jeffrey A. Towbin, William J. Dreyer, Brady S. Moffett, Naomi J. Kertesz, Sarah K. Clunie, Susan W. Denfield. (2006) Outpatient Continuous Parenteral Inotropic Therapy as Bridge to Transplantation in Children With Advanced Heart Failure. Journal of Cardiac Failure 12:2, 139-143
CrossRef1265
Eric J. Rashba, N.A. Mark Estes, Paul Wang, Andi Schaechter, Adam Howard, Wojciech Zareba, Jean-Philippe Couderc, Juha Perkiomaki, Joseph Levine, Alan Kadish. (2006) Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial. Heart Rhythm 3:3, 281-286
CrossRef1266
Bernard J Gersh, Robert D Simari. (2006) Cardiac cell-repair therapy: clinical issues. Nature Clinical Practice Cardiovascular Medicine 3, S105-S109
CrossRef1267
F. T. Wegener, G. C. Grönefeld, G. Duray, J. R. Ehrlich, S. H. Hohnloser. (2006) Pharmakotherapie der ventrikulären Rhythmusstörungen. Der Internist 47:3, 297-307
CrossRef1268
A. Bauer, J. Bauer, M. Bauer, K. Kelemen, F. Voss, J. Senges-Becker, S. Weretka, H. A. Katus, R. Becker. (2006) Effizienzpotential in der Nachsorge von Schrittmachern und implantierbaren Kardioverter Defibrillatoren. Herzschrittmachertherapie & Elektrophysiologie 17:1, 26-34
CrossRef1269
Imran S. Virk, John R. Ip, Rubinder S. Ruby, David Tepper. (2006) T-Wave Alternans: Is It an Appropriate Test for Primary Prevention Implantable Cardioverter-Defibrillator Risk Stratification?. The Role of Continuous Positive Airway Pressure in Heart Failure Patients With Central Sleep Apnea. Congestive Heart Failure 12:2, 116-118
CrossRef1270
M. Azizi, M. A. Castel, S. Behrens, W. Rödiger, H. Nägele. (2006) Experience with coronary sinus lead implantations for cardiac resynchronization therapy in 244 patients. Herzschrittmachertherapie & Elektrophysiologie 17:1, 13-18
CrossRef1271
James D. Allred, Andrew E. Epstein, Raymond E. Ideker. (2006) The Sign of Four and the SDNN of one of three. Heart Rhythm 3:3, 287-289
CrossRef1272
William J. Groh. (2006) Lessons From a Population. Journal of the American College of Cardiology 47:6, 1167-1168
CrossRef1273
BRIAN OLSHANSKY, JOHN DAY, MAUREEN McGUIRE, STEPHEN HAHN, SCOTT BROWN, DARIN R. LEREW. (2006) Reduction of Right Ventricular Pacing in Patients with Dual-Chamber ICDs. Pacing and Clinical Electrophysiology 29:3, 237-243
CrossRef1274
Michael O. Sweeney. 2006. Cardiac Resynchronization Therapy. , 259-300.
CrossRef1275
James P. Daubert, Henry W. Sesselberg, David T. Huang. (2006) Implantable Cardioverter-Defibrillators for Primary Prevention: How Do the Data Pertain to the Aged?. The American Journal of Geriatric Cardiology 15:2, 88-92
CrossRef1276
Akshay S. Desai, Bruce A Koplan. 2006. Device Therapy for Advanced Heart Disease: The Role of Implantable Defibrillators. , 301-324.
CrossRef1277
Eric C. Stecker, Catherine Vickers, Justin Waltz, Carmen Socoteanu, Benjamin T. John, Ronald Mariani, John H. McAnulty, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction. Journal of the American College of Cardiology 47:6, 1161-1166
CrossRef1278
Stuart D. Russell. 2006. Acute Heart Failure. , 203-226.
CrossRef1279
Claudia Martinez, Assaf Tzur, Hakop Hrachian, Joseph Zebede, Gervasio A. Lamas. (2006) Pacemakers and Defibrillators: Recent and Ongoing Studies That Impact the Elderly. The American Journal of Geriatric Cardiology 15:2, 82-87
CrossRef1280
Genevieve Smith, Sandra B. Dunbar, Amy L. Valderrama, Bindu Viswanathan. (2006) Gender Differences in Implantable Cardioverter-Defibrillator Patients at the Time of Insertion. Progress in Cardiovascular Nursing 21:2, 76-82
CrossRef1281
Usha B. Tedrow, William G. Stevenson. 2006. Management of Ventricular Arrhythmias in Heart Failure. , 183-202.
CrossRef1282
Luis A. Pires. (2006) Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy. Current Opinion in Anaesthesiology 19:1, 69-74
CrossRef1283
Barry M. Massie, Thomas Force. (2006) The Year in Heart Failure 2005. Journal of Cardiac Failure 12:1, 1-9
CrossRef1284
Andrew E. Epstein. (2006) Implantable cardioverter-defibrillators are still getting smarter: Now a way to identify lead failure and prevent resultant inappropriate shocks. Heart Rhythm 3:2, 163-164
CrossRef1285
Bruce D. Gunderson, Jeffrey M. Gillberg, Mark A. Wood, Pugazhendhi Vijayaraman, Richard K. Shepard, Kenneth A. Ellenbogen. (2006) Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm 3:2, 155-162
CrossRef1286
Andrew McKeon, Carl Vaughan, Norman Delanty. (2006) Seizure versus syncope. The Lancet Neurology 5:2, 171-180
CrossRef1287
Robert D Winslow, Sean Pinney, Valentin Fuster. (2006) Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure. Nature Clinical Practice Cardiovascular Medicine 3:2, 86-93
CrossRef1288
J. A. Mariani, P. A. Gould, A. Broughton, D. M. Kaye. (2006) Cardiac resynchronisation therapy for heart failure. Internal Medicine Journal 36:2, 114-123
CrossRef1289
Heart Failure Society of America. (2006) Section 9: Electrophysiologic Testing and the Use of Devices in Heart Failure. Journal of Cardiac Failure 12:1, e70-e75
CrossRef1290
BRYAN C. CANNON, RICHARD A. FRIEDMAN, ARNOLD L. FENRICH, CHARLES D. FRASER, E. DEAN McKENZIE, NAOMI J. KERTESZ. (2006) Innovative Techniques for Placement of Implantable Cardioverter-Defibrillator Leads in Patients with Limited Venous Access to the Heart. Pacing and Clinical Electrophysiology 29:2, 181-187
CrossRef1291
HEATHER BLOOM, BRIAN HEEKE, ANGEL LEON, FERNANDO MERA, DAVID DELURGIO, JOHN BESHAI, JONATHAN LANGBERG. (2006) Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery. Pacing and Clinical Electrophysiology 29:2, 142-145
CrossRef1292
Heart Failure Society of America. (2006) Section 7: Heart Failure in Patients With Left Ventricular Systolic Dysfunction. Journal of Cardiac Failure 12:1, e38-e57
CrossRef1293
(2006) Cost-Effectiveness of ICDs. New England Journal of Medicine 354:2, 205-207
Full Text1294
MAURIZIO GASPARINI, PAOLA GALIMBERTI, FRANCOIS REGOLI, CARLO CERIOTTI, MARIKA BONADIES. (2006) Delayed Defibrillation Testing in Patients Implanted with Biventricular ICD (CRT-D): A Reliable and Safe Approach. Journal of Cardiovascular Electrophysiology 0:0, 060118052427042-???
CrossRef1295
Robert J. Myerburg, Agustin Castellanos. (2006) Clinical Research Designs and Implantable Defibrillator Indications. Journal of the American College of Cardiology 47:1, 108-111
CrossRef1296
S. Adam Strickberger, D. Woodrow Benson, Italo Biaggioni, David J. Callans, Mitchell I. Cohen, Kenneth A. Ellenbogen, Andrew E. Epstein, Paul Friedman, Jeffrey Goldberger, Paul A. Heidenreich, George J. Klein, Bradley P. Knight, Carlos A. Morillo, Robert J. Myerburg, Cathy A. Sila. (2006) AHA/ACCF Scientific Statement on the Evaluation of Syncope. Journal of the American College of Cardiology 47:2, 473-484
CrossRef1297
CHARLES D. SWERDLOW, PAUL A. FRIEDMAN. (2006) Advanced ICD Troubleshooting: Part II. Pacing and Clinical Electrophysiology 29:1, 70-96
CrossRef1298
Michael H Gollob. (2006) Genetic profiling as a marker for risk of sudden cardiac death. Current Opinion in Cardiology 21:1, 42-46
CrossRef1299
MINORU HORIE. (2006) Nihon Naika Gakkai Zasshi 95:3, 520-523
CrossRef1300
Remzi Karaoguz, Sevgül Maydanozcu, Timuçin Altun, Muharrem Güldal, Ömer Akyürek, Çetin Erol. (2006) Appropriate ICD Therapy in Patients With Idiopathic Dilated Cardiomyopathy. International Heart Journal 47:5, 763-773
CrossRef1301
Satoko Kitamura, Kazuhiro Satomi, Takashi Kurita, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Kazuo Niwaya, Junjiro Kobayashi, Shiro Kamakura. (2006) Long-Term Follow-up of Transvenous Defibrillation Leads. Circulation Journal 70:3, 273-277
CrossRef1302
Sanjiv M. Narayan. (2006) T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias. Journal of the American College of Cardiology 47:2, 269-281
CrossRef1303
M. Borggrefe, C. Wolpert. (2006) Amiodaron oder ICD bei Patienten mit Herzinsuffizienz. Der Internist 47:1, 89-91
CrossRef1304
HIROSHI KASANUKI. (2006) Present status and prospect of non-pharmacotherapy of arrhythmia.. Nihon Naika Gakkai Zasshi 95:9, 1912-1921
CrossRef1305
José Azpitarte. (2006) Profilaxis primaria con desfibrilador-cardioversor implantable en la insuficiencia cardiaca: un punto de vista clínico. Revista Española de Cardiología 59, 10-22
CrossRef1306
J. Malcolm O. Arnold, Peter Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam Haddad, George A. Heckman, Jonathan G. Howlett, Andrew Ignaszewski, David E. Johnstone, Philip Jong, Robert S. McKelvie, Gordon W. Moe, John D. Parker, Vivek Rao, Heather J. Ross, Errol J. Sequeira, Anna M. Svendsen, Koon Teo, Ross T. Tsuyuki, Michel White. (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology 22:1, 23-45
CrossRef1307
Ignacio Fernández Lozano, José L. Merino Llorens. (2006) Temas de actualidad 2005: electrofisiología y arritmias. Revista Española de Cardiología 59, 20-30
CrossRef1308
Harold L. Kennedy. (2006) The History, Science, and Innovation of Holter Technology. Annals of Noninvasive Electrocardiology 11:1, 85-94
CrossRef1309
Masaru Yuge, Shinichi Niwano, Masahiko Moriguchi, Takeshi Sasaki, Shoji Hirasawa, Ryuta Imaki, Daisuke Sato, Tohru Izumi. (2006) Clinical Significance of the Electrophysiologic Study (EPS)-Guided Therapy for the Secondary Prevention of Ventricular Tachycardia. Circulation Journal 70:3, 268-272
CrossRef1310
EIICHI WATANABE. (2006) Nihon Naika Gakkai Zasshi 95:2, 261-270
CrossRef1311
Kazuhiro Satomi, Takashi Kurita, Seiji Takatsuki, Yasuhiro Yokoyama, Masaomi Chinushi, Naoya Tsuboi, Takashi Nitta, Morio Shoda, Hideo Mitamura. (2006) Amiodarone Therapy in Patients Implanted With Cardioverter-Defibrillator for Life-Threatening Ventricular Arrhythmias. Circulation Journal 70:8, 977-984
CrossRef1312
Ulrik Sartipy, Anders Albåge, Eva Strååt, Per Insulander, Dan Lindblom. (2006) Surgery for Ventricular Tachycardia in Patients Undergoing Left Ventricular Reconstruction by the Dor Procedure. The Annals of Thoracic Surgery 81:1, 65-71
CrossRef1313
TOSHIYUKI ISHIKAWA. (2006) Nihon Naika Gakkai Zasshi 95:2, 278-284
CrossRef1314
Kathryn A. Glatter, J. Nilas Young, Matthew D. McElvany. (2006) Implantable Cardioverter?Defibrillators: A New Preventive Medical Option. Preventive Cardiology 9:1, 49-55
CrossRef1315
Wilbert S. Aronow. (2006) Treatment of Systolic and Diastolic Heart Failure in the Elderly. Journal of the American Medical Directors Association 7:1, 29-36
CrossRef1316
Daniel M. Bloomfield, J. Thomas Bigger, Richard C. Steinman, Pearila B. Namerow, Michael K. Parides, Anne B. Curtis, Elizabeth S. Kaufman, Jorge M. Davidenko, Timothy S. Shinn, John M. Fontaine. (2006) Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 47:2, 456-463
CrossRef1317
A.L. Waldo. (2006) Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. Yearbook of Cardiology 2006, 446-447
CrossRef1318
Manuel F. Jiménez Navarro, Javier Díez Martínez, Juan F. Delgado Jiménez, María G. Crespo Leiro. (2006) La insuficiencia cardíaca en el año 2005. Revista Española de Cardiología 59, 55-65
CrossRef1319
Amir Kashani, S. Serge Barold. (2005) Significance of QRS Complex Duration in Patients With Heart Failure. Journal of the American College of Cardiology 46:12, 2183-2192
CrossRef1320
Ulf Landmesser, Helmut Drexler. (2005) Chronic heart failure: an overview of conventional treatment versus novel approaches. Nature Clinical Practice Cardiovascular Medicine 2:12, 628-638
CrossRef1321
Vijay K Verma, Steven M Hollenberg. (2005) Update on acute coronary syndromes and ST-elevation myocardial infarction. Current Opinion in Internal Medicine 4:6, 614-618
CrossRef1322
Gabor Duray, Sergio Richter, Johannes Manegold, Carsten W. Israel, Gerian Grönefeld, Stefan H. Hohnloser. (2005) Efficacy and Safety of ICD Therapy in a Population of Elderly Patients Treated with Optimal Background Medication. Journal of Interventional Cardiac Electrophysiology 14:3, 169-173
CrossRef1323
Rafael Peinado, Ángel Arenal, Fernando Arribas, Esteban Torrecilla, Miguel Álvarez, José M. Ormaetxe, Nicasio Pérez-Castellano. (2005) Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004). Revista Española de Cardiología 58:12, 1435-1449
CrossRef1324
PF Bögels, DJ Veldhuisen. (2005) Implanteerbare cardioverterende defibrillator, geen overbodige luxe. Huisarts en Wetenschap 48:12, 144-147
CrossRef1325
Peter Carson, Inder Anand, Christopher O’Connor, Brian Jaski, Jonathan Steinberg, Amy Lwin, JoAnn Lindenfeld, Jalil Ghali, Jodi H. Barnet, Arthur M. Feldman, Michael R. Bristow. (2005) Mode of Death in Advanced Heart Failure. Journal of the American College of Cardiology 46:12, 2329-2334
CrossRef1326
Martin C. Burke, James A. Coman, Adam W. Cates, Curtis C. Lindstrom, David A. Sandler, Susan S. Kim, Bradley P. Knight. (2005) Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: Implications for a total subcutaneous implantable defibrillator. Heart Rhythm 2:12, 1332-1338
CrossRef1327
W. S. Aronow. (2005) Drug Treatment of Systolic and of Diastolic Heart Failure in Elderly Persons. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:12, 1597-1605
CrossRef1328
Kenneth A. Ellenbogen, Mark A. Wood, Helmut U. Klein. (2005) Why Should We Care About CARE-HF?. Journal of the American College of Cardiology 46:12, 2199-2203
CrossRef1329
Cynthia J. Berg, Margaret A. Harper, Samuel M. Atkinson, Elizabeth A. Bell, Haywood L. Brown, Marvin L. Hage, Avick G. Mitra, Kenneth J. Moise, William M. Callaghan. (2005) Preventability of Pregnancy-Related Deaths. Obstetrics & Gynecology 106:6, 1228-1234
CrossRef1330
MAURIZIO GASPARINI, PAOLA GALIMBERTI, FRANÇOIS REGOLI, CARLO CERIOTTI, MARIKA BONADIES. (2005) Delayed Defibrillation Testing in Patients Implanted with Biventricular ICD (CRT-D): A Reliable and Safe Approach. Journal of Cardiovascular Electrophysiology 16:12, 1279-1283
CrossRef1331
J. Claude Daubert, Christophe Leclercq, Philippe Mabo. (2005) There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure. Journal of the American College of Cardiology 46:12, 2204-2207
CrossRef1332
Martin Cadeiras, Manuel Prinz Von Bayern, Amandeep Pal, Tomohiro Asai, Yoshifumi Naka, Mario C Deng. (2005) Destination therapy: an alternative for end-stage heart failure patients not eligible for heart transplantation. Current Opinion in Organ Transplantation 10:4, 369-375
CrossRef1333
Mark A. Hlatky. (2005) Cost Effectiveness of Cardiac Resynchronization Therapy
CrossRef1334
H. Volkmann, C. Bergmann, M. Walter. (2005) Kardiale Resynchronisation: Wer ist geeignet?—. Zeitschrift für Kardiologie 94:S4, iv60-iv64
CrossRef1335
Abdou Elhendy, Scott Chapman, Thomas R. Porter, John Windle. (2005) Association of Myocardial Ischemia With Mortality and Implantable Cardioverter-Defibrillator Therapy in Patients With Coronary Artery Disease at Risk of Arrhythmic Death. Journal of the American College of Cardiology 46:9, 1721-1726
CrossRef1336
Michelle M Kittleson, Joshua M Hare. (2005) Molecular signature analysis: the potential of gene-expression analysis in cardiomyopathy. Future Cardiology 1:6, 793-808
CrossRef1337
H. P. Schultheiss, M. Noutsias, U. Kühl, D. Lassner, U. Gross, W. Poller, M. Pauschinger. (2005) Kardiomyopathien. Der Internist 46:11, 1245-1258
CrossRef1338
John D. Fisher. (2005) Who Needs a Defibrillator?. Journal of the American College of Cardiology 46:9, 1727-1728
CrossRef1339
Gerald V. Naccarelli. (2005) Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices. Clinical Cardiology 28:S1, 51-57
CrossRef1340
Andrew E. Epstein. (2005) New insights into cardiac resynchronization therapy. Clinical Cardiology 28:S1, 45-50
CrossRef1341
Kelley P. Anderson. (2005) Sudden Cardiac Death Unresponsive to Implantable Defibrillator Therapy: An Urgent Target for Clinicians, Industry and Government. Journal of Interventional Cardiac Electrophysiology 14:2, 71-78
CrossRef1342
Jagmeet P. Singh, W. Jackson Hall, Scott McNitt, Hongyue Wang, James P. Daubert, Wojciech Zareba, Jeremy N. Ruskin, Arthur J. Moss. (2005) Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation. Journal of the American College of Cardiology 46:9, 1712-1720
CrossRef1343
Eric N. Prystowsky. (2005) Prevention of sudden cardiac death. Clinical Cardiology 28:S1, 12-18
CrossRef1344
Jonathan P. Piccini, Darshan Dalal, Ariel Roguin, Chandra Bomma, Alan Cheng, Kalpana Prakasa, Jun Dong, Crystal Tichnell, Cynthia James, Stuart Russell, Jane Crosson, Ronald D. Berger, Joseph E. Marine, Gordon Tomaselli, Hugh Calkins. (2005) Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2:11, 1188-1194
CrossRef1345
Sanders, Gillian D., Hlatky, Mark A., Owens, Douglas K., . (2005) Cost-Effectiveness of Implantable Cardioverter–Defibrillators. New England Journal of Medicine 353:14, 1471-1480
Full Text1346
Ilan Goldenberg, Arthur J. Moss, Barry J. Maron, Andrew W. Dick, Wojciech Zareba. (2005) Cost-Effectiveness of Implanted Defibrillators in Young People with Inherited Cardiac Arrhythmias. Annals of Noninvasive Electrocardiology 10:s4, 67-83
CrossRef1347
Dee Ann Rivera, Michael R. Bristow. (2005) Cardiac Resynchronization-A Heart Failure Perspective. Annals of Noninvasive Electrocardiology 10:s4, 16-23
CrossRef1348
PHILIPPINE KIES, ERIC BOERSMA, JEROEN J. BAX, ALIDA E. BORGER van der BURG, MARIANNE BOOTSMA, LIESELOT van ERVEN, ERNST E. van der WALL, MARTIN J. SCHALIJ. (2005) Determinants of Recurrent Ventricular Arrhythmia or Death in 300 Consecutive Patients with Ischemic Heart Disease Who Experienced Aborted Sudden Death: Data from the Leiden Out-of-Hospital Cardiac Arrest Study. Journal of Cardiovascular Electrophysiology 16:10, 1049-1056
CrossRef1349
JOHN J V MCMURRAY. (2005) Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment. Kidney International 68:4, 1419-1426
CrossRef1350
Anne B. Curtis. (2005) Experience Counts. Journal of the American College of Cardiology 46:8, 1541-1542
CrossRef1351
Arthur J. Moss, Mary W. Brown, David S. Cannom, James P. Daubert, Mark Estes, Elyse Foster, Henry M. Greenberg, W. Jackson Hall, Steven L. Higgins, Helmut Klein, Mark Pfeffer, David Wilber, Wojciech Zareba. (2005) Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): Design and Clinical Protocol. Annals of Noninvasive Electrocardiology 10:s4, 34-43
CrossRef1352
Sana M. Al-Khatib, F. Lee Lucas, James G. Jollis, David J. Malenka, David E. Wennberg. (2005) The Relation Between Patients’ Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. Journal of the American College of Cardiology 46:8, 1536-1540
CrossRef1353
M.G. Crespo Leiro, R. Marzoa Rivas, M.J. Paniagua Martín, A. Castro Beiras. (2005) Miocardiopatías: concepto, clasificación. Miocardiopatía dilatada idiopática. Medicine - Programa de Formación Médica Continuada Acreditado 9:42, 2765-2774
CrossRef1354
Antonis A Armoundas, Stefan H Hohnloser, Takanori Ikeda, Richard J Cohen. (2005) Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?. Nature Clinical Practice Cardiovascular Medicine 2:10, 522-528
CrossRef1355
David S. Cannom, Morton Mower. (2005) Relationship of the Implantable Cardioverter Defibrillator and Chronic Resynchronization Therapy: The Perfect Marriage?. Annals of Noninvasive Electrocardiology 10:s4, 24-33
CrossRef1356
Clyde W. Yancy. (2005) Heart Failure in African Americans. The American Journal of Cardiology 96:7, 3-12
CrossRef1357
LESLIE SAXON. (2005) Delayed Defibrillation Testing After CRT-D Implant-Weighing Competing Risks. Journal of Cardiovascular Electrophysiology 0:0, 050928083434002
CrossRef1358
CRAIG J. McCOTTER, J. FRITZ ANGLE, LIZA A. PRUDENTE, J. PAUL MOUNSEY, JOHN D. FERGUSON, JOHN P. DiMARCO, JAMES P. HUMMEL, J. MICHAEL MANGRUM. (2005) Placement of Transvenous Pacemaker and ICD Leads Across Total Chronic Occlusions. Pacing and Clinical Electrophysiology 28:9, 921-925
CrossRef1359
DAVID A. KASS. (2005) Cardiac Resynchronization Therapy. Journal of Cardiovascular Electrophysiology 16:s1, S35-S41
CrossRef1360
Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article. Journal of the American College of Cardiology 46:6, 1116-1143
CrossRef1361
Prash Jayaraj, Kevin M. Monahan. (2005) Sudden cardiac death and the role of device therapy in dilated cardiomyopathy. Current Heart Failure Reports 2:3, 124-127
CrossRef1362
PETER ALTER, STEFAN WALDHANS, EVELINE PLACHTA, RAINER MOOSDORF, WOLFRAM GRIMM. (2005) Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients. Pacing and Clinical Electrophysiology 28:9, 926-932
CrossRef1363
Frank A. Cuoco, Steven N. Singh. (2005) Nonsustained ventricular tachycardia in dilated cardiomyopathy. Current Cardiology Reports 7:5, 368-375
CrossRef1364
Wataru Shimizu, Kazuhiro Satomi. (2005) Implications and problems of the Sudden Cardiac Death in Heart Failure Trial. Future Cardiology 1:5, 599-603
CrossRef1365
Matthew W. Ebinger, Subramaniam Krishnan, Claudio D. Schuger. (2005) Mechanisms of ventricular arrhythmias in heart failure. Current Heart Failure Reports 2:3, 111-117
CrossRef1366
John V Terrovitis, Maria I Anastasiou-Nana, John N Nanas. (2005) Out-patient management of chronic heart failure. Expert Opinion on Pharmacotherapy 6:11, 1857-1881
CrossRef1367
Anooshirvan Shayeganpour, Andrew S. Jun, Dion R. Brocks. (2005) Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models. Biopharmaceutics & Drug Disposition 26:6, 249-257
CrossRef1368
Ezra A. Amsterdam. (2005) Revised American College of Cardiology/American Heart Association Guidelines for the Management of Heart Failure. Preventive Cardiology 8:4, 254-256
CrossRef1369
Arnold Pinter, Paul Dorian. (2005) Approach to antiarrhythmic therapy in patients with ICDs and frequent activations. Current Cardiology Reports 7:5, 376-381
CrossRef1370
Safwat Gassis, Angel R. Le. (2005) Cardiac Resynchronization Therapy: Strategies for Device Programming, Troubleshooting and Follow-Up. Journal of Interventional Cardiac Electrophysiology 13:3, 209-222
CrossRef1371
Zachary Goldberger, Brian Elbel, Craig A. McPherson, A. David Paltiel, Rachel Lampert. (2005) Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. Journal of the American College of Cardiology 46:5, 850-857
CrossRef1372
Sharon Ann Hunt. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Journal of the American College of Cardiology 46:6, e1-e82
CrossRef1373
(2005) Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Revista Española de Cardiología 58:9, 1062-1092
CrossRef1374
Brian T. Schuler, Angel R. León. (2005) Cardiac resynchronization therapy. Current Cardiology Reports 7:5, 321-328
CrossRef1375
DAVID S. CANNOM. (2005) Prevention of Sudden Cardiac Death. Journal of Cardiovascular Electrophysiology 16:s1, S21-S24
CrossRef1376
GEORGE J. KLEIN, ANDREW D. KRAHN, ALLAN C. SKANES, RAYMOND YEE, LORNE J. GULA. (2005) Primary Prophylaxis of Sudden Death in Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Dilated Cardiomyopathy. Journal of Cardiovascular Electrophysiology 16:s1, S28-S34
CrossRef1377
W. Jung, R. Birkemeyer. (2005) Home Monitoring mit implantierbaren Defibrillatoren. Herzschrittmachertherapie & Elektrophysiologie 16:3, 183-190
CrossRef1378
U. C. Hoppe, M. Böhm, R. Dietz, P. Hanrath, H. K. Kroemer, A. Osterspey, A. A. Schmaltz, E. Erdmann. (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Zeitschrift für Kardiologie 94:8, 488-509
CrossRef1379
Sandeep A. Kamath, Clyde W. Yancy. (2005) Treatment of the african-american patient with congestive heart failure. Current Treatment Options in Cardiovascular Medicine 7:4, 307-315
CrossRef1380
Hygriv B. Rao, Sanjeev Saksena. (2005) Implantable Defibrillators Configured for Hybrid Therapy of Persistent and Permanent Atrial Fibrillation: Initial Clinical Experience with a Novel Lead System
. Journal of Interventional Cardiac Electrophysiology 13:S1, 79-86
CrossRef1381
Y. Juillière. (2005) Stratification du risque dans l'insuffisance cardiaque chronique. Annales de Cardiologie et d'Angéiologie 54:4, 172-178
CrossRef1382
(2005) Cardiac-Resynchronization Therapy in Heart Failure. New England Journal of Medicine 353:2, 205-206
Full Text1383
N. A. Mark Estes III. (2005) Primary Prevention of Sudden Cardiac Death: A Rational Approach to the Use of the Implantable Cardioverter Defibrillator. Journal of Interventional Cardiac Electrophysiology 13:2, 91-93
CrossRef1384
Vincent Ganion, Melissa Rhodes, Robert W. Stadler. (2005) Intrathoracic Impedance to Monitor Heart Failure Status: A Comparison of Two Methods in a Chronic Heart Failure Dog Model. Congestive Heart Failure 11:4, 177-211
CrossRef1385
Arthur J. Moss. (2005) Heart Failure: A Central Factor in Progressive Mechanical and Electrical Cardiac Dysfunction. Annals of Noninvasive Electrocardiology 10:3, 279-279
CrossRef1386
Robert D Winslow, Davendra Mehta, Valentin Fuster. (2005) Sudden cardiac death: mechanisms, therapies and challenges. Nature Clinical Practice Cardiovascular Medicine 2:7, 352-360
CrossRef1387
Brian Olshansky. (2005) Wide QRS, Narrow QRS. Journal of the American College of Cardiology 46:2, 317-319
CrossRef1388
Solomon, Scott D., Zelenkofske, Steve, McMurray, John J.V., Finn, Peter V., Velazquez, Eric, Ertl, George, Harsanyi, Adam, Rouleau, Jean L., Maggioni, Aldo, Kober, Lars, White, Harvey, Van de Werf, Frans, Pieper, Karen, Califf, Robert M., Pfeffer, Marc A., . (2005) Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. New England Journal of Medicine 352:25, 2581-2588
Full Text1389
H.-R Arntz, H.-J. Trappe. (2005) Frühdefibrillation: Perspektiven und Ausblick. Herzschrittmachertherapie & Elektrophysiologie 16:2, 112-117
CrossRef1390
Robert G. Hauser. (2005) The Growing Mismatch Between Patient Longevity and the Service Life of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 45:12, 2022-2025
CrossRef1391
RICHARD L. VERRIER, KEVIN F. KWAKU, BRUCE D. NEARING, MARK E. JOSEPHSON. (2005) T-Wave Alternans: Does Size Matter. Journal of Cardiovascular Electrophysiology 16:6, 625-628
CrossRef1392
Philip B. Adamson, Roger C. Barr, David J. Callans, Peng-Sheng Chen, David A. Lathrop, Jonathan C. Makielski, Jeanne M. Nerbonne, H. Bradley Nuss, Jeffrey E. Olgin, Dennis A. Przywara, Michael R. Rosen, George J. Rozanski, Madison S. Spach, Kathryn A. Yamada. (2005) The perplexing complexity of cardiac arrhythmias: Beyond electrical remodeling. Heart Rhythm 2:6, 650-659
CrossRef1393
Marc T. Silver. (2005) Primary Prevention Implantable Cardioverter-Defibrillators: Economics and Ethics. The American Heart Hospital Journal 3:3, 205-206
CrossRef1394
T. Jared Bunch, Stephen C. Hammill, Roger D. White. (2005) Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival. Mayo Clinic Proceedings 80:6, 774-782
CrossRef1395
(2005) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 352:19, 2022-2025
Full Text1396
Duncan Graham-Rowe. (2005) Hotwire my heart. Nature 435:7038, 14-15
CrossRef1397
Raymond E. Ideker, Gregory P. Walcott, Andrew E. Epstein, Vance J. Plumb, Neal Kay. (2005) Ventricular fibrillation and defibrillation—What are the major unresolved issues?. Heart Rhythm 2:5, 555-558
CrossRef1398
Eric M. Crespo, Jane Kim, Kimberly A. Selzman. (2005) The Use of Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: A Review of the Evidence and Implications. The American Journal of the Medical Sciences 329:5, 238-246
CrossRef1399
Raymond E. Ideker, Andrew E. Epstein, Vance J. Plumb. (2005) Should shocks still be administered during implantable cardioverter-defibrillator insertion?. Heart Rhythm 2:5, 462-463
CrossRef1400
John JV McMurray, Marc A Pfeffer. (2005) Heart failure. The Lancet 365:9474, 1877-1889
CrossRef1401
Arash Arya, Majid Haghjoo, Mohammad Ali Sadr-Ameli. (2005) Can Amiodarone Prevent Sudden Cardiac Death in Patients with Hemodynamically Tolerated Sustained Ventricular Tachycardia and Coronary Artery Disease?. Cardiovascular Drugs and Therapy 19:3, 219-226
CrossRef1402
Cleland, John G.F., Daubert, Jean-Claude, Erdmann, Erland, Freemantle, Nick, Gras, Daniel, Kappenberger, Lukas, Tavazzi, Luigi, . (2005) The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. New England Journal of Medicine 352:15, 1539-1549
Full Text1403
Alan Kadish. (2005) Should every patient with left-ventricular systolic dysfunction receive implantable cardioverter-defibrillators?. Nature Clinical Practice Cardiovascular Medicine 2:4, 188-189
CrossRef1404
Gerald V. Naccarelli, Mary Ann Lukas. (2005) Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction. Clinical Cardiology 28:4, 165-173
CrossRef1405
Greg C. Flaker. (2005) “Show-me” the money. Heart Rhythm 2:4, 374-375
CrossRef1406
Anne B Curtis. (2005) Do implantable cardioverter-defibrillators benefit patients immediately after acute myocardial infarction?. Nature Clinical Practice Cardiovascular Medicine 2:4, 192-193
CrossRef1407
Eyal Herzog, Cathleen Varley, Marrick Kukin. (2005) Pathway for the Management of Acute Heart Failure. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:1, 37-42
CrossRef1408
G. Fr
hlig. (2005) Besonderheiten der Nachsorge nach kardialer Resynchronisationstherapie. Herzschrittmachertherapie & Elektrophysiologie 16:1, 44-57
CrossRef1409
D. B
CrossRef1410
B. Lemke. (2005) Aktuelle Leitlinien. Herzschrittmachertherapie & Elektrophysiologie 16:1, 38-43
CrossRef1411
M. Block, J. Br
CrossRef1412
(2005) Prevention of sudden death in congestive heart failure patients. Nature Clinical Practice Cardiovascular Medicine 2:3, 122-122
CrossRef1413
Timothy D. Brennan, Garrie J. Haas. (2005) The role of prophylactic implantable cardioverter defibrillators in heart failure: Recent trials usher in a new era of device therapy. Current Heart Failure Reports 2:1, 40-45
CrossRef1414
C. Stellbrink. (2005) Kardiale Resynchronisationstherapie?Was bringt die Zukunft?. Herzschrittmachertherapie & Elektrophysiologie 16:1, 58-62
CrossRef1415
McClellan, Mark B., Tunis, Sean R., . (2005) Medicare Coverage of ICDs. New England Journal of Medicine 352:3, 222-224
Full Text1416
Kadish, Alan, . (2005) Prophylactic Defibrillator Implantation — Toward an Evidence-Based Approach. New England Journal of Medicine 352:3, 285-287
Full Text1417
Sergio Richter, Gabor Duray, Gerian Grönefeld, Carsten W Israel, Stefan H Hohnloser. (2005) Prevention of Sudden Cardiac Death. Circulation Journal 69:6, 625-629
CrossRef
- Letters
